data_1ily_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ily _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.84 125.52 37.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.635 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 84' ' ' VAL . 3.7 tt -89.45 144.03 26.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 m -145.82 108.53 4.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.43 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 4.5 p -98.3 123.43 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.177 0.513 . . . . 0.0 111.882 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -106.98 145.26 32.48 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -150.29 119.17 6.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.74 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.66 -69.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.072 0.463 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.6 mt -147.6 -59.16 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.441 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -119.37 4.36 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.379 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -109.1 116.25 31.59 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.994 0.426 . . . . 0.0 111.356 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.0 tp -104.09 129.09 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 20.3 m-85 -143.16 151.21 40.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.215 0.531 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -137.61 122.52 18.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.397 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 113.26 25.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.0 110.547 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 HD13 HD21 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -97.02 100.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.02 163.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.892 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.63 114.03 26.26 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -90.26 26.65 1.86 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.331 1.019 . . . . 0.0 112.419 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.67 -47.64 3.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.29 118.22 17.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.82 89.25 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.374 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.5 t -138.3 112.41 8.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -76.94 119.35 20.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 1.4 mp -102.32 -57.57 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 75' ' ' LYS . 2.1 t -122.69 146.12 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 0.0 111.907 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -150.16 114.91 5.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.98 148.4 44.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.886 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.47 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.43 136.77 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.978 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.007 179.745 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.812 0.339 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 69.0 t -86.08 -21.46 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.198 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -30.6 -43.98 0.05 Allowed 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -64.12 -60.94 2.61 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.517 0.675 . . . . 0.0 109.398 178.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -48.45 -25.28 1.58 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.23 177.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -80.13 -33.16 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.639 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.532 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -77.52 -27.91 58.44 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.161 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.7 ppt_? -74.77 -38.61 62.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -70.27 -34.94 73.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 1.8 tp -68.98 -54.29 16.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.82 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . -61.94 -25.31 67.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.913 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.9 mt-10 -77.88 -30.22 50.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.3 mttt -72.77 -69.27 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.518 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.72 -42.55 7.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -55.85 -39.1 70.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.023 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.01 13.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.54 -27.77 20.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.28 14.93 12.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.297 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.473 HG21 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -70.88 107.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.496 0.665 . . . . 0.0 110.237 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 110' ' ' GLU . 24.4 ttpt -94.53 -52.45 4.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.361 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.431 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -114.85 142.61 46.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.204 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -128.04 161.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.414 0.626 . . . . 0.0 112.058 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.02 100.88 11.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.282 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 1.9 t80 -81.06 106.25 12.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.155 0.502 . . . . 0.0 111.216 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.16 43.16 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.2 ptt180 -37.71 -39.18 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.809 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.72 -117.32 5.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.734 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.15 50.62 3.6 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 111.979 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 5.9 m-85 -123.22 102.23 7.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -71.52 139.33 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.881 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -52.11 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -103.73 -165.12 1.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.148 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.82 -55.81 9.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.987 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -45.77 -71.25 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.653 0.263 . . . . 0.0 110.586 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 8.8 p -42.59 -32.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -66.37 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.96 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -47.28 -35.87 8.4 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.772 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -70.18 -41.24 74.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.07 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -66.65 -34.93 78.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.461 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.742 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -66.25 -44.2 84.35 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.32 -57.0 10.93 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.548 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -61.26 -33.02 72.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.552 -1.324 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.815 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.1 tpp180 -90.05 -26.25 20.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.721 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.742 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.3 pt-20 -80.82 -33.33 34.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -71.91 -46.68 35.86 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.946 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.9 -31.42 0.07 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 119.989 -1.101 . . . . 0.0 114.731 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.3 mp -71.36 143.99 50.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' CB ' ' HG3' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -127.9 95.15 4.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.136 178.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.531 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 2.2 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.754 0.312 . . . . 0.0 110.585 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' CB ' ' HB3' ' A' ' 41' ' ' ASP . 1.5 ttp85 -101.12 127.16 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' HG ' HD12 ' A' ' 38' ' ' ILE . 2.7 tt -89.42 140.87 29.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.15 112.34 7.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.24 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -92.74 135.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.564 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 1.4 t80 -123.93 115.64 21.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.102 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.59 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -126.27 118.72 25.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.542 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.25 -48.58 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' ' NH1' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -170.52 -64.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.27 20.81 13.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.405 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 1.5 m80 -127.74 132.68 49.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.032 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 96' ' ' ARG . 4.0 tp -121.85 118.47 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.303 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.552 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 9.2 m-85 -136.5 108.39 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -97.54 126.03 42.58 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 116.07 29.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.321 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.48 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -97.43 98.35 7.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.169 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.71 165.45 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.039 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.16 112.07 24.02 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.721 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.1 p30 -91.12 27.04 1.97 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.15 0.906 . . . . 0.0 112.252 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -110.15 -46.9 3.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.3 mptt -134.62 118.25 17.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.83 90.33 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.341 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.6 t -140.98 112.53 3.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -76.48 123.12 25.55 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 1.3 mp -104.02 -61.78 1.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -120.59 144.9 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.224 0.535 . . . . 0.0 111.952 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.4 p -150.21 116.06 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.175 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB1' ' HG ' ' A' ' 72' ' ' LEU . . . -126.54 151.22 48.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.212 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.552 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 7.1 t -150.44 134.88 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.884 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 5.4 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.035 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 67' ' ' GLN . 53.0 t -93.99 -18.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.722 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -35.43 -39.32 0.12 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.8 -59.96 3.09 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.554 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.7 mt-30 -49.58 -27.28 4.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.297 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -75.01 -33.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -76.78 -27.26 61.07 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.7 -33.58 72.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.9 -36.62 56.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 ' HA2' ' A' ' 69' ' ' GLY . 6.3 mt -65.39 -45.54 83.61 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -73.06 -33.27 65.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.845 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 46.4 mt-10 -71.34 -33.22 69.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 19.7 mttt -70.17 -67.65 0.48 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' A' ' 109' ' ' LEU . . . -46.37 -41.08 13.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.963 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 11.0 mt -57.97 -38.97 77.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.023 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.52 -23.61 10.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.946 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.469 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.53 -27.38 20.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.5 16.59 10.81 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.206 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.485 HG23 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -72.16 107.96 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.516 0.674 . . . . 0.0 110.393 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -95.15 -53.45 3.8 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.442 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -115.14 142.57 46.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.44 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -128.55 163.47 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.496 0.665 . . . . 0.0 111.884 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.11 98.8 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.169 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 2.1 t80 -81.15 113.89 19.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.459 0.647 . . . . 0.0 111.806 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.17 33.7 0.66 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.675 ' C ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -43.31 -41.6 4.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.795 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.445 ' N ' ' HD3' ' A' ' 88' ' ' ARG . . . 156.28 -136.61 5.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -95.73 37.85 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.193 2.595 . . . . 0.0 112.736 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' NH2' ' A' ' 88' ' ' ARG . 4.7 m-30 -88.62 84.94 6.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.339 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -71.85 133.62 45.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.559 ' C ' ' O ' ' A' ' 92' ' ' LYS . 1.4 t80 0.69 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.533 0.521 . . . . 0.0 112.304 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.543 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.1 m170 -94.18 148.31 22.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.216 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -29.01 -39.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.095 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.59 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.6 mmt180 -79.49 -65.43 1.0 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.678 0.275 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 31.8 t -30.48 -49.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -53.99 -72.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.495 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.56 -40.94 96.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.476 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.4 tt -63.19 -45.71 90.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.473 0.654 . . . . 0.0 110.446 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.58 -30.32 69.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.291 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.02 -46.74 70.4 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.25 -54.71 9.69 Favored Glycine 0 CA--C 1.508 -0.393 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.524 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -64.83 -36.15 83.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.269 -1.465 . . . . 0.0 111.469 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -87.48 -24.25 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.412 . . . . 0.0 110.764 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -82.59 -37.47 24.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -66.78 -47.98 64.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.002 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.31 -30.06 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.513 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.8 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.0 mp -71.41 143.7 50.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.42 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -127.69 99.38 5.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.881 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.546 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 p90 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.895 . . . . 0.0 111.068 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.799 0.333 . . . . 0.0 110.411 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -101.54 125.16 48.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.9 tt -89.55 143.42 26.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.412 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 72.3 m -146.97 108.76 4.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.966 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 100' ' ' LEU . 7.7 p -93.39 119.77 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.07 140.22 37.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.785 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' CG ' HD12 ' A' ' 34' ' ' ILE . 3.2 mmm180 -150.08 118.92 6.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.951 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.74 -64.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.21 0.529 . . . . 0.0 110.291 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 -58.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -119.71 2.28 11.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.634 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -110.33 117.66 34.22 Favored 'General case' 0 N--CA 1.46 0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 112.089 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 3.8 tp -106.45 131.0 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.768 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' A' ' 34' ' ' ILE . 37.1 m-85 -148.98 111.97 4.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 72' ' ' LEU . . . -93.72 123.59 37.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.56 113.52 26.38 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.481 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -99.04 96.51 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.4 164.7 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.306 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -95.61 113.19 24.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 10.0 t70 -88.35 21.83 2.72 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.376 1.048 . . . . 0.0 112.352 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.47 -48.85 3.18 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 45' ' ' VAL . 4.3 mmtp -129.77 118.17 21.4 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.72 87.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.722 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' LYS . 53.0 t -136.39 112.5 12.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -75.86 117.81 17.99 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 75' ' ' LYS . 1.6 t -119.07 143.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 112.238 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.03 114.69 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.36 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -120.81 159.18 25.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.89 126.86 15.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.49 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.464 ' OG ' HG22 ' A' ' 34' ' ' ILE . 1.3 m . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.35 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.751 0.31 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 65' ' ' ALA . 97.9 t -80.73 -19.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.662 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.571 ' O ' HG13 ' A' ' 68' ' ' VAL . . . -35.22 -37.96 0.08 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.904 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -69.66 -58.9 3.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.4 mt-30 -49.84 -22.63 1.53 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.488 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.23 -33.63 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -76.64 -33.6 46.75 Favored Glycine 0 C--O 1.217 -0.93 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.131 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -72.31 -41.78 66.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.663 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.95 -40.58 91.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -64.34 -54.49 32.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.2 -25.25 31.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.8 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.8 tt0 -72.14 -36.85 69.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 10.2 mttp -71.85 -64.49 0.92 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.843 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -44.88 -42.65 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.318 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -59.23 -40.8 87.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.257 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.44 -25.66 6.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.417 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.42 -28.0 20.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 12.9 13.18 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.627 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.488 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.78 104.1 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.649 0.738 . . . . 0.0 110.036 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 110' ' ' GLU . 21.2 ttpp -92.79 -49.75 5.91 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.147 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.43 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -117.43 136.31 53.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.362 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -123.89 162.93 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.376 0.608 . . . . 0.0 111.838 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.2 102.55 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.961 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.58 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.47 121.19 25.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.49 . . . . 0.0 111.549 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 1.3 t70 -148.48 45.88 1.04 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.162 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.417 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.9 ptt-85 -40.39 -31.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.661 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.48 -125.01 7.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.5 59.84 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.418 2.078 . . . . 0.0 111.754 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.417 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 8.4 m-85 -131.66 157.51 43.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 111.391 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -132.21 140.78 48.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.357 178.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -41.0 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CG ' HG22 ' A' ' 97' ' ' VAL . 18.8 p80 -112.88 151.16 30.79 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 94' ' ' HIS . . . -20.88 -55.97 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.164 -0.925 . . . . 0.0 114.039 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 1.9 mmp_? -57.63 -64.54 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 88.7 t -35.41 -46.65 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.567 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.36 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.44 -43.27 62.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.889 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.2 tt -61.62 -45.22 95.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.347 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.72 -37.63 86.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.805 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.809 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -67.42 -42.65 82.86 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.551 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.14 -58.94 8.07 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.92 -35.13 74.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.802 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -87.92 -30.43 20.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.418 . . . . 0.0 110.692 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.809 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.0 pt-20 -74.22 -35.15 63.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.72 -46.26 54.69 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.458 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.476 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 174.42 -27.76 0.08 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.941 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.46 145.24 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER -128.16 93.98 3.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.504 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.938 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.428 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 16.3 ttp-105 -101.28 125.0 47.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.4 tt -89.11 141.76 28.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.938 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.439 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.27 107.95 5.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.084 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 100' ' ' LEU . 9.6 p -95.53 116.5 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.263 0.554 . . . . 0.0 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 1.3 t80 -93.61 134.98 35.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.972 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' NH2' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -123.34 118.12 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 t -90.25 -79.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.06 -58.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.36 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.27 1.85 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.182 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.15 174.57 6.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.342 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' CD1' ' NH2' ' A' ' 29' ' ' ARG . 2.8 tp -150.45 111.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -136.56 140.67 43.1 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -128.54 127.95 43.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.257 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.05 114.02 25.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.441 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -98.19 95.2 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.317 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.84 163.89 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.858 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HA ' HD23 ' A' ' 23' ' ' LEU . 1.4 t0 -95.19 114.71 26.53 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.711 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.6 t70 -90.28 23.53 2.87 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.405 1.065 . . . . 0.0 112.311 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.13 -47.77 3.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.19 118.17 16.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 174.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.95 89.97 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.28 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.0 t -139.63 112.42 5.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -72.1 113.6 9.31 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 23' ' ' LEU . 1.9 mp -92.86 -65.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.91 148.33 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.266 0.555 . . . . 0.0 111.63 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -150.14 114.84 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.654 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.62 138.98 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 111.853 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.48 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 36.9 p -150.3 132.63 15.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ALA . 73.9 t -94.26 -22.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.766 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 68' ' ' VAL . . . -33.92 -39.8 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.673 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.35 -59.55 3.32 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.525 0.678 . . . . 0.0 109.172 178.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.5 mt-30 -49.66 -26.56 3.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.205 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -77.43 -32.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -76.38 -26.39 63.72 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 8.2 ptt85 -73.47 -39.83 64.61 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 70' ' ' ARG . . . -68.57 -36.23 78.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 1.1 tp -68.69 -53.48 21.97 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.015 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . -63.35 -25.12 68.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.528 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 15.8 mt-10 -78.2 -29.98 48.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mttt -71.82 -69.16 0.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.403 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' A' ' 109' ' ' LEU . . . -44.84 -42.84 8.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.181 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -56.02 -39.16 71.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.71 -24.58 8.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.071 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.71 -27.04 20.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.62 21.82 7.0 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.061 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.436 HG12 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -84.53 102.84 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.136 0.494 . . . . 0.0 110.771 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.652 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.97 -25.62 12.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.55 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -125.27 125.24 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.187 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -125.12 164.54 23.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 112.06 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -105.31 105.51 15.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.391 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.568 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.37 118.01 22.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.394 0.616 . . . . 0.0 112.011 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.03 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.644 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.43 -29.57 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 88' ' ' ARG . . . 123.12 -151.43 16.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.94 55.99 4.63 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.927 2.418 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.467 ' CG ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m-30 -100.18 166.52 10.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.024 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.91 153.51 50.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.47 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -47.33 109.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.502 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.508 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -126.25 156.53 40.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -38.44 -30.01 0.08 OUTLIER Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 1.2 mmt85 -76.7 -70.97 0.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.598 0.237 . . . . 0.0 111.606 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 60.0 t -31.01 -50.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -57.96 -75.06 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.864 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.58 -37.67 68.37 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.172 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.1 tt -67.66 -49.16 64.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.3 -33.16 73.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.402 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.758 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -66.53 -46.54 75.81 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.08 -57.91 7.52 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.741 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -58.15 -39.95 80.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.354 -1.423 . . . . 0.0 111.428 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.812 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -82.58 -51.42 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -49.44 -40.57 37.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -65.58 -48.81 64.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.359 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.14 -26.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.092 -1.051 . . . . 0.0 114.713 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.812 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.37 145.98 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -128.2 91.99 3.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.455 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.568 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.3 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.955 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.837 0.351 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.02 124.32 36.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' N ' HG13 ' A' ' 84' ' ' VAL . 3.4 tt -89.35 143.54 26.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.408 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -144.61 108.48 4.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.753 0.311 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 100' ' ' LEU . 2.8 p -97.68 121.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.872 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.422 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -107.26 139.54 41.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.831 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.481 HH21 HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -150.31 126.25 10.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.518 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -80.73 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.765 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.9 -51.25 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -119.1 23.18 11.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.904 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -123.91 172.44 8.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.133 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' C ' ' CD1' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -160.22 126.95 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.996 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 41.9 m-85 -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.056 0.455 . . . . 0.0 112.024 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HB2' HD22 ' A' ' 72' ' ' LEU . . . -134.75 121.36 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.14 113.36 25.58 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 110.485 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.449 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -95.78 99.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.37 161.81 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.197 -0.911 . . . . 0.0 113.315 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -93.79 110.5 22.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.443 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -88.32 27.43 1.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.235 0.959 . . . . 0.0 112.552 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.35 -48.54 3.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.62 118.32 19.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 174.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.22 88.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' LYS . 95.8 t -136.81 112.67 11.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -76.55 119.33 20.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 23' ' ' LEU . 1.8 mp -98.84 -62.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.42 148.63 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 112.302 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.1 p -150.21 131.01 14.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.064 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.01 165.74 24.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 0.0 111.755 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.463 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.15 126.86 10.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.075 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.43 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.514 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.876 0.369 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 67' ' ' GLN . 89.6 t -94.16 -15.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.862 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.527 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -33.36 -41.5 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.897 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.65 -59.48 3.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' HB2' HG11 ' A' ' 64' ' ' VAL . 1.8 mt-30 -49.7 -23.41 1.75 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.478 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -80.38 -32.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -78.04 -28.4 56.45 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -73.88 -37.95 64.55 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.04 -35.41 69.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 36' ' ' ALA . 1.9 tp -67.68 -53.79 24.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.74 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -62.83 -26.26 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -75.89 -33.0 59.92 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 14.9 mttt -72.15 -68.97 0.42 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.816 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -43.73 -42.22 5.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.274 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -56.81 -40.03 75.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.062 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.14 -23.85 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.13 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.45 18.9 9.21 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.193 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.43 102.98 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.58 0.705 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.4 tttt -88.13 -59.37 2.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.705 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.25 148.24 29.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.56 158.91 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.369 0.604 . . . . 0.0 112.107 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.77 101.9 12.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.77 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -81.47 114.92 20.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.149 0.499 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.79 56.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -44.57 -40.2 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.47 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.32 -111.79 3.15 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.686 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.09 28.15 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.907 2.405 . . . . 0.0 112.693 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.0 m-30 -96.58 164.08 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -131.92 150.31 52.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.466 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -51.18 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.223 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -115.43 169.58 9.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.3 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.25 -38.27 4.93 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.759 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 7.1 mmt180 -62.54 -70.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 44.1 t -37.94 -41.74 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 110.887 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.58 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.116 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.632 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.88 -37.04 75.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.092 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.0 tt -67.76 -47.83 68.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.223 0.535 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.54 -31.64 72.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.508 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.07 -44.02 73.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.532 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.35 -57.65 10.04 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -62.88 -31.53 72.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.71 -1.245 . . . . 0.0 111.187 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.7 mtm-85 -89.83 -25.68 20.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -82.46 -33.87 28.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.93 -47.38 39.21 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.992 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.49 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.87 -29.25 0.07 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 119.857 -1.164 . . . . 0.0 114.867 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.6 mp -71.1 146.19 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.8 mp0 -127.72 91.82 3.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.417 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.587 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 3.4 p90 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.894 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 40' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.945 0.402 . . . . 0.0 110.616 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -101.29 126.52 48.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.02 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.7 tt -89.69 142.53 27.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.409 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -146.47 108.7 4.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 HD13 ' A' ' 100' ' ' LEU . 11.9 p -96.77 117.16 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.256 0.551 . . . . 0.0 111.748 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.41 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 1.1 t80 -100.02 137.22 38.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.834 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -143.35 118.85 10.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.934 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.75 -80.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.877 0.37 . . . . 0.0 110.717 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.37 -65.38 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 17.46 13.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.113 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -117.05 140.36 49.58 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 121.123 0.487 . . . . 0.0 111.6 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.427 HD13 ' CG ' ' A' ' 29' ' ' ARG . 6.5 tp -127.97 129.46 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 30.0 m-85 -144.92 112.21 6.07 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' A' ' 72' ' ' LEU . . . -93.25 120.93 34.09 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.8 113.01 25.28 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.486 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.449 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -96.75 102.27 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.323 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -99.2 161.41 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.686 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.465 ' HA ' HD23 ' A' ' 23' ' ' LEU . 1.7 t70 -92.36 117.86 30.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.986 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.7 t0 -91.95 22.72 4.09 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 124.411 1.069 . . . . 0.0 112.198 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -107.23 -47.47 3.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.04 118.1 15.39 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.04 90.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.173 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 43' ' ' LYS . 75.3 t -137.93 112.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -73.43 116.73 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.432 HD13 HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -99.66 -58.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 72' ' ' LEU . 1.6 t -119.83 142.48 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.324 0.583 . . . . 0.0 112.226 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -150.17 114.86 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.876 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -125.3 161.9 25.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 111.796 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -143.76 137.52 28.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.798 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.426 ' HB3' HG21 ' A' ' 34' ' ' ILE . 9.2 p . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.72 0.295 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 64' ' ' VAL . 84.4 t -94.18 -18.58 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -35.6 -38.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.848 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.68 -58.59 3.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 18.3 mt-30 -50.27 -23.06 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.473 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.573 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -80.03 -34.52 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.573 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -76.57 -33.28 48.14 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.155 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -71.71 -42.27 67.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.77 -42.62 90.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 38' ' ' ILE . 4.3 tp -65.06 -51.71 59.93 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.79 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.88 -26.21 46.15 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.403 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -71.88 -35.94 69.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.821 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.6 mttt -73.19 -63.6 1.15 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.801 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 109' ' ' LEU . . . -44.91 -41.95 7.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.285 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -60.62 -41.02 94.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.18 -25.9 6.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.38 -27.29 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 10.06 19.23 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.251 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.1 103.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.586 0.708 . . . . 0.0 110.192 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 110' ' ' GLU . 7.5 tttm -92.8 -55.5 3.34 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.044 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.2 OUTLIER -111.07 139.13 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.362 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -126.56 163.76 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 111.762 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.16 104.95 14.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -81.48 113.46 19.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.787 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -137.32 44.22 2.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.952 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.402 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 17.4 ptt-85 -40.57 -32.07 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.44 -128.67 9.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.273 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.79 52.66 3.02 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.654 2.236 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.41 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 4.4 m-85 -117.34 142.11 47.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -115.01 149.76 36.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.447 ' CD2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.13 105.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.529 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -123.87 163.97 20.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.0 -27.97 3.74 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.869 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.1 mmt180 -68.88 -70.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.399 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 24.7 t -39.43 -38.4 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.42 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HE2' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.4 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.965 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.91 -36.54 70.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.816 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.1 tt -68.47 -48.96 63.12 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 111.155 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.93 -31.02 69.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.178 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.97 -46.46 68.05 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.17 -58.47 7.12 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -60.59 -37.81 82.57 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.574 -1.313 . . . . 0.0 111.387 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.82 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -86.43 -29.34 22.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 110.92 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.7 pt-20 -74.15 -37.55 63.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -66.23 -47.17 73.97 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.103 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 173.52 -26.31 0.08 OUTLIER Glycine 0 C--N 1.342 0.901 0 C-N-CA 120.173 -1.013 . . . . 0.0 114.72 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.82 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.49 145.0 49.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.23 95.95 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.42 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.021 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.41 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -101.15 125.36 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' N ' HG13 ' A' ' 84' ' ' VAL . 3.7 tt -89.57 143.32 26.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.852 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -136.5 147.9 47.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.734 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 2.6 p -140.59 118.65 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.361 0.6 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.422 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.5 OUTLIER -108.68 142.16 39.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.739 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 32.8 mtm180 -142.7 122.38 13.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.143 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 t -89.36 -78.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.331 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.29 -58.54 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -119.32 23.21 11.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.941 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.51 169.84 9.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 52' ' ' SER . 2.1 tp -156.35 131.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.555 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 51' ' ' SER . 30.8 m-85 -147.3 148.29 31.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.978 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 72' ' ' LEU . . . -135.89 121.17 19.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.04 112.97 24.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.21 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.444 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -94.52 92.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.55 162.09 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.741 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -96.83 108.76 21.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.4 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.91 26.85 1.45 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.163 0.914 . . . . 0.0 112.242 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.02 -47.34 3.22 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' VAL . 8.3 mttt -133.12 118.17 18.38 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.16 90.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.588 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' LYS . 63.0 t -139.1 112.62 6.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -78.65 118.94 21.22 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.1 mp -102.64 -56.96 2.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 38' ' ' ILE . 1.9 t -117.14 144.84 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.641 . . . . 0.0 112.287 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -150.33 114.6 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.342 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.32 153.09 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.042 0.449 . . . . 0.0 112.106 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 2.4 t -150.42 131.12 14.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.429 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 20.1 m . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.409 . . . . 0.0 110.382 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.293 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 65' ' ' ALA . 72.1 t -94.07 -24.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -31.59 -42.44 0.05 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.017 0.437 . . . . 0.0 111.724 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.65 -60.25 3.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 3.6 mp0 -47.55 -26.43 1.43 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.247 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.93 -32.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.977 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.525 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -79.38 -30.18 46.48 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.464 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.94 -39.9 65.85 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 75' ' ' LYS . . . -69.15 -37.55 78.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 1.4 tp -65.9 -53.42 39.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.305 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -64.69 -23.36 67.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.153 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.61 -29.76 56.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -89.5 -47.73 7.79 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -51.58 -40.21 59.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -60.11 -38.56 83.38 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.781 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.18 -22.96 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.466 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.44 -26.89 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 16.0 13.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.058 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.466 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.55 0.691 . . . . 0.0 110.251 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.5 tttt -89.78 -57.72 2.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.216 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.409 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -111.47 147.41 35.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.293 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -134.58 164.05 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.358 0.599 . . . . 0.0 112.058 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.53 101.75 12.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.192 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -81.04 106.01 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.349 0.595 . . . . 0.0 112.37 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' N ' ' NH1' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -142.8 75.25 1.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.237 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -57.39 -38.02 73.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.095 0.474 . . . . 0.0 110.584 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.04 -110.79 2.59 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -90.09 31.15 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.833 2.355 . . . . 0.0 112.334 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 2.8 m-85 -103.06 154.91 18.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.2 150.8 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.222 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.545 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -47.82 109.68 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.436 ' O ' ' NZ ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -121.27 -77.78 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.66 -54.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.784 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.426 ' HG3' ' HD2' ' A' ' 29' ' ' ARG . 3.2 mtt180 -54.53 -59.59 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 27.2 t -40.1 -40.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.952 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.545 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.91 -76.33 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.935 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.1 -34.77 75.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.831 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.7 tt -66.57 -48.39 69.75 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.769 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.14 -33.41 74.44 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.239 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.804 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.73 -45.41 75.1 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.3 -57.02 8.51 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -61.96 -36.3 81.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.465 -1.368 . . . . 0.0 111.341 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.797 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 2.5 tpp85 -87.13 -28.52 22.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.932 0.396 . . . . 0.0 110.683 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -76.6 -35.69 57.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.48 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -68.64 -48.16 51.8 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.554 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.42 -27.74 0.07 OUTLIER Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.657 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.797 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.22 143.34 50.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -127.74 93.83 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.375 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.119 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 120.72 0.295 . . . . 0.0 110.793 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 126.28 40.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.3 tt -89.47 142.75 27.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.1 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.67 108.82 5.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.128 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 3.3 p -98.29 125.28 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.615 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.76 143.19 41.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.11 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.4 tpt180 -150.19 119.01 6.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.999 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -89.81 -44.07 10.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.459 . . . . 0.0 110.757 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 179.92 -54.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.737 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -119.28 7.57 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.648 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 9.0 m170 -125.97 131.05 52.33 Favored 'General case' 0 N--CA 1.46 0.042 0 CA-C-O 120.959 0.409 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CG2' ' HB2' ' A' ' 52' ' ' SER . 2.9 tp -118.24 132.21 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.621 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE2' ' OG ' ' A' ' 51' ' ' SER . 29.9 m-85 -145.82 111.04 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.494 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -96.21 122.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 113.26 25.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.474 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.34 98.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.51 162.67 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.148 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 t0 -93.38 114.02 26.33 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.75 25.98 2.54 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.17 0.919 . . . . 0.0 112.189 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -109.48 -48.13 3.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.79 118.18 17.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 174.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.8 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.31 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' LYS . 75.0 t -138.85 112.56 7.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.81 122.57 23.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 1.6 mp -104.43 -64.2 1.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.49 144.4 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 111.96 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -150.2 125.16 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -131.05 160.91 33.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.749 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.438 ' OG ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.27 126.42 13.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.286 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.406 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 64' ' ' VAL . 48.4 t -94.06 -14.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.551 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -29.93 -44.11 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.66 -61.03 2.32 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.583 0.706 . . . . 0.0 109.368 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -48.27 -25.88 1.74 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.154 177.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -76.86 -36.39 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -73.8 -28.23 65.41 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.796 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 11.7 ptt180 -70.04 -36.49 75.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.31 -37.77 68.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 6.3 mt -67.1 -45.69 76.46 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.52 0.676 . . . . 0.0 109.436 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -72.35 -27.78 62.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.829 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 41.1 mt-10 -78.5 -29.67 46.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 15.4 mttt -72.79 -69.23 0.42 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.474 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 109' ' ' LEU . . . -45.63 -43.42 12.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.316 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 11.1 mt -55.76 -39.74 71.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.84 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.5 9.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.73 -29.38 18.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.53 15.8 8.59 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.635 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.444 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -75.99 106.98 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.616 0.722 . . . . 0.0 110.307 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.03 -48.32 5.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.427 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.376 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.0 163.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.317 0.579 . . . . 0.0 111.785 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.37 105.99 15.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.738 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.553 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -81.46 113.68 19.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.178 0.513 . . . . 0.0 111.602 -178.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.57 44.36 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.118 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 12.8 ptt-85 -40.71 -48.01 2.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.54 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.47 -114.08 2.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.64 -10.66 13.08 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.2 m-85 -57.25 132.63 53.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.02 154.88 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.105 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -45.21 108.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.04 0.448 . . . . 0.0 110.629 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -119.25 -125.69 0.28 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.394 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.61 -12.24 3.8 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.902 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 -89.4 -68.97 0.74 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.926 0.363 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.598 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 57.4 t -38.81 -28.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.658 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.121 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.01 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.83 -38.96 7.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.178 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -67.91 -46.67 70.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.162 0.506 . . . . 0.0 110.608 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.598 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.95 -33.22 75.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.081 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.806 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.47 -45.61 75.44 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.32 -56.8 8.8 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -62.78 -34.39 77.16 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 113.507 -1.346 . . . . 0.0 111.543 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.848 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -90.09 -26.45 20.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 0.0 110.809 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.806 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.4 pt-20 -78.07 -32.1 50.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.499 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -75.37 -45.43 18.89 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.476 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 179.54 -32.43 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 119.935 -1.126 . . . . 0.0 114.87 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.848 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.33 146.17 49.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.26 93.19 3.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.484 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.553 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.982 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 37.0 ttp85 -100.43 123.76 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HG ' HD12 ' A' ' 38' ' ' ILE . 2.9 tt -89.46 144.67 25.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.428 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -148.71 108.04 3.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.094 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 7.2 p -92.99 115.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.385 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 139.26 31.59 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.929 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' NH2' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -140.02 118.17 11.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -103.93 -155.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -71.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -120.12 35.39 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.39 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 5.4 m170 -115.33 132.9 56.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.18 0.515 . . . . 0.0 112.305 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.633 HG12 ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -121.2 111.6 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.666 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 38.4 m-85 -146.42 154.07 41.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.412 0.625 . . . . 0.0 112.675 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -135.21 129.82 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.946 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.97 115.0 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.114 0.483 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.526 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -99.72 94.07 3.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.316 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -94.43 164.62 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.659 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.416 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 t0 -96.75 115.27 27.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 7.9 t0 -90.89 23.72 3.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.346 1.028 . . . . 0.0 112.319 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -108.09 -47.37 3.57 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mptp? -135.4 118.16 16.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.12 90.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.343 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.4 t -140.69 112.29 4.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.7 119.82 17.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.418 HD12 HD11 ' A' ' 23' ' ' LEU . 1.3 mp -99.97 -63.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -118.08 148.68 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 112.153 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -150.11 129.98 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.72 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.95 162.48 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 112.147 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.31 134.83 17.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.436 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.633 ' HB2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.83 0.347 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 67' ' ' GLN . 57.4 t -94.15 -15.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.695 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 68' ' ' VAL . . . -34.58 -38.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 111.932 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.36 -59.59 2.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 4.0 mt-30 -49.46 -22.74 1.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.374 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -82.69 -32.79 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -77.23 -28.37 58.25 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.216 -0.992 . . . . 0.0 111.005 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 3.5 ppt_? -76.74 -38.75 53.65 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.42 -34.38 74.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 1.1 tm? -69.45 -56.26 7.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.593 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -59.37 -24.77 63.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.989 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 51.6 mt-10 -79.14 -30.95 43.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.6 mttt -70.27 -68.91 0.39 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.271 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -45.38 -44.04 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.2 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -55.4 -40.11 71.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.975 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.68 -24.93 9.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.032 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.72 -28.73 19.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.0 18.02 8.56 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.575 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 HG23 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -75.28 105.68 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 110.52 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 110' ' ' GLU . 28.7 tttp -90.32 -59.39 2.2 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.204 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.414 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -109.02 140.82 42.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.24 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -127.79 162.52 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 111.949 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.84 103.42 13.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.841 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.45 111.38 17.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.21 0.529 . . . . 0.0 111.666 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.48 44.45 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.111 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 ptt-85 -42.09 -46.14 4.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.489 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.38 -131.92 7.58 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.184 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.46 48.97 2.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.595 2.197 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.4 m-30 -100.49 155.75 17.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.91 154.76 48.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.279 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.538 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.6 109.67 0.27 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.979 0.418 . . . . 0.0 110.55 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -115.99 -124.29 0.29 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.409 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.13 -27.46 1.22 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.46 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . 8.5 mtt-85 -78.07 -67.24 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.606 0.241 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.9 t -37.74 -29.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.019 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.46 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.39 -41.11 38.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD12 ' CG2' ' A' ' 27' ' ' VAL . 1.2 tt -64.94 -46.15 82.78 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.198 0.523 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.66 -35.25 79.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.603 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.826 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.34 -46.86 59.52 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -46.9 -54.69 9.05 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -65.59 -33.91 77.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.238 -1.481 . . . . 0.0 111.382 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -90.09 -22.47 21.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.573 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -84.34 -32.34 24.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.85 -45.79 25.96 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.91 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.505 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.77 -30.69 0.08 OUTLIER Glycine 0 C--N 1.342 0.875 0 C-N-CA 120.012 -1.089 . . . . 0.0 114.833 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.762 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.11 142.87 50.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.75 93.76 3.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.533 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.587 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.999 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.52 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -104.37 126.41 51.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.78 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' N ' HG12 ' A' ' 84' ' ' VAL . 3.6 tt -89.7 143.69 26.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.976 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.429 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 16.0 m -144.79 108.31 4.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.728 0.299 . . . . 0.0 110.675 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.456 HG22 HD12 ' A' ' 100' ' ' LEU . 5.8 p -97.07 120.7 46.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.193 0.52 . . . . 0.0 111.802 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -100.75 148.9 24.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.781 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -150.4 120.68 7.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.81 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -89.71 -84.64 0.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.671 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -61.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.13 21.62 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.8 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -116.95 156.71 26.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 96' ' ' ARG . 4.3 tp -141.75 130.98 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.757 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 38.4 m-85 -148.95 150.33 32.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 0.0 111.845 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -133.27 121.41 22.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.414 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.76 113.34 25.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.487 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.477 HD11 HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.12 105.14 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.369 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -102.44 158.73 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -89.61 119.55 30.13 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.877 178.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -93.19 23.56 4.31 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.432 1.082 . . . . 0.0 112.294 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -106.86 -47.64 3.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.258 -2.126 . . . . 0.0 105.258 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' VAL . 16.5 mttt -137.95 118.1 13.53 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.5 90.46 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.489 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.3 t -138.59 112.5 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -69.93 113.12 6.85 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.424 HD11 HD23 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -90.56 -57.5 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 1.8 t -127.56 148.96 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.299 0.571 . . . . 0.0 112.123 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 58.5 p -150.21 114.9 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.786 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.62 150.93 50.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 112.028 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.492 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.4 t -150.42 149.97 30.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.425 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 37.2 m . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.688 0.28 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 67' ' ' GLN . 78.8 t -92.22 -25.73 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.59 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.66 -40.69 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.999 0.428 . . . . 0.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.03 -59.56 3.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.484 0.659 . . . . 0.0 109.278 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.517 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 12.9 mt-30 -49.41 -26.15 3.05 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.225 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -76.8 -32.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.425 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -77.9 -26.33 60.6 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.838 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 10.3 ptt180 -72.22 -39.21 68.7 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.47 -38.93 77.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 36' ' ' ALA . 1.5 tp -66.14 -52.34 49.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.171 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -64.37 -27.17 68.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.57 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 29.6 mt-10 -77.13 -32.48 56.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 11.8 mtmm -71.48 -68.69 0.43 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.726 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.01 -43.12 6.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.19 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -56.11 -38.28 70.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.027 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -54.78 -23.11 16.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.899 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.43 -26.5 20.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.33 17.35 10.08 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.138 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -76.25 102.91 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.686 0.755 . . . . 0.0 110.271 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -97.02 -46.78 6.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.954 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.03 134.86 54.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.22 165.85 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.965 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.47 106.12 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.63 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.577 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -81.4 120.45 24.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.267 0.556 . . . . 0.0 111.73 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.05 51.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.067 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.2 -31.33 0.37 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.523 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.17 -119.06 5.59 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.99 20.63 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.734 2.29 . . . . 0.0 112.426 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.6 m-30 -80.81 159.45 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 154.81 48.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.369 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -43.77 109.35 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.571 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.505 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.2 t-80 -124.67 157.96 34.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.477 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -41.13 -26.7 0.18 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.689 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HB3' HD11 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -82.09 -67.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.689 0.244 . . . . 0.0 111.182 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 90.0 t -29.83 -50.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -57.72 -75.37 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.801 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.75 -38.15 66.81 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.228 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.0 tt -67.51 -47.26 70.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.447 0.641 . . . . 0.0 110.428 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.1 -32.13 72.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.384 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.785 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -68.12 -44.65 75.66 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.67 -58.41 8.38 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.625 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -59.75 -35.35 74.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.621 -1.289 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.846 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.99 -30.65 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.861 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.785 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -72.2 -34.91 68.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.499 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -70.52 -46.91 45.18 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.797 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.26 -29.07 0.07 OUTLIER Glycine 0 C--N 1.341 0.831 0 C-N-CA 120.052 -1.07 . . . . 0.0 114.752 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.846 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.45 145.52 49.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -128.12 92.58 3.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.296 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.997 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' CD2' HG13 ' A' ' 81' ' ' ILE . 3.7 mp . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.99 0.424 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -98.83 124.87 44.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.289 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.33 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.359 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.412 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.76 108.73 4.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.153 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 9.2 p -99.19 115.48 39.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 1.0 OUTLIER -93.02 152.06 19.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.421 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 55.6 mtm-85 -149.15 118.91 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.916 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -46.4 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.994 0.426 . . . . 0.0 111.066 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.34 -59.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -116.73 12.68 14.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.323 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.3 174.36 6.1 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 ' CD1' HD13 ' A' ' 100' ' ' LEU . 6.9 tp -159.99 115.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 5.3 m-85 -129.68 111.21 12.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 72' ' ' LEU . . . -93.79 123.32 37.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 117.02 29.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.448 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.451 HD11 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -98.87 101.77 12.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.2 mp -101.52 161.61 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.966 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.424 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.42 117.27 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.715 177.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.424 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 5.6 t0 -93.3 27.45 2.54 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.278 0.986 . . . . 0.0 112.282 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -108.8 -46.48 3.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -137.94 118.14 13.58 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.32 89.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.503 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' LYS . 92.5 t -137.89 112.53 9.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -75.65 124.54 27.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' CD1' HD21 ' A' ' 23' ' ' LEU . 1.2 mp -107.35 -58.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 75' ' ' LYS . 2.1 t -120.06 141.71 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 112.076 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.23 114.79 5.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.5 151.89 48.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.02 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.528 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.0 p -150.58 142.74 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.602 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.443 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.93 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.617 0.246 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 94.3 t -94.05 -21.73 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -36.92 -38.21 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 0.0 110.855 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.5 -58.96 3.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 12.7 mt-30 -49.81 -23.02 1.64 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.667 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.563 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -78.29 -37.01 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.563 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -75.63 -36.21 43.94 Favored Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -66.43 -36.55 83.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -62.75 -53.87 47.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.776 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -63.66 -46.04 87.43 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -55.46 -27.15 46.39 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.689 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.4 tt0 -73.61 -35.34 65.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 7.5 mttt -74.79 -63.7 1.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.907 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 109' ' ' LEU . . . -43.89 -42.55 5.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.2 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -58.54 -40.68 83.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.4 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.01 -24.81 7.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.28 -27.13 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.57 11.57 19.11 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.15 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -64.02 103.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.616 0.722 . . . . 0.0 110.142 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -91.7 -57.47 2.74 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.345 -178.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.417 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -109.52 143.19 39.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.387 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -130.49 162.91 37.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.636 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.38 103.6 13.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.808 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.48 112.48 18.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -142.65 51.44 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -41.21 -38.37 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.651 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.09 -124.93 6.25 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.34 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -90.05 42.87 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.873 2.382 . . . . 0.0 112.066 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.639 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.7 m-30 -99.56 163.6 12.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.229 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 154.64 49.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.443 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -46.88 112.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.593 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.462 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.3 t60 -133.43 154.04 51.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.301 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -33.47 -37.04 0.06 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.851 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.462 ' HG3' ' HD2' ' A' ' 29' ' ' ARG . 2.0 mmt85 -70.74 -70.86 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.586 0.193 . . . . 0.0 111.407 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 98.5 t -29.91 -51.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -56.75 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 110.292 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.92 -43.0 49.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.14 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -66.66 -49.09 67.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.458 0.646 . . . . 0.0 110.649 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' N ' HD22 ' A' ' 100' ' ' LEU . . . -57.08 -34.82 68.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.081 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.761 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.32 -43.3 81.95 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.06 -61.5 5.72 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -54.12 -41.83 68.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.932 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -79.21 -55.68 4.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.761 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.6 pt-20 -46.58 -43.33 17.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.509 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -60.84 -50.01 72.3 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.994 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.16 -25.48 0.07 OUTLIER Glycine 0 C--N 1.341 0.859 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.667 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.816 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.48 146.41 48.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.18 93.08 3.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.215 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.591 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.018 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.7 mp . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.747 0.308 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -96.18 126.86 41.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.43 140.79 29.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.554 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 3.0 t -142.3 114.07 8.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 110.996 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 100' ' ' LEU . 4.0 p -101.53 120.35 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.215 0.531 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -99.14 148.97 23.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.964 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' HD2' ' CG ' ' A' ' 96' ' ' ARG . 15.8 mtm-85 -146.72 119.76 8.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.584 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.79 -50.64 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tt -179.24 -54.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.362 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 10.12 12.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.885 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -119.55 148.15 43.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 96' ' ' ARG . 4.1 tp -131.18 131.61 63.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.704 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 29.6 m-85 -146.95 149.93 34.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.832 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 72' ' ' LEU . . . -135.18 120.93 19.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.221 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 26' ' ' SER . 4.8 pt20 -113.63 113.06 24.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.316 0.579 . . . . 0.0 109.921 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -90.92 97.15 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.85 164.26 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.283 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.53 103.16 14.88 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.485 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -86.65 27.16 1.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.172 0.92 . . . . 0.0 112.328 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -113.09 -47.9 3.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -129.33 118.5 22.35 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 174.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.63 86.29 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.725 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' LYS . 47.3 t -137.51 112.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' HA ' HG22 ' A' ' 39' ' ' ILE . 22.5 m -77.11 122.66 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.19 -64.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -123.12 147.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 111.876 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 21.8 p -150.6 117.36 5.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.729 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.12 151.23 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.237 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.8 t -150.3 147.24 27.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.751 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 5.9 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.25 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.771 0.32 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 72.8 t -91.93 -19.0 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.683 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.532 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -30.74 -43.75 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -64.74 -61.34 2.25 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.499 0.666 . . . . 0.0 109.365 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 23.5 mt-30 -48.47 -24.56 1.32 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.4 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -80.32 -33.41 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.653 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.548 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -77.89 -27.43 58.54 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.167 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -75.01 -39.53 61.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.39 71.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 36' ' ' ALA . 1.9 tp -68.91 -54.44 15.49 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.845 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -62.04 -26.11 68.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.974 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 48.3 mt-10 -77.49 -31.18 53.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.456 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 21.0 mttt -72.51 -68.74 0.45 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.523 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.25 -43.21 7.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -56.04 -39.86 72.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.942 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.9 -23.81 14.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.019 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.43 -27.89 20.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.82 15.51 13.07 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.252 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -72.98 102.98 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 110.202 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -91.24 -57.3 2.83 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.423 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.11 137.97 46.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -126.84 166.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.368 0.604 . . . . 0.0 111.666 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -115.33 109.41 17.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.834 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.554 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -80.53 106.36 12.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.299 0.571 . . . . 0.0 111.919 -177.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.6 46.09 2.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.277 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.29 -45.49 5.91 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.26 -112.83 3.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.54 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.95 25.08 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.772 2.315 . . . . 0.0 112.863 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -93.97 157.13 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 111.056 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 151.53 49.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.675 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.464 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.21 94.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.416 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -114.21 170.93 7.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.384 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -41.94 -47.94 5.21 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.203 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' CG ' ' HD2' ' A' ' 29' ' ' ARG . 1.3 mtt85 -57.01 -68.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.64 0.257 . . . . 0.0 110.506 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.6 t -38.32 -39.96 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.567 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.33 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.8 -34.31 67.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.858 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.0 tt -70.11 -48.37 57.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.213 0.53 . . . . 0.0 110.959 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.02 -28.7 69.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -71.5 -46.44 59.72 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.67 -56.17 8.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . . . -64.24 -34.6 78.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.41 -1.395 . . . . 0.0 111.111 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.3 mmm180 -87.14 -24.42 24.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.2 pt-20 -84.45 -33.36 23.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.496 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -70.8 -46.47 45.69 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.074 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.94 -28.64 0.07 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 120.031 -1.08 . . . . 0.0 114.597 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.21 146.61 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -127.73 94.39 3.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.374 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.554 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 4.5 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' CD2' HG13 ' A' ' 81' ' ' ILE . 4.9 mp . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.014 0.435 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 25.4 ttp85 -103.0 123.31 46.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.225 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 38' ' ' ILE . 2.7 tt -89.17 143.79 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.602 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.42 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -146.72 108.8 4.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.454 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' CG2' HD11 ' A' ' 100' ' ' LEU . 9.7 p -102.48 116.71 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.91 136.25 35.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.445 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -132.81 118.71 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.978 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.58 -70.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -148.86 -62.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.773 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -119.13 20.19 12.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.197 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.42 175.62 5.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.166 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' CD1' HD11 ' A' ' 100' ' ' LEU . 6.6 tp -160.03 122.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.93 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -137.79 111.56 8.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.09 125.57 41.66 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 113.27 21.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.169 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.516 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -97.76 100.95 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.512 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -102.61 160.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.805 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' N ' HG21 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -92.15 116.96 29.4 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.856 178.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 1.7 t70 -93.38 28.11 2.35 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 124.281 0.988 . . . . 0.0 112.185 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -109.76 -47.42 3.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.2 mttp -136.49 118.14 14.96 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.11 90.58 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.532 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 80.6 t -139.62 112.47 5.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 121.09 23.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.59 -59.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG11 HD21 ' A' ' 72' ' ' LEU . 2.1 t -115.81 140.36 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.175 0.512 . . . . 0.0 111.971 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -150.27 114.93 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.266 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' HG ' ' A' ' 72' ' ' LEU . . . -133.51 151.4 51.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.245 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.513 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 43.6 p -150.54 139.6 21.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.35 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.708 0.289 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 67' ' ' GLN . 95.5 t -94.14 -20.01 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.761 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -35.48 -38.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 3.7 ttm180 -67.59 -59.13 3.6 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -50.89 -24.31 3.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.533 178.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -77.54 -33.23 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -78.36 -32.37 43.09 Favored Glycine 0 C--O 1.218 -0.854 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.71 -36.79 83.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.77 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -45.59 78.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.409 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' HG ' ' CB ' ' A' ' 50' ' ' ALA . 1.1 mt -62.58 -50.04 72.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -59.56 -26.1 65.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 12.4 tt0 -72.04 -34.66 68.95 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.1 mttp -77.08 -64.12 1.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.862 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -43.96 -42.6 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.639 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -58.76 -40.51 84.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.373 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.55 -25.18 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.227 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.476 HD13 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.47 -26.51 20.91 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.2 13.81 14.62 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.198 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.476 HG12 HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -71.43 102.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.016 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -103.87 -27.89 11.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.853 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.11 140.51 52.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.035 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -135.27 164.49 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.507 0.67 . . . . 0.0 112.345 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -106.43 103.82 13.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.835 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.72 106.35 13.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 111.509 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.09 43.69 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.231 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 21.0 ptt-85 -43.48 -48.76 7.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.502 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.59 -126.37 5.5 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -89.9 48.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.859 2.373 . . . . 0.0 112.125 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.1 m-30 -99.99 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.436 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 154.75 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.69 106.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.019 0.438 . . . . 0.0 110.681 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -110.63 -125.08 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.56 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.83 1.29 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.276 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' LYS . 2.2 mmt85 -79.77 -69.65 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.937 0.369 . . . . 0.0 110.941 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.4 t -35.03 -31.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.79 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.868 0.366 . . . . 0.0 110.992 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.85 -43.23 63.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.192 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.8 tt -60.53 -40.94 93.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.235 0.541 . . . . 0.0 110.639 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.96 -35.73 78.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.267 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 106' ' ' GLU . 1.3 mt-10 -69.55 -46.59 66.07 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.542 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.42 -58.27 5.31 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.718 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -59.56 -46.47 88.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.242 -1.479 . . . . 0.0 111.14 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.799 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 mtm180 -74.92 -55.48 5.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.175 0.512 . . . . 0.0 109.663 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.797 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -47.81 -44.43 28.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.475 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -61.16 -47.59 90.24 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.352 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.72 -25.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.623 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.799 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.2 mp -71.46 150.17 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -128.38 91.49 3.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.583 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 6.0 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.959 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' CB ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -102.52 126.27 49.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 2.0 tt -89.56 143.49 26.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.217 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.428 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -143.27 111.97 6.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.4 p -98.22 153.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.381 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.17 114.81 5.25 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -129.24 118.92 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -33.03 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.232 0.539 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.65 -61.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.471 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 9.64 11.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.595 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 7.4 m170 -121.99 100.05 6.77 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 29' ' ' ARG . 4.5 tp -99.19 117.94 45.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.499 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 12.5 m-85 -131.54 112.8 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 72' ' ' LEU . . . -102.84 122.55 44.76 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.53 113.07 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.501 ' CG1' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.93 99.34 9.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.337 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.45 163.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.601 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.59 111.59 23.35 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.4 p30 -88.06 24.5 1.81 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.282 0.989 . . . . 0.0 112.524 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 15.7 pt-20 -111.13 -45.24 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 45' ' ' VAL . 25.9 mmtm -132.8 118.38 18.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.95 86.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.672 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.604 ' N ' ' O ' ' A' ' 43' ' ' LYS . 46.1 t -135.08 112.39 14.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 120.86 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.46 HD11 HD13 ' A' ' 23' ' ' LEU . 1.5 mp -101.86 -62.45 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.09 143.74 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.344 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 p -150.24 114.98 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 72' ' ' LEU . . . -126.47 145.43 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.499 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 55.7 p -150.22 134.96 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.791 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 179.056 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.92 0.39 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 64' ' ' VAL . 59.7 t -92.33 -16.11 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.534 ' O ' HG13 ' A' ' 68' ' ' VAL . . . -32.03 -41.55 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.01 0.434 . . . . 0.0 111.689 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.79 -61.03 2.3 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.433 0.635 . . . . 0.0 109.346 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 18.5 mt-30 -50.22 -24.86 3.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.514 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -78.73 -32.31 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -76.65 -25.16 65.76 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.214 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -78.73 -37.48 41.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -68.35 -38.9 81.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 2.0 tt -72.88 -46.53 52.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -62.64 -25.02 67.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -79.71 -30.08 40.86 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 21.6 mttt -69.47 -69.09 0.36 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.173 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.6 -44.92 9.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.4 mt -54.53 -39.08 67.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.152 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.24 -24.45 18.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.865 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.61 -26.1 20.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.51 13.47 16.79 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.076 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -75.1 102.62 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -104.43 -24.76 13.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.77 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -127.47 136.42 51.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.125 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -136.67 163.74 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.374 0.607 . . . . 0.0 112.191 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.52 98.5 8.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.774 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -80.92 111.73 17.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.599 . . . . 0.0 111.776 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.1 61.18 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' HD2' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -48.9 -28.42 3.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.644 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.41 -117.81 3.33 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.73 38.0 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.758 2.305 . . . . 0.0 111.663 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.448 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 3.5 m-30 -98.61 144.9 27.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.28 155.01 49.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.4 t80 -39.83 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.168 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.456 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 2.0 t-160 -115.44 -109.87 0.36 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.151 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -131.25 -17.16 1.46 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.714 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG2' ' CG ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -95.38 -71.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 48.3 t -32.94 -37.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -64.65 -78.85 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.301 0.572 . . . . 0.0 110.429 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -46.26 -42.88 15.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.314 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 tt -67.51 -45.72 74.99 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.05 -35.76 79.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.362 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -63.45 -49.9 71.85 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.05 -56.21 6.08 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -56.43 -46.93 80.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 112.792 -1.704 . . . . 0.0 111.816 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.6 mmm-85 -78.84 -47.29 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.139 0.495 . . . . 0.0 109.976 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.676 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -53.4 -35.4 60.33 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -74.24 -49.19 12.81 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.499 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.33 -24.04 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 C-N-CA 119.737 -1.22 . . . . 0.0 115.405 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.17 146.2 49.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.204 1.002 . . . . 0.0 113.598 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.37 97.16 4.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.208 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CE2' ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.609 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 41' ' ' ASP . 2.8 mp . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.992 0.425 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 1.4 ttt180 -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.334 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.9 tt -89.58 142.19 27.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.422 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.1 m -144.94 108.59 4.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.481 HG21 HD13 ' A' ' 100' ' ' LEU . 8.8 p -94.2 117.73 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 111.749 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.409 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -99.26 146.95 25.67 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NH1' ' CG2' ' A' ' 97' ' ' VAL . 22.9 mtm-85 -150.14 122.34 8.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.996 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.9 p -89.66 -72.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.411 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 -58.26 0.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.566 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.23 2.56 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -101.82 155.57 18.05 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.177 0.513 . . . . 0.0 111.427 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 52' ' ' SER . 5.5 tp -142.63 119.74 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.573 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 14.1 m-85 -137.05 112.86 9.54 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -93.74 121.05 34.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.61 113.32 26.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.693 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.443 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -96.78 99.52 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.261 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -98.7 163.09 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.008 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -93.29 115.32 27.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.608 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.3 t0 -90.64 22.8 3.33 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.428 1.08 . . . . 0.0 112.354 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -110.15 -46.38 3.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 11.6 mmmt -134.02 118.28 17.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.99 87.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.778 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 43' ' ' LYS . 60.4 t -137.53 112.32 9.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -71.57 117.68 13.43 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 HD13 ' CD2' ' A' ' 23' ' ' LEU . 1.3 mp -95.34 -63.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -121.11 147.75 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.794 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.4 p -150.17 114.83 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.063 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.38 158.29 33.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.707 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.462 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 79.5 p -150.18 143.02 24.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.973 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.437 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 11.8 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.104 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 64' ' ' VAL . 58.2 t -94.13 -16.49 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -32.65 -41.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.882 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.83 -59.21 3.73 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.702 0.763 . . . . 0.0 109.035 178.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.1 mt-30 -49.78 -23.27 1.75 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.442 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -81.29 -33.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -75.91 -28.91 59.88 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.4 ppt_? -76.67 -37.24 56.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.08 73.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -69.63 -54.51 13.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.704 178.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -59.8 -25.68 65.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.8 mt-10 -78.18 -31.01 49.35 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 23.2 mttt -71.67 -69.14 0.4 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.497 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -44.68 -43.48 8.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.126 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -56.11 -39.67 72.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.041 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.5 -23.78 11.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.918 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.59 -27.7 20.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.7 8.08 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.071 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -78.21 105.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.536 0.684 . . . . 0.0 110.478 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 110' ' ' GLU . 8.1 ttmt -92.44 -59.49 2.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.8 138.63 44.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -126.6 164.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 111.901 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.93 103.26 12.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.795 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.596 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.44 116.49 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 111.616 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -145.54 47.59 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 6.9 ptt-85 -37.64 -37.58 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.762 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.27 -112.58 3.61 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.631 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -88.72 23.56 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.83 2.353 . . . . 0.0 112.767 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.525 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.8 m-30 -93.26 131.84 38.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.31 148.4 25.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -46.69 109.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.524 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -126.54 165.99 18.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.28 -40.41 7.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.79 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HB3' HD11 ' A' ' 34' ' ' ILE . 15.0 mmt-85 -57.36 -70.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.572 0.225 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 37.2 t -38.39 -37.8 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.35 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.72 -76.71 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.029 0.442 . . . . 0.0 110.965 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.31 -36.4 68.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.732 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.8 tt -68.96 -49.1 60.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.216 0.531 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -60.9 -32.1 71.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.42 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -68.54 -46.23 70.08 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.61 -57.15 8.69 Favored Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -62.03 -33.21 73.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.512 -1.344 . . . . 0.0 111.327 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.765 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.6 tpp85 -90.08 -25.06 20.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.1 pt-20 -81.02 -33.17 33.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.493 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -72.38 -46.78 31.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.858 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.73 -29.7 0.08 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.036 -1.078 . . . . 0.0 114.76 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.765 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.33 142.77 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.81 94.88 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.469 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.964 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 3.0 mp . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 126.33 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.38 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' N ' HG11 ' A' ' 84' ' ' VAL . 4.1 tt -89.29 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.693 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.06 108.82 4.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 111.318 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.43 ' CG1' ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -97.02 126.97 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -110.46 145.72 37.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 13.5 mtm105 -150.12 120.67 7.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.749 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 m -89.59 -81.04 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.684 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -139.86 -56.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.717 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -119.12 18.73 13.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.212 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -117.54 167.67 11.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.162 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 3.3 tp -153.3 130.96 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.551 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.516 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 32.9 m-85 -150.01 152.18 34.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.243 0.544 . . . . 0.0 112.171 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -136.83 120.96 17.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.692 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.76 113.22 25.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.453 HD11 HD22 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.72 98.84 8.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.8 160.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.165 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 115.63 28.27 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.603 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -90.75 26.16 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.297 0.998 . . . . 0.0 112.403 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.46 -47.97 3.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.39 118.04 14.97 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.96 90.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.448 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.9 t -137.68 112.57 9.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 m -73.92 119.72 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 mp -98.87 -58.28 1.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.0 t -124.36 147.3 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 112.239 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 82.5 p -150.28 115.02 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.946 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.26 150.77 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.919 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.516 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 3.1 t -150.46 141.94 23.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.512 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.405 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 32.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.689 0.281 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 67' ' ' GLN . 75.6 t -94.05 -17.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.693 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' HG11 ' A' ' 68' ' ' VAL . . . -34.89 -39.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.991 0.425 . . . . 0.0 111.414 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.29 -59.28 3.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -50.98 -22.95 2.55 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.408 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.53 -31.76 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.253 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -77.73 -30.86 51.53 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.26 -38.46 68.85 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.57 -39.39 88.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -65.54 -54.98 20.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.57 -24.99 35.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.99 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -73.18 -35.59 66.42 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.3 mttt -71.58 -67.4 0.53 Allowed 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.921 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HB2' HD12 ' A' ' 109' ' ' LEU . . . -43.93 -41.28 5.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.623 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -58.67 -40.23 82.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.226 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.44 -23.89 6.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.075 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.469 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.33 -27.82 20.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.66 18.04 9.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.136 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -71.73 106.87 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.505 0.669 . . . . 0.0 110.338 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLU . 18.9 ttmt -91.1 -58.14 2.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.393 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -111.86 147.58 35.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.463 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -134.33 161.15 41.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.319 0.58 . . . . 0.0 111.775 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.41 103.64 15.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.254 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.676 ' CE2' ' CZ ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -81.17 106.34 13.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.255 0.55 . . . . 0.0 112.071 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.76 72.16 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.983 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.676 ' CZ ' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -52.19 -42.9 63.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.27 -117.35 3.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -90.35 35.95 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.746 2.298 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.3 m-30 -100.65 162.59 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 111.469 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.33 148.93 50.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.013 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -46.7 103.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.736 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -122.3 165.22 16.58 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.88 -42.46 11.4 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.983 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.436 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 55.4 mmt-85 -55.76 -71.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.704 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 t -38.92 -43.57 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.635 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.2 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.023 0.439 . . . . 0.0 111.133 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -59.24 -40.0 84.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 101' ' ' ALA . 1.5 tt -65.04 -47.29 77.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.351 0.596 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.26 -38.09 85.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -66.75 -39.71 88.01 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -52.49 -59.35 9.19 Favored Glycine 0 CA--C 1.501 -0.789 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -61.04 -28.81 69.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.831 -1.185 . . . . 0.0 110.559 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.7 mmm-85 -89.11 -30.48 18.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 110.917 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.795 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.9 pt-20 -78.84 -36.9 41.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -66.67 -46.38 76.36 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.773 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.42 -31.33 0.07 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.032 -1.08 . . . . 0.0 114.754 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.7 mp -71.28 147.05 48.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -128.23 91.68 3.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.348 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.063 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.9 mp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.18 126.96 47.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.078 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HG ' HD11 ' A' ' 38' ' ' ILE . 2.1 tt -93.39 145.1 24.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.939 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.474 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.03 108.43 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.415 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' N ' ' HD3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -96.18 129.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.023 0.44 . . . . 0.0 111.313 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -114.78 125.92 54.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -129.52 118.6 22.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.57 178.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.2 m -90.03 -45.14 9.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.78 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.171 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -119.35 -0.93 10.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.344 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -110.71 111.07 22.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 111.572 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.63 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -99.93 131.28 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 40.7 m-85 -149.08 147.76 28.89 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.146 0.498 . . . . 0.0 112.085 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.489 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -132.46 128.28 37.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -117.83 113.06 21.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.205 0.526 . . . . 0.0 110.767 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -100.13 102.23 13.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -104.91 160.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.977 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -92.28 118.03 30.48 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.818 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 13.6 t0 -91.82 20.61 5.48 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.44 1.088 . . . . 0.0 112.217 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.49 -48.62 3.4 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 45' ' ' VAL . 8.3 mmtp -131.11 118.15 20.1 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.82 89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.841 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' LYS . 60.8 t -136.09 112.61 13.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 m -77.42 109.6 11.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -91.53 -53.07 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.408 HG23 ' CB ' ' A' ' 75' ' ' LYS . 1.4 t -124.16 145.84 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.571 0.701 . . . . 0.0 112.791 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 78.3 p -150.22 115.02 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.313 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' CB ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.92 162.94 24.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 126.91 10.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.007 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.496 ' OG ' HG22 ' A' ' 34' ' ' ILE . 1.1 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 0.0 111.24 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 64' ' ' VAL . 39.6 t -94.05 -13.78 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.058 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.559 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -30.26 -43.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -65.96 -60.83 2.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.378 0.608 . . . . 0.0 109.46 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 18.3 mt-30 -48.12 -28.19 2.77 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.292 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -71.88 -38.44 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.2 178.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.615 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -67.64 -56.78 10.29 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 5.5 ppt_? -44.95 -35.33 2.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -64.12 -50.19 69.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.08 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' CD1' ' HB1' ' A' ' 36' ' ' ALA . 1.2 mt -62.96 -52.62 62.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . -53.51 -27.3 24.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.063 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -75.09 -32.89 61.57 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 33.0 mttm -76.79 -63.69 1.29 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -45.59 -43.19 11.97 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.792 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -56.2 -40.03 73.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.977 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.59 -24.33 13.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.952 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.42 -28.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.78 13.55 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.254 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.478 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -68.4 111.03 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 110.126 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 23.6 ttpp -95.89 -57.48 2.35 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.787 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -110.75 148.67 31.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -132.65 164.93 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 0.0 112.182 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.02 87.87 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.944 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 12.0 t80 -81.17 112.37 18.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.93 111.02 4.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' A' ' 27' ' ' VAL . 3.1 tpt85 -99.82 -21.11 15.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.28 -97.83 1.04 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.81 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.42 33.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.903 2.402 . . . . 0.0 112.197 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 4.3 m-85 -99.93 135.7 40.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.95 154.78 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.7 t80 -46.86 97.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 110.35 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.414 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 1.9 t60 -105.35 -99.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.901 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -142.52 -30.94 0.12 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mmt85 -85.87 -71.14 0.55 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 55.4 t -33.07 -35.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HZ2' ' HB ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -62.14 -76.42 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.667 0.746 . . . . 0.0 109.551 179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.32 -44.51 11.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.655 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -68.12 -49.24 62.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 110.221 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -55.61 -32.49 63.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -68.79 -41.95 78.01 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.13 -57.48 8.88 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.45 -34.63 77.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.477 -1.362 . . . . 0.0 110.986 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.866 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.33 -26.61 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.411 . . . . 0.0 110.887 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.837 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -78.08 -36.57 48.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.19 -43.84 69.37 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.725 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.473 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 179.36 -31.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 119.999 -1.096 . . . . 0.0 114.904 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.866 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.42 151.1 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.76 96.01 4.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 4.5 p90 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.07 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.452 ' CD1' HG13 ' A' ' 81' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 3.1 ttt-85 -102.73 126.46 49.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.49 145.61 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.58 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.406 ' N ' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -147.4 108.88 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.468 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 100' ' ' LEU . 9.6 p -100.59 132.18 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.006 0.432 . . . . 0.0 111.761 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -113.35 143.99 43.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.278 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' NH1' HG21 ' A' ' 97' ' ' VAL . 19.9 ptt-85 -151.53 118.76 5.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.093 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.78 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 110.788 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tt -177.36 -68.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.94 14.16 18.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.905 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 1.7 m-70 -127.33 150.18 49.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.655 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 22.5 pt -139.16 142.35 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -142.04 108.39 5.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.158 -177.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -93.73 121.01 34.73 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -114.75 118.64 34.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.486 HD11 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.99 103.82 15.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' A' ' 47' ' ' LEU . 3.5 mp -108.16 162.46 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.709 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.0 t70 -92.87 113.58 25.9 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.039 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -92.97 24.82 3.48 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.253 0.971 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.8 -47.85 3.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' VAL . 16.5 mtpt -132.19 118.12 19.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.77 90.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.453 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 43' ' ' LYS . 91.5 t -141.05 112.2 3.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 m -78.83 117.48 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -95.65 -56.87 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -128.57 145.12 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 111.986 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 p -150.19 114.53 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.422 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 148.78 50.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.631 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.499 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 15.2 p -150.22 136.14 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.821 178.848 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.732 0.301 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 65' ' ' ALA . 99.5 t -94.0 -20.09 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.685 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -34.18 -39.55 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 111.551 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.77 -60.21 2.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 4.8 mt-30 -49.36 -24.59 1.97 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.572 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -76.98 -36.14 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.806 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.545 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -77.06 -35.8 37.53 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.941 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 4.3 ppt_? -65.03 -36.12 83.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.609 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.47 -55.13 26.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -62.69 -44.58 95.88 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -56.83 -27.8 60.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.742 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.6 tt0 -72.94 -34.35 66.5 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 14.2 mttt -76.64 -63.19 1.4 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.072 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.29 -42.05 6.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.346 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -58.0 -40.38 80.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.184 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.08 -23.63 8.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.466 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.41 -28.44 19.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.46 15.69 12.05 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.197 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -69.29 104.47 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.589 0.709 . . . . 0.0 110.152 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 110' ' ' GLU . 14.6 tttt -92.51 -56.38 3.05 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.388 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -110.0 145.03 37.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.384 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -132.1 164.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.469 0.652 . . . . 0.0 112.048 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -106.02 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.746 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -82.02 106.32 13.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.105 0.479 . . . . 0.0 111.373 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 45.0 2.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.176 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.7 ptt180 -41.51 -32.47 0.34 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.582 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.91 -121.46 6.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.433 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -88.99 36.33 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 3.6 m-30 -95.55 150.97 19.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.989 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -116.91 147.0 42.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.476 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -49.31 100.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.056 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -120.07 168.46 11.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.456 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.46 -38.16 3.86 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.912 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -61.72 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.567 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 33.1 t -38.67 -40.97 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.57 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.476 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.4 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 0.0 111.001 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.28 -37.27 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.896 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 101' ' ' ALA . 2.2 tt -67.48 -48.21 67.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 111.167 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.21 -33.4 70.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.17 -43.79 81.34 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.01 -62.06 5.27 Favored Glycine 0 CA--C 1.506 -0.517 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -54.98 -38.93 68.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 113.821 -1.19 . . . . 0.0 110.571 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.4 mmm-85 -79.79 -60.17 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -43.59 -43.15 5.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.158 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.518 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -62.01 -50.51 64.82 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.995 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.31 -26.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.125 -1.036 . . . . 0.0 114.808 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.806 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.4 mp -71.49 147.77 47.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.28 92.24 3.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.25 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.038 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 81' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.844 0.354 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 125.26 50.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.694 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' N ' HG11 ' A' ' 84' ' ' VAL . 5.1 tt -89.74 142.32 27.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.682 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.434 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 2.0 m -142.21 134.84 28.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.609 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -119.79 134.58 62.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 0.0 110.831 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -122.92 132.31 54.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' HG2' HD12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -137.32 118.83 14.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.214 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -89.24 -38.91 13.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.007 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tt -179.87 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -119.03 3.87 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.31 154.82 23.98 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD12 ' HG2' ' A' ' 29' ' ' ARG . 3.8 tp -141.34 123.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.83 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 16.9 m-85 -139.22 110.72 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 72' ' ' LEU . . . -100.17 121.45 41.45 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -110.22 113.47 26.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.321 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.78 101.71 12.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 37' ' ' GLN . 2.9 mp -104.84 164.03 4.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.44 113.98 25.93 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.809 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.3 t70 -91.38 25.54 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.335 1.022 . . . . 0.0 112.359 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -109.61 -48.15 3.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 45' ' ' VAL . 4.8 mttp -135.64 118.09 15.79 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.3 89.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.546 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' LYS . 66.3 t -137.86 112.49 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -75.5 114.54 14.18 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.401 HD12 ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -93.11 -60.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.1 t -125.21 147.25 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 111.882 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 p -150.23 114.91 5.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 72' ' ' LEU . . . -124.89 151.89 44.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.522 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.5 p -150.22 127.14 11.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.892 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 76.1 t -94.18 -26.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.83 -40.75 0.06 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.634 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -66.49 -60.02 3.12 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.745 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 28.3 mt-30 -48.24 -27.14 2.29 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.248 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.585 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -77.06 -36.24 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.585 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -73.98 -29.74 62.36 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.27 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.745 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 6.5 ppt_? -69.51 -36.17 76.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -73.94 -38.07 64.36 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.567 ' CD1' ' HB2' ' A' ' 36' ' ' ALA . 7.2 mt -65.4 -43.58 90.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.419 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -75.51 -30.97 60.0 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.085 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 21.2 mt-10 -75.65 -28.46 58.77 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 8.3 mtmm -76.12 -67.79 0.65 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.399 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.465 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -45.44 -40.89 8.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 11.0 mt -57.79 -39.02 76.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.718 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.5 -22.88 14.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.937 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.44 -27.38 20.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.21 19.69 9.26 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.077 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -76.92 103.79 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.588 0.708 . . . . 0.0 110.449 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLU . 19.1 tttp -91.54 -56.92 2.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.363 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.68 146.91 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.482 HG11 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -134.07 167.16 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.458 0.647 . . . . 0.0 112.169 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.21 103.74 14.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.255 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 88' ' ' ARG . 1.5 t80 -80.75 110.58 16.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 112.723 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.0 106.36 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.066 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -92.34 -33.91 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.058 0.456 . . . . 0.0 110.304 -178.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.76 -110.22 2.76 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -90.31 32.7 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.849 2.366 . . . . 0.0 112.262 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.522 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 3.4 m-30 -102.27 152.79 20.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.131 0.491 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.26 148.91 52.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.446 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.486 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -44.75 111.83 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.979 0.419 . . . . 0.0 110.334 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -124.01 -122.69 0.26 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.639 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.04 -12.4 3.21 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.964 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.419 ' HG3' ' HD2' ' A' ' 29' ' ' ARG . 1.7 mmt85 -87.95 -70.77 0.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.851 0.325 . . . . 0.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 55.8 t -36.14 -32.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 123.035 0.534 . . . . 0.0 111.672 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.486 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.14 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.969 0.414 . . . . 0.0 110.96 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -44.25 -40.84 5.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -67.73 -45.77 74.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 110.214 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.84 -30.63 70.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.772 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -69.91 -49.0 56.41 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.515 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.74 -55.21 7.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.754 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.873 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.808 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.17 -45.04 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.772 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -56.63 -35.2 68.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.835 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.474 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -73.34 -49.08 16.55 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.119 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . -179.53 -29.99 0.05 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.728 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.808 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 8.0 mp -71.15 146.86 48.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -128.04 91.71 3.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.104 178.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.026 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.464 ' HA ' ' H ' ' A' ' 41' ' ' ASP . 1.4 mp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.914 0.388 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.59 126.93 52.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.705 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.84 141.53 28.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.419 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.21 108.72 5.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.692 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 4.7 p -95.78 125.45 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.16 144.15 40.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.83 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 26.2 tpt180 -150.12 118.63 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.765 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.9 p -89.93 -42.97 10.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.657 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -178.61 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 13.5 mtmt -119.27 -1.67 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.649 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 25.8 m170 -112.15 116.96 31.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.036 0.446 . . . . 0.0 111.492 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 51' ' ' SER . 5.8 tp -106.94 112.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' A' ' 51' ' ' SER . 8.9 m-85 -127.87 110.69 12.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HB1' HD13 ' A' ' 72' ' ' LEU . . . -96.04 124.84 40.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.78 113.4 25.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.515 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.09 99.16 8.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.119 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.84 163.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.127 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.95 114.08 26.22 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.754 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 22.0 t70 -91.5 25.47 2.62 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.438 1.086 . . . . 0.0 112.303 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -109.46 -47.92 3.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.89 118.25 15.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 90.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.613 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.6 t -139.99 112.32 5.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -73.31 114.13 11.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.45 HD12 HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -91.58 -64.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.1 t -121.7 145.87 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 111.792 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.9 p -150.36 114.82 5.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.041 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 72' ' ' LEU . . . -126.73 156.25 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.1 145.56 26.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.237 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.436 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 34.7 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.689 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' ALA . 68.8 t -83.94 -19.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -31.83 -42.14 0.05 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.962 0.411 . . . . 0.0 111.965 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.76 -61.04 2.3 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.521 0.676 . . . . 0.0 109.301 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.564 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -48.67 -25.08 1.6 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.3 177.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -78.97 -33.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.671 178.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.535 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -79.77 -27.28 54.31 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.357 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -73.61 -38.37 65.12 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.38 -34.8 70.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.507 HD13 ' HB1' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -69.21 -49.6 54.98 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.322 178.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -67.46 -25.4 65.87 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.896 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -77.91 -31.28 51.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 13.5 mttt -71.95 -69.34 0.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.515 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB2' HD12 ' A' ' 109' ' ' LEU . . . -44.28 -43.38 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.136 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -55.52 -39.23 70.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.052 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.28 -23.56 15.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.962 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.485 ' HB2' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.58 -27.16 20.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.29 16.69 10.83 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.156 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -74.7 103.02 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.725 0.774 . . . . 0.0 110.307 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -94.44 -51.93 4.55 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.75 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 135.16 54.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -124.02 165.1 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.4 0.619 . . . . 0.0 111.769 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.85 105.4 14.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.379 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.34 106.31 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.529 -178.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.73 44.08 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.008 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 16.3 ptt-85 -39.4 -47.84 1.84 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.827 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.93 -114.68 2.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.15 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.03 -13.53 21.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.426 2.084 . . . . 0.0 112.275 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.426 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.5 m-85 -60.63 138.11 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.02 0.438 . . . . 0.0 111.159 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 154.11 49.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.999 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 1.3 t80 -42.4 113.56 0.47 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -128.89 -77.95 0.56 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' NZ ' ' A' ' 98' ' ' LYS . . . -155.37 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.167 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -65.55 -60.85 2.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 42.1 t -35.97 -39.18 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.994 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.543 ' CE ' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.65 -80.16 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.391 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -53.77 -36.39 62.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.015 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.4 tt -68.98 -48.23 63.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.149 0.5 . . . . 0.0 110.972 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.79 -30.79 71.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.323 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.21 -45.04 70.85 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.77 -57.24 9.92 Favored Glycine 0 CA--C 1.508 -0.375 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -62.92 -33.12 74.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.357 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.1 mtm180 -88.46 -30.05 19.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.749 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.793 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -76.94 -34.36 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -71.17 -47.38 37.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.106 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.46 -29.47 0.07 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.878 -1.153 . . . . 0.0 114.942 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.25 147.14 48.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -127.85 91.84 3.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.413 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.4 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.935 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 41' ' ' ASP . 3.6 mp . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.926 0.393 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -103.85 125.34 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.442 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.518 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tt -89.81 143.81 26.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.406 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 50.9 m -145.43 108.69 4.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 0.0 111.343 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 8.0 p -101.99 121.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -103.64 129.39 50.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.603 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -136.69 118.55 15.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -89.75 -77.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.476 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -134.33 -61.24 0.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.828 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.29 18.32 12.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.557 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -117.71 164.05 15.56 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.997 0.427 . . . . 0.0 111.25 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 27' ' ' VAL . 6.5 tp -155.8 126.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' CE2' ' CB ' ' A' ' 51' ' ' SER . 18.8 m-85 -140.86 110.2 6.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB1' ' CD2' ' A' ' 72' ' ' LEU . . . -94.04 121.46 35.55 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.33 117.4 30.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.205 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -100.24 103.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.479 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -105.95 161.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.449 -177.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.407 ' N ' HG21 ' A' ' 39' ' ' ILE . 16.2 t0 -92.7 114.32 26.84 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.962 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 25.4 t0 -92.05 23.58 3.69 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.277 0.985 . . . . 0.0 112.148 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.25 -47.82 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.6 mppt? -133.31 118.09 18.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.68 90.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.432 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . 67.4 t -139.61 112.28 5.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.15 114.79 16.33 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -94.19 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.2 t -123.67 144.51 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.338 0.59 . . . . 0.0 112.093 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -150.24 114.78 5.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.826 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.06 161.98 27.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.804 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.486 ' CB ' ' CE2' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -150.06 144.36 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.875 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.5 -179.818 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 64' ' ' VAL . 40.7 t -94.2 -16.3 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.56 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.566 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -30.5 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.26 -60.53 2.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 1.6 mt-30 -48.01 -26.11 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.419 178.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -76.66 -39.27 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.992 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.607 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -70.5 -37.42 69.01 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.815 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 16.1 ptt85 -64.27 -36.88 85.56 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.706 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.97 -54.95 26.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.097 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.506 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -63.79 -42.15 97.8 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 69' ' ' GLY . . . -62.46 -27.7 69.3 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.715 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.3 tt0 -78.04 -25.52 47.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.466 178.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.706 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 2.4 mttp -82.4 -62.11 1.71 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -46.08 -43.28 14.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.407 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -55.97 -39.65 72.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.107 178.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.54 -23.95 12.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.878 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -89.38 -27.14 20.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.59 17.7 10.27 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.961 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -69.1 106.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.513 0.673 . . . . 0.0 110.346 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLU . 1.5 ttpt -92.45 -61.07 1.68 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.207 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.39 146.32 34.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.356 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -131.72 165.78 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.205 0.526 . . . . 0.0 111.776 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.17 104.75 14.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.838 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.133 0.492 . . . . 0.0 111.741 -178.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -122.26 38.89 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.957 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 20.6 ptt180 -40.45 -33.38 0.26 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.516 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.77 -129.38 8.62 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.306 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.93 44.99 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.777 2.318 . . . . 0.0 112.298 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.6 m-30 -97.38 153.71 17.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.007 0.432 . . . . 0.0 111.114 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.34 154.66 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.884 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -49.29 101.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 110.201 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.426 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 31.4 t-80 -111.92 -112.38 0.33 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.002 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.29 -37.12 0.31 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.672 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 10.4 mpt_? -67.96 -71.06 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 70.8 t -36.41 -32.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.968 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.624 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -63.74 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.037 0.446 . . . . 0.0 110.893 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -43.2 -40.79 3.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.334 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -69.81 -48.77 57.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.757 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -55.35 -30.69 60.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.52 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.849 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.68 -47.0 57.11 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.764 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.19 -57.27 7.23 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . . . -62.78 -37.87 88.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.517 -1.342 . . . . 0.0 111.599 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -85.4 -33.16 22.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.068 0.461 . . . . 0.0 110.487 179.549 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.849 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.8 pt-20 -70.0 -37.53 75.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -68.24 -50.13 41.28 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.375 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 174.92 -26.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.945 -1.121 . . . . 0.0 114.978 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.34 144.68 49.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.95 96.75 4.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.47 178.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.591 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.093 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -105.33 129.13 53.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.546 -179.108 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.2 tt -89.47 141.27 28.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.392 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.434 ' OG ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -144.7 108.37 4.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.777 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 14.9 p -97.06 126.98 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.765 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.76 141.56 42.22 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.679 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 97' ' ' VAL . 35.7 mtt85 -150.11 118.69 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 p -89.91 -42.51 11.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.166 0.508 . . . . 0.0 110.416 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tt -179.98 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.723 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -119.29 -6.7 10.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -109.07 116.4 31.89 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.885 0.374 . . . . 0.0 111.617 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 52' ' ' SER . 2.0 tp -105.25 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.034 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 27.5 m-85 -146.93 109.24 4.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -93.45 125.47 38.08 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -113.85 113.45 24.91 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.837 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -97.87 102.98 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.905 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.434 ' CD1' ' OG ' ' A' ' 26' ' ' SER . 3.6 mp -107.68 161.27 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HA ' HD21 ' A' ' 23' ' ' LEU . 5.3 t0 -89.44 115.14 26.65 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.779 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 4.0 t70 -92.3 24.08 3.57 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.376 1.048 . . . . 0.0 112.274 -178.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -109.49 -47.63 3.35 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 177.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.5 mttp -133.54 118.12 17.92 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.95 89.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.301 -177.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' LYS . 98.6 t -137.88 112.52 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -76.38 119.19 19.91 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.84 -56.81 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.62 142.1 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.211 0.529 . . . . 0.0 112.208 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.4 115.21 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.997 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -122.98 163.76 19.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.059 0.457 . . . . 0.0 111.963 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 18.2 p -146.06 126.9 14.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.046 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.471 ' HB3' HG23 ' A' ' 34' ' ' ILE . 1.1 p . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 64' ' ' VAL . 95.0 t -94.06 -17.19 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.621 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -33.94 -40.45 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.602 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.43 -60.13 2.82 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.47 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.9 mt-30 -49.34 -23.53 1.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.645 177.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -77.53 -35.5 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.524 178.573 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -78.48 -34.79 34.78 Favored Glycine 0 C--O 1.218 -0.901 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -64.77 -37.23 86.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.722 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -46.41 76.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.6 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -61.55 -51.18 69.65 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.315 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -59.04 -25.87 64.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.745 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 18.2 tt0 -72.0 -35.59 69.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.467 0.651 . . . . 0.0 109.37 178.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 9.1 mttt -78.81 -63.76 1.34 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.994 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -42.96 -42.45 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.706 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -58.45 -41.2 84.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.387 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -50.28 -25.86 4.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.319 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.189 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 113.94 15.12 8.77 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.855 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -76.83 102.66 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.13 0.491 . . . . 0.0 110.187 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -106.3 -23.37 12.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.841 -179.564 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.49 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -129.84 125.29 35.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.284 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -123.09 165.41 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.435 0.636 . . . . 0.0 111.839 -179.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.14 111.63 22.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.754 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -80.95 111.41 17.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 111.789 -178.219 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.03 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 9.4 ptt-85 -41.82 -37.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.01 -125.41 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.47 0.26 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.521 2.147 . . . . 0.0 112.877 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CD2' ' CE1' ' A' ' 94' ' ' HIS . 4.4 m-85 -58.71 144.03 44.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.97 109.57 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.544 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER 0.11 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.123 0.569 . . . . 0.0 112.103 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -131.02 173.42 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.468 -179.009 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -36.58 -67.81 0.37 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.741 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -47.34 -66.36 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.593 0.235 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 89.9 t -29.61 -45.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.022 0.529 . . . . 0.0 112.014 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.43 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.031 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.38 -37.6 75.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.075 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 4.8 tt -64.68 -47.77 77.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.389 0.614 . . . . 0.0 111.238 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.08 -31.6 72.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.694 -178.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.767 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -66.58 -46.31 76.37 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.31 -59.4 5.83 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.958 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -57.74 -43.19 85.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.609 -1.295 . . . . 0.0 111.405 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.894 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -80.99 -48.14 12.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.302 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.3 pt-20 -52.89 -43.75 66.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.488 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -60.82 -48.39 86.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.19 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 178.46 -27.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.609 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.894 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.64 149.64 45.37 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -129.14 91.82 3.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.091 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.027 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.135 0 CA-C-O 120.688 0.28 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -100.53 125.36 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.948 0.404 . . . . 0.0 111.067 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.477 ' HG ' HD13 ' A' ' 38' ' ' ILE . 2.8 tt -89.53 141.47 28.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.959 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.446 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -150.33 108.86 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.141 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 5.0 p -102.48 120.45 52.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.215 0.531 . . . . 0.0 111.661 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.5 OUTLIER -97.38 144.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.683 -179.405 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.512 ' NE ' ' CB ' ' A' ' 96' ' ' ARG . 16.3 mtt85 -150.61 118.53 6.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.219 178.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.24 -35.85 12.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.671 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.93 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.459 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -119.3 6.59 11.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.485 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 33.5 m170 -115.89 103.14 10.33 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.467 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.5 tt -99.34 133.91 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.968 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 33.3 m-85 -147.3 110.2 4.73 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -93.01 120.91 33.79 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.402 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -112.42 113.03 25.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.283 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -95.83 98.76 8.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.221 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 37' ' ' GLN . 2.6 mp -100.62 166.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.574 -177.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.34 111.92 24.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.77 26.55 1.75 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.127 0.892 . . . . 0.0 112.304 -178.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -110.03 -47.45 3.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 17.0 mttp -135.11 118.13 16.38 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 174.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.19 90.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.439 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 43' ' ' LYS . 67.2 t -137.92 112.62 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -78.38 119.64 22.0 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -102.92 -58.56 1.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.331 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 75' ' ' LYS . 1.4 t -120.55 146.73 24.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.313 0.578 . . . . 0.0 111.916 -178.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -150.13 114.74 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.883 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.89 156.41 33.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.55 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.14 126.75 10.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' HG23 ' A' ' 34' ' ' ILE . 4.4 p . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 75.8 t -94.16 -20.83 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.65 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.18 -43.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.109 0.48 . . . . 0.0 111.759 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -65.48 -59.08 4.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.532 0.682 . . . . 0.0 109.413 178.938 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 16.1 mt-30 -50.35 -23.66 2.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.473 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.61 -32.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.52 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.516 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -78.03 -29.88 52.86 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.9 178.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.16 -40.11 71.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.634 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.24 -40.31 90.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.493 HD23 HD12 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -63.76 -55.41 23.36 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.1 -24.93 28.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.04 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -71.37 -37.51 71.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 18.2 mttt -71.82 -64.52 0.91 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.018 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -45.03 -41.02 7.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.536 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -59.74 -40.18 87.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.243 178.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.26 -24.21 7.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.28 -28.06 20.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.236 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.08 13.27 16.02 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.482 HG12 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.66 109.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 110.193 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.6 tttm -93.58 -56.23 2.99 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.39 -178.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.455 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -112.93 151.1 30.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.272 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -135.33 161.53 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.509 0.671 . . . . 0.0 112.132 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.85 87.79 2.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 19.9 t80 -80.7 108.33 14.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -176.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.37 98.58 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.685 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 7.3 tpt180 -90.42 11.66 20.89 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.467 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 90' ' ' PRO . . . 87.19 -113.94 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.147 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 2.3 Cg_endo -81.06 45.12 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.803 2.335 . . . . 0.0 112.122 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.461 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 3.2 m-85 -112.19 133.15 54.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 111.011 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.6 155.04 48.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.3 t80 -33.06 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -103.82 -166.34 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -178.752 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.703 ' C ' ' HE2' ' A' ' 98' ' ' LYS . . . -76.18 -17.14 80.2 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.235 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' CB ' ' NE ' ' A' ' 29' ' ' ARG . 3.8 mmt85 -97.92 -64.55 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.484 ' O ' ' C ' ' A' ' 98' ' ' LYS . 13.6 t -28.84 -70.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.703 ' HE2' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -29.47 -60.18 0.15 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.223 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' N ' ' HG2' ' A' ' 98' ' ' LYS . . . -69.99 -46.89 64.19 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.398 -177.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -61.41 -47.69 84.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.814 0.816 . . . . 0.0 109.422 179.247 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.458 ' N ' HD21 ' A' ' 100' ' ' LEU . . . -57.07 -40.36 76.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.64 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -62.58 -38.85 91.72 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.87 -59.34 8.15 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -60.89 -31.03 70.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.812 -1.194 . . . . 0.0 110.598 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.874 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 3.2 tpp85 -88.77 -25.52 22.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -82.7 -38.45 23.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -64.35 -46.35 90.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.638 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.81 -30.67 0.08 OUTLIER Glycine 0 C--N 1.341 0.835 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.556 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.874 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.57 146.56 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.455 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -128.32 99.7 5.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.127 178.328 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.5 p90 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.064 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.224 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.356 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 13.6 ttp180 -93.36 124.5 37.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.908 -178.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 2.5 tt -89.66 145.99 24.85 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.255 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.428 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -150.38 119.06 6.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.212 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.771 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.8 t -101.29 139.99 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.863 0.363 . . . . 0.0 111.664 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' HA ' ' OH ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -125.67 112.5 16.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HG2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.68 118.66 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.814 177.48 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -89.5 -78.88 0.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.55 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.58 -61.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -119.25 20.06 12.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.231 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -117.77 161.64 19.38 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.332 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' CD1' HD12 ' A' ' 100' ' ' LEU . 2.4 tp -151.37 128.05 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.939 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.449 ' CE2' ' OG ' ' A' ' 51' ' ' SER . 29.4 m-85 -145.42 150.83 37.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.153 0.502 . . . . 0.0 111.8 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -132.67 121.11 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 113.13 24.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.187 0.518 . . . . 0.0 110.22 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.484 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -96.21 96.31 5.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.24 163.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.921 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -96.9 109.31 22.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.574 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 18.2 p-10 -89.05 26.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.158 0.911 . . . . 0.0 112.273 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -110.67 -47.15 3.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.1 mppp? -133.26 118.17 18.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 174.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.43 89.72 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.418 -177.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 67.8 t -139.59 112.45 5.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.47 119.48 21.12 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 23' ' ' LEU . 1.2 mp -99.56 -59.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.193 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 76' ' ' ALA . 1.9 t -121.91 146.17 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.344 0.592 . . . . 0.0 112.004 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 88.3 p -150.18 114.86 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.943 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.37 158.3 33.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.844 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.449 ' OG ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.22 134.14 16.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.423 ' CB ' HG21 ' A' ' 34' ' ' ILE . 9.0 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 111.053 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.832 0.349 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.87 -19.81 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.291 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.543 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -34.28 -38.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.794 -179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.628 0.728 . . . . 0.0 109.157 178.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 10.6 mt-30 -49.68 -24.11 2.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.299 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.03 -32.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.534 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -76.99 -31.77 51.91 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.242 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.42 -42.59 68.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.62 -38.02 88.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.434 HD22 HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -65.48 -54.57 26.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.226 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -56.79 -24.22 48.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.938 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.27 -37.79 68.97 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 21.9 mttt -70.75 -67.12 0.53 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.095 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 109' ' ' LEU . . . -43.6 -41.96 4.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.685 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -59.3 -40.52 86.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.052 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.53 -23.92 7.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.455 HD13 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.46 -27.97 20.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.129 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.38 14.31 14.88 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.273 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -70.77 106.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.556 0.693 . . . . 0.0 110.019 179.722 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' GLU . 5.0 tttp -93.17 -54.55 3.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.493 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.73 144.2 41.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -130.73 159.89 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.5 0.667 . . . . 0.0 112.028 -179.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 17.1 t80 -80.39 106.51 12.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.635 0.731 . . . . 0.0 112.548 -176.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.95 97.78 2.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.362 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.771 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.4 tpt85 -83.55 -7.07 59.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.52 -110.21 2.0 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.24 34.94 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.021 2.48 . . . . 0.0 112.092 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 88' ' ' ARG . 2.9 m-30 -77.1 138.28 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.823 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 93' ' ' TYR . 9.4 tptt -121.28 99.49 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.796 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER 0.61 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.676 0.61 . . . . 0.0 112.236 -179.313 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.77 163.55 15.98 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.338 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -39.53 -60.64 1.69 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.55 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 33.6 mmt180 -47.72 -69.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.675 0.274 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.6 t -33.98 -38.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.809 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.64 -79.06 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.607 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.9 -34.45 65.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.542 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 101' ' ' ALA . 3.8 tt -68.17 -51.83 41.37 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.297 0.57 . . . . 0.0 110.969 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' N ' HD22 ' A' ' 100' ' ' LEU . . . -62.38 -29.63 70.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.671 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.02 -44.95 71.69 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.33 -57.66 7.96 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -62.25 -33.67 75.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.534 -1.333 . . . . 0.0 110.875 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.852 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 -22.84 23.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -85.2 -34.87 21.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -69.41 -44.63 63.98 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.655 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.14 -31.03 0.08 OUTLIER Glycine 0 C--N 1.341 0.828 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.632 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.852 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.4 mp -71.42 147.01 48.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.32 96.71 4.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.412 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p90 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' HG ' HG13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.139 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 122.73 37.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.501 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.507 ' HG ' HD13 ' A' ' 38' ' ' ILE . 2.7 tt -89.43 143.02 27.14 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.518 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.418 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 1.3 m -146.23 108.55 4.44 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.008 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG21 HD12 ' A' ' 100' ' ' LEU . 6.7 p -97.03 119.23 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.321 0.582 . . . . 0.0 112.132 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.423 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.3 t80 -105.62 140.84 38.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.702 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -150.46 126.32 10.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.782 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 t -89.65 -85.78 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.924 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.87 -58.28 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.002 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.47 19.24 13.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.336 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -119.04 156.92 28.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' C ' ' CD1' ' A' ' 35' ' ' TYR . 2.7 tp -142.76 132.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 39.1 m-85 -149.55 149.97 31.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 111.963 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 72' ' ' LEU . . . -133.74 128.4 34.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.24 113.26 21.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.722 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -99.55 99.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.32 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 40' ' ' ASP . 3.0 mp -104.32 160.05 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.794 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.0 t0 -91.36 114.19 26.65 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.51 22.74 2.85 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.077 0.861 . . . . 0.0 112.508 -178.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.67 -48.92 3.42 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.65 118.01 19.45 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.503 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.06 90.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.341 -177.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 60.2 t -136.1 112.58 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -77.87 118.48 20.23 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.1 mp -103.67 -50.85 3.32 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -126.86 142.59 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.442 0.639 . . . . 0.0 112.385 -178.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 80.8 p -150.08 115.01 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.498 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' CB ' ' HG ' ' A' ' 72' ' ' LEU . . . -126.0 161.78 26.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.32 127.06 10.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 179.527 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 68' ' ' VAL . 10.3 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.203 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.787 0.327 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 65' ' ' ALA . 79.2 t -93.99 -24.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.469 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.18 -40.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.961 0.41 . . . . 0.0 111.748 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.06 -60.36 2.69 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.385 0.612 . . . . 0.0 109.376 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.0 mt-30 -48.66 -27.04 2.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.194 178.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.578 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -74.63 -35.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.57 178.616 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -75.38 -36.93 43.01 Favored Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.068 178.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.642 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -62.14 -35.72 79.63 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -67.27 -45.93 75.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.067 178.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 68' ' ' VAL . 2.5 mt -63.55 -53.95 43.8 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.666 0.746 . . . . 0.0 109.019 178.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.91 -25.75 61.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.905 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -76.66 -26.92 55.37 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.108 178.183 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 27.2 mttm -82.9 -63.01 1.45 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.536 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.539 ' HB1' HD12 ' A' ' 109' ' ' LEU . . . -45.57 -42.6 11.24 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.02 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -55.84 -40.15 72.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.127 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.63 -24.98 9.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.04 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.52 -28.29 19.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.32 15.43 11.49 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.352 -179.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.522 HG13 ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -66.52 106.21 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.519 0.676 . . . . 0.0 110.192 179.865 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.17 -56.78 3.03 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.165 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -113.73 144.72 42.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.261 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -128.16 161.7 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.651 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.85 103.28 12.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.999 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -81.56 108.42 15.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.124 0.487 . . . . 0.0 111.592 -179.078 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.24 45.81 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 1.3 ptt180 -41.53 -33.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.611 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.45 -117.96 5.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -88.74 20.07 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.771 2.314 . . . . 0.0 112.705 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.2 m-85 -80.92 138.74 36.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 0.0 111.214 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.02 151.34 25.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.6 106.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.649 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.32 164.57 18.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.85 -42.6 7.87 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.134 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -57.89 -70.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 0.0 110.668 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.0 t -37.45 -40.49 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.952 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.91 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.62 -35.36 70.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.699 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.4 tt -67.34 -49.6 63.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.084 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.17 -29.57 69.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.172 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.854 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -69.88 -44.26 70.16 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.369 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.77 -56.96 9.05 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -64.87 -31.43 72.66 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 113.578 -1.311 . . . . 0.0 111.013 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -89.97 -25.7 20.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.022 0.439 . . . . 0.0 110.726 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.1 pt-20 -80.48 -37.66 31.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -66.8 -48.32 62.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.493 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.01 -29.16 0.07 OUTLIER Glycine 0 C--N 1.343 0.949 0 C-N-CA 119.905 -1.14 . . . . 0.0 115.023 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.48 146.54 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.418 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -128.24 96.31 4.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.379 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.4 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.004 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 81' ' ' ILE . 1.7 mp . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 120.815 0.341 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -102.71 126.82 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.176 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD11 ' CD1' ' A' ' 111' ' ' PHE . 5.3 tt -89.74 147.15 24.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.818 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 2.1 m -139.16 158.58 43.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.581 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -146.09 127.45 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.967 0.413 . . . . 0.0 110.265 179.219 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -128.68 122.49 30.91 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.912 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -130.81 123.55 29.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.639 178.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.09 -91.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.833 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.39 -64.76 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 109.829 179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 27.99 8.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.794 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -119.69 161.87 19.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.439 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 52' ' ' SER . 3.5 tp -149.34 128.23 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.513 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.482 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 27.4 m-85 -144.02 160.15 41.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.312 0.577 . . . . 0.0 111.839 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -145.77 126.97 14.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.006 177.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -115.33 113.18 23.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 110.679 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.2 92.34 3.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.58 161.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.53 115.44 27.6 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.826 177.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.7 t0 -92.42 28.67 1.89 Allowed 'General case' 0 N--CA 1.464 0.239 0 O-C-N 124.289 0.993 . . . . 0.0 112.22 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.45 -47.72 3.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.1 mptt -136.78 118.25 14.77 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 174.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.37 89.16 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.545 -177.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 43' ' ' LYS . 92.8 t -137.43 112.61 10.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.194 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -74.86 119.26 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -98.23 -63.63 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.23 147.51 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.402 0.62 . . . . 0.0 112.4 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.4 p -150.27 129.44 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.82 179.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 72' ' ' LEU . . . -141.75 157.61 44.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.494 . . . . 0.0 112.32 -179.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.39 129.19 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.515 179.594 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 48.1 m . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.769 179.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.754 0.312 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 73.2 t -94.06 -23.14 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.33 -41.66 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.735 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.01 -60.82 2.46 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.475 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.4 mt-30 -48.14 -26.19 1.78 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.241 177.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.552 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -77.49 -34.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.586 178.597 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.561 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.51 -31.33 54.68 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -67.94 -34.96 77.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.943 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.52 -41.48 65.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.151 177.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.561 HD12 ' HA2' ' A' ' 69' ' ' GLY . 5.1 mt -63.68 -46.33 86.02 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -68.32 -27.18 66.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -67.43 -37.16 82.58 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 109.298 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 3.2 mttt -81.34 -63.96 1.29 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.068 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -41.21 -42.34 2.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.135 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -61.15 -40.33 93.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.963 179.4 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.9 -22.57 5.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.483 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.17 -27.09 20.92 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.028 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.33 17.08 11.05 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.068 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -70.84 103.91 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.694 0.759 . . . . 0.0 110.312 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLU . 10.2 ttpt -95.75 -46.71 6.48 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.07 -178.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 140.63 52.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.379 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -127.89 167.45 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.473 0.654 . . . . 0.0 111.975 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.74 105.17 15.31 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 88' ' ' ARG . 1.6 t80 -80.67 106.24 12.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.823 0.82 . . . . 0.0 112.597 -177.291 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.41 105.46 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.834 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -90.39 -48.06 7.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.675 -178.029 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.3 -112.48 2.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.163 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.16 26.84 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.834 2.356 . . . . 0.0 112.59 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 m-30 -99.66 162.54 12.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 111.368 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -132.01 148.07 52.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.886 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -44.61 103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.609 -179.858 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.06 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.142 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.31 -42.51 25.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.129 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -56.27 -71.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.537 0.208 . . . . 0.0 110.985 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -39.46 -43.12 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.742 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.451 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.04 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.041 0.448 . . . . 0.0 111.067 -179.643 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.36 -36.84 71.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.213 -179.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.2 tt -68.32 -49.11 62.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 110.82 -179.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -58.65 -32.99 69.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.333 -178.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.74 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.75 -47.83 65.28 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.599 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.04 -58.32 6.37 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 177.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -58.36 -42.55 87.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.363 -1.419 . . . . 0.0 111.354 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -79.55 -53.77 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -48.35 -41.25 28.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.258 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 73' ' ' ALA . . . -65.14 -49.58 61.35 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.842 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 178.66 -27.89 0.06 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.16 -1.019 . . . . 0.0 114.522 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.84 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.5 147.73 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.35 91.91 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 178.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.507 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.011 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' CD1' HG13 ' A' ' 81' ' ' ILE . 1.1 mp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.907 0.384 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -105.28 124.64 49.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.1 tt -90.54 143.02 27.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.257 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.442 ' CA ' ' HD3' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -145.14 110.17 5.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.165 -179.816 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 2.2 p -100.83 123.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.072 0.463 . . . . 0.0 111.921 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.482 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -100.5 154.24 18.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 112.316 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 18.1 mtm105 -150.29 118.81 6.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.32 179.133 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 -45.28 9.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.054 0.454 . . . . 0.0 110.994 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tp 179.89 -63.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -115.29 22.2 13.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.285 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -122.2 173.15 7.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.958 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.458 ' CD1' HD12 ' A' ' 100' ' ' LEU . 5.2 tp -158.4 132.69 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 30.8 m-85 -148.21 148.69 30.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 72' ' ' LEU . . . -134.23 121.29 21.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.876 177.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -111.76 112.88 24.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -98.31 105.3 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.106 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.409 ' HA ' HD12 ' A' ' 47' ' ' LEU . 3.8 mp -108.26 160.08 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -88.83 116.33 27.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.831 178.109 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.4 t0 -91.74 22.38 4.18 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.415 1.072 . . . . 0.0 112.256 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.04 -46.67 3.43 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mmmt -133.16 118.31 18.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 174.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.56 86.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 43' ' ' LYS . 61.7 t -134.89 112.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -72.4 113.87 9.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.9 -57.29 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.713 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG13 HD23 ' A' ' 72' ' ' LEU . 2.3 t -131.62 152.76 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.234 0.54 . . . . 0.0 111.902 -178.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -150.31 119.61 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.934 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.66 148.56 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 112.128 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.39 139.97 21.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.641 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 111.469 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 64' ' ' VAL . 63.9 t -94.03 -18.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.924 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 68' ' ' VAL . . . -31.11 -42.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 111.95 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.03 -60.41 2.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.584 0.707 . . . . 0.0 109.205 178.648 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 25.2 mt-30 -49.18 -24.14 1.59 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.368 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.17 -32.37 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.268 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -77.44 -26.82 60.57 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.276 178.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 7.5 ppt_? -77.31 -38.45 50.55 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.346 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.37 72.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -72.21 -52.12 17.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.981 178.428 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -62.85 -23.67 67.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.532 178.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 42.7 mt-10 -77.79 -30.04 51.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 16.5 mttt -73.82 -68.29 0.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.416 177.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.45 -42.44 7.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.104 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -57.12 -38.89 74.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.823 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -54.55 -23.07 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.932 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.903 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 18.97 9.53 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.109 -178.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.41 104.93 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.559 0.695 . . . . 0.0 110.356 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 4.1 tttt -90.99 -57.22 2.88 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.372 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.91 146.91 35.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.421 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.83 165.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.5 0.667 . . . . 0.0 112.023 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.38 97.3 7.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.324 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 5.3 t80 -81.12 109.68 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.28 86.48 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.651 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.0 tpt180 -77.66 -27.7 50.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.046 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.29 -109.31 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.226 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.19 34.2 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.823 2.348 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.475 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 2.7 m-85 -96.34 138.11 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.124 0.488 . . . . 0.0 111.558 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 149.54 30.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.932 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.497 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -45.51 97.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.779 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.5 159.11 17.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.459 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -40.17 -51.44 3.55 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.492 -179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.456 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . 2.4 mtt-85 -55.0 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.636 0.255 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -40.28 -38.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.273 179.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -61.16 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.012 0.434 . . . . 0.0 110.592 -179.96 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.73 -36.08 64.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.99 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 101' ' ' ALA . 1.3 tt -70.35 -52.68 20.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.204 0.526 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -56.41 -32.32 64.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.319 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.794 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.6 -44.6 70.39 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.043 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.79 -57.09 8.92 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -61.78 -33.69 74.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.49 -1.355 . . . . 0.0 110.93 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.843 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.5 tpp85 -88.97 -24.11 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.794 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -83.6 -34.94 25.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.482 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -69.3 -45.35 61.41 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.921 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.03 -30.64 0.08 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.178 -1.011 . . . . 0.0 114.454 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.843 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.36 142.81 50.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.193 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 2.0 mp0 -127.7 99.8 5.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.066 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 2.1 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.091 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.54 0.21 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -43.37 124.02 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.724 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.84 125.52 37.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.635 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 84' ' ' VAL . 3.7 tt -89.45 144.03 26.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 m -145.82 108.53 4.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.43 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 4.5 p -98.3 123.43 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.177 0.513 . . . . 0.0 111.882 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -106.98 145.26 32.48 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -150.29 119.17 6.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.74 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.66 -69.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.072 0.463 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.6 mt -147.6 -59.16 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.441 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -119.37 4.36 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.379 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -109.1 116.25 31.59 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.994 0.426 . . . . 0.0 111.356 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.0 tp -104.09 129.09 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 20.3 m-85 -143.16 151.21 40.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.215 0.531 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 72' ' ' LEU . . . -137.61 122.52 18.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.397 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 113.26 25.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.0 110.547 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 HD13 HD21 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -97.02 100.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.02 163.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.892 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.63 114.03 26.26 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -90.26 26.65 1.86 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.331 1.019 . . . . 0.0 112.419 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.67 -47.64 3.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.29 118.22 17.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.82 89.25 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.374 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.5 t -138.3 112.41 8.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -76.94 119.35 20.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 1.4 mp -102.32 -57.57 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 75' ' ' LYS . 2.1 t -122.69 146.12 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 0.0 111.907 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -150.16 114.91 5.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.98 148.4 44.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.886 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.47 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.43 136.77 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.978 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.3 m -60.39 -57.49 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.007 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.0 tm? -64.09 -15.39 59.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.58 -62.02 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mp -52.45 -52.07 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.642 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.12 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.812 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 75.5 mt -51.86 115.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 24.69 9.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.02 -116.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.77 178.02 7.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.747 0.308 . . . . 0.0 110.828 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -38.77 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -28.09 16.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -54.12 50.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.739 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 69.0 t -86.08 -21.46 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.198 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -30.6 -43.98 0.05 Allowed 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -64.12 -60.94 2.61 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.517 0.675 . . . . 0.0 109.398 178.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -48.45 -25.28 1.58 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.23 177.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -80.13 -33.16 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.639 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.532 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -77.52 -27.91 58.44 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.161 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.7 ppt_? -74.77 -38.61 62.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -70.27 -34.94 73.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 1.8 tp -68.98 -54.29 16.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.82 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . -61.94 -25.31 67.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.913 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.9 mt-10 -77.88 -30.22 50.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.3 mttt -72.77 -69.27 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.518 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.72 -42.55 7.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -55.85 -39.1 70.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.023 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.01 13.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.54 -27.77 20.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.28 14.93 12.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.297 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.473 HG21 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -70.88 107.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.496 0.665 . . . . 0.0 110.237 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 110' ' ' GLU . 24.4 ttpt -94.53 -52.45 4.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.361 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.431 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -114.85 142.61 46.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.204 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -128.04 161.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.414 0.626 . . . . 0.0 112.058 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.02 100.88 11.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.282 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 1.9 t80 -81.06 106.25 12.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.155 0.502 . . . . 0.0 111.216 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.16 43.16 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.155 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.2 ptt180 -37.71 -39.18 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.809 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.72 -117.32 5.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.734 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.15 50.62 3.6 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 111.979 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 5.9 m-85 -123.22 102.23 7.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -71.52 139.33 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.881 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -52.11 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -103.73 -165.12 1.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.148 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.82 -55.81 9.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.987 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -45.77 -71.25 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.653 0.263 . . . . 0.0 110.586 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 8.8 p -42.59 -32.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -66.37 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.96 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -47.28 -35.87 8.4 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.772 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -70.18 -41.24 74.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.07 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -66.65 -34.93 78.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.461 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.742 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -66.25 -44.2 84.35 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.32 -57.0 10.93 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.548 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -61.26 -33.02 72.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.552 -1.324 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.815 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.1 tpp180 -90.05 -26.25 20.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.721 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.742 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.3 pt-20 -80.82 -33.33 34.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -71.91 -46.68 35.86 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.946 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.9 -31.42 0.07 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 119.989 -1.101 . . . . 0.0 114.731 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.3 mp -71.36 143.99 50.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' CB ' ' HG3' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -127.9 95.15 4.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.136 178.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 2.2 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.2 ttm105 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -107.07 135.48 48.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' CB ' ' HB3' ' A' ' 41' ' ' ASP . 1.5 ttp85 -101.12 127.16 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' HG ' HD12 ' A' ' 38' ' ' ILE . 2.7 tt -89.42 140.87 29.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.15 112.34 7.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.24 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -92.74 135.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.564 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 1.4 t80 -123.93 115.64 21.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.102 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.59 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -126.27 118.72 25.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.542 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.25 -48.58 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' ' NH1' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -170.52 -64.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.27 20.81 13.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.405 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 1.5 m80 -127.74 132.68 49.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.032 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 96' ' ' ARG . 4.0 tp -121.85 118.47 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.303 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.552 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 9.2 m-85 -136.5 108.39 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -97.54 126.03 42.58 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 116.07 29.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.321 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -97.43 98.35 7.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.169 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.71 165.45 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.039 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.16 112.07 24.02 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.721 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.1 p30 -91.12 27.04 1.97 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.15 0.906 . . . . 0.0 112.252 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -110.15 -46.9 3.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.3 mptt -134.62 118.25 17.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.83 90.33 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.341 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.6 t -140.98 112.53 3.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -76.48 123.12 25.55 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 1.3 mp -104.02 -61.78 1.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -120.59 144.9 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.224 0.535 . . . . 0.0 111.952 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.4 p -150.21 116.06 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.175 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB1' ' HG ' ' A' ' 72' ' ' LEU . . . -126.54 151.22 48.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.212 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.552 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 7.1 t -150.44 134.88 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.884 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 5.4 t -52.67 -26.25 13.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.035 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.51 -62.48 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.728 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.4 -25.9 51.5 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.424 0.631 . . . . 0.0 109.946 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.6 mp -90.14 12.49 17.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.881 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 3.09 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.64 0.776 . . . . 0.0 112.804 -177.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 55' ' ' LEU . 1.9 pt? -46.75 171.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.332 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 32.6 6.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.36 -155.8 9.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.13 -71.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -175.95 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 p -93.11 -10.24 36.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.33 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -68.15 -42.34 80.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 67' ' ' GLN . 53.0 t -93.99 -18.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.722 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.52 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -35.43 -39.32 0.12 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.8 -59.96 3.09 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.554 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.7 mt-30 -49.58 -27.28 4.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.297 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -75.01 -33.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -76.78 -27.26 61.07 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.7 -33.58 72.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.9 -36.62 56.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 ' HA2' ' A' ' 69' ' ' GLY . 6.3 mt -65.39 -45.54 83.61 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -73.06 -33.27 65.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.845 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 46.4 mt-10 -71.34 -33.22 69.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 19.7 mttt -70.17 -67.65 0.48 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' A' ' 109' ' ' LEU . . . -46.37 -41.08 13.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.963 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 11.0 mt -57.97 -38.97 77.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.023 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.52 -23.61 10.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.946 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.469 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.53 -27.38 20.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.5 16.59 10.81 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.206 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.485 HG23 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -72.16 107.96 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.516 0.674 . . . . 0.0 110.393 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -95.15 -53.45 3.8 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.442 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -115.14 142.57 46.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.44 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -128.55 163.47 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.496 0.665 . . . . 0.0 111.884 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.11 98.8 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.169 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 2.1 t80 -81.15 113.89 19.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.459 0.647 . . . . 0.0 111.806 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.17 33.7 0.66 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.675 ' C ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -43.31 -41.6 4.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.795 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' N ' ' HD3' ' A' ' 88' ' ' ARG . . . 156.28 -136.61 5.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -95.73 37.85 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.193 2.595 . . . . 0.0 112.736 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' NH2' ' A' ' 88' ' ' ARG . 4.7 m-30 -88.62 84.94 6.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.339 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -71.85 133.62 45.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.559 ' C ' ' O ' ' A' ' 92' ' ' LYS . 1.4 t80 0.69 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.533 0.521 . . . . 0.0 112.304 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.543 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.1 m170 -94.18 148.31 22.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.216 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -29.01 -39.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.095 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.59 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.6 mmt180 -79.49 -65.43 1.0 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.678 0.275 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 31.8 t -30.48 -49.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -53.99 -72.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.495 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.56 -40.94 96.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.476 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.4 tt -63.19 -45.71 90.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.473 0.654 . . . . 0.0 110.446 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.58 -30.32 69.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.291 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.02 -46.74 70.4 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.25 -54.71 9.69 Favored Glycine 0 CA--C 1.508 -0.393 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -64.83 -36.15 83.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.269 -1.465 . . . . 0.0 111.469 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -87.48 -24.25 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.412 . . . . 0.0 110.764 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -82.59 -37.47 24.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -66.78 -47.98 64.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.002 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.31 -30.06 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.513 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.8 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.0 mp -71.41 143.7 50.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.42 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -127.69 99.38 5.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.881 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.546 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 p90 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.895 . . . . 0.0 111.068 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.816 0.341 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -102.34 132.4 48.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.411 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -101.54 125.16 48.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.9 tt -89.55 143.42 26.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.412 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 72.3 m -146.97 108.76 4.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.966 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.452 HG23 HD12 ' A' ' 100' ' ' LEU . 7.7 p -93.39 119.77 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.07 140.22 37.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.785 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' CG ' HD12 ' A' ' 34' ' ' ILE . 3.2 mmm180 -150.08 118.92 6.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.951 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.74 -64.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.21 0.529 . . . . 0.0 110.291 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 -58.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -119.71 2.28 11.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.634 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 32.5 m170 -110.33 117.66 34.22 Favored 'General case' 0 N--CA 1.46 0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 112.089 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 3.8 tp -106.45 131.0 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.768 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' A' ' 34' ' ' ILE . 37.1 m-85 -148.98 111.97 4.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 72' ' ' LEU . . . -93.72 123.59 37.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.56 113.52 26.38 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.481 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -99.04 96.51 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.4 164.7 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.306 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -95.61 113.19 24.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 10.0 t70 -88.35 21.83 2.72 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.376 1.048 . . . . 0.0 112.352 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.47 -48.85 3.18 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 45' ' ' VAL . 4.3 mmtp -129.77 118.17 21.4 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.72 87.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.722 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' LYS . 53.0 t -136.39 112.5 12.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -75.86 117.81 17.99 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 75' ' ' LYS . 1.6 t -119.07 143.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 112.238 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.03 114.69 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.36 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -120.81 159.18 25.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.89 126.86 15.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.49 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.515 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.3 m -63.98 -34.09 77.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.35 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 57' ' ' LEU . 3.6 pp -70.39 -8.89 54.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.425 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.91 -53.55 5.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mp -52.37 -44.49 65.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 tttt 178.99 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.453 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 52' ' ' SER . 4.8 tt -40.11 133.91 1.64 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.941 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -132.05 -45.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.26 -80.42 1.33 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.598 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.42 120.57 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.65 -60.23 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 1.1 p -55.41 -23.55 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.322 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.56 -66.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 65' ' ' ALA . 97.9 t -80.73 -19.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.662 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.571 ' O ' HG13 ' A' ' 68' ' ' VAL . . . -35.22 -37.96 0.08 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.904 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -69.66 -58.9 3.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.4 mt-30 -49.84 -22.63 1.53 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.488 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.23 -33.63 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -76.64 -33.6 46.75 Favored Glycine 0 C--O 1.217 -0.93 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.131 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -72.31 -41.78 66.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.663 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.95 -40.58 91.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -64.34 -54.49 32.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.2 -25.25 31.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.8 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.8 tt0 -72.14 -36.85 69.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 10.2 mttp -71.85 -64.49 0.92 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.843 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -44.88 -42.65 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.318 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -59.23 -40.8 87.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.257 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.44 -25.66 6.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.417 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.42 -28.0 20.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 12.9 13.18 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.627 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.488 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.78 104.1 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.649 0.738 . . . . 0.0 110.036 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 110' ' ' GLU . 21.2 ttpp -92.79 -49.75 5.91 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.147 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.43 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -117.43 136.31 53.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.362 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -123.89 162.93 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.376 0.608 . . . . 0.0 111.838 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.2 102.55 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.961 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.58 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.47 121.19 25.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.49 . . . . 0.0 111.549 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 1.3 t70 -148.48 45.88 1.04 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.162 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.417 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.9 ptt-85 -40.39 -31.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.661 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.48 -125.01 7.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.5 59.84 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.418 2.078 . . . . 0.0 111.754 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.417 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 8.4 m-85 -131.66 157.51 43.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 111.391 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -132.21 140.78 48.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.357 178.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -41.0 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CG ' HG22 ' A' ' 97' ' ' VAL . 18.8 p80 -112.88 151.16 30.79 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 94' ' ' HIS . . . -20.88 -55.97 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.164 -0.925 . . . . 0.0 114.039 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 1.9 mmp_? -57.63 -64.54 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 88.7 t -35.41 -46.65 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.567 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.36 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.44 -43.27 62.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.889 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.2 tt -61.62 -45.22 95.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.347 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.72 -37.63 86.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.805 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.809 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -67.42 -42.65 82.86 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.551 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.14 -58.94 8.07 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.92 -35.13 74.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.802 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -87.92 -30.43 20.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.418 . . . . 0.0 110.692 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.809 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.0 pt-20 -74.22 -35.15 63.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.72 -46.26 54.69 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.458 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.476 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 174.42 -27.76 0.08 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.941 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.46 145.24 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER -128.16 93.98 3.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.504 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.938 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -104.22 133.83 48.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.428 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 16.3 ttp-105 -101.28 125.0 47.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.4 tt -89.11 141.76 28.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.938 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.439 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.27 107.95 5.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.084 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 100' ' ' LEU . 9.6 p -95.53 116.5 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.263 0.554 . . . . 0.0 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 1.3 t80 -93.61 134.98 35.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.972 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' NH2' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -123.34 118.12 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 t -90.25 -79.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.06 -58.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.36 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.27 1.85 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.182 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.15 174.57 6.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.342 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' CD1' ' NH2' ' A' ' 29' ' ' ARG . 2.8 tp -150.45 111.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -136.56 140.67 43.1 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -128.54 127.95 43.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.257 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.05 114.02 25.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.441 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -98.19 95.2 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.317 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.84 163.89 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.858 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HA ' HD23 ' A' ' 23' ' ' LEU . 1.4 t0 -95.19 114.71 26.53 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.711 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.6 t70 -90.28 23.53 2.87 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.405 1.065 . . . . 0.0 112.311 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.13 -47.77 3.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.19 118.17 16.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 174.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.95 89.97 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.28 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.0 t -139.63 112.42 5.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -72.1 113.6 9.31 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 23' ' ' LEU . 1.9 mp -92.86 -65.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.91 148.33 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.266 0.555 . . . . 0.0 111.63 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -150.14 114.84 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.654 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.62 138.98 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 111.853 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.48 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 36.9 p -150.3 132.63 15.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -51.39 -33.2 29.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -59.71 -63.62 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.334 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.97 62.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.534 . . . . 0.0 110.174 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 mp -89.07 11.37 18.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.278 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.5 tttt 2.17 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.33 0.652 . . . . 0.0 112.463 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -100.66 176.1 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.037 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -80.19 74.38 7.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.624 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.446 ' HA3' ' CG2' ' A' ' 64' ' ' VAL . . . -136.25 -168.46 11.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.781 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -133.31 -55.92 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.576 0.227 . . . . 0.0 110.995 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -175.54 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.681 0.277 . . . . 0.0 111.619 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -43.0 57.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.749 0.309 . . . . 0.0 111.614 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -50.76 -39.02 51.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.313 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.446 ' CG2' ' HA3' ' A' ' 59' ' ' GLY . 73.9 t -94.26 -22.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.766 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 68' ' ' VAL . . . -33.92 -39.8 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.673 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.35 -59.55 3.32 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.525 0.678 . . . . 0.0 109.172 178.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.5 mt-30 -49.66 -26.56 3.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.205 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -77.43 -32.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -76.38 -26.39 63.72 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 8.2 ptt85 -73.47 -39.83 64.61 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 70' ' ' ARG . . . -68.57 -36.23 78.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 1.1 tp -68.69 -53.48 21.97 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.015 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . -63.35 -25.12 68.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.528 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 15.8 mt-10 -78.2 -29.98 48.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mttt -71.82 -69.16 0.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.403 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' A' ' 109' ' ' LEU . . . -44.84 -42.84 8.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.181 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -56.02 -39.16 71.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.71 -24.58 8.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.071 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.71 -27.04 20.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.62 21.82 7.0 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.061 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.436 HG12 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -84.53 102.84 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.136 0.494 . . . . 0.0 110.771 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.652 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.97 -25.62 12.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.55 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -125.27 125.24 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.187 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -125.12 164.54 23.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 112.06 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -105.31 105.51 15.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.391 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.568 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.37 118.01 22.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.394 0.616 . . . . 0.0 112.011 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.03 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.644 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HG3' ' CG ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.43 -29.57 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' N ' ' HG2' ' A' ' 88' ' ' ARG . . . 123.12 -151.43 16.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.94 55.99 4.63 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.927 2.418 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.467 ' CG ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m-30 -100.18 166.52 10.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.024 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.91 153.51 50.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.47 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -47.33 109.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.502 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.508 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -126.25 156.53 40.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -38.44 -30.01 0.08 OUTLIER Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 1.2 mmt85 -76.7 -70.97 0.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.598 0.237 . . . . 0.0 111.606 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 60.0 t -31.01 -50.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -57.96 -75.06 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.864 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.58 -37.67 68.37 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.172 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.1 tt -67.66 -49.16 64.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.3 -33.16 73.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.402 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.758 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -66.53 -46.54 75.81 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.08 -57.91 7.52 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.741 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -58.15 -39.95 80.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.354 -1.423 . . . . 0.0 111.428 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.812 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -82.58 -51.42 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -49.44 -40.57 37.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -65.58 -48.81 64.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.359 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.14 -26.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.092 -1.051 . . . . 0.0 114.713 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.812 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.37 145.98 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -128.2 91.99 3.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.455 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.568 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.3 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.955 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HD3' ' HB2' ' A' ' 42' ' ' GLU . 7.7 ptm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -33.86 137.62 0.1 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.198 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.02 124.32 36.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' N ' HG13 ' A' ' 84' ' ' VAL . 3.4 tt -89.35 143.54 26.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.408 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -144.61 108.48 4.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.753 0.311 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 100' ' ' LEU . 2.8 p -97.68 121.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.872 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.422 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -107.26 139.54 41.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.831 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.481 HH21 HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -150.31 126.25 10.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.518 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -80.73 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.765 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.9 -51.25 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -119.1 23.18 11.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.904 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -123.91 172.44 8.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.133 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' C ' ' CD1' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -160.22 126.95 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.996 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 41.9 m-85 -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.056 0.455 . . . . 0.0 112.024 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HB2' HD22 ' A' ' 72' ' ' LEU . . . -134.75 121.36 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.14 113.36 25.58 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 110.485 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.449 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -95.78 99.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.37 161.81 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.197 -0.911 . . . . 0.0 113.315 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -93.79 110.5 22.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.443 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -88.32 27.43 1.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.235 0.959 . . . . 0.0 112.552 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 32.0 tt0 -111.35 -48.54 3.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.62 118.32 19.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 174.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.22 88.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' LYS . 95.8 t -136.81 112.67 11.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -76.55 119.33 20.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 23' ' ' LEU . 1.8 mp -98.84 -62.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.42 148.63 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 112.302 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.1 p -150.21 131.01 14.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.064 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.01 165.74 24.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 0.0 111.755 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.463 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.15 126.86 10.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.075 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.459 ' OG ' HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -62.9 -65.47 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.514 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.57 -36.94 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.573 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.01 -48.71 11.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.496 0.665 . . . . 0.0 111.197 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.75 -34.63 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt 179.79 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' A' ' 52' ' ' SER . 1.9 mt -46.39 154.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 111.571 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -127.05 -56.03 1.35 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.413 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.48 18.58 3.65 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.28 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' CB ' ' CD2' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.26 -168.77 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.792 0.296 . . . . 0.0 110.653 179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -51.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.458 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.5 p -91.77 15.39 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.535 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -94.21 -57.34 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 67' ' ' GLN . 89.6 t -94.16 -15.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.862 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.527 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -33.36 -41.5 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.897 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.65 -59.48 3.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' HB2' HG11 ' A' ' 64' ' ' VAL . 1.8 mt-30 -49.7 -23.41 1.75 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.478 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -80.38 -32.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -78.04 -28.4 56.45 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -73.88 -37.95 64.55 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.04 -35.41 69.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 36' ' ' ALA . 1.9 tp -67.68 -53.79 24.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.74 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -62.83 -26.26 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -75.89 -33.0 59.92 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 14.9 mttt -72.15 -68.97 0.42 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.816 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -43.73 -42.22 5.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.274 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -56.81 -40.03 75.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.062 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.14 -23.85 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.13 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.45 18.9 9.21 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.193 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -75.43 102.98 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.58 0.705 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.4 tttt -88.13 -59.37 2.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.705 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.25 148.24 29.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.398 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.56 158.91 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.369 0.604 . . . . 0.0 112.107 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.77 101.9 12.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.77 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -81.47 114.92 20.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.149 0.499 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.79 56.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -44.57 -40.2 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.47 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.32 -111.79 3.15 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.686 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.09 28.15 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.907 2.405 . . . . 0.0 112.693 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.0 m-30 -96.58 164.08 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -131.92 150.31 52.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.466 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -51.18 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.223 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -115.43 169.58 9.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.3 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.25 -38.27 4.93 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.759 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 7.1 mmt180 -62.54 -70.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 44.1 t -37.94 -41.74 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 110.887 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.58 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.116 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.632 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.88 -37.04 75.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.092 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.0 tt -67.76 -47.83 68.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.223 0.535 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.54 -31.64 72.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.508 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.07 -44.02 73.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.532 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.35 -57.65 10.04 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -62.88 -31.53 72.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.71 -1.245 . . . . 0.0 111.187 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.7 mtm-85 -89.83 -25.68 20.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -82.46 -33.87 28.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.93 -47.38 39.21 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.992 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.49 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.87 -29.25 0.07 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 119.857 -1.164 . . . . 0.0 114.867 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.6 mp -71.1 146.19 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.8 mp0 -127.72 91.82 3.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.417 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.587 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 3.4 p90 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.894 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -106.68 137.55 44.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.616 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -101.29 126.52 48.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.02 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.7 tt -89.69 142.53 27.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.409 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -146.47 108.7 4.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 HD13 ' A' ' 100' ' ' LEU . 11.9 p -96.77 117.16 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.256 0.551 . . . . 0.0 111.748 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.41 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 1.1 t80 -100.02 137.22 38.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.834 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -143.35 118.85 10.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.934 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.75 -80.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.877 0.37 . . . . 0.0 110.717 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.37 -65.38 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 17.46 13.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.113 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -117.05 140.36 49.58 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 121.123 0.487 . . . . 0.0 111.6 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.427 HD13 ' CG ' ' A' ' 29' ' ' ARG . 6.5 tp -127.97 129.46 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 30.0 m-85 -144.92 112.21 6.07 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' A' ' 72' ' ' LEU . . . -93.25 120.93 34.09 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.8 113.01 25.28 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.486 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.449 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -96.75 102.27 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.323 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -99.2 161.41 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.686 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' HA ' HD23 ' A' ' 23' ' ' LEU . 1.7 t70 -92.36 117.86 30.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.986 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.7 t0 -91.95 22.72 4.09 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 124.411 1.069 . . . . 0.0 112.198 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -107.23 -47.47 3.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.04 118.1 15.39 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.04 90.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.173 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 43' ' ' LYS . 75.3 t -137.93 112.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -73.43 116.73 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.432 HD13 HD12 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -99.66 -58.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 72' ' ' LEU . 1.6 t -119.83 142.48 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.324 0.583 . . . . 0.0 112.226 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -150.17 114.86 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.876 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -125.3 161.9 25.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 111.796 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -143.76 137.52 28.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.798 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.541 ' HB2' HD13 ' A' ' 57' ' ' LEU . 9.2 p -59.51 -33.94 71.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -7.76 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.295 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -81.44 -60.28 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.401 0.62 . . . . 0.0 111.729 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.468 HD13 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -52.64 -41.51 63.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.3 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.81 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 52' ' ' SER . 4.6 tt -42.43 145.34 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 111.792 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' N ' ' CD2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -132.08 -53.51 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.13 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.13 -21.85 3.34 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.13 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 8.0 m120 -51.19 169.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.137 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -125.48 -84.85 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -93.35 32.16 1.39 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -55.15 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.422 ' HB ' HD13 ' A' ' 57' ' ' LEU . 84.4 t -94.18 -18.58 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -35.6 -38.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.848 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.68 -58.59 3.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 18.3 mt-30 -50.27 -23.06 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.473 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.573 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -80.03 -34.52 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.573 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -76.57 -33.28 48.14 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.155 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -71.71 -42.27 67.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.77 -42.62 90.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 38' ' ' ILE . 4.3 tp -65.06 -51.71 59.93 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.79 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.88 -26.21 46.15 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.403 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -71.88 -35.94 69.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.821 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.6 mttt -73.19 -63.6 1.15 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.801 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 109' ' ' LEU . . . -44.91 -41.95 7.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.285 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -60.62 -41.02 94.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.18 -25.9 6.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.38 -27.29 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 10.06 19.23 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.251 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.1 103.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.586 0.708 . . . . 0.0 110.192 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 110' ' ' GLU . 7.5 tttm -92.8 -55.5 3.34 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.044 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.2 OUTLIER -111.07 139.13 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.362 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -126.56 163.76 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 111.762 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.16 104.95 14.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -81.48 113.46 19.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.787 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -137.32 44.22 2.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.952 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.402 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 17.4 ptt-85 -40.57 -32.07 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.44 -128.67 9.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.273 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.79 52.66 3.02 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.654 2.236 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.41 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 4.4 m-85 -117.34 142.11 47.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -115.01 149.76 36.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.447 ' CD2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.13 105.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.529 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -123.87 163.97 20.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.0 -27.97 3.74 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.869 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.1 mmt180 -68.88 -70.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.399 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 24.7 t -39.43 -38.4 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.42 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HE2' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.4 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.965 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.91 -36.54 70.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.816 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.1 tt -68.47 -48.96 63.12 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 111.155 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.93 -31.02 69.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.178 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.97 -46.46 68.05 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.17 -58.47 7.12 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -60.59 -37.81 82.57 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.574 -1.313 . . . . 0.0 111.387 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.82 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -86.43 -29.34 22.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 110.92 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.7 pt-20 -74.15 -37.55 63.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -66.23 -47.17 73.97 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.103 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 173.52 -26.31 0.08 OUTLIER Glycine 0 C--N 1.342 0.901 0 C-N-CA 120.173 -1.013 . . . . 0.0 114.72 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.82 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.49 145.0 49.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.23 95.95 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.42 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.021 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -106.93 132.46 52.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.41 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -101.15 125.36 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' N ' HG13 ' A' ' 84' ' ' VAL . 3.7 tt -89.57 143.32 26.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.852 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -136.5 147.9 47.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.734 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 2.6 p -140.59 118.65 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.361 0.6 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.422 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.5 OUTLIER -108.68 142.16 39.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.739 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 32.8 mtm180 -142.7 122.38 13.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.143 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 t -89.36 -78.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.331 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.29 -58.54 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -119.32 23.21 11.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.941 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.51 169.84 9.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 52' ' ' SER . 2.1 tp -156.35 131.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.555 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 51' ' ' SER . 30.8 m-85 -147.3 148.29 31.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.978 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 72' ' ' LEU . . . -135.89 121.17 19.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.04 112.97 24.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.21 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.444 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -94.52 92.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.55 162.09 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.741 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -96.83 108.76 21.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.4 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.91 26.85 1.45 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.163 0.914 . . . . 0.0 112.242 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.02 -47.34 3.22 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' VAL . 8.3 mttt -133.12 118.17 18.38 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.16 90.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.588 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' LYS . 63.0 t -139.1 112.62 6.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -78.65 118.94 21.22 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.1 mp -102.64 -56.96 2.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 38' ' ' ILE . 1.9 t -117.14 144.84 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.641 . . . . 0.0 112.287 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -150.33 114.6 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.342 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.32 153.09 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.042 0.449 . . . . 0.0 112.106 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 2.4 t -150.42 131.12 14.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.429 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 20.1 m -58.71 -29.57 66.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.409 . . . . 0.0 110.382 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.75 -48.1 70.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.787 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.09 70.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.221 0.534 . . . . 0.0 110.064 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.9 mp -91.83 10.91 26.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.968 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 2.29 63.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.562 0.745 . . . . 0.0 112.994 -178.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 55' ' ' LEU . 9.4 mt -81.46 176.16 9.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.669 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -77.66 67.06 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.823 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.89 -150.25 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.544 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.24 -68.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -144.76 -78.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 p -84.96 3.31 38.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.284 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.6 -46.19 17.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.293 . . . . 0.0 110.922 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 65' ' ' ALA . 72.1 t -94.07 -24.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -31.59 -42.44 0.05 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.017 0.437 . . . . 0.0 111.724 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.65 -60.25 3.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 3.6 mp0 -47.55 -26.43 1.43 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.247 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.93 -32.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.977 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -79.38 -30.18 46.48 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.464 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.94 -39.9 65.85 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 75' ' ' LYS . . . -69.15 -37.55 78.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 1.4 tp -65.9 -53.42 39.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.305 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -64.69 -23.36 67.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.153 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.61 -29.76 56.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -89.5 -47.73 7.79 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -51.58 -40.21 59.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -60.11 -38.56 83.38 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.781 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.18 -22.96 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.466 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.44 -26.89 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 16.0 13.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.058 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.466 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.55 0.691 . . . . 0.0 110.251 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.5 tttt -89.78 -57.72 2.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.216 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.409 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -111.47 147.41 35.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.293 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -134.58 164.05 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.358 0.599 . . . . 0.0 112.058 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.53 101.75 12.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.192 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -81.04 106.01 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.349 0.595 . . . . 0.0 112.37 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' N ' ' NH1' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -142.8 75.25 1.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.237 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -57.39 -38.02 73.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.095 0.474 . . . . 0.0 110.584 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.04 -110.79 2.59 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -90.09 31.15 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.833 2.355 . . . . 0.0 112.334 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 2.8 m-85 -103.06 154.91 18.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.2 150.8 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.222 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.545 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -47.82 109.68 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.436 ' O ' ' NZ ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -121.27 -77.78 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.66 -54.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.784 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.426 ' HG3' ' HD2' ' A' ' 29' ' ' ARG . 3.2 mtt180 -54.53 -59.59 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 27.2 t -40.1 -40.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.952 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.545 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.91 -76.33 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.935 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.1 -34.77 75.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.831 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.7 tt -66.57 -48.39 69.75 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.769 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.14 -33.41 74.44 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.239 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.804 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.73 -45.41 75.1 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.3 -57.02 8.51 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -61.96 -36.3 81.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.465 -1.368 . . . . 0.0 111.341 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.797 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 2.5 tpp85 -87.13 -28.52 22.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.932 0.396 . . . . 0.0 110.683 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -76.6 -35.69 57.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.48 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -68.64 -48.16 51.8 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.554 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.42 -27.74 0.07 OUTLIER Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.657 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.797 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.22 143.34 50.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -127.74 93.83 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.375 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.119 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -44.76 125.32 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.793 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 126.28 40.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.3 tt -89.47 142.75 27.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.1 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.67 108.82 5.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.128 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 3.3 p -98.29 125.28 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.615 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.76 143.19 41.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.11 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.4 tpt180 -150.19 119.01 6.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.999 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -89.81 -44.07 10.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.459 . . . . 0.0 110.757 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 179.92 -54.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.737 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -119.28 7.57 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.648 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 9.0 m170 -125.97 131.05 52.33 Favored 'General case' 0 N--CA 1.46 0.042 0 CA-C-O 120.959 0.409 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CG2' ' HB2' ' A' ' 52' ' ' SER . 2.9 tp -118.24 132.21 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.621 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE2' ' OG ' ' A' ' 51' ' ' SER . 29.9 m-85 -145.82 111.04 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -96.21 122.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 113.26 25.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.474 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.34 98.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.51 162.67 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.148 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 t0 -93.38 114.02 26.33 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.75 25.98 2.54 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.17 0.919 . . . . 0.0 112.189 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -109.48 -48.13 3.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.79 118.18 17.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 174.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.8 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.31 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' LYS . 75.0 t -138.85 112.56 7.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.81 122.57 23.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' CD1' ' CD1' ' A' ' 23' ' ' LEU . 1.6 mp -104.43 -64.2 1.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.49 144.4 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 111.96 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -150.2 125.16 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -131.05 160.91 33.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.749 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.438 ' OG ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -146.27 126.42 13.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.286 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -57.82 -51.34 70.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.406 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.436 HD12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -61.06 -10.22 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.4 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -84.96 -50.69 7.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.6 -38.64 60.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 111.281 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.8 pttp 179.35 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD11 ' OG ' ' A' ' 52' ' ' SER . 9.3 mt -47.79 140.48 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -132.11 -40.58 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.222 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.18 -47.94 0.63 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.864 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 9.9 m120 -51.5 177.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.322 . . . . 0.0 111.065 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.85 -68.23 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.385 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 p -93.17 27.93 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.457 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.09 -53.35 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.703 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 64' ' ' VAL . 48.4 t -94.06 -14.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.551 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -29.93 -44.11 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.66 -61.03 2.32 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.583 0.706 . . . . 0.0 109.368 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -48.27 -25.88 1.74 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.154 177.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -76.86 -36.39 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -73.8 -28.23 65.41 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.796 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 11.7 ptt180 -70.04 -36.49 75.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.31 -37.77 68.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 6.3 mt -67.1 -45.69 76.46 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.52 0.676 . . . . 0.0 109.436 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -72.35 -27.78 62.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.829 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 41.1 mt-10 -78.5 -29.67 46.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 15.4 mttt -72.79 -69.23 0.42 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.474 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 109' ' ' LEU . . . -45.63 -43.42 12.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.316 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 11.1 mt -55.76 -39.74 71.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.84 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.5 9.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.73 -29.38 18.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.53 15.8 8.59 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.635 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.444 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -75.99 106.98 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.616 0.722 . . . . 0.0 110.307 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.03 -48.32 5.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.427 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.376 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.0 163.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.317 0.579 . . . . 0.0 111.785 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.37 105.99 15.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.738 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.553 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -81.46 113.68 19.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.178 0.513 . . . . 0.0 111.602 -178.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.57 44.36 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.118 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 12.8 ptt-85 -40.71 -48.01 2.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.54 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.47 -114.08 2.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.64 -10.66 13.08 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.2 m-85 -57.25 132.63 53.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.02 154.88 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.105 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -45.21 108.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.04 0.448 . . . . 0.0 110.629 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -119.25 -125.69 0.28 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.394 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.61 -12.24 3.8 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.902 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 -89.4 -68.97 0.74 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.926 0.363 . . . . 0.0 110.746 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.598 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 57.4 t -38.81 -28.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.658 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.121 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.01 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.83 -38.96 7.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.178 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -67.91 -46.67 70.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.162 0.506 . . . . 0.0 110.608 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.598 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.95 -33.22 75.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.081 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.806 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.47 -45.61 75.44 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.32 -56.8 8.8 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -62.78 -34.39 77.16 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 113.507 -1.346 . . . . 0.0 111.543 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.848 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -90.09 -26.45 20.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 0.0 110.809 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.806 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.4 pt-20 -78.07 -32.1 50.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.499 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -75.37 -45.43 18.89 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.476 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 179.54 -32.43 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 119.935 -1.126 . . . . 0.0 114.87 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.848 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.33 146.17 49.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.26 93.19 3.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.484 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.553 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.2 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.982 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -101.95 131.62 48.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.332 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 37.0 ttp85 -100.43 123.76 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HG ' HD12 ' A' ' 38' ' ' ILE . 2.9 tt -89.46 144.67 25.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.428 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -148.71 108.04 3.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.094 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 7.2 p -92.99 115.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.385 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 139.26 31.59 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.929 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' NH2' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -140.02 118.17 11.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -103.93 -155.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -71.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -120.12 35.39 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.39 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 5.4 m170 -115.33 132.9 56.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.18 0.515 . . . . 0.0 112.305 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.633 HG12 ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -121.2 111.6 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.666 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 38.4 m-85 -146.42 154.07 41.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.412 0.625 . . . . 0.0 112.675 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -135.21 129.82 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.946 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.97 115.0 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.114 0.483 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.526 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -99.72 94.07 3.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.316 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -94.43 164.62 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.659 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 t0 -96.75 115.27 27.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 7.9 t0 -90.89 23.72 3.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.346 1.028 . . . . 0.0 112.319 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -108.09 -47.37 3.57 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mptp? -135.4 118.16 16.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.12 90.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.343 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.4 t -140.69 112.29 4.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.7 119.82 17.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.418 HD12 HD11 ' A' ' 23' ' ' LEU . 1.3 mp -99.97 -63.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -118.08 148.68 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 112.153 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -150.11 129.98 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.72 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.95 162.48 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 112.147 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.31 134.83 17.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.436 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.633 ' HB2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -65.76 -53.0 46.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.573 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.89 -33.05 55.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.238 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.5 -48.6 8.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.425 0.631 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.73 -36.87 58.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.614 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tttm 179.6 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.49 HD13 ' HB ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -45.02 140.77 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.666 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 -39.7 1.61 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.022 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.55 76.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.52 -173.14 0.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -142.88 -67.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 p -93.19 25.03 3.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.289 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.96 -59.14 2.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 0.0 110.81 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 57' ' ' LEU . 57.4 t -94.15 -15.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.695 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 68' ' ' VAL . . . -34.58 -38.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 111.932 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.36 -59.59 2.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 4.0 mt-30 -49.46 -22.74 1.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.374 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -82.69 -32.79 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . -77.23 -28.37 58.25 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.216 -0.992 . . . . 0.0 111.005 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 3.5 ppt_? -76.74 -38.75 53.65 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.42 -34.38 74.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 1.1 tm? -69.45 -56.26 7.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.593 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -59.37 -24.77 63.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.989 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 51.6 mt-10 -79.14 -30.95 43.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.6 mttt -70.27 -68.91 0.39 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.271 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -45.38 -44.04 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.2 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -55.4 -40.11 71.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.975 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.68 -24.93 9.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.032 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.72 -28.73 19.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.0 18.02 8.56 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.575 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.438 HG23 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -75.28 105.68 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 110.52 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 110' ' ' GLU . 28.7 tttp -90.32 -59.39 2.2 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.204 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.414 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -109.02 140.82 42.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.24 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -127.79 162.52 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 111.949 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.84 103.42 13.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.841 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.45 111.38 17.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.21 0.529 . . . . 0.0 111.666 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.48 44.45 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.111 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 ptt-85 -42.09 -46.14 4.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.489 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.38 -131.92 7.58 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.184 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.46 48.97 2.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.595 2.197 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.4 m-30 -100.49 155.75 17.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.91 154.76 48.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.279 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.538 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.6 109.67 0.27 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.979 0.418 . . . . 0.0 110.55 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -115.99 -124.29 0.29 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.409 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.13 -27.46 1.22 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.46 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . 8.5 mtt-85 -78.07 -67.24 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.606 0.241 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.9 t -37.74 -29.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.019 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.46 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.39 -41.11 38.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD12 ' CG2' ' A' ' 27' ' ' VAL . 1.2 tt -64.94 -46.15 82.78 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.198 0.523 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.66 -35.25 79.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.603 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.826 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.34 -46.86 59.52 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -46.9 -54.69 9.05 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -65.59 -33.91 77.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.238 -1.481 . . . . 0.0 111.382 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -90.09 -22.47 21.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.573 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -84.34 -32.34 24.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.85 -45.79 25.96 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.91 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.505 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.77 -30.69 0.08 OUTLIER Glycine 0 C--N 1.342 0.875 0 C-N-CA 120.012 -1.089 . . . . 0.0 114.833 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.762 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.11 142.87 50.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.75 93.76 3.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.533 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.587 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.999 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.8 mp -119.76 138.02 53.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.651 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -104.37 126.41 51.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.78 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' N ' HG12 ' A' ' 84' ' ' VAL . 3.6 tt -89.7 143.69 26.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.976 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.429 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 16.0 m -144.79 108.31 4.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.728 0.299 . . . . 0.0 110.675 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.456 HG22 HD12 ' A' ' 100' ' ' LEU . 5.8 p -97.07 120.7 46.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.193 0.52 . . . . 0.0 111.802 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -100.75 148.9 24.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.781 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -150.4 120.68 7.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.81 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -89.71 -84.64 0.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.671 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -61.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.13 21.62 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.8 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 38.7 m170 -116.95 156.71 26.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.194 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 96' ' ' ARG . 4.3 tp -141.75 130.98 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.757 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 38.4 m-85 -148.95 150.33 32.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 0.0 111.845 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -133.27 121.41 22.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.414 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.76 113.34 25.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.487 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.477 HD11 HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.12 105.14 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.369 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -102.44 158.73 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -89.61 119.55 30.13 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.877 178.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -93.19 23.56 4.31 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.432 1.082 . . . . 0.0 112.294 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -106.86 -47.64 3.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.258 -2.126 . . . . 0.0 105.258 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 45' ' ' VAL . 16.5 mttt -137.95 118.1 13.53 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.5 90.46 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.489 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.3 t -138.59 112.5 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -69.93 113.12 6.85 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.424 HD11 HD23 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -90.56 -57.5 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 1.8 t -127.56 148.96 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.299 0.571 . . . . 0.0 112.123 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 58.5 p -150.21 114.9 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.786 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.62 150.93 50.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 112.028 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.492 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.4 t -150.42 149.97 30.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.425 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 37.2 m -60.66 -53.69 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 3.1 pp -68.01 -9.49 46.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.557 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.81 -64.75 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mp -53.67 -52.16 60.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.592 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 177.35 -41.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 54.2 mt -54.41 115.46 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.05 10.23 4.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.159 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.52 -83.55 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -68.17 175.33 3.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -130.71 -54.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -89.98 -24.8 21.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -66.51 -40.58 89.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.139 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 67' ' ' GLN . 78.8 t -92.22 -25.73 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.59 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.66 -40.69 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.999 0.428 . . . . 0.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.03 -59.56 3.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.484 0.659 . . . . 0.0 109.278 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.517 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 12.9 mt-30 -49.41 -26.15 3.05 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.225 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -76.8 -32.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.425 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -77.9 -26.33 60.6 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.838 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 10.3 ptt180 -72.22 -39.21 68.7 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.47 -38.93 77.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 36' ' ' ALA . 1.5 tp -66.14 -52.34 49.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.171 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -64.37 -27.17 68.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.57 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 29.6 mt-10 -77.13 -32.48 56.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 11.8 mtmm -71.48 -68.69 0.43 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.726 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.01 -43.12 6.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.19 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -56.11 -38.28 70.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.027 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -54.78 -23.11 16.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.899 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.43 -26.5 20.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.33 17.35 10.08 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.138 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -76.25 102.91 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.686 0.755 . . . . 0.0 110.271 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -97.02 -46.78 6.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.954 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.03 134.86 54.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.22 165.85 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.965 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.47 106.12 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.63 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.577 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -81.4 120.45 24.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.267 0.556 . . . . 0.0 111.73 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.05 51.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.067 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.2 -31.33 0.37 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.523 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.17 -119.06 5.59 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.99 20.63 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.734 2.29 . . . . 0.0 112.426 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.6 m-30 -80.81 159.45 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 154.81 48.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.369 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -43.77 109.35 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.571 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.505 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.2 t-80 -124.67 157.96 34.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.477 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -41.13 -26.7 0.18 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.689 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HB3' HD11 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -82.09 -67.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.689 0.244 . . . . 0.0 111.182 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 90.0 t -29.83 -50.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -57.72 -75.37 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.801 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.75 -38.15 66.81 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.228 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.0 tt -67.51 -47.26 70.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.447 0.641 . . . . 0.0 110.428 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.1 -32.13 72.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.384 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.785 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -68.12 -44.65 75.66 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.67 -58.41 8.38 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.625 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -59.75 -35.35 74.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.621 -1.289 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.846 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.99 -30.65 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.861 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.785 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -72.2 -34.91 68.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.499 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -70.52 -46.91 45.18 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.797 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.26 -29.07 0.07 OUTLIER Glycine 0 C--N 1.341 0.831 0 C-N-CA 120.052 -1.07 . . . . 0.0 114.752 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.846 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.45 145.52 49.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -128.12 92.58 3.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.296 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.997 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.756 0.312 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' CD2' HG13 ' A' ' 81' ' ' ILE . 3.7 mp -42.67 130.6 4.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.305 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -98.83 124.87 44.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.289 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.33 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.359 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.412 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.76 108.73 4.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.153 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 9.2 p -99.19 115.48 39.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 1.0 OUTLIER -93.02 152.06 19.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.421 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 55.6 mtm-85 -149.15 118.91 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.916 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -46.4 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.994 0.426 . . . . 0.0 111.066 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.34 -59.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -116.73 12.68 14.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.323 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.3 174.36 6.1 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' CD1' HD13 ' A' ' 100' ' ' LEU . 6.9 tp -159.99 115.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 5.3 m-85 -129.68 111.21 12.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 72' ' ' LEU . . . -93.79 123.32 37.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 117.02 29.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.448 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.451 HD11 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -98.87 101.77 12.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.2 mp -101.52 161.61 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.966 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.42 117.27 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.715 177.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.424 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 5.6 t0 -93.3 27.45 2.54 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.278 0.986 . . . . 0.0 112.282 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -108.8 -46.48 3.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -137.94 118.14 13.58 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.32 89.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.503 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' LYS . 92.5 t -137.89 112.53 9.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -75.65 124.54 27.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' CD1' HD21 ' A' ' 23' ' ' LEU . 1.2 mp -107.35 -58.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 75' ' ' LYS . 2.1 t -120.06 141.71 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 112.076 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.23 114.79 5.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.5 151.89 48.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.02 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.528 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.0 p -150.58 142.74 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.602 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -54.0 -24.87 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.93 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -49.72 -65.72 0.52 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.31 -24.4 54.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.385 0.612 . . . . 0.0 109.83 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.2 mp -89.62 11.83 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.825 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 55' ' ' LEU . 19.7 mtpp 2.58 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.85 0.86 . . . . 0.0 113.025 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 55' ' ' LEU . 2.1 pt? -58.05 176.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.936 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -80.48 114.53 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.37 106.91 0.18 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -69.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.784 0.326 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.81 -150.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.727 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.3 p -69.7 61.34 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.895 0.379 . . . . 0.0 110.8 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.43 -52.5 4.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.633 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 57' ' ' LEU . 94.3 t -94.05 -21.73 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -36.92 -38.21 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 0.0 110.855 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.5 -58.96 3.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 12.7 mt-30 -49.81 -23.02 1.64 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.667 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.563 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -78.29 -37.01 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.563 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -75.63 -36.21 43.94 Favored Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -66.43 -36.55 83.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -62.75 -53.87 47.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.776 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -63.66 -46.04 87.43 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -55.46 -27.15 46.39 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.689 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.4 tt0 -73.61 -35.34 65.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 7.5 mttt -74.79 -63.7 1.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.907 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 109' ' ' LEU . . . -43.89 -42.55 5.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.2 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -58.54 -40.68 83.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.4 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.01 -24.81 7.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.28 -27.13 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.57 11.57 19.11 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.15 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -64.02 103.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.616 0.722 . . . . 0.0 110.142 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -91.7 -57.47 2.74 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.345 -178.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.417 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -109.52 143.19 39.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.387 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -130.49 162.91 37.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.636 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.38 103.6 13.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.808 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.48 112.48 18.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -142.65 51.44 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -41.21 -38.37 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.651 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.09 -124.93 6.25 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.34 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -90.05 42.87 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.873 2.382 . . . . 0.0 112.066 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.639 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.7 m-30 -99.56 163.6 12.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.229 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 154.64 49.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.443 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -46.88 112.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.593 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.462 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.3 t60 -133.43 154.04 51.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.301 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -33.47 -37.04 0.06 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.851 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.462 ' HG3' ' HD2' ' A' ' 29' ' ' ARG . 2.0 mmt85 -70.74 -70.86 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.586 0.193 . . . . 0.0 111.407 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 98.5 t -29.91 -51.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -56.75 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 110.292 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.92 -43.0 49.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.14 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -66.66 -49.09 67.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.458 0.646 . . . . 0.0 110.649 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' N ' HD22 ' A' ' 100' ' ' LEU . . . -57.08 -34.82 68.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.081 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.761 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.32 -43.3 81.95 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.06 -61.5 5.72 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -54.12 -41.83 68.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.932 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -79.21 -55.68 4.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.761 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.6 pt-20 -46.58 -43.33 17.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.509 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -60.84 -50.01 72.3 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.994 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.16 -25.48 0.07 OUTLIER Glycine 0 C--N 1.341 0.859 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.667 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.816 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.48 146.41 48.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.18 93.08 3.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.215 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.591 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.018 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.81 0.338 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.7 mp -32.07 132.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.555 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -96.18 126.86 41.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.43 140.79 29.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.554 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 3.0 t -142.3 114.07 8.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 110.996 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 100' ' ' LEU . 4.0 p -101.53 120.35 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.215 0.531 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -99.14 148.97 23.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.964 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' HD2' ' CG ' ' A' ' 96' ' ' ARG . 15.8 mtm-85 -146.72 119.76 8.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.584 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.79 -50.64 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tt -179.24 -54.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.362 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 10.12 12.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.885 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -119.55 148.15 43.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 96' ' ' ARG . 4.1 tp -131.18 131.61 63.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.704 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 29.6 m-85 -146.95 149.93 34.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.832 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 72' ' ' LEU . . . -135.18 120.93 19.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.221 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 26' ' ' SER . 4.8 pt20 -113.63 113.06 24.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.316 0.579 . . . . 0.0 109.921 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -90.92 97.15 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.85 164.26 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.283 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.53 103.16 14.88 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.485 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -86.65 27.16 1.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.172 0.92 . . . . 0.0 112.328 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -113.09 -47.9 3.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -129.33 118.5 22.35 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 174.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.63 86.29 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.725 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' A' ' 43' ' ' LYS . 47.3 t -137.51 112.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' HA ' HG22 ' A' ' 39' ' ' ILE . 22.5 m -77.11 122.66 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.19 -64.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -123.12 147.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 111.876 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 21.8 p -150.6 117.36 5.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.729 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.12 151.23 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.237 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.8 t -150.3 147.24 27.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.751 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 5.9 m -62.48 -68.41 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 2.6 tm? -60.29 -16.49 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.623 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 51' ' ' SER . . . -77.05 -64.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mp -54.05 -52.3 61.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.06 0.457 . . . . 0.0 111.492 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 177.21 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.445 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' CD1' ' CG1' ' A' ' 64' ' ' VAL . 16.4 mt -51.14 121.06 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.736 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 58.68 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.727 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.19 133.65 33.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.601 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.01 -51.05 5.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 110.794 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -153.61 -96.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.6 p -93.61 30.96 1.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.668 0.271 . . . . 0.0 111.182 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -94.05 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.206 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 72.8 t -91.93 -19.0 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.683 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.532 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -30.74 -43.75 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -64.74 -61.34 2.25 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.499 0.666 . . . . 0.0 109.365 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 23.5 mt-30 -48.47 -24.56 1.32 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.4 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -80.32 -33.41 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.653 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.548 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -77.89 -27.43 58.54 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.167 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -75.01 -39.53 61.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.39 71.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 36' ' ' ALA . 1.9 tp -68.91 -54.44 15.49 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.845 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -62.04 -26.11 68.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.974 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 48.3 mt-10 -77.49 -31.18 53.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.456 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 21.0 mttt -72.51 -68.74 0.45 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.523 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.25 -43.21 7.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -56.04 -39.86 72.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.942 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.9 -23.81 14.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.019 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.43 -27.89 20.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.82 15.51 13.07 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.252 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -72.98 102.98 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 110.202 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -91.24 -57.3 2.83 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.423 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.11 137.97 46.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -126.84 166.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.368 0.604 . . . . 0.0 111.666 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -115.33 109.41 17.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.834 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.554 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -80.53 106.36 12.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.299 0.571 . . . . 0.0 111.919 -177.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.6 46.09 2.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.277 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.29 -45.49 5.91 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.26 -112.83 3.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.54 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.95 25.08 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.772 2.315 . . . . 0.0 112.863 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -93.97 157.13 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 111.056 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 151.53 49.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.675 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.464 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.21 94.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.416 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -114.21 170.93 7.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.384 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -41.94 -47.94 5.21 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.203 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' CG ' ' HD2' ' A' ' 29' ' ' ARG . 1.3 mtt85 -57.01 -68.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.64 0.257 . . . . 0.0 110.506 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.6 t -38.32 -39.96 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.567 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.33 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.8 -34.31 67.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.858 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.0 tt -70.11 -48.37 57.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.213 0.53 . . . . 0.0 110.959 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.02 -28.7 69.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -71.5 -46.44 59.72 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.67 -56.17 8.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . . . -64.24 -34.6 78.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.41 -1.395 . . . . 0.0 111.111 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.3 mmm180 -87.14 -24.42 24.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.2 pt-20 -84.45 -33.36 23.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.496 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -70.8 -46.47 45.69 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.074 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.94 -28.64 0.07 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 120.031 -1.08 . . . . 0.0 114.597 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.21 146.61 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -127.73 94.39 3.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.374 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.554 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 4.5 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.838 0.351 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' CD2' HG13 ' A' ' 81' ' ' ILE . 4.9 mp -102.84 134.8 45.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 25.4 ttp85 -103.0 123.31 46.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.225 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 38' ' ' ILE . 2.7 tt -89.17 143.79 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.602 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.42 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -146.72 108.8 4.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.454 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' CG2' HD11 ' A' ' 100' ' ' LEU . 9.7 p -102.48 116.71 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.91 136.25 35.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.445 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 mtm105 -132.81 118.71 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.978 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.58 -70.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -148.86 -62.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.773 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -119.13 20.19 12.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.197 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.42 175.62 5.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.166 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' CD1' HD11 ' A' ' 100' ' ' LEU . 6.6 tp -160.03 122.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.93 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -137.79 111.56 8.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.09 125.57 41.66 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 113.27 21.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.169 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.516 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -97.76 100.95 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.512 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -102.61 160.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.805 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' N ' HG21 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -92.15 116.96 29.4 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.856 178.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 1.7 t70 -93.38 28.11 2.35 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 124.281 0.988 . . . . 0.0 112.185 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -109.76 -47.42 3.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.2 mttp -136.49 118.14 14.96 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.11 90.58 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.532 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 80.6 t -139.62 112.47 5.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 121.09 23.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.59 -59.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG11 HD21 ' A' ' 72' ' ' LEU . 2.1 t -115.81 140.36 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.175 0.512 . . . . 0.0 111.971 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -150.27 114.93 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.266 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' HG ' ' A' ' 72' ' ' LEU . . . -133.51 151.4 51.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.245 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.513 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 43.6 p -150.54 139.6 21.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -47.2 -29.11 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.22 -50.84 71.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.659 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 -25.73 65.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.118 0.485 . . . . 0.0 110.401 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.9 mp -88.46 11.26 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.383 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mtmp? 1.73 63.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.468 0.707 . . . . 0.0 112.807 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 55' ' ' LEU . 11.6 mt -61.43 176.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.118 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.19 -29.59 57.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.02 67.98 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.384 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -149.04 106.36 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -84.77 -70.27 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.41 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -85.92 -24.19 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.53 -45.57 81.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 67' ' ' GLN . 95.5 t -94.14 -20.01 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.761 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -35.48 -38.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 3.7 ttm180 -67.59 -59.13 3.6 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -50.89 -24.31 3.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.533 178.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -77.54 -33.23 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -78.36 -32.37 43.09 Favored Glycine 0 C--O 1.218 -0.854 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.71 -36.79 83.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.77 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -45.59 78.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.409 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' HG ' ' CB ' ' A' ' 50' ' ' ALA . 1.1 mt -62.58 -50.04 72.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -59.56 -26.1 65.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 12.4 tt0 -72.04 -34.66 68.95 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.1 mttp -77.08 -64.12 1.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.862 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -43.96 -42.6 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.639 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -58.76 -40.51 84.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.373 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.55 -25.18 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.227 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.476 HD13 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.47 -26.51 20.91 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.2 13.81 14.62 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.198 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.476 HG12 HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -71.43 102.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.016 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -103.87 -27.89 11.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.853 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.11 140.51 52.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.035 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -135.27 164.49 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.507 0.67 . . . . 0.0 112.345 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -106.43 103.82 13.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.835 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.72 106.35 13.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 111.509 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.09 43.69 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.231 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 21.0 ptt-85 -43.48 -48.76 7.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.502 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.59 -126.37 5.5 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -89.9 48.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.859 2.373 . . . . 0.0 112.125 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.1 m-30 -99.99 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.436 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 154.75 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.69 106.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.019 0.438 . . . . 0.0 110.681 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -110.63 -125.08 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.56 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.83 1.29 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.276 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' LYS . 2.2 mmt85 -79.77 -69.65 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.937 0.369 . . . . 0.0 110.941 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.4 t -35.03 -31.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.79 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.868 0.366 . . . . 0.0 110.992 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.85 -43.23 63.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.192 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.8 tt -60.53 -40.94 93.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.235 0.541 . . . . 0.0 110.639 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.96 -35.73 78.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.267 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 106' ' ' GLU . 1.3 mt-10 -69.55 -46.59 66.07 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.542 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.42 -58.27 5.31 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.718 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -59.56 -46.47 88.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.242 -1.479 . . . . 0.0 111.14 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.799 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 mtm180 -74.92 -55.48 5.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.175 0.512 . . . . 0.0 109.663 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.797 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -47.81 -44.43 28.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.475 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -61.16 -47.59 90.24 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.352 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.72 -25.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.623 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.799 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.2 mp -71.46 150.17 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -128.38 91.49 3.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.583 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 6.0 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.959 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.907 0.384 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -108.65 133.89 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.208 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' CB ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -102.52 126.27 49.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 2.0 tt -89.56 143.49 26.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.217 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.428 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -143.27 111.97 6.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.4 p -98.22 153.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.381 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.17 114.81 5.25 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -129.24 118.92 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -33.03 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.232 0.539 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.65 -61.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.471 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 9.64 11.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.595 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 7.4 m170 -121.99 100.05 6.77 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 29' ' ' ARG . 4.5 tp -99.19 117.94 45.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.499 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 12.5 m-85 -131.54 112.8 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 72' ' ' LEU . . . -102.84 122.55 44.76 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.53 113.07 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.501 ' CG1' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.93 99.34 9.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.337 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.45 163.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.601 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.59 111.59 23.35 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.4 p30 -88.06 24.5 1.81 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.282 0.989 . . . . 0.0 112.524 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 15.7 pt-20 -111.13 -45.24 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 45' ' ' VAL . 25.9 mmtm -132.8 118.38 18.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.95 86.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.672 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.604 ' N ' ' O ' ' A' ' 43' ' ' LYS . 46.1 t -135.08 112.39 14.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 120.86 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD11 HD13 ' A' ' 23' ' ' LEU . 1.5 mp -101.86 -62.45 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.09 143.74 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.344 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 p -150.24 114.98 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 72' ' ' LEU . . . -126.47 145.43 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.499 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 55.7 p -150.22 134.96 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.791 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t -52.62 -38.5 60.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.05 -52.35 64.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.107 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.02 -30.37 67.96 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.366 0.603 . . . . 0.0 109.768 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.0 mp -87.06 12.12 12.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.933 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER 3.03 63.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.528 0.68 . . . . 0.0 112.534 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -80.8 176.21 10.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.723 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -99.34 43.15 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.64 -143.08 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.695 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -126.28 -70.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.652 0.263 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -160.92 -83.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 96' ' ' ARG . 32.2 p -88.55 -4.32 58.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -44.9 95.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.92 0.39 . . . . 0.0 110.251 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 64' ' ' VAL . 59.7 t -92.33 -16.11 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.534 ' O ' HG13 ' A' ' 68' ' ' VAL . . . -32.03 -41.55 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.01 0.434 . . . . 0.0 111.689 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.79 -61.03 2.3 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.433 0.635 . . . . 0.0 109.346 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 18.5 mt-30 -50.22 -24.86 3.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.514 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -78.73 -32.31 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -76.65 -25.16 65.76 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.214 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -78.73 -37.48 41.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -68.35 -38.9 81.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 2.0 tt -72.88 -46.53 52.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -62.64 -25.02 67.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -79.71 -30.08 40.86 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 21.6 mttt -69.47 -69.09 0.36 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.173 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.6 -44.92 9.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.4 mt -54.53 -39.08 67.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.152 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.24 -24.45 18.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.865 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.61 -26.1 20.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.51 13.47 16.79 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.076 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -75.1 102.62 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -104.43 -24.76 13.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.77 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -127.47 136.42 51.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.125 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -136.67 163.74 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.374 0.607 . . . . 0.0 112.191 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.52 98.5 8.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.774 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -80.92 111.73 17.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.599 . . . . 0.0 111.776 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.1 61.18 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' HD2' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -48.9 -28.42 3.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.644 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.41 -117.81 3.33 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.73 38.0 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.758 2.305 . . . . 0.0 111.663 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.448 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 3.5 m-30 -98.61 144.9 27.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.28 155.01 49.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.4 t80 -39.83 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.168 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 2.0 t-160 -115.44 -109.87 0.36 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.151 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -131.25 -17.16 1.46 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.714 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG2' ' CG ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -95.38 -71.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 48.3 t -32.94 -37.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -64.65 -78.85 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.301 0.572 . . . . 0.0 110.429 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -46.26 -42.88 15.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.314 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.1 tt -67.51 -45.72 74.99 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.05 -35.76 79.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.362 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.676 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -63.45 -49.9 71.85 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.05 -56.21 6.08 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -56.43 -46.93 80.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 112.792 -1.704 . . . . 0.0 111.816 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.6 mmm-85 -78.84 -47.29 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.139 0.495 . . . . 0.0 109.976 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.676 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -53.4 -35.4 60.33 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -74.24 -49.19 12.81 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.499 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.33 -24.04 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 C-N-CA 119.737 -1.22 . . . . 0.0 115.405 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.17 146.2 49.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.204 1.002 . . . . 0.0 113.598 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.37 97.16 4.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.208 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CE2' ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.609 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.867 0.365 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 41' ' ' ASP . 2.8 mp -113.09 134.22 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.79 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 1.4 ttt180 -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.334 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.9 tt -89.58 142.19 27.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.422 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.1 m -144.94 108.59 4.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.481 HG21 HD13 ' A' ' 100' ' ' LEU . 8.8 p -94.2 117.73 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 111.749 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.409 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -99.26 146.95 25.67 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NH1' ' CG2' ' A' ' 97' ' ' VAL . 22.9 mtm-85 -150.14 122.34 8.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.996 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.9 p -89.66 -72.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.411 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 -58.26 0.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.566 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.23 2.56 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -101.82 155.57 18.05 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.177 0.513 . . . . 0.0 111.427 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 52' ' ' SER . 5.5 tp -142.63 119.74 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.573 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 14.1 m-85 -137.05 112.86 9.54 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -93.74 121.05 34.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.61 113.32 26.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.693 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.443 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -96.78 99.52 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.261 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -98.7 163.09 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.008 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -93.29 115.32 27.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.608 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.3 t0 -90.64 22.8 3.33 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.428 1.08 . . . . 0.0 112.354 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -110.15 -46.38 3.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 45' ' ' VAL . 11.6 mmmt -134.02 118.28 17.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.99 87.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.778 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 43' ' ' LYS . 60.4 t -137.53 112.32 9.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -71.57 117.68 13.43 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 HD13 ' CD2' ' A' ' 23' ' ' LEU . 1.3 mp -95.34 -63.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -121.11 147.75 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.794 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.4 p -150.17 114.83 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.063 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.38 158.29 33.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.707 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.462 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 79.5 p -150.18 143.02 24.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.973 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 57' ' ' LEU . 11.8 p -55.46 -44.92 76.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.104 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD11 ' N ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.18 -7.74 25.99 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB1' HD13 ' A' ' 55' ' ' LEU . . . -75.39 -59.75 2.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.0 110.948 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.454 HD13 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -52.78 -42.51 65.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.911 -178.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 52' ' ' SER . 1.4 mt -46.99 171.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -131.56 -42.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.55 78.39 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.428 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -122.86 -175.4 3.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -166.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 p -70.99 60.82 0.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 0.0 110.937 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.4 -57.68 2.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 64' ' ' VAL . 58.2 t -94.13 -16.49 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -32.65 -41.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.882 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.83 -59.21 3.73 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.702 0.763 . . . . 0.0 109.035 178.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.1 mt-30 -49.78 -23.27 1.75 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.442 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -81.29 -33.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -75.91 -28.91 59.88 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.4 ppt_? -76.67 -37.24 56.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.08 73.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -69.63 -54.51 13.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.704 178.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -59.8 -25.68 65.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.8 mt-10 -78.18 -31.01 49.35 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 23.2 mttt -71.67 -69.14 0.4 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.497 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -44.68 -43.48 8.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.126 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.9 mt -56.11 -39.67 72.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.041 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.5 -23.78 11.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.918 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.59 -27.7 20.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.7 8.08 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.071 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -78.21 105.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.536 0.684 . . . . 0.0 110.478 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 110' ' ' GLU . 8.1 ttmt -92.44 -59.49 2.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.8 138.63 44.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -126.6 164.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 111.901 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.93 103.26 12.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.795 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.596 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.44 116.49 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 111.616 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -145.54 47.59 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 6.9 ptt-85 -37.64 -37.58 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.762 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.27 -112.58 3.61 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.631 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -88.72 23.56 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.83 2.353 . . . . 0.0 112.767 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.525 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.8 m-30 -93.26 131.84 38.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.31 148.4 25.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -46.69 109.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.524 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -126.54 165.99 18.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.28 -40.41 7.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.79 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HB3' HD11 ' A' ' 34' ' ' ILE . 15.0 mmt-85 -57.36 -70.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.572 0.225 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 37.2 t -38.39 -37.8 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.35 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.72 -76.71 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.029 0.442 . . . . 0.0 110.965 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.31 -36.4 68.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.732 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.8 tt -68.96 -49.1 60.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.216 0.531 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -60.9 -32.1 71.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.42 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -68.54 -46.23 70.08 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.61 -57.15 8.69 Favored Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -62.03 -33.21 73.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.512 -1.344 . . . . 0.0 111.327 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.765 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.6 tpp85 -90.08 -25.06 20.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.1 pt-20 -81.02 -33.17 33.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.493 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -72.38 -46.78 31.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.858 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 175.73 -29.7 0.08 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.036 -1.078 . . . . 0.0 114.76 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.765 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.33 142.77 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.81 94.88 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.469 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.964 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 3.0 mp -43.42 128.21 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.258 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 126.33 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.38 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' N ' HG11 ' A' ' 84' ' ' VAL . 4.1 tt -89.29 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.693 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.06 108.82 4.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 111.318 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.43 ' CG1' ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -97.02 126.97 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -110.46 145.72 37.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 13.5 mtm105 -150.12 120.67 7.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.749 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 m -89.59 -81.04 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.684 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -139.86 -56.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.717 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -119.12 18.73 13.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.212 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -117.54 167.67 11.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.162 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 3.3 tp -153.3 130.96 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.551 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.516 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 32.9 m-85 -150.01 152.18 34.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.243 0.544 . . . . 0.0 112.171 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -136.83 120.96 17.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.692 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.76 113.22 25.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.453 HD11 HD22 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.72 98.84 8.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.8 160.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.165 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 115.63 28.27 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.603 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -90.75 26.16 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.297 0.998 . . . . 0.0 112.403 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.46 -47.97 3.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.39 118.04 14.97 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.96 90.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.448 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.9 t -137.68 112.57 9.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 m -73.92 119.72 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 mp -98.87 -58.28 1.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.0 t -124.36 147.3 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 112.239 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 82.5 p -150.28 115.02 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.946 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.26 150.77 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.919 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.516 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 3.1 t -150.46 141.94 23.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.512 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.405 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 32.1 m -57.72 -40.76 80.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.26 -46.48 83.54 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.66 -30.8 63.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.516 0.674 . . . . 0.0 109.487 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -92.34 13.11 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.64 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 55' ' ' LEU . 2.6 mtpt 3.67 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.782 0.801 . . . . 0.0 112.366 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -64.56 176.1 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.505 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -118.71 46.84 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.05 2.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -170.67 1.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -92.6 -48.31 6.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -93.13 -25.91 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.87 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -57.63 -42.04 82.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.159 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 67' ' ' GLN . 75.6 t -94.05 -17.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.693 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' HG11 ' A' ' 68' ' ' VAL . . . -34.89 -39.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.991 0.425 . . . . 0.0 111.414 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.29 -59.28 3.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -50.98 -22.95 2.55 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.408 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.53 -31.76 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.253 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -77.73 -30.86 51.53 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.26 -38.46 68.85 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.57 -39.39 88.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -65.54 -54.98 20.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.57 -24.99 35.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.99 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -73.18 -35.59 66.42 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.3 mttt -71.58 -67.4 0.53 Allowed 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.921 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HB2' HD12 ' A' ' 109' ' ' LEU . . . -43.93 -41.28 5.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.623 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -58.67 -40.23 82.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.226 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.44 -23.89 6.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.075 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.469 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.33 -27.82 20.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.66 18.04 9.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.136 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -71.73 106.87 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.505 0.669 . . . . 0.0 110.338 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLU . 18.9 ttmt -91.1 -58.14 2.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.393 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -111.86 147.58 35.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.463 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -134.33 161.15 41.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.319 0.58 . . . . 0.0 111.775 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.41 103.64 15.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.254 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.676 ' CE2' ' CZ ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -81.17 106.34 13.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.255 0.55 . . . . 0.0 112.071 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.76 72.16 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.983 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.676 ' CZ ' ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -52.19 -42.9 63.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.27 -117.35 3.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -90.35 35.95 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.746 2.298 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.3 m-30 -100.65 162.59 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 111.469 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.33 148.93 50.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.013 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -46.7 103.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.736 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -122.3 165.22 16.58 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.88 -42.46 11.4 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.983 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.436 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 55.4 mmt-85 -55.76 -71.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.704 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 t -38.92 -43.57 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.635 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.2 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.023 0.439 . . . . 0.0 111.133 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -59.24 -40.0 84.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 101' ' ' ALA . 1.5 tt -65.04 -47.29 77.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.351 0.596 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.26 -38.09 85.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -66.75 -39.71 88.01 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -52.49 -59.35 9.19 Favored Glycine 0 CA--C 1.501 -0.789 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -61.04 -28.81 69.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.831 -1.185 . . . . 0.0 110.559 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.7 mmm-85 -89.11 -30.48 18.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 110.917 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.795 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.9 pt-20 -78.84 -36.9 41.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -66.67 -46.38 76.36 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.773 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.42 -31.33 0.07 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.032 -1.08 . . . . 0.0 114.754 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.809 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.7 mp -71.28 147.05 48.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -128.23 91.68 3.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.348 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.063 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.9 mp -113.5 133.83 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.18 126.96 47.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.078 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HG ' HD11 ' A' ' 38' ' ' ILE . 2.1 tt -93.39 145.1 24.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.939 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.474 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.03 108.43 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.415 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' N ' ' HD3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -96.18 129.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.023 0.44 . . . . 0.0 111.313 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -114.78 125.92 54.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -129.52 118.6 22.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.57 178.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.2 m -90.03 -45.14 9.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.78 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.171 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -119.35 -0.93 10.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.344 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -110.71 111.07 22.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 111.572 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -99.93 131.28 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 40.7 m-85 -149.08 147.76 28.89 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.146 0.498 . . . . 0.0 112.085 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.489 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -132.46 128.28 37.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -117.83 113.06 21.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.205 0.526 . . . . 0.0 110.767 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -100.13 102.23 13.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -104.91 160.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.977 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -92.28 118.03 30.48 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.818 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 13.6 t0 -91.82 20.61 5.48 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.44 1.088 . . . . 0.0 112.217 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.49 -48.62 3.4 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 45' ' ' VAL . 8.3 mmtp -131.11 118.15 20.1 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.82 89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.841 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' LYS . 60.8 t -136.09 112.61 13.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 m -77.42 109.6 11.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -91.53 -53.07 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.408 HG23 ' CB ' ' A' ' 75' ' ' LYS . 1.4 t -124.16 145.84 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.571 0.701 . . . . 0.0 112.791 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 78.3 p -150.22 115.02 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.313 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' CB ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.92 162.94 24.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 126.91 10.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.007 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 57' ' ' LEU . 1.1 m -61.79 -39.54 92.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 0.0 111.24 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.7 -18.52 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.41 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.31 -49.09 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.846 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 52' ' ' SER . 5.5 mp -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.24 -31.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.953 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 52' ' ' SER . 8.8 mt -52.69 160.75 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -36.04 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.8 51.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.57 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.42 -168.61 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.82 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' A' ' 62' ' ' THR . 10.3 ttmm -109.21 -110.65 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.697 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.425 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 4.2 p -93.63 52.25 1.68 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -75.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.51 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 64' ' ' VAL . 39.6 t -94.05 -13.78 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.058 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.559 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -30.26 -43.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -65.96 -60.83 2.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.378 0.608 . . . . 0.0 109.46 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 18.3 mt-30 -48.12 -28.19 2.77 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.292 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -71.88 -38.44 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.2 178.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.615 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -67.64 -56.78 10.29 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 5.5 ppt_? -44.95 -35.33 2.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -64.12 -50.19 69.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.08 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' CD1' ' HB1' ' A' ' 36' ' ' ALA . 1.2 mt -62.96 -52.62 62.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . -53.51 -27.3 24.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.063 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -75.09 -32.89 61.57 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 33.0 mttm -76.79 -63.69 1.29 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -45.59 -43.19 11.97 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.792 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -56.2 -40.03 73.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.977 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.59 -24.33 13.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.952 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.42 -28.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.78 13.55 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.254 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.478 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -68.4 111.03 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 110.126 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 23.6 ttpp -95.89 -57.48 2.35 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.787 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -110.75 148.67 31.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -132.65 164.93 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 0.0 112.182 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.02 87.87 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.944 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 12.0 t80 -81.17 112.37 18.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.93 111.02 4.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' A' ' 27' ' ' VAL . 3.1 tpt85 -99.82 -21.11 15.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.28 -97.83 1.04 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.81 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.42 33.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.903 2.402 . . . . 0.0 112.197 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 4.3 m-85 -99.93 135.7 40.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.95 154.78 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.7 t80 -46.86 97.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 110.35 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.414 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 1.9 t60 -105.35 -99.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.901 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -142.52 -30.94 0.12 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mmt85 -85.87 -71.14 0.55 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 55.4 t -33.07 -35.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HZ2' ' HB ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -62.14 -76.42 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.667 0.746 . . . . 0.0 109.551 179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.32 -44.51 11.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.655 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -68.12 -49.24 62.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 110.221 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -55.61 -32.49 63.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -68.79 -41.95 78.01 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.13 -57.48 8.88 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.45 -34.63 77.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.477 -1.362 . . . . 0.0 110.986 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.866 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.33 -26.61 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.411 . . . . 0.0 110.887 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.837 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -78.08 -36.57 48.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.19 -43.84 69.37 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.725 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.473 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 179.36 -31.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 119.999 -1.096 . . . . 0.0 114.904 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.866 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.42 151.1 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.76 96.01 4.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 4.5 p90 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.07 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.452 ' CD1' HG13 ' A' ' 81' ' ' ILE . 1.8 mp -117.28 131.96 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 3.1 ttt-85 -102.73 126.46 49.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.49 145.61 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.58 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.406 ' N ' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -147.4 108.88 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.468 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 100' ' ' LEU . 9.6 p -100.59 132.18 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.006 0.432 . . . . 0.0 111.761 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -113.35 143.99 43.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.278 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' NH1' HG21 ' A' ' 97' ' ' VAL . 19.9 ptt-85 -151.53 118.76 5.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.093 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.78 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 110.788 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tt -177.36 -68.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.94 14.16 18.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.905 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 1.7 m-70 -127.33 150.18 49.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.655 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 22.5 pt -139.16 142.35 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -142.04 108.39 5.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.158 -177.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -93.73 121.01 34.73 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -114.75 118.64 34.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.486 HD11 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.99 103.82 15.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' A' ' 47' ' ' LEU . 3.5 mp -108.16 162.46 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.709 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.0 t70 -92.87 113.58 25.9 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.039 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -92.97 24.82 3.48 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.253 0.971 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.8 -47.85 3.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 45' ' ' VAL . 16.5 mtpt -132.19 118.12 19.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.77 90.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.453 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 43' ' ' LYS . 91.5 t -141.05 112.2 3.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 m -78.83 117.48 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -95.65 -56.87 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -128.57 145.12 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 111.986 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 p -150.19 114.53 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.422 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 148.78 50.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.631 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.499 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 15.2 p -150.22 136.14 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.406 ' CA ' HD23 ' A' ' 57' ' ' LEU . 19.1 m -44.62 -31.27 1.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.821 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.92 -61.95 2.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.602 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -27.23 64.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.26 0.552 . . . . 0.0 110.043 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.4 mp -90.67 11.57 21.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.083 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 55' ' ' LEU . 7.5 mttm 2.07 63.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.617 0.767 . . . . 0.0 112.785 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -57.6 156.51 8.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.542 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.23 88.61 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.68 -100.97 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.49 -169.77 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 0.0 110.824 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.79 -67.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.1 p -66.85 -17.64 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -49.74 70.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 65' ' ' ALA . 99.5 t -94.0 -20.09 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.685 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -34.18 -39.55 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 111.551 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.77 -60.21 2.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 4.8 mt-30 -49.36 -24.59 1.97 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.572 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -76.98 -36.14 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.806 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.545 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -77.06 -35.8 37.53 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.941 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 4.3 ppt_? -65.03 -36.12 83.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.609 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.47 -55.13 26.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -62.69 -44.58 95.88 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -56.83 -27.8 60.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.742 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.6 tt0 -72.94 -34.35 66.5 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 14.2 mttt -76.64 -63.19 1.4 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.072 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.29 -42.05 6.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.346 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.5 mt -58.0 -40.38 80.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.184 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.08 -23.63 8.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.466 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.41 -28.44 19.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.46 15.69 12.05 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.197 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -69.29 104.47 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.589 0.709 . . . . 0.0 110.152 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 110' ' ' GLU . 14.6 tttt -92.51 -56.38 3.05 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.388 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -110.0 145.03 37.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.384 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -132.1 164.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.469 0.652 . . . . 0.0 112.048 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -106.02 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.746 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -82.02 106.32 13.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.105 0.479 . . . . 0.0 111.373 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 45.0 2.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.176 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.7 ptt180 -41.51 -32.47 0.34 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.582 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.91 -121.46 6.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.433 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -88.99 36.33 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 3.6 m-30 -95.55 150.97 19.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.989 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -116.91 147.0 42.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.476 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -49.31 100.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.056 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -120.07 168.46 11.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.456 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.46 -38.16 3.86 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.912 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -61.72 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.567 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 33.1 t -38.67 -40.97 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.57 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.476 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.4 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 0.0 111.001 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.28 -37.27 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.896 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 101' ' ' ALA . 2.2 tt -67.48 -48.21 67.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 111.167 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.21 -33.4 70.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.17 -43.79 81.34 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.01 -62.06 5.27 Favored Glycine 0 CA--C 1.506 -0.517 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -54.98 -38.93 68.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 113.821 -1.19 . . . . 0.0 110.571 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.806 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.4 mmm-85 -79.79 -60.17 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -43.59 -43.15 5.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.158 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.518 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -62.01 -50.51 64.82 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.995 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.31 -26.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.125 -1.036 . . . . 0.0 114.808 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.806 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.4 mp -71.49 147.77 47.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.28 92.24 3.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.25 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.038 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 81' ' ' ILE . 1.1 mp -120.42 133.56 55.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 125.26 50.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.694 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' N ' HG11 ' A' ' 84' ' ' VAL . 5.1 tt -89.74 142.32 27.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.682 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 2.0 m -142.21 134.84 28.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.609 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -119.79 134.58 62.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 0.0 110.831 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -122.92 132.31 54.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' HG2' HD12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -137.32 118.83 14.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.214 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -89.24 -38.91 13.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.007 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tt -179.87 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -119.03 3.87 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.31 154.82 23.98 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD12 ' HG2' ' A' ' 29' ' ' ARG . 3.8 tp -141.34 123.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.83 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 16.9 m-85 -139.22 110.72 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 72' ' ' LEU . . . -100.17 121.45 41.45 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -110.22 113.47 26.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.321 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.78 101.71 12.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 37' ' ' GLN . 2.9 mp -104.84 164.03 4.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.44 113.98 25.93 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.809 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.3 t70 -91.38 25.54 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.335 1.022 . . . . 0.0 112.359 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -109.61 -48.15 3.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 45' ' ' VAL . 4.8 mttp -135.64 118.09 15.79 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.3 89.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.546 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' LYS . 66.3 t -137.86 112.49 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -75.5 114.54 14.18 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.401 HD12 ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -93.11 -60.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.1 t -125.21 147.25 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 111.882 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 p -150.23 114.91 5.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 72' ' ' LEU . . . -124.89 151.89 44.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.522 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.5 p -150.22 127.14 11.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.892 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 m -53.05 -25.84 13.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.82 -52.21 61.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.014 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.25 -29.23 68.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.077 0.465 . . . . 0.0 110.47 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -91.4 10.58 26.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.9 mtmp? 1.77 63.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.468 0.707 . . . . 0.0 112.878 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 55' ' ' LEU . 10.9 mt -80.99 176.16 10.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.852 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 68.29 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.98 -159.01 9.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.84 -73.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -74.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.6 p -91.69 14.72 14.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.255 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.81 -43.38 11.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 110.856 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 76.1 t -94.18 -26.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.83 -40.75 0.06 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.634 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -66.49 -60.02 3.12 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.745 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 28.3 mt-30 -48.24 -27.14 2.29 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.248 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.585 HG13 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -77.06 -36.24 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.585 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -73.98 -29.74 62.36 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.27 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.745 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 6.5 ppt_? -69.51 -36.17 76.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -73.94 -38.07 64.36 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.567 ' CD1' ' HB2' ' A' ' 36' ' ' ALA . 7.2 mt -65.4 -43.58 90.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.419 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -75.51 -30.97 60.0 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.085 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 21.2 mt-10 -75.65 -28.46 58.77 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 8.3 mtmm -76.12 -67.79 0.65 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.399 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.465 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -45.44 -40.89 8.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 11.0 mt -57.79 -39.02 76.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.718 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.5 -22.88 14.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.937 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.44 -27.38 20.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.21 19.69 9.26 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.077 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -76.92 103.79 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.588 0.708 . . . . 0.0 110.449 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLU . 19.1 tttp -91.54 -56.92 2.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.363 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.68 146.91 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.482 HG11 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -134.07 167.16 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.458 0.647 . . . . 0.0 112.169 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.21 103.74 14.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.255 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 88' ' ' ARG . 1.5 t80 -80.75 110.58 16.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 112.723 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.0 106.36 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.066 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -92.34 -33.91 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.058 0.456 . . . . 0.0 110.304 -178.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.76 -110.22 2.76 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -90.31 32.7 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.849 2.366 . . . . 0.0 112.262 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.522 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 3.4 m-30 -102.27 152.79 20.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.131 0.491 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.26 148.91 52.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.446 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.486 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -44.75 111.83 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.979 0.419 . . . . 0.0 110.334 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -124.01 -122.69 0.26 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.639 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.04 -12.4 3.21 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.964 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.419 ' HG3' ' HD2' ' A' ' 29' ' ' ARG . 1.7 mmt85 -87.95 -70.77 0.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.851 0.325 . . . . 0.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 55.8 t -36.14 -32.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 123.035 0.534 . . . . 0.0 111.672 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.486 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.14 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.969 0.414 . . . . 0.0 110.96 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -44.25 -40.84 5.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -67.73 -45.77 74.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 110.214 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.84 -30.63 70.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.772 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -69.91 -49.0 56.41 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.515 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.74 -55.21 7.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.754 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.873 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.808 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.17 -45.04 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.772 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -56.63 -35.2 68.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.835 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.474 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -73.34 -49.08 16.55 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.119 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . -179.53 -29.99 0.05 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.728 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.808 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 8.0 mp -71.15 146.86 48.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -128.04 91.71 3.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.104 178.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.1 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.026 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.853 0.358 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.464 ' HA ' ' H ' ' A' ' 41' ' ' ASP . 1.4 mp -122.12 134.09 54.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.72 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.59 126.93 52.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.705 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.0 tt -89.84 141.53 28.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.419 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.21 108.72 5.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.692 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 4.7 p -95.78 125.45 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.16 144.15 40.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.83 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 26.2 tpt180 -150.12 118.63 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.765 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.9 p -89.93 -42.97 10.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.657 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -178.61 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 13.5 mtmt -119.27 -1.67 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.649 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 25.8 m170 -112.15 116.96 31.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.036 0.446 . . . . 0.0 111.492 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 51' ' ' SER . 5.8 tp -106.94 112.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' A' ' 51' ' ' SER . 8.9 m-85 -127.87 110.69 12.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HB1' HD13 ' A' ' 72' ' ' LEU . . . -96.04 124.84 40.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.78 113.4 25.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.515 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.09 99.16 8.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.119 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.84 163.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.127 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.95 114.08 26.22 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.754 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 22.0 t70 -91.5 25.47 2.62 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.438 1.086 . . . . 0.0 112.303 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -109.46 -47.92 3.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.89 118.25 15.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 90.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.613 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.6 t -139.99 112.32 5.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -73.31 114.13 11.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD12 HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -91.58 -64.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.1 t -121.7 145.87 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 111.792 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.9 p -150.36 114.82 5.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.041 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 72' ' ' LEU . . . -126.73 156.25 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.1 145.56 26.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.237 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.436 ' N ' ' CG2' ' A' ' 68' ' ' VAL . 34.7 m -53.56 -82.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.689 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -59.14 -10.23 2.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.88 -64.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.689 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mp -55.79 -51.94 65.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.63 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 mt -56.8 115.35 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.278 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -109.38 85.51 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.19 175.39 28.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -101.58 -76.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 -155.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -74.48 57.35 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.0 110.957 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -94.34 -59.18 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.814 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' ALA . 68.8 t -83.94 -19.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -31.83 -42.14 0.05 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.962 0.411 . . . . 0.0 111.965 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.76 -61.04 2.3 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.521 0.676 . . . . 0.0 109.301 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.564 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -48.67 -25.08 1.6 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.3 177.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -78.97 -33.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.671 178.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.535 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -79.77 -27.28 54.31 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.357 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -73.61 -38.37 65.12 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.38 -34.8 70.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.507 HD13 ' HB1' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -69.21 -49.6 54.98 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.322 178.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -67.46 -25.4 65.87 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.896 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -77.91 -31.28 51.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 13.5 mttt -71.95 -69.34 0.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.515 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB2' HD12 ' A' ' 109' ' ' LEU . . . -44.28 -43.38 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.136 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -55.52 -39.23 70.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.052 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.28 -23.56 15.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.962 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.485 ' HB2' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.58 -27.16 20.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.29 16.69 10.83 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.156 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -74.7 103.02 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.725 0.774 . . . . 0.0 110.307 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -94.44 -51.93 4.55 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.75 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 135.16 54.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -124.02 165.1 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.4 0.619 . . . . 0.0 111.769 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.85 105.4 14.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.379 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -81.34 106.31 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.529 -178.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.73 44.08 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.008 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 16.3 ptt-85 -39.4 -47.84 1.84 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.827 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.93 -114.68 2.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.15 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.03 -13.53 21.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.426 2.084 . . . . 0.0 112.275 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.426 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.5 m-85 -60.63 138.11 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.02 0.438 . . . . 0.0 111.159 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 154.11 49.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.999 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 1.3 t80 -42.4 113.56 0.47 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -128.89 -77.95 0.56 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' NZ ' ' A' ' 98' ' ' LYS . . . -155.37 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.167 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -65.55 -60.85 2.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 42.1 t -35.97 -39.18 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.994 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' CE ' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.65 -80.16 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.391 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -53.77 -36.39 62.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.015 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 2.4 tt -68.98 -48.23 63.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.149 0.5 . . . . 0.0 110.972 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.79 -30.79 71.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.323 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.21 -45.04 70.85 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.77 -57.24 9.92 Favored Glycine 0 CA--C 1.508 -0.375 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -62.92 -33.12 74.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.357 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.1 mtm180 -88.46 -30.05 19.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.749 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.793 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -76.94 -34.36 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -71.17 -47.38 37.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.106 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.46 -29.47 0.07 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.878 -1.153 . . . . 0.0 114.942 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.25 147.14 48.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -127.85 91.84 3.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.413 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.4 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.935 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 41' ' ' ASP . 3.6 mp -110.63 134.89 52.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.761 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -103.85 125.34 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.442 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tt -89.81 143.81 26.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.406 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 50.9 m -145.43 108.69 4.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 0.0 111.343 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' CG2' ' CD1' ' A' ' 100' ' ' LEU . 8.0 p -101.99 121.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -103.64 129.39 50.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.603 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -136.69 118.55 15.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -89.75 -77.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.476 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -134.33 -61.24 0.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.828 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.29 18.32 12.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.557 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -117.71 164.05 15.56 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.997 0.427 . . . . 0.0 111.25 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 27' ' ' VAL . 6.5 tp -155.8 126.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.486 ' CE2' ' CB ' ' A' ' 51' ' ' SER . 18.8 m-85 -140.86 110.2 6.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB1' ' CD2' ' A' ' 72' ' ' LEU . . . -94.04 121.46 35.55 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.33 117.4 30.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.205 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -100.24 103.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.479 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -105.95 161.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.449 -177.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' N ' HG21 ' A' ' 39' ' ' ILE . 16.2 t0 -92.7 114.32 26.84 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.962 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 25.4 t0 -92.05 23.58 3.69 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.277 0.985 . . . . 0.0 112.148 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.25 -47.82 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.6 mppt? -133.31 118.09 18.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.68 90.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.432 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' LYS . 67.4 t -139.61 112.28 5.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.15 114.79 16.33 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -94.19 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.2 t -123.67 144.51 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.338 0.59 . . . . 0.0 112.093 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -150.24 114.78 5.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.826 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.06 161.98 27.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.804 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.486 ' CB ' ' CE2' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -150.06 144.36 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.875 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 p -56.33 -48.43 76.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.5 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 57' ' ' LEU . 3.7 pp -71.13 -7.91 49.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.76 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.41 -54.27 5.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 111.696 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 5.7 mp -52.48 -46.85 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.173 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 36.4 ttmt 179.2 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.527 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 53' ' ' LEU . 5.1 tt -41.62 137.73 1.54 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.656 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.12 -44.58 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.35 72.69 0.38 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.67 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -169.42 160.3 9.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.75 0.309 . . . . 0.0 110.73 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CB ' ' NH2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -109.88 -88.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.403 ' CG2' ' HD2' ' A' ' 96' ' ' ARG . 9.3 p -93.19 11.89 26.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.65 0.262 . . . . 0.0 111.079 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -58.67 -53.24 60.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 64' ' ' VAL . 40.7 t -94.2 -16.3 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.56 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.566 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -30.5 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.26 -60.53 2.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 1.6 mt-30 -48.01 -26.11 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.419 178.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -76.66 -39.27 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.992 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.607 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -70.5 -37.42 69.01 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.815 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 16.1 ptt85 -64.27 -36.88 85.56 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.706 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.97 -54.95 26.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.097 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -63.79 -42.15 97.8 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 69' ' ' GLY . . . -62.46 -27.7 69.3 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.715 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.3 tt0 -78.04 -25.52 47.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.466 178.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.706 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 2.4 mttp -82.4 -62.11 1.71 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -46.08 -43.28 14.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.407 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -55.97 -39.65 72.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.107 178.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.54 -23.95 12.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.878 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -89.38 -27.14 20.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.59 17.7 10.27 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.961 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -69.1 106.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.513 0.673 . . . . 0.0 110.346 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLU . 1.5 ttpt -92.45 -61.07 1.68 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.207 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.39 146.32 34.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.356 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -131.72 165.78 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.205 0.526 . . . . 0.0 111.776 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.17 104.75 14.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.838 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.133 0.492 . . . . 0.0 111.741 -178.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -122.26 38.89 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.957 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 20.6 ptt180 -40.45 -33.38 0.26 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.516 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.77 -129.38 8.62 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.306 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.93 44.99 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.777 2.318 . . . . 0.0 112.298 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.6 m-30 -97.38 153.71 17.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.007 0.432 . . . . 0.0 111.114 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.34 154.66 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.884 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.624 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -49.29 101.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 110.201 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.426 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 31.4 t-80 -111.92 -112.38 0.33 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.002 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.29 -37.12 0.31 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.672 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 10.4 mpt_? -67.96 -71.06 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 70.8 t -36.41 -32.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.968 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.624 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -63.74 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.037 0.446 . . . . 0.0 110.893 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -43.2 -40.79 3.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.334 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -69.81 -48.77 57.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.757 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -55.35 -30.69 60.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.52 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.849 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.68 -47.0 57.11 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.764 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.19 -57.27 7.23 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . . . -62.78 -37.87 88.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.517 -1.342 . . . . 0.0 111.599 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -85.4 -33.16 22.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.068 0.461 . . . . 0.0 110.487 179.549 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.849 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.8 pt-20 -70.0 -37.53 75.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -68.24 -50.13 41.28 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.375 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 174.92 -26.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.945 -1.121 . . . . 0.0 114.978 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.34 144.68 49.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.95 96.75 4.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.47 178.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.591 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.093 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 tpp85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.895 0.379 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -104.71 134.05 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.229 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -105.33 129.13 53.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.546 -179.108 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 3.2 tt -89.47 141.27 28.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.392 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' OG ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -144.7 108.37 4.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.777 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 14.9 p -97.06 126.98 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.765 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.76 141.56 42.22 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.679 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 97' ' ' VAL . 35.7 mtt85 -150.11 118.69 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 p -89.91 -42.51 11.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.166 0.508 . . . . 0.0 110.416 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tt -179.98 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.723 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' CG ' ' HA3' ' A' ' 59' ' ' GLY . 1.4 ttpt -119.29 -6.7 10.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.973 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -109.07 116.4 31.89 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.885 0.374 . . . . 0.0 111.617 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 52' ' ' SER . 2.0 tp -105.25 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.034 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 27.5 m-85 -146.93 109.24 4.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -93.45 125.47 38.08 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -113.85 113.45 24.91 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.837 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -97.87 102.98 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.905 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' CD1' ' OG ' ' A' ' 26' ' ' SER . 3.6 mp -107.68 161.27 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HA ' HD21 ' A' ' 23' ' ' LEU . 5.3 t0 -89.44 115.14 26.65 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.779 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 4.0 t70 -92.3 24.08 3.57 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.376 1.048 . . . . 0.0 112.274 -178.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -109.49 -47.63 3.35 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 177.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.5 mttp -133.54 118.12 17.92 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.95 89.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.301 -177.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' LYS . 98.6 t -137.88 112.52 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -76.38 119.19 19.91 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.84 -56.81 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.62 142.1 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.211 0.529 . . . . 0.0 112.208 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.4 115.21 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.997 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -122.98 163.76 19.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.059 0.457 . . . . 0.0 111.963 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 18.2 p -146.06 126.9 14.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.046 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.582 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.1 p -56.35 -43.82 79.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.434 -179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 51' ' ' SER . 0.0 OUTLIER -62.52 -10.28 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.089 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.16 -54.65 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.752 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 mp -52.64 -44.81 66.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.191 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tttp 179.21 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.513 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -43.79 154.32 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.65 25.03 4.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 32' ' ' LYS . . . 69.0 63.97 3.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.622 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -102.96 -48.15 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.97 -163.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 p -82.48 57.52 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.785 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -94.17 -58.19 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.074 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 57' ' ' LEU . 95.0 t -94.06 -17.19 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.621 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -33.94 -40.45 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.602 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.43 -60.13 2.82 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.47 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.9 mt-30 -49.34 -23.53 1.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.645 177.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -77.53 -35.5 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.524 178.573 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -78.48 -34.79 34.78 Favored Glycine 0 C--O 1.218 -0.901 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -64.77 -37.23 86.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.722 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -46.41 76.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.6 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -61.55 -51.18 69.65 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.315 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -59.04 -25.87 64.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.745 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 18.2 tt0 -72.0 -35.59 69.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.467 0.651 . . . . 0.0 109.37 178.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 9.1 mttt -78.81 -63.76 1.34 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.994 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -42.96 -42.45 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.706 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -58.45 -41.2 84.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.387 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -50.28 -25.86 4.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.319 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.189 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 113.94 15.12 8.77 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.855 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -76.83 102.66 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.13 0.491 . . . . 0.0 110.187 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -106.3 -23.37 12.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.841 -179.564 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.49 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -129.84 125.29 35.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.284 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -123.09 165.41 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.435 0.636 . . . . 0.0 111.839 -179.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.14 111.63 22.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.754 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -80.95 111.41 17.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 111.789 -178.219 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.03 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 9.4 ptt-85 -41.82 -37.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.01 -125.41 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.47 0.26 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.521 2.147 . . . . 0.0 112.877 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CD2' ' CE1' ' A' ' 94' ' ' HIS . 4.4 m-85 -58.71 144.03 44.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.97 109.57 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.544 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER 0.11 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.123 0.569 . . . . 0.0 112.103 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -131.02 173.42 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.468 -179.009 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -36.58 -67.81 0.37 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.741 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -47.34 -66.36 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.593 0.235 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 89.9 t -29.61 -45.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.022 0.529 . . . . 0.0 112.014 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.43 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.031 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.38 -37.6 75.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.075 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 4.8 tt -64.68 -47.77 77.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.389 0.614 . . . . 0.0 111.238 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.08 -31.6 72.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.694 -178.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.767 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -66.58 -46.31 76.37 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.31 -59.4 5.83 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.958 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -57.74 -43.19 85.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.609 -1.295 . . . . 0.0 111.405 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.894 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -80.99 -48.14 12.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.302 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.3 pt-20 -52.89 -43.75 66.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.488 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -60.82 -48.39 86.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.19 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 178.46 -27.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.609 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.894 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.64 149.64 45.37 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -129.14 91.82 3.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.091 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.027 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.15 134.98 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.42 179.774 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -100.53 125.36 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.948 0.404 . . . . 0.0 111.067 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.477 ' HG ' HD13 ' A' ' 38' ' ' ILE . 2.8 tt -89.53 141.47 28.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.959 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.446 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -150.33 108.86 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.141 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 5.0 p -102.48 120.45 52.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.215 0.531 . . . . 0.0 111.661 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.5 OUTLIER -97.38 144.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.683 -179.405 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.512 ' NE ' ' CB ' ' A' ' 96' ' ' ARG . 16.3 mtt85 -150.61 118.53 6.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.219 178.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.24 -35.85 12.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.671 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.93 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.459 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -119.3 6.59 11.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.485 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 33.5 m170 -115.89 103.14 10.33 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.467 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.5 tt -99.34 133.91 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.968 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 33.3 m-85 -147.3 110.2 4.73 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -93.01 120.91 33.79 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.402 ' HB3' HD11 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -112.42 113.03 25.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.283 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -95.83 98.76 8.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.221 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 37' ' ' GLN . 2.6 mp -100.62 166.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.574 -177.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.34 111.92 24.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.77 26.55 1.75 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.127 0.892 . . . . 0.0 112.304 -178.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -110.03 -47.45 3.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' VAL . 17.0 mttp -135.11 118.13 16.38 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 174.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.19 90.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.439 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 43' ' ' LYS . 67.2 t -137.92 112.62 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -78.38 119.64 22.0 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -102.92 -58.56 1.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.331 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 75' ' ' LYS . 1.4 t -120.55 146.73 24.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.313 0.578 . . . . 0.0 111.916 -178.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -150.13 114.74 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.883 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.89 156.41 33.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.55 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.14 126.75 10.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' HG23 ' A' ' 34' ' ' ILE . 4.4 p -56.76 -57.67 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 3.0 tm? -58.82 -21.5 56.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.98 -55.08 5.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.074 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.16 -50.29 62.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.19 -33.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.18 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 6.5 tt -37.28 124.76 0.98 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.958 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -131.96 -6.94 3.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.31 -107.2 1.53 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -56.45 106.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.9 -47.72 11.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.161 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.2 p -66.75 -38.0 85.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.981 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -54.18 -45.1 72.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.784 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 75.8 t -94.16 -20.83 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.65 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.18 -43.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.109 0.48 . . . . 0.0 111.759 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -65.48 -59.08 4.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.532 0.682 . . . . 0.0 109.413 178.938 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 16.1 mt-30 -50.35 -23.66 2.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.473 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.61 -32.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.52 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -78.03 -29.88 52.86 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.9 178.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.16 -40.11 71.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.634 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.24 -40.31 90.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.493 HD23 HD12 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -63.76 -55.41 23.36 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.1 -24.93 28.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.04 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -71.37 -37.51 71.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 18.2 mttt -71.82 -64.52 0.91 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.018 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -45.03 -41.02 7.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.536 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -59.74 -40.18 87.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.243 178.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.26 -24.21 7.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.28 -28.06 20.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.236 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.08 13.27 16.02 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.482 HG12 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.66 109.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 110.193 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.6 tttm -93.58 -56.23 2.99 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.39 -178.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -112.93 151.1 30.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.272 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -135.33 161.53 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.509 0.671 . . . . 0.0 112.132 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.85 87.79 2.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 19.9 t80 -80.7 108.33 14.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -176.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.37 98.58 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.685 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 7.3 tpt180 -90.42 11.66 20.89 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.467 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 90' ' ' PRO . . . 87.19 -113.94 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.147 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 2.3 Cg_endo -81.06 45.12 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.803 2.335 . . . . 0.0 112.122 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.461 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 3.2 m-85 -112.19 133.15 54.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 111.011 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.6 155.04 48.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.3 t80 -33.06 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -103.82 -166.34 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -178.752 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.703 ' C ' ' HE2' ' A' ' 98' ' ' LYS . . . -76.18 -17.14 80.2 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.235 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' CB ' ' NE ' ' A' ' 29' ' ' ARG . 3.8 mmt85 -97.92 -64.55 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.484 ' O ' ' C ' ' A' ' 98' ' ' LYS . 13.6 t -28.84 -70.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.703 ' HE2' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -29.47 -60.18 0.15 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.223 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' N ' ' HG2' ' A' ' 98' ' ' LYS . . . -69.99 -46.89 64.19 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.398 -177.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -61.41 -47.69 84.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.814 0.816 . . . . 0.0 109.422 179.247 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.458 ' N ' HD21 ' A' ' 100' ' ' LEU . . . -57.07 -40.36 76.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.64 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -62.58 -38.85 91.72 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.87 -59.34 8.15 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -60.89 -31.03 70.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.812 -1.194 . . . . 0.0 110.598 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.874 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 3.2 tpp85 -88.77 -25.52 22.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -82.7 -38.45 23.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -64.35 -46.35 90.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.638 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.81 -30.67 0.08 OUTLIER Glycine 0 C--N 1.341 0.835 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.556 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.874 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.57 146.56 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.455 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -128.32 99.7 5.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.127 178.328 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 2.5 p90 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.064 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 tpp180 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.769 0.319 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -30.87 134.1 0.07 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.356 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 13.6 ttp180 -93.36 124.5 37.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.908 -178.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 2.5 tt -89.66 145.99 24.85 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.255 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.428 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -150.38 119.06 6.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.212 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.771 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.8 t -101.29 139.99 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.863 0.363 . . . . 0.0 111.664 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' HA ' ' OH ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -125.67 112.5 16.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HG2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.68 118.66 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.814 177.48 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -89.5 -78.88 0.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.55 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.58 -61.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -119.25 20.06 12.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.231 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CD2' ' CD2' ' A' ' 53' ' ' LEU . 51.4 m170 -117.77 161.64 19.38 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' CD1' HD12 ' A' ' 100' ' ' LEU . 2.4 tp -151.37 128.05 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.939 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.449 ' CE2' ' OG ' ' A' ' 51' ' ' SER . 29.4 m-85 -145.42 150.83 37.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.153 0.502 . . . . 0.0 111.8 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' SER . . . -132.67 121.11 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 113.13 24.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.187 0.518 . . . . 0.0 110.22 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.484 HD11 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -96.21 96.31 5.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.24 163.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.921 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -96.9 109.31 22.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.574 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 18.2 p-10 -89.05 26.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.158 0.911 . . . . 0.0 112.273 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -110.67 -47.15 3.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.1 mppp? -133.26 118.17 18.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 174.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.43 89.72 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.418 -177.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 67.8 t -139.59 112.45 5.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.47 119.48 21.12 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 23' ' ' LEU . 1.2 mp -99.56 -59.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.193 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 76' ' ' ALA . 1.9 t -121.91 146.17 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.344 0.592 . . . . 0.0 112.004 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 88.3 p -150.18 114.86 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.943 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.37 158.3 33.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.844 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.449 ' OG ' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.22 134.14 16.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.423 ' CB ' HG21 ' A' ' 34' ' ' ILE . 9.0 t -54.5 -45.3 73.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 111.053 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' CD2' ' CD2' ' A' ' 33' ' ' HIS . 4.5 pp -74.39 -7.86 54.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.09 -54.36 15.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.466 . . . . 0.0 111.401 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mp -52.52 -48.85 65.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.805 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.89 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.639 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.8 mt -49.39 176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.5 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -123.47 -43.26 2.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.66 99.75 1.04 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.433 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -116.73 -41.19 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.983 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -176.3 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.1 p -86.22 51.4 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 -49.1 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.87 -19.81 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.291 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.543 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -34.28 -38.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.794 -179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.628 0.728 . . . . 0.0 109.157 178.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 10.6 mt-30 -49.68 -24.11 2.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.299 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.03 -32.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.534 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -76.99 -31.77 51.91 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.242 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.42 -42.59 68.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.62 -38.02 88.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.434 HD22 HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -65.48 -54.57 26.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.226 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -56.79 -24.22 48.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.938 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.27 -37.79 68.97 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 21.9 mttt -70.75 -67.12 0.53 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.095 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 109' ' ' LEU . . . -43.6 -41.96 4.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.685 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -59.3 -40.52 86.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.052 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.53 -23.92 7.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 HD13 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.46 -27.97 20.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.129 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.38 14.31 14.88 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.273 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -70.77 106.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.556 0.693 . . . . 0.0 110.019 179.722 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' GLU . 5.0 tttp -93.17 -54.55 3.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.493 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.73 144.2 41.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -130.73 159.89 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.5 0.667 . . . . 0.0 112.028 -179.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 17.1 t80 -80.39 106.51 12.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.635 0.731 . . . . 0.0 112.548 -176.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.95 97.78 2.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.362 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.771 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.4 tpt85 -83.55 -7.07 59.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.52 -110.21 2.0 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.24 34.94 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.021 2.48 . . . . 0.0 112.092 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 88' ' ' ARG . 2.9 m-30 -77.1 138.28 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.823 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 93' ' ' TYR . 9.4 tptt -121.28 99.49 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.796 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER 0.61 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.676 0.61 . . . . 0.0 112.236 -179.313 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.77 163.55 15.98 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.338 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -39.53 -60.64 1.69 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.55 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 33.6 mmt180 -47.72 -69.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.675 0.274 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.6 t -33.98 -38.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.809 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.64 -79.06 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.607 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.9 -34.45 65.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.542 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 101' ' ' ALA . 3.8 tt -68.17 -51.83 41.37 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.297 0.57 . . . . 0.0 110.969 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' N ' HD22 ' A' ' 100' ' ' LEU . . . -62.38 -29.63 70.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.671 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.02 -44.95 71.69 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.33 -57.66 7.96 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -62.25 -33.67 75.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.534 -1.333 . . . . 0.0 110.875 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.852 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 -22.84 23.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -85.2 -34.87 21.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -69.41 -44.63 63.98 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.655 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.14 -31.03 0.08 OUTLIER Glycine 0 C--N 1.341 0.828 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.632 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.852 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.4 mp -71.42 147.01 48.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.32 96.71 4.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.412 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 3.1 p90 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.842 0.353 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' HG ' HG13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -43.32 125.06 3.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.843 -179.401 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 122.73 37.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.501 -178.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.507 ' HG ' HD13 ' A' ' 38' ' ' ILE . 2.7 tt -89.43 143.02 27.14 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.518 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.418 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 1.3 m -146.23 108.55 4.44 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.008 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG21 HD12 ' A' ' 100' ' ' LEU . 6.7 p -97.03 119.23 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.321 0.582 . . . . 0.0 112.132 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.423 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.3 t80 -105.62 140.84 38.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.702 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -150.46 126.32 10.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.782 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 t -89.65 -85.78 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.924 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.87 -58.28 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.002 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.47 19.24 13.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.336 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -119.04 156.92 28.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' C ' ' CD1' ' A' ' 35' ' ' TYR . 2.7 tp -142.76 132.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 39.1 m-85 -149.55 149.97 31.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 111.963 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 72' ' ' LEU . . . -133.74 128.4 34.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.24 113.26 21.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.722 -179.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -99.55 99.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.32 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 40' ' ' ASP . 3.0 mp -104.32 160.05 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.794 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.0 t0 -91.36 114.19 26.65 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.51 22.74 2.85 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.077 0.861 . . . . 0.0 112.508 -178.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.67 -48.92 3.42 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.65 118.01 19.45 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.503 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.06 90.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.341 -177.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 60.2 t -136.1 112.58 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -77.87 118.48 20.23 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.1 mp -103.67 -50.85 3.32 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -126.86 142.59 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.442 0.639 . . . . 0.0 112.385 -178.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 80.8 p -150.08 115.01 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.498 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' CB ' ' HG ' ' A' ' 72' ' ' LEU . . . -126.0 161.78 26.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.32 127.06 10.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 179.527 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 68' ' ' VAL . 10.3 m -56.96 -26.93 60.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.12 -39.51 60.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.02 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.55 69.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -92.17 11.34 25.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.032 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.4 tptp 2.35 63.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.443 0.697 . . . . 0.0 112.618 -178.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' LEU . 8.5 mt -79.08 176.08 9.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 61.84 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.4 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.42 -160.21 9.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.543 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.91 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.353 . . . . 0.0 110.96 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.05 -77.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.23 -23.98 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -38.56 71.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 65' ' ' ALA . 79.2 t -93.99 -24.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.469 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.18 -40.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.961 0.41 . . . . 0.0 111.748 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.06 -60.36 2.69 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.385 0.612 . . . . 0.0 109.376 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.0 mt-30 -48.66 -27.04 2.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.194 178.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.578 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -74.63 -35.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.57 178.616 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' HG11 ' A' ' 68' ' ' VAL . . . -75.38 -36.93 43.01 Favored Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.068 178.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.642 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -62.14 -35.72 79.63 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -67.27 -45.93 75.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.067 178.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 68' ' ' VAL . 2.5 mt -63.55 -53.95 43.8 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.666 0.746 . . . . 0.0 109.019 178.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.91 -25.75 61.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.905 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -76.66 -26.92 55.37 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.108 178.183 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 27.2 mttm -82.9 -63.01 1.45 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.536 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.539 ' HB1' HD12 ' A' ' 109' ' ' LEU . . . -45.57 -42.6 11.24 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.02 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.6 mt -55.84 -40.15 72.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.127 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.63 -24.98 9.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.04 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -89.52 -28.29 19.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.32 15.43 11.49 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.352 -179.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.522 HG13 ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -66.52 106.21 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.519 0.676 . . . . 0.0 110.192 179.865 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.17 -56.78 3.03 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.165 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -113.73 144.72 42.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.261 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -128.16 161.7 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.651 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.85 103.28 12.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.999 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -81.56 108.42 15.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.124 0.487 . . . . 0.0 111.592 -179.078 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.24 45.81 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 1.3 ptt180 -41.53 -33.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.611 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.45 -117.96 5.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -88.74 20.07 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.771 2.314 . . . . 0.0 112.705 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.2 m-85 -80.92 138.74 36.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 0.0 111.214 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.02 151.34 25.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.6 106.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.649 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.32 164.57 18.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.85 -42.6 7.87 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.134 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -57.89 -70.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 0.0 110.668 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.0 t -37.45 -40.49 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.952 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.91 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.62 -35.36 70.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.699 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.4 tt -67.34 -49.6 63.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.084 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.17 -29.57 69.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.172 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.854 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -69.88 -44.26 70.16 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.369 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.77 -56.96 9.05 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -64.87 -31.43 72.66 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 113.578 -1.311 . . . . 0.0 111.013 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -89.97 -25.7 20.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.022 0.439 . . . . 0.0 110.726 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.1 pt-20 -80.48 -37.66 31.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' HA3' ' HB2' ' A' ' 73' ' ' ALA . . . -66.8 -48.32 62.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.493 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 177.01 -29.16 0.07 OUTLIER Glycine 0 C--N 1.343 0.949 0 C-N-CA 119.905 -1.14 . . . . 0.0 115.023 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.48 146.54 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.418 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -128.24 96.31 4.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.379 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.563 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 1.4 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.004 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.796 0.331 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -121.25 132.18 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -102.71 126.82 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.176 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD11 ' CD1' ' A' ' 111' ' ' PHE . 5.3 tt -89.74 147.15 24.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.818 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 2.1 m -139.16 158.58 43.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.581 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -146.09 127.45 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.967 0.413 . . . . 0.0 110.265 179.219 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -128.68 122.49 30.91 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.912 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -130.81 123.55 29.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.639 178.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.09 -91.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.833 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.39 -64.76 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 109.829 179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 27.99 8.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.794 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -119.69 161.87 19.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.439 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 52' ' ' SER . 3.5 tp -149.34 128.23 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.513 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.482 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 27.4 m-85 -144.02 160.15 41.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.312 0.577 . . . . 0.0 111.839 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . . . -145.77 126.97 14.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.006 177.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -115.33 113.18 23.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 110.679 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.2 92.34 3.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -96.58 161.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.53 115.44 27.6 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.826 177.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.7 t0 -92.42 28.67 1.89 Allowed 'General case' 0 N--CA 1.464 0.239 0 O-C-N 124.289 0.993 . . . . 0.0 112.22 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.45 -47.72 3.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.1 mptt -136.78 118.25 14.77 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 174.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.37 89.16 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.545 -177.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 43' ' ' LYS . 92.8 t -137.43 112.61 10.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.194 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -74.86 119.26 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -98.23 -63.63 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.23 147.51 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.402 0.62 . . . . 0.0 112.4 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.4 p -150.27 129.44 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.82 179.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 72' ' ' LEU . . . -141.75 157.61 44.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.494 . . . . 0.0 112.32 -179.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.39 129.19 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.515 179.594 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 48.1 m -53.84 -25.13 18.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.77 -28.4 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.115 0.483 . . . . 0.0 110.411 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.6 mp -91.28 10.74 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.306 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 1.66 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.137 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 55' ' ' LEU . 12.6 mt -79.26 176.04 10.04 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.723 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -93.04 69.8 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.4 -136.41 2.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.582 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -140.33 -168.09 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.931 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.966 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 p -75.8 -25.14 56.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -40.42 72.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.138 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 73.2 t -94.06 -23.14 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 100' ' ' LEU . . . -32.33 -41.66 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.735 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.01 -60.82 2.46 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.475 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.4 mt-30 -48.14 -26.19 1.78 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.241 177.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG11 ' N ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -77.49 -34.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.586 178.597 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.561 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.51 -31.33 54.68 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -67.94 -34.96 77.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.943 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.52 -41.48 65.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.151 177.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.561 HD12 ' HA2' ' A' ' 69' ' ' GLY . 5.1 mt -63.68 -46.33 86.02 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . -68.32 -27.18 66.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -67.43 -37.16 82.58 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 109.298 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 3.2 mttt -81.34 -63.96 1.29 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.068 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.451 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -41.21 -42.34 2.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.135 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.7 mt -61.15 -40.33 93.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.963 179.4 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.9 -22.57 5.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.483 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.17 -27.09 20.92 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.028 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.33 17.08 11.05 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.068 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -70.84 103.91 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.694 0.759 . . . . 0.0 110.312 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLU . 10.2 ttpt -95.75 -46.71 6.48 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.07 -178.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 140.63 52.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.379 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -127.89 167.45 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.473 0.654 . . . . 0.0 111.975 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.74 105.17 15.31 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 88' ' ' ARG . 1.6 t80 -80.67 106.24 12.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.823 0.82 . . . . 0.0 112.597 -177.291 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.41 105.46 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.834 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -90.39 -48.06 7.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.675 -178.029 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.3 -112.48 2.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.163 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.16 26.84 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.834 2.356 . . . . 0.0 112.59 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 m-30 -99.66 162.54 12.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 111.368 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -132.01 148.07 52.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.886 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -44.61 103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.609 -179.858 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.06 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.142 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.31 -42.51 25.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.129 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -56.27 -71.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.537 0.208 . . . . 0.0 110.985 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -39.46 -43.12 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.742 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.451 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.04 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.041 0.448 . . . . 0.0 111.067 -179.643 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.36 -36.84 71.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.213 -179.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 1.2 tt -68.32 -49.11 62.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 110.82 -179.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -58.65 -32.99 69.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.333 -178.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.74 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.75 -47.83 65.28 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.599 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.04 -58.32 6.37 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 177.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 73' ' ' ALA . . . -58.36 -42.55 87.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.363 -1.419 . . . . 0.0 111.354 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -79.55 -53.77 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -48.35 -41.25 28.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.258 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 73' ' ' ALA . . . -65.14 -49.58 61.35 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.842 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 178.66 -27.89 0.06 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.16 -1.019 . . . . 0.0 114.522 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.84 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.5 147.73 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.35 91.91 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 178.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.507 ' CD2' ' CD1' ' A' ' 86' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.011 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.875 0.369 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' CD1' HG13 ' A' ' 81' ' ' ILE . 1.1 mp -126.64 134.99 50.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -105.28 124.64 49.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.771 -178.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 86' ' ' PHE . 2.1 tt -90.54 143.02 27.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.257 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.442 ' CA ' ' HD3' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -145.14 110.17 5.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.165 -179.816 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 2.2 p -100.83 123.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.072 0.463 . . . . 0.0 111.921 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.482 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -100.5 154.24 18.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 112.316 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 18.1 mtm105 -150.29 118.81 6.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.32 179.133 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 -45.28 9.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.054 0.454 . . . . 0.0 110.994 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tp 179.89 -63.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -115.29 22.2 13.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.285 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.431 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 29.6 m80 -122.2 173.15 7.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.958 -179.436 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.458 ' CD1' HD12 ' A' ' 100' ' ' LEU . 5.2 tp -158.4 132.69 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CZ ' HD12 ' A' ' 53' ' ' LEU . 30.8 m-85 -148.21 148.69 30.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 72' ' ' LEU . . . -134.23 121.29 21.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.876 177.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -111.76 112.88 24.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -98.31 105.3 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.106 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.409 ' HA ' HD12 ' A' ' 47' ' ' LEU . 3.8 mp -108.26 160.08 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -88.83 116.33 27.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.831 178.109 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.4 t0 -91.74 22.38 4.18 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.415 1.072 . . . . 0.0 112.256 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.04 -46.67 3.43 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mmmt -133.16 118.31 18.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 174.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.56 86.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 43' ' ' LYS . 61.7 t -134.89 112.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -72.4 113.87 9.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.9 -57.29 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.713 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG13 HD23 ' A' ' 72' ' ' LEU . 2.3 t -131.62 152.76 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.234 0.54 . . . . 0.0 111.902 -178.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -150.31 119.61 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.934 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.66 148.56 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 112.128 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.39 139.97 21.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.641 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.96 -67.41 0.25 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 111.469 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.551 HD12 ' CZ ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -58.22 -9.69 1.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.05 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.032 0.444 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mp -52.59 -51.95 57.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.639 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tttt 177.5 -37.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -83.36 117.62 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.704 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HA ' ' CB ' ' A' ' 53' ' ' LEU . 17.0 tttm -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.847 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.63 106.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.699 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.22 -30.03 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.621 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.04 -161.73 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.381 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -86.73 48.97 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -94.23 -55.01 3.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 64' ' ' VAL . 63.9 t -94.03 -18.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.924 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 68' ' ' VAL . . . -31.11 -42.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 111.95 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.03 -60.41 2.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.584 0.707 . . . . 0.0 109.205 178.648 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 25.2 mt-30 -49.18 -24.14 1.59 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.368 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.17 -32.37 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.268 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -77.44 -26.82 60.57 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.276 178.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 7.5 ppt_? -77.31 -38.45 50.55 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.346 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.37 72.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -72.21 -52.12 17.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.981 178.428 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -62.85 -23.67 67.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.532 178.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 42.7 mt-10 -77.79 -30.04 51.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 16.5 mttt -73.82 -68.29 0.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.416 177.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 79' ' ' LEU . . . -44.45 -42.44 7.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.104 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 10.8 mt -57.12 -38.89 74.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.823 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -54.55 -23.07 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.932 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.903 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 18.97 9.53 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.109 -178.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.41 104.93 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.559 0.695 . . . . 0.0 110.356 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 4.1 tttt -90.99 -57.22 2.88 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.372 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.91 146.91 35.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.421 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.83 165.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.5 0.667 . . . . 0.0 112.023 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -108.38 97.3 7.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.324 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 5.3 t80 -81.12 109.68 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.28 86.48 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.651 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.0 tpt180 -77.66 -27.7 50.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.046 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.29 -109.31 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.226 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.19 34.2 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.823 2.348 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.475 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 2.7 m-85 -96.34 138.11 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.124 0.488 . . . . 0.0 111.558 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 149.54 30.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.932 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.497 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -45.51 97.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.779 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.5 159.11 17.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.459 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -40.17 -51.44 3.55 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.492 -179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.456 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . 2.4 mtt-85 -55.0 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.636 0.255 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -40.28 -38.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.273 179.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -61.16 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.012 0.434 . . . . 0.0 110.592 -179.96 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.73 -36.08 64.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.99 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 101' ' ' ALA . 1.3 tt -70.35 -52.68 20.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.204 0.526 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -56.41 -32.32 64.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.319 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.794 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.6 -44.6 70.39 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.043 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.79 -57.09 8.92 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' LEU . . . -61.78 -33.69 74.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.49 -1.355 . . . . 0.0 110.93 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.843 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.5 tpp85 -88.97 -24.11 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.794 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -83.6 -34.94 25.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.482 ' HA3' ' HB1' ' A' ' 73' ' ' ALA . . . -69.3 -45.35 61.41 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.921 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 77' ' ' LEU . . . 176.03 -30.64 0.08 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.178 -1.011 . . . . 0.0 114.454 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.843 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.36 142.81 50.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.193 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 2.0 mp0 -127.7 99.8 5.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.066 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 84' ' ' VAL . 2.1 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.091 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -92.84 125.52 37.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.635 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.869 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.45 144.03 26.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.869 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 m -145.82 108.53 4.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.85 HG11 HG23 ' A' ' 97' ' ' VAL . 4.5 p -98.3 123.43 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.177 0.513 . . . . 0.0 111.882 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -106.98 145.26 32.48 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -150.29 119.17 6.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.74 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.66 -69.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.072 0.463 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.6 mt -147.6 -59.16 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.441 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -119.37 4.36 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.379 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.1 116.25 31.59 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.994 0.426 . . . . 0.0 111.356 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.636 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.0 tp -104.09 129.09 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 20.3 m-85 -143.16 151.21 40.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.215 0.531 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -137.61 122.52 18.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.397 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.63 113.26 25.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.0 110.547 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.02 100.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -102.02 163.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.892 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 t0 -93.63 114.03 26.26 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -90.26 26.65 1.86 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.331 1.019 . . . . 0.0 112.419 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.67 -47.64 3.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.29 118.22 17.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.82 89.25 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.374 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.5 t -138.3 112.41 8.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -76.94 119.35 20.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.4 mp -102.32 -57.57 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -122.69 146.12 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 0.0 111.907 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -150.16 114.91 5.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -120.98 148.4 44.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.886 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.472 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.43 136.77 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.978 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 16.3 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.007 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.812 0.339 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 69.0 t -86.08 -21.46 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.198 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.067 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.6 -43.98 0.05 Allowed 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -64.12 -60.94 2.61 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.517 0.675 . . . . 0.0 109.398 178.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -48.45 -25.28 1.58 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.23 177.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.067 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.13 -33.16 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.639 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.52 -27.91 58.44 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.161 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.7 ppt_? -74.77 -38.61 62.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -70.27 -34.94 73.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 38' ' ' ILE . 1.8 tp -68.98 -54.29 16.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.82 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -61.94 -25.31 67.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.913 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.9 mt-10 -77.88 -30.22 50.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.3 mttt -72.77 -69.27 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.518 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.72 -42.55 7.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -55.85 -39.1 70.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.023 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.79 -24.01 13.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.54 -27.77 20.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.28 14.93 12.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.297 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.88 107.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.496 0.665 . . . . 0.0 110.237 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 110' ' ' GLU . 24.4 ttpt -94.53 -52.45 4.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.361 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.44 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -114.85 142.61 46.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.204 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.643 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.04 161.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.414 0.626 . . . . 0.0 112.058 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -102.02 100.88 11.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.282 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 1.9 t80 -81.06 106.25 12.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.155 0.502 . . . . 0.0 111.216 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -137.16 43.16 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.155 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' NH1' HG21 ' A' ' 97' ' ' VAL . 7.2 ptt180 -37.71 -39.18 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.809 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.72 -117.32 5.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.734 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.15 50.62 3.6 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 111.979 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.46 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 5.9 m-85 -123.22 102.23 7.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -71.52 139.33 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.881 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -52.11 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -103.73 -165.12 1.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.148 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.82 -55.81 9.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.987 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.636 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -45.77 -71.25 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.653 0.263 . . . . 0.0 110.586 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.85 HG23 HG11 ' A' ' 27' ' ' VAL . 8.8 p -42.59 -32.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -66.37 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.96 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -47.28 -35.87 8.4 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.772 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -70.18 -41.24 74.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.07 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -66.65 -34.93 78.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.461 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.742 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -66.25 -44.2 84.35 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.32 -57.0 10.93 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.97 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.26 -33.02 72.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.552 -1.324 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.1 tpp180 -90.05 -26.25 20.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.721 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.742 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.3 pt-20 -80.82 -33.33 34.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.65 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.91 -46.68 35.86 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.946 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.9 -31.42 0.07 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 119.989 -1.101 . . . . 0.0 114.731 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.835 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.3 mp -71.36 143.99 50.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' CB ' ' HG3' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -127.9 95.15 4.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.136 178.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.663 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.2 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.754 0.312 . . . . 0.0 110.585 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.5 ttp85 -101.12 127.16 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.42 140.87 29.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.757 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.15 112.34 7.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.24 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -92.74 135.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.564 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 1.4 t80 -123.93 115.64 21.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.102 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -126.27 118.72 25.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.542 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.25 -48.58 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -170.52 -64.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -117.27 20.81 13.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.405 178.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.3 m-70 -127.74 132.68 49.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.032 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 100' ' ' LEU . 4.0 tp -121.85 118.47 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.303 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 9.2 m-85 -136.5 108.39 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.706 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -97.54 126.03 42.58 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 116.07 29.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.321 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.81 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -97.43 98.35 7.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.169 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.2 mp -100.71 165.45 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.039 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -97.16 112.07 24.02 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.721 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.1 p30 -91.12 27.04 1.97 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.15 0.906 . . . . 0.0 112.252 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -110.15 -46.9 3.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.3 mptt -134.62 118.25 17.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.83 90.33 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.341 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.6 t -140.98 112.53 3.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -76.48 123.12 25.55 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -104.02 -61.78 1.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -120.59 144.9 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.224 0.535 . . . . 0.0 111.952 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.4 p -150.21 116.06 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.175 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.859 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.54 151.22 48.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.212 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.56 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 7.1 t -150.44 134.88 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.884 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.663 ' H ' HG23 ' A' ' 34' ' ' ILE . 5.4 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.035 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 67' ' ' GLN . 53.0 t -93.99 -18.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.722 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.025 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.43 -39.32 0.12 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.8 -59.96 3.09 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.7 mt-30 -49.58 -27.28 4.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.297 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -75.01 -33.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.78 -27.26 61.07 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.7 -33.58 72.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.9 -36.62 56.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.859 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -65.39 -45.54 83.61 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -73.06 -33.27 65.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.845 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 46.4 mt-10 -71.34 -33.22 69.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 48' ' ' VAL . 19.7 mttt -70.17 -67.65 0.48 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.79 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.37 -41.08 13.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.963 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.719 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.97 -38.97 77.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.023 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.52 -23.61 10.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.946 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.53 -27.38 20.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.5 16.59 10.81 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.206 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -72.16 107.96 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.516 0.674 . . . . 0.0 110.393 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -95.15 -53.45 3.8 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.442 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -115.14 142.57 46.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.44 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.55 163.47 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.496 0.665 . . . . 0.0 111.884 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.11 98.8 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.169 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.749 ' CE1' HD22 ' A' ' 25' ' ' LEU . 2.1 t80 -81.15 113.89 19.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.459 0.647 . . . . 0.0 111.806 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.442 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -150.17 33.7 0.66 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.677 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.667 ' C ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -43.31 -41.6 4.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.795 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.465 ' N ' ' HD3' ' A' ' 88' ' ' ARG . . . 156.28 -136.61 5.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -95.73 37.85 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.193 2.595 . . . . 0.0 112.736 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' NH2' ' A' ' 88' ' ' ARG . 4.7 m-30 -88.62 84.94 6.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.339 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -71.85 133.62 45.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.559 ' C ' ' O ' ' A' ' 92' ' ' LYS . 1.4 t80 0.69 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.533 0.521 . . . . 0.0 112.304 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.536 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -94.18 148.31 22.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.216 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.432 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -29.01 -39.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.095 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.6 mmt180 -79.49 -65.43 1.0 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.678 0.275 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 31.8 t -30.48 -49.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -53.99 -72.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.495 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.56 -40.94 96.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.476 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 34' ' ' ILE . 2.4 tt -63.19 -45.71 90.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.473 0.654 . . . . 0.0 110.446 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.528 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -67.58 -30.32 69.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.291 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.02 -46.74 70.4 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.25 -54.71 9.69 Favored Glycine 0 CA--C 1.508 -0.393 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.965 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.83 -36.15 83.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.269 -1.465 . . . . 0.0 111.469 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -87.48 -24.25 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.412 . . . . 0.0 110.764 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -82.59 -37.47 24.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.78 -47.98 64.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.002 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.719 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -30.06 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.513 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.817 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.0 mp -71.41 143.7 50.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.444 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -127.69 99.38 5.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.881 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.895 . . . . 0.0 111.068 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.799 0.333 . . . . 0.0 110.411 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -101.54 125.16 48.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.55 143.42 26.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.821 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 m -146.97 108.76 4.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.966 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG21 HD13 ' A' ' 100' ' ' LEU . 7.7 p -93.39 119.77 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.07 140.22 37.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.785 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 34' ' ' ILE . 3.2 mmm180 -150.08 118.92 6.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.951 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.74 -64.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.21 0.529 . . . . 0.0 110.291 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 -58.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -119.71 2.28 11.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.634 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -110.33 117.66 34.22 Favored 'General case' 0 N--CA 1.46 0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 112.089 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.86 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.8 tp -106.45 131.0 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.768 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' A' ' 34' ' ' ILE . 37.1 m-85 -148.98 111.97 4.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.721 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -93.72 123.59 37.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.56 113.52 26.38 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -99.04 96.51 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -98.4 164.7 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.306 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -95.61 113.19 24.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 10.0 t70 -88.35 21.83 2.72 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.376 1.048 . . . . 0.0 112.352 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.47 -48.85 3.18 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.3 mmtp -129.77 118.17 21.4 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.72 87.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.722 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 43' ' ' LYS . 53.0 t -136.39 112.5 12.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -75.86 117.81 17.99 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -101.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.07 143.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 112.238 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.03 114.69 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.36 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -120.81 159.18 25.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.89 126.86 15.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.49 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.628 ' N ' HG21 ' A' ' 68' ' ' VAL . 1.3 m . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.35 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.751 0.31 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 67' ' ' GLN . 97.9 t -80.73 -19.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.662 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.052 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.22 -37.96 0.08 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.904 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -69.66 -58.9 3.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.4 mt-30 -49.84 -22.63 1.53 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.488 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.052 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.23 -33.63 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -76.64 -33.6 46.75 Favored Glycine 0 C--O 1.217 -0.93 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.131 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -72.31 -41.78 66.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.95 -40.58 91.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -64.34 -54.49 32.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.2 -25.25 31.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.8 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.8 tt0 -72.14 -36.85 69.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 10.2 mttp -71.85 -64.49 0.92 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.843 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.821 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.88 -42.65 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.318 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.772 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -59.23 -40.8 87.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.257 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -51.44 -25.66 6.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.417 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.42 -28.0 20.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 12.9 13.18 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.627 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.78 104.1 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.649 0.738 . . . . 0.0 110.036 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 110' ' ' GLU . 21.2 ttpp -92.79 -49.75 5.91 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.147 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -117.43 136.31 53.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.362 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.533 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.89 162.93 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.376 0.608 . . . . 0.0 111.838 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.2 102.55 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.47 121.19 25.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.49 . . . . 0.0 111.549 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 1.3 t70 -148.48 45.88 1.04 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.162 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.9 ptt-85 -40.39 -31.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.661 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.48 -125.01 7.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.5 59.84 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.418 2.078 . . . . 0.0 111.754 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 8.4 m-85 -131.66 157.51 43.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 111.391 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -132.21 140.78 48.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.357 178.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.508 ' CZ ' ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -41.0 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.917 ' CE1' HG23 ' A' ' 97' ' ' VAL . 18.8 p80 -112.88 151.16 30.79 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 94' ' ' HIS . . . -20.88 -55.97 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.164 -0.925 . . . . 0.0 114.039 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.86 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.9 mmp_? -57.63 -64.54 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.917 HG23 ' CE1' ' A' ' 94' ' ' HIS . 88.7 t -35.41 -46.65 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.567 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HD3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.36 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.44 -43.27 62.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.889 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -61.62 -45.22 95.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.347 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.564 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -65.72 -37.63 86.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.805 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.809 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -67.42 -42.65 82.86 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.14 -58.94 8.07 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.972 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.92 -35.13 74.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.82 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -87.92 -30.43 20.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.418 . . . . 0.0 110.692 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.809 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.0 pt-20 -74.22 -35.15 63.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.659 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.72 -46.26 54.69 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.458 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.772 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.42 -27.76 0.08 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.941 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.3 mp -71.46 145.24 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER -128.16 93.98 3.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.504 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.696 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.938 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.428 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 16.3 ttp-105 -101.28 125.0 47.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.11 141.76 28.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.938 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.27 107.95 5.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.084 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.6 p -95.53 116.5 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.263 0.554 . . . . 0.0 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -93.61 134.98 35.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.972 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.71 ' NH2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -123.34 118.12 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 t -90.25 -79.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.06 -58.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.36 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.27 1.85 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.182 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.15 174.57 6.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.342 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.71 HD12 ' NH2' ' A' ' 29' ' ' ARG . 2.8 tp -150.45 111.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -136.56 140.67 43.1 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -128.54 127.95 43.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.257 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.05 114.02 25.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.038 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -98.19 95.2 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.317 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -95.84 163.89 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.858 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.4 t0 -95.19 114.71 26.53 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.711 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.6 t70 -90.28 23.53 2.87 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.405 1.065 . . . . 0.0 112.311 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.13 -47.77 3.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.19 118.17 16.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 174.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.95 89.97 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.28 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.0 t -139.63 112.42 5.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -72.1 113.6 9.31 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.9 mp -92.86 -65.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.91 148.33 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.266 0.555 . . . . 0.0 111.63 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -150.14 114.84 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.654 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -123.62 138.98 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 111.853 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 36.9 p -150.3 132.63 15.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.595 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.8 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 67' ' ' GLN . 73.9 t -94.26 -22.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.766 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.035 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.92 -39.8 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.673 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.35 -59.55 3.32 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.525 0.678 . . . . 0.0 109.172 178.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.5 mt-30 -49.66 -26.56 3.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.205 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.035 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.43 -32.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.38 -26.39 63.72 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 8.2 ptt85 -73.47 -39.83 64.61 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 70' ' ' ARG . . . -68.57 -36.23 78.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.038 HD21 HD11 ' A' ' 38' ' ' ILE . 1.1 tp -68.69 -53.48 21.97 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.015 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -63.35 -25.12 68.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.528 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 15.8 mt-10 -78.2 -29.98 48.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mttt -71.82 -69.16 0.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.403 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.84 -42.84 8.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.181 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.697 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.5 mt -56.02 -39.16 71.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.71 -24.58 8.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.071 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.71 -27.04 20.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.62 21.82 7.0 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.061 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' CG1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.53 102.84 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.136 0.494 . . . . 0.0 110.771 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.652 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.97 -25.62 12.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -125.27 125.24 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.187 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.12 164.54 23.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 112.06 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.31 105.51 15.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.391 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.37 118.01 22.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.394 0.616 . . . . 0.0 112.011 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.03 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.644 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.43 -29.57 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 88' ' ' ARG . . . 123.12 -151.43 16.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.94 55.99 4.63 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.927 2.418 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.484 ' CG ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m-30 -100.18 166.52 10.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.024 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.91 153.51 50.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -47.33 109.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.502 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.496 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -126.25 156.53 40.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -38.44 -30.01 0.08 OUTLIER Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.633 ' CD ' HD13 ' A' ' 34' ' ' ILE . 1.2 mmt85 -76.7 -70.97 0.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.598 0.237 . . . . 0.0 111.606 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 60.0 t -31.01 -50.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -57.96 -75.06 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.864 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.58 -37.67 68.37 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.172 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.1 tt -67.66 -49.16 64.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.3 -33.16 73.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.402 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.758 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -66.53 -46.54 75.81 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.08 -57.91 7.52 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.949 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.15 -39.95 80.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.354 -1.423 . . . . 0.0 111.428 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.841 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -82.58 -51.42 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -49.44 -40.57 37.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.58 -48.81 64.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.359 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.14 -26.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.092 -1.051 . . . . 0.0 114.713 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.841 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.37 145.98 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -128.2 91.99 3.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.455 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.3 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.955 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.837 0.351 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -93.02 124.32 36.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.35 143.54 26.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.832 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -144.61 108.48 4.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.753 0.311 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.629 HG21 HH22 ' A' ' 29' ' ' ARG . 2.8 p -97.68 121.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.872 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.26 139.54 41.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.831 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.629 HH22 HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -150.31 126.25 10.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.518 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -80.73 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.765 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.9 -51.25 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -119.1 23.18 11.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.904 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -123.91 172.44 8.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.133 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -160.22 126.95 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.996 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.792 ' N ' HD12 ' A' ' 34' ' ' ILE . 41.9 m-85 -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.056 0.455 . . . . 0.0 112.024 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -134.75 121.36 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.14 113.36 25.58 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 110.485 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.78 99.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.3 mp -101.37 161.81 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.197 -0.911 . . . . 0.0 113.315 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -93.79 110.5 22.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.443 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -88.32 27.43 1.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.235 0.959 . . . . 0.0 112.552 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.35 -48.54 3.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.62 118.32 19.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 174.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.22 88.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' LYS . 95.8 t -136.81 112.67 11.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -76.55 119.33 20.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.505 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.8 mp -98.84 -62.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.42 148.63 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 112.302 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 14.1 p -150.21 131.01 14.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.064 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.01 165.74 24.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 0.0 111.755 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.15 126.86 10.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.075 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.612 ' N ' HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.514 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.876 0.369 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 67' ' ' GLN . 89.6 t -94.16 -15.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.862 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.36 -41.5 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.897 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.65 -59.48 3.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.8 mt-30 -49.7 -23.41 1.75 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.478 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.38 -32.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.04 -28.4 56.45 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -73.88 -37.95 64.55 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.04 -35.41 69.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -67.68 -53.79 24.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.74 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.83 -26.26 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -75.89 -33.0 59.92 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 14.9 mttt -72.15 -68.97 0.42 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.816 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.73 -42.22 5.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.274 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.786 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -56.81 -40.03 75.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.062 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.14 -23.85 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.13 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.45 18.9 9.21 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.193 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.43 102.98 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.58 0.705 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.4 tttt -88.13 -59.37 2.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.705 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.408 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -107.25 148.24 29.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.398 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.56 158.91 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.369 0.604 . . . . 0.0 112.107 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.77 101.9 12.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.77 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.707 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.47 114.92 20.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.149 0.499 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.79 56.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -44.57 -40.2 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.47 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.32 -111.79 3.15 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.686 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.09 28.15 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.907 2.405 . . . . 0.0 112.693 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.0 m-30 -96.58 164.08 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -131.92 150.31 52.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -51.18 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.223 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -115.43 169.58 9.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.3 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.25 -38.27 4.93 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.759 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 7.1 mmt180 -62.54 -70.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 44.1 t -37.94 -41.74 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 110.887 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.58 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.116 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -58.88 -37.04 75.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.092 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.76 -47.83 68.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.223 0.535 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.54 -31.64 72.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.508 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.07 -44.02 73.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.35 -57.65 10.04 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.995 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.88 -31.53 72.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.71 -1.245 . . . . 0.0 111.187 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.7 mtm-85 -89.83 -25.68 20.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -82.46 -33.87 28.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.657 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.93 -47.38 39.21 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.992 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.786 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.87 -29.25 0.07 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 119.857 -1.164 . . . . 0.0 114.867 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.822 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.6 mp -71.1 146.19 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.8 mp0 -127.72 91.82 3.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.417 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.649 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.4 p90 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.894 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.945 0.402 . . . . 0.0 110.616 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -101.29 126.52 48.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.02 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.856 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.7 tt -89.69 142.53 27.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.82 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -146.47 108.7 4.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 100' ' ' LEU . 11.9 p -96.77 117.16 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.256 0.551 . . . . 0.0 111.748 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.02 137.22 38.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.834 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -143.35 118.85 10.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.934 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.75 -80.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.877 0.37 . . . . 0.0 110.717 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -127.37 -65.38 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 17.46 13.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.113 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.05 140.36 49.58 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 121.123 0.487 . . . . 0.0 111.6 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.808 HD11 HD13 ' A' ' 100' ' ' LEU . 6.5 tp -127.97 129.46 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 30.0 m-85 -144.92 112.21 6.07 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.25 120.93 34.09 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.8 113.01 25.28 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.486 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.935 HD11 ' CD2' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.75 102.27 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.323 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -99.2 161.41 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.686 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 t70 -92.36 117.86 30.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.986 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.7 t0 -91.95 22.72 4.09 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 124.411 1.069 . . . . 0.0 112.198 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -107.23 -47.47 3.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.04 118.1 15.39 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.04 90.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.173 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.3 t -137.93 112.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -73.43 116.73 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -99.66 -58.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.83 142.48 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.324 0.583 . . . . 0.0 112.226 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -150.17 114.86 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.876 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -125.3 161.9 25.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 111.796 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -143.76 137.52 28.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.798 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.686 ' N ' HG21 ' A' ' 68' ' ' VAL . 9.2 p . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.72 0.295 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 67' ' ' GLN . 84.4 t -94.18 -18.58 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.6 -38.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.848 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.68 -58.59 3.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -50.27 -23.06 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.473 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.03 -34.52 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.57 -33.28 48.14 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.155 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -71.71 -42.27 67.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.652 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.77 -42.62 90.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.935 ' CD2' HD11 ' A' ' 38' ' ' ILE . 4.3 tp -65.06 -51.71 59.93 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.79 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.88 -26.21 46.15 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.403 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -71.88 -35.94 69.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.821 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.6 mttt -73.19 -63.6 1.15 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.801 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.91 -41.95 7.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.285 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -60.62 -41.02 94.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.18 -25.9 6.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.38 -27.29 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.349 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 10.06 19.23 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.251 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.489 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.1 103.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.586 0.708 . . . . 0.0 110.192 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 110' ' ' GLU . 7.5 tttm -92.8 -55.5 3.34 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.044 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.2 OUTLIER -111.07 139.13 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.362 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.56 163.76 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 111.762 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.16 104.95 14.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.639 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.856 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.48 113.46 19.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.787 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -137.32 44.22 2.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.952 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 17.4 ptt-85 -40.57 -32.07 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.44 -128.67 9.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.273 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.79 52.66 3.02 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.654 2.236 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 4.4 m-85 -117.34 142.11 47.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -115.01 149.76 36.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.13 105.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.529 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -123.87 163.97 20.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.0 -27.97 3.74 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.869 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 34' ' ' ILE . 16.1 mmt180 -68.88 -70.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.399 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 24.7 t -39.43 -38.4 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.42 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.4 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.965 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.91 -36.54 70.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.816 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 34' ' ' ILE . 2.1 tt -68.47 -48.96 63.12 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 111.155 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.93 -31.02 69.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.178 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.97 -46.46 68.05 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.17 -58.47 7.12 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.944 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.59 -37.81 82.57 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.574 -1.313 . . . . 0.0 111.387 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -86.43 -29.34 22.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 110.92 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.7 pt-20 -74.15 -37.55 63.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.668 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.23 -47.17 73.97 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.103 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 173.52 -26.31 0.08 OUTLIER Glycine 0 C--N 1.342 0.901 0 C-N-CA 120.173 -1.013 . . . . 0.0 114.72 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.49 145.0 49.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.23 95.95 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.42 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.021 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.41 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp85 -101.15 125.36 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.57 143.32 26.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.852 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.887 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -136.5 147.9 47.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.734 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HE ' ' A' ' 88' ' ' ARG . 2.6 p -140.59 118.65 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.361 0.6 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -108.68 142.16 39.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.739 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 32.8 mtm180 -142.7 122.38 13.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.143 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 t -89.36 -78.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.331 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.29 -58.54 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -119.32 23.21 11.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.941 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.51 169.84 9.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.873 HD11 HD13 ' A' ' 100' ' ' LEU . 2.1 tp -156.35 131.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.555 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 51' ' ' SER . 30.8 m-85 -147.3 148.29 31.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.978 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.89 121.17 19.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.04 112.97 24.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.21 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.089 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -94.52 92.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.4 mp -96.55 162.09 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.741 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.493 ' N ' HG22 ' A' ' 39' ' ' ILE . 2.0 t0 -96.83 108.76 21.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.4 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.91 26.85 1.45 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.163 0.914 . . . . 0.0 112.242 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.02 -47.34 3.22 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mttt -133.12 118.17 18.38 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.16 90.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.588 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' LYS . 63.0 t -139.1 112.62 6.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -78.65 118.94 21.22 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 79' ' ' LEU . 1.1 mp -102.64 -56.96 2.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' HD3' ' A' ' 75' ' ' LYS . 1.9 t -117.14 144.84 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.641 . . . . 0.0 112.287 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -150.33 114.6 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.342 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -134.32 153.09 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.042 0.449 . . . . 0.0 112.106 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 2.4 t -150.42 131.12 14.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 34' ' ' ILE . 20.1 m . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.409 . . . . 0.0 110.382 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.293 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 67' ' ' GLN . 72.1 t -94.07 -24.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.062 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.59 -42.44 0.05 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.017 0.437 . . . . 0.0 111.724 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.65 -60.25 3.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.501 ' HB2' HG13 ' A' ' 64' ' ' VAL . 3.6 mp0 -47.55 -26.43 1.43 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.247 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.062 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.93 -32.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.977 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.38 -30.18 46.48 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.464 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.94 -39.9 65.85 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -69.15 -37.55 78.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.089 HD21 HD11 ' A' ' 38' ' ' ILE . 1.4 tp -65.9 -53.42 39.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.305 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.69 -23.36 67.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.153 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.61 -29.76 56.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.5 -47.73 7.79 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -51.58 -40.21 59.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.765 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -60.11 -38.56 83.38 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.781 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.18 -22.96 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.44 -26.89 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 16.0 13.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.058 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.577 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.55 0.691 . . . . 0.0 110.251 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.5 tttt -89.78 -57.72 2.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.216 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.47 147.41 35.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.293 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -134.58 164.05 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.358 0.599 . . . . 0.0 112.058 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.53 101.75 12.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.192 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.663 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -81.04 106.01 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.349 0.595 . . . . 0.0 112.37 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' N ' ' NH1' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -142.8 75.25 1.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.237 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -57.39 -38.02 73.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.095 0.474 . . . . 0.0 110.584 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.04 -110.79 2.59 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -90.09 31.15 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.833 2.355 . . . . 0.0 112.334 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 2.8 m-85 -103.06 154.91 18.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.2 150.8 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.222 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -47.82 109.68 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.414 ' O ' ' NZ ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -121.27 -77.78 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.66 -54.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.784 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.454 ' HD2' HD13 ' A' ' 34' ' ' ILE . 3.2 mtt180 -54.53 -59.59 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 27.2 t -40.1 -40.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.952 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.91 -76.33 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.935 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -61.1 -34.77 75.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.831 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 34' ' ' ILE . 2.7 tt -66.57 -48.39 69.75 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.769 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.14 -33.41 74.44 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.239 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.804 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.73 -45.41 75.1 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.3 -57.02 8.51 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.96 -36.3 81.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.465 -1.368 . . . . 0.0 111.341 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 2.5 tpp85 -87.13 -28.52 22.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.932 0.396 . . . . 0.0 110.683 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -76.6 -35.69 57.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.655 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.64 -48.16 51.8 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.554 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.765 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.42 -27.74 0.07 OUTLIER Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.657 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.837 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.2 mp -71.22 143.34 50.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -127.74 93.83 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.375 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.119 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 120.72 0.295 . . . . 0.0 110.793 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -95.4 126.28 40.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.467 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.844 HD23 ' N ' ' A' ' 26' ' ' SER . 3.3 tt -89.47 142.75 27.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.1 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.844 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.67 108.82 5.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.128 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.802 HG11 HG22 ' A' ' 97' ' ' VAL . 3.3 p -98.29 125.28 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.615 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.76 143.19 41.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.11 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.4 tpt180 -150.19 119.01 6.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.999 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -89.81 -44.07 10.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.459 . . . . 0.0 110.757 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER 179.92 -54.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.737 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.0 tttt -119.28 7.57 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.648 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 m80 -125.97 131.05 52.33 Favored 'General case' 0 N--CA 1.46 0.042 0 CA-C-O 120.959 0.409 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.748 HD11 HD13 ' A' ' 100' ' ' LEU . 2.9 tp -118.24 132.21 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.621 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 34' ' ' ILE . 29.9 m-85 -145.82 111.04 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -96.21 122.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 113.26 25.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.734 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.34 98.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -99.51 162.67 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.148 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 t0 -93.38 114.02 26.33 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.75 25.98 2.54 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.17 0.919 . . . . 0.0 112.189 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -109.48 -48.13 3.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.79 118.18 17.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 174.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.8 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.31 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.0 t -138.85 112.56 7.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.81 122.57 23.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.483 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.6 mp -104.43 -64.2 1.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.49 144.4 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 111.96 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -150.2 125.16 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -131.05 160.91 33.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.749 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 126.42 13.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.286 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.406 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 67' ' ' GLN . 48.4 t -94.06 -14.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.072 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -29.93 -44.11 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.66 -61.03 2.32 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.583 0.706 . . . . 0.0 109.368 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 1.5 mp0 -48.27 -25.88 1.74 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.154 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.072 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.86 -36.39 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.8 -28.23 65.41 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.796 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 11.7 ptt180 -70.04 -36.49 75.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.31 -37.77 68.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.751 ' CD2' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -67.1 -45.69 76.46 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.52 0.676 . . . . 0.0 109.436 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.99 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -72.35 -27.78 62.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.829 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 41.1 mt-10 -78.5 -29.67 46.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 15.4 mttt -72.79 -69.23 0.42 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.474 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.63 -43.42 12.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.316 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.747 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.1 mt -55.76 -39.74 71.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.84 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.84 -24.5 9.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.73 -29.38 18.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.53 15.8 8.59 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.635 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.586 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.99 106.98 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.616 0.722 . . . . 0.0 110.307 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -97.03 -48.32 5.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.427 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.376 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -117.0 163.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.317 0.579 . . . . 0.0 111.785 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.37 105.99 15.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.738 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.46 113.68 19.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.178 0.513 . . . . 0.0 111.602 -178.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.57 44.36 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.118 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 12.8 ptt-85 -40.71 -48.01 2.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.54 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.47 -114.08 2.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.64 -10.66 13.08 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.2 m-85 -57.25 132.63 53.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.02 154.88 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.105 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.528 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -45.21 108.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.04 0.448 . . . . 0.0 110.629 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -119.25 -125.69 0.28 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.394 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.61 -12.24 3.8 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.902 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mmt-85 -89.4 -68.97 0.74 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.926 0.363 . . . . 0.0 110.746 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.802 HG22 HG11 ' A' ' 27' ' ' VAL . 57.4 t -38.81 -28.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.658 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.121 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.01 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.83 -38.96 7.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.178 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -67.91 -46.67 70.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.162 0.506 . . . . 0.0 110.608 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -63.95 -33.22 75.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.081 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.806 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.47 -45.61 75.44 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.547 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.32 -56.8 8.8 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.99 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -34.39 77.16 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 113.507 -1.346 . . . . 0.0 111.543 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.867 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -90.09 -26.45 20.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 0.0 110.809 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.806 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.4 pt-20 -78.07 -32.1 50.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -75.37 -45.43 18.89 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.747 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.54 -32.43 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 119.935 -1.126 . . . . 0.0 114.87 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.867 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.33 146.17 49.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.26 93.19 3.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.484 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.982 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 37.0 ttp85 -100.43 123.76 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.86 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.46 144.67 25.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.428 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.846 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -148.71 108.04 3.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.094 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 7.2 p -92.99 115.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.385 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 139.26 31.59 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.929 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' NH2' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -140.02 118.17 11.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.93 -155.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -71.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -120.12 35.39 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.39 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -115.33 132.9 56.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.18 0.515 . . . . 0.0 112.305 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -121.2 111.6 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.666 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 38.4 m-85 -146.42 154.07 41.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.412 0.625 . . . . 0.0 112.675 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -135.21 129.82 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.946 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.97 115.0 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.114 0.483 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -99.72 94.07 3.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.316 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -94.43 164.62 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.659 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.2 t0 -96.75 115.27 27.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 7.9 t0 -90.89 23.72 3.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.346 1.028 . . . . 0.0 112.319 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -108.09 -47.37 3.57 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mptp? -135.4 118.16 16.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.12 90.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.343 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.4 t -140.69 112.29 4.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.7 119.82 17.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -99.97 -63.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -118.08 148.68 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 112.153 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -150.11 129.98 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.72 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.95 162.48 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 112.147 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.31 134.83 17.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.436 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.83 0.347 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 67' ' ' GLN . 57.4 t -94.15 -15.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.695 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.012 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.58 -38.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 111.932 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.36 -59.59 2.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.0 mt-30 -49.46 -22.74 1.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.374 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.012 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -82.69 -32.79 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -77.23 -28.37 58.25 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.216 -0.992 . . . . 0.0 111.005 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 3.5 ppt_? -76.74 -38.75 53.65 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.42 -34.38 74.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 38' ' ' ILE . 1.1 tm? -69.45 -56.26 7.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.593 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.007 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.37 -24.77 63.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.989 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 51.6 mt-10 -79.14 -30.95 43.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.6 mttt -70.27 -68.91 0.39 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.271 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.38 -44.04 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.2 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -55.4 -40.11 71.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.975 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.68 -24.93 9.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.032 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.72 -28.73 19.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.0 18.02 8.56 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.575 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.28 105.68 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 110.52 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 110' ' ' GLU . 28.7 tttp -90.32 -59.39 2.2 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.204 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -109.02 140.82 42.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.24 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.79 162.52 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 111.949 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.84 103.42 13.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.841 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.86 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.45 111.38 17.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.21 0.529 . . . . 0.0 111.666 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.48 44.45 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.111 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 ptt-85 -42.09 -46.14 4.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.489 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.38 -131.92 7.58 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.184 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.46 48.97 2.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.595 2.197 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.4 m-30 -100.49 155.75 17.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.91 154.76 48.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.279 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.6 109.67 0.27 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.979 0.418 . . . . 0.0 110.55 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -115.99 -124.29 0.29 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.409 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.13 -27.46 1.22 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 34' ' ' ILE . 8.5 mtt-85 -78.07 -67.24 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.606 0.241 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.9 t -37.74 -29.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.019 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.46 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -49.39 -41.11 38.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -64.94 -46.15 82.78 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.198 0.523 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.66 -35.25 79.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.603 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.826 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.34 -46.86 59.52 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -46.9 -54.69 9.05 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -65.59 -33.91 77.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.238 -1.481 . . . . 0.0 111.382 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -90.09 -22.47 21.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.573 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -84.34 -32.34 24.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.85 -45.79 25.96 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.91 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.813 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.77 -30.69 0.08 OUTLIER Glycine 0 C--N 1.342 0.875 0 C-N-CA 120.012 -1.089 . . . . 0.0 114.833 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 76' ' ' ALA . 7.7 mp -71.11 142.87 50.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.75 93.76 3.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.533 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.657 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.999 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp . . . . . 0 CA--C 1.52 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp180 -104.37 126.41 51.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.78 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.853 HD23 ' N ' ' A' ' 26' ' ' SER . 3.6 tt -89.7 143.69 26.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.976 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.853 ' N ' HD23 ' A' ' 25' ' ' LEU . 16.0 m -144.79 108.31 4.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.728 0.299 . . . . 0.0 110.675 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 100' ' ' LEU . 5.8 p -97.07 120.7 46.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.193 0.52 . . . . 0.0 111.802 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -100.75 148.9 24.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.781 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' NH1' ' A' ' 29' ' ' ARG . 15.1 mtm105 -150.4 120.68 7.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -89.71 -84.64 0.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.671 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -61.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.13 21.62 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.8 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -116.95 156.71 26.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 100' ' ' LEU . 4.3 tp -141.75 130.98 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.757 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.509 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 38.4 m-85 -148.95 150.33 32.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 0.0 111.845 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.937 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -133.27 121.41 22.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.414 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.76 113.34 25.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.487 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.063 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.12 105.14 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.369 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -102.44 158.73 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' N ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -89.61 119.55 30.13 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.877 178.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -93.19 23.56 4.31 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.432 1.082 . . . . 0.0 112.294 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -106.86 -47.64 3.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.258 -2.126 . . . . 0.0 105.258 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mttt -137.95 118.1 13.53 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.5 90.46 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.489 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' LYS . 87.3 t -138.59 112.5 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -69.93 113.12 6.85 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -90.56 -57.5 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 75' ' ' LYS . 1.8 t -127.56 148.96 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.299 0.571 . . . . 0.0 112.123 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 58.5 p -150.21 114.9 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.786 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.86 ' HB2' ' CE ' ' A' ' 75' ' ' LYS . . . -129.62 150.93 50.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 112.028 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.509 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.4 t -150.42 149.97 30.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.606 ' N ' HG21 ' A' ' 68' ' ' VAL . 37.2 m . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.688 0.28 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 67' ' ' GLN . 78.8 t -92.22 -25.73 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.59 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.04 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.66 -40.69 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.999 0.428 . . . . 0.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.03 -59.56 3.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.484 0.659 . . . . 0.0 109.278 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 12.9 mt-30 -49.41 -26.15 3.05 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.225 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.04 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -76.8 -32.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.425 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.9 -26.33 60.6 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.838 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 10.3 ptt180 -72.22 -39.21 68.7 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.47 -38.93 77.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.063 HD21 HD11 ' A' ' 38' ' ' ILE . 1.5 tp -66.14 -52.34 49.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.171 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.37 -27.17 68.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.57 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 29.6 mt-10 -77.13 -32.48 56.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.86 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 11.8 mtmm -71.48 -68.69 0.43 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.726 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.01 -43.12 6.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.19 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.11 -38.28 70.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.027 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.78 -23.11 16.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.899 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.561 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.43 -26.5 20.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.33 17.35 10.08 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.138 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.715 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.25 102.91 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.686 0.755 . . . . 0.0 110.271 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -97.02 -46.78 6.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.954 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.03 134.86 54.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -126.22 165.85 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.965 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.47 106.12 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.63 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.756 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.4 120.45 24.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.267 0.556 . . . . 0.0 111.73 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.05 51.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.067 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.2 -31.33 0.37 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.523 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.17 -119.06 5.59 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.99 20.63 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.734 2.29 . . . . 0.0 112.426 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.597 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.6 m-30 -80.81 159.45 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 154.81 48.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.369 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.468 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -43.77 109.35 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.571 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.497 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.2 t-80 -124.67 157.96 34.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.477 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -41.13 -26.7 0.18 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.689 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -82.09 -67.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.689 0.244 . . . . 0.0 111.182 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 90.0 t -29.83 -50.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -57.72 -75.37 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.801 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.75 -38.15 66.81 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.228 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.51 -47.26 70.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.447 0.641 . . . . 0.0 110.428 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.1 -32.13 72.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.384 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.785 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -68.12 -44.65 75.66 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.369 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.67 -58.41 8.38 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.942 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.75 -35.35 74.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.621 -1.289 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.866 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.99 -30.65 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.861 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.785 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -72.2 -34.91 68.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.627 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -70.52 -46.91 45.18 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.797 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.26 -29.07 0.07 OUTLIER Glycine 0 C--N 1.341 0.831 0 C-N-CA 120.052 -1.07 . . . . 0.0 114.752 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.866 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.45 145.52 49.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -128.12 92.58 3.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.296 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.997 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.806 HD22 HG13 ' A' ' 81' ' ' ILE . 3.7 mp . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.99 0.424 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 4.7 ttp180 -98.83 124.87 44.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.289 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.33 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.359 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.814 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.76 108.73 4.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.153 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.553 HG21 HD13 ' A' ' 100' ' ' LEU . 9.2 p -99.19 115.48 39.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -93.02 152.06 19.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 55.6 mtm-85 -149.15 118.91 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.916 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -46.4 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.994 0.426 . . . . 0.0 111.066 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.34 -59.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -116.73 12.68 14.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.323 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.3 174.36 6.1 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.779 HD11 HD13 ' A' ' 100' ' ' LEU . 6.9 tp -159.99 115.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 5.3 m-85 -129.68 111.21 12.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.996 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.79 123.32 37.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.59 117.02 29.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.448 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -98.87 101.77 12.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.2 mp -101.52 161.61 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.966 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.528 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.42 117.27 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.715 177.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 5.6 t0 -93.3 27.45 2.54 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.278 0.986 . . . . 0.0 112.282 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HG2' ' HD3' ' A' ' 43' ' ' LYS . 2.6 tt0 -108.8 -46.48 3.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -137.94 118.14 13.58 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.32 89.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.503 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.5 t -137.89 112.53 9.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -75.65 124.54 27.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 23' ' ' LEU . 1.2 mp -107.35 -58.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.724 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.1 t -120.06 141.71 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 112.076 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.23 114.79 5.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.5 151.89 48.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.02 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.0 p -150.58 142.74 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.602 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.468 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.93 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.617 0.246 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 67' ' ' GLN . 94.3 t -94.05 -21.73 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.081 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -36.92 -38.21 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 0.0 110.855 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.5 -58.96 3.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 12.7 mt-30 -49.81 -23.02 1.64 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.667 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.081 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -78.29 -37.01 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -75.63 -36.21 43.94 Favored Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -66.43 -36.55 83.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -62.75 -53.87 47.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.776 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.66 -46.04 87.43 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.906 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.46 -27.15 46.39 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.689 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.4 tt0 -73.61 -35.34 65.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.724 ' HB2' HG21 ' A' ' 48' ' ' VAL . 7.5 mttt -74.79 -63.7 1.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.907 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.89 -42.55 5.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.2 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -58.54 -40.68 83.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.4 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.01 -24.81 7.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.491 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.28 -27.13 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.32 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.57 11.57 19.11 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.15 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.806 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -64.02 103.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.616 0.722 . . . . 0.0 110.142 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -91.7 -57.47 2.74 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.345 -178.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -109.52 143.19 39.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.387 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.668 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -130.49 162.91 37.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.636 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.38 103.6 13.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.808 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.48 112.48 18.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -142.65 51.44 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.668 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -41.21 -38.37 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.651 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.09 -124.93 6.25 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.34 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -90.05 42.87 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.873 2.382 . . . . 0.0 112.066 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.668 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.7 m-30 -99.56 163.6 12.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.229 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 154.64 49.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -46.88 112.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.593 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.3 t60 -133.43 154.04 51.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.301 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -33.47 -37.04 0.06 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.851 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.736 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.0 mmt85 -70.74 -70.86 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.586 0.193 . . . . 0.0 111.407 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 98.5 t -29.91 -51.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.551 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -56.75 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 110.292 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.92 -43.0 49.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.14 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -66.66 -49.09 67.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.458 0.646 . . . . 0.0 110.649 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.559 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.08 -34.82 68.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.081 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.761 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.32 -43.3 81.95 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.06 -61.5 5.72 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.906 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.12 -41.83 68.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.932 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -79.21 -55.68 4.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.761 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.6 pt-20 -46.58 -43.33 17.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.689 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.84 -50.01 72.3 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.994 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.16 -25.48 0.07 OUTLIER Glycine 0 C--N 1.341 0.859 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.667 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.84 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.48 146.41 48.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.18 93.08 3.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.215 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.018 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 81' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.747 0.308 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 7.0 ptt180 -96.18 126.86 41.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.0 tt -89.43 140.79 29.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.554 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.829 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.0 t -142.3 114.07 8.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 110.996 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 100' ' ' LEU . 4.0 p -101.53 120.35 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.215 0.531 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.466 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -99.14 148.97 23.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.964 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HD2' ' CG ' ' A' ' 96' ' ' ARG . 15.8 mtm-85 -146.72 119.76 8.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.584 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.79 -50.64 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tt -179.24 -54.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.362 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 10.12 12.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.885 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -119.55 148.15 43.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 100' ' ' LEU . 4.1 tp -131.18 131.61 63.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.704 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 29.6 m-85 -146.95 149.93 34.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.832 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.933 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.18 120.93 19.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.221 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.816 ' HG3' HD11 ' A' ' 39' ' ' ILE . 4.8 pt20 -113.63 113.06 24.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.316 0.579 . . . . 0.0 109.921 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.081 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -90.92 97.15 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.85 164.26 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.283 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -99.53 103.16 14.88 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.485 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -86.65 27.16 1.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.172 0.92 . . . . 0.0 112.328 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -113.09 -47.9 3.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -129.33 118.5 22.35 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 174.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.63 86.29 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.725 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 43' ' ' LYS . 47.3 t -137.51 112.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.421 ' HA ' HG23 ' A' ' 39' ' ' ILE . 22.5 m -77.11 122.66 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.626 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.4 mp -103.19 -64.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -123.12 147.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 111.876 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 21.8 p -150.6 117.36 5.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.729 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.12 151.23 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.237 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.8 t -150.3 147.24 27.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.751 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' HG21 ' A' ' 68' ' ' VAL . 5.9 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.25 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.771 0.32 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 67' ' ' GLN . 72.8 t -91.93 -19.0 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.683 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.74 -43.75 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -64.74 -61.34 2.25 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.499 0.666 . . . . 0.0 109.365 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 23.5 mt-30 -48.47 -24.56 1.32 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.4 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.32 -33.41 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.653 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.89 -27.43 58.54 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.167 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -75.01 -39.53 61.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.05 -34.39 71.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -68.91 -54.44 15.49 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.845 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.016 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.04 -26.11 68.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.974 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 48.3 mt-10 -77.49 -31.18 53.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 21.0 mttt -72.51 -68.74 0.45 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.523 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.25 -43.21 7.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.828 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.04 -39.86 72.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.942 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.9 -23.81 14.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.43 -27.89 20.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.82 15.51 13.07 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.252 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -72.98 102.98 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 110.202 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -91.24 -57.3 2.83 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.423 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.11 137.97 46.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.84 166.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.368 0.604 . . . . 0.0 111.666 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -115.33 109.41 17.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.834 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -80.53 106.36 12.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.299 0.571 . . . . 0.0 111.919 -177.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.6 46.09 2.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.277 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.29 -45.49 5.91 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.26 -112.83 3.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.54 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.95 25.08 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.772 2.315 . . . . 0.0 112.863 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -93.97 157.13 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 111.056 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 151.53 49.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.675 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.21 94.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.416 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -114.21 170.93 7.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.384 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -41.94 -47.94 5.21 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.203 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.3 mtt85 -57.01 -68.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.64 0.257 . . . . 0.0 110.506 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.6 t -38.32 -39.96 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.567 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.33 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -56.8 -34.31 67.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.858 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.875 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -70.11 -48.37 57.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.213 0.53 . . . . 0.0 110.959 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.02 -28.7 69.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -71.5 -46.44 59.72 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.178 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.53 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.67 -56.17 8.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.016 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.24 -34.6 78.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.41 -1.395 . . . . 0.0 111.111 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.3 mmm180 -87.14 -24.42 24.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.2 pt-20 -84.45 -33.36 23.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.8 -46.47 45.69 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.074 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.828 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.94 -28.64 0.07 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 120.031 -1.08 . . . . 0.0 114.597 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.816 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.21 146.61 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -127.73 94.39 3.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.374 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.638 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.768 HD22 HG13 ' A' ' 81' ' ' ILE . 4.9 mp . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.014 0.435 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 25.4 ttp85 -103.0 123.31 46.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.225 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.17 143.79 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.602 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.812 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -146.72 108.8 4.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.454 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.7 p -102.48 116.71 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.91 136.25 35.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.445 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.598 ' HD3' HG23 ' A' ' 97' ' ' VAL . 22.9 mtm105 -132.81 118.71 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.978 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.58 -70.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -148.86 -62.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.773 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -119.13 20.19 12.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.197 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.42 175.62 5.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.166 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.899 HD11 HD13 ' A' ' 100' ' ' LEU . 6.6 tp -160.03 122.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.93 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -137.79 111.56 8.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -97.09 125.57 41.66 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 113.27 21.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.169 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.657 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.76 100.95 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.512 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -102.61 160.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.805 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -92.15 116.96 29.4 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.856 178.09 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 1.7 t70 -93.38 28.11 2.35 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 124.281 0.988 . . . . 0.0 112.185 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -109.76 -47.42 3.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.2 mttp -136.49 118.14 14.96 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.11 90.58 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.532 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 80.6 t -139.62 112.47 5.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.402 HG23 HG13 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -77.75 121.09 23.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.477 HD21 ' OD1' ' A' ' 40' ' ' ASP . 1.1 mp -103.59 -59.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' CG1' HD23 ' A' ' 72' ' ' LEU . 2.1 t -115.81 140.36 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.175 0.512 . . . . 0.0 111.971 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -150.27 114.93 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.266 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -133.51 151.4 51.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.245 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 43.6 p -150.54 139.6 21.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 34' ' ' ILE . 68.2 m . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.708 0.289 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 67' ' ' GLN . 95.5 t -94.14 -20.01 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.761 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.051 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.48 -38.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 3.7 ttm180 -67.59 -59.13 3.6 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -50.89 -24.31 3.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.533 178.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.54 -33.23 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.36 -32.37 43.09 Favored Glycine 0 C--O 1.218 -0.854 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.71 -36.79 83.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.779 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -45.59 78.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.409 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.864 HD23 ' CG1' ' A' ' 48' ' ' VAL . 1.1 mt -62.58 -50.04 72.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.56 -26.1 65.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 12.4 tt0 -72.04 -34.66 68.95 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.1 mttp -77.08 -64.12 1.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.862 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.96 -42.6 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.639 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -58.76 -40.51 84.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.373 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.55 -25.18 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.227 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.47 -26.51 20.91 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.2 13.81 14.62 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.198 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.768 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.43 102.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.016 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -103.87 -27.89 11.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.853 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -126.11 140.51 52.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.035 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -135.27 164.49 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.507 0.67 . . . . 0.0 112.345 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.43 103.82 13.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.835 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.72 106.35 13.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 111.509 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.09 43.69 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.231 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 21.0 ptt-85 -43.48 -48.76 7.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.502 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.59 -126.37 5.5 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -89.9 48.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.859 2.373 . . . . 0.0 112.125 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.1 m-30 -99.99 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.436 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 154.75 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.608 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.69 106.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.019 0.438 . . . . 0.0 110.681 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -110.63 -125.08 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.56 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.83 1.29 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.276 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.848 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.2 mmt85 -79.77 -69.65 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.937 0.369 . . . . 0.0 110.941 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 ' HD3' ' A' ' 29' ' ' ARG . 47.4 t -35.03 -31.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.79 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.868 0.366 . . . . 0.0 110.992 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.85 -43.23 63.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.192 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -60.53 -40.94 93.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.235 0.541 . . . . 0.0 110.639 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.96 -35.73 78.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.267 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 106' ' ' GLU . 1.3 mt-10 -69.55 -46.59 66.07 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.554 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.42 -58.27 5.31 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.932 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.56 -46.47 88.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.242 -1.479 . . . . 0.0 111.14 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 mtm180 -74.92 -55.48 5.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.175 0.512 . . . . 0.0 109.663 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.797 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -47.81 -44.43 28.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.664 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -61.16 -47.59 90.24 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.352 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.72 -25.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.623 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.828 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.2 mp -71.46 150.17 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -128.38 91.49 3.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.583 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 6.0 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.959 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -102.52 126.27 49.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 26' ' ' SER . 2.0 tt -89.56 143.49 26.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.217 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.799 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -143.27 111.97 6.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 88' ' ' ARG . 1.4 p -98.22 153.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.381 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.17 114.81 5.25 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -129.24 118.92 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -33.03 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.232 0.539 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.65 -61.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.471 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 9.64 11.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.595 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.0 m-70 -121.99 100.05 6.77 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.823 HD11 HD13 ' A' ' 100' ' ' LEU . 4.5 tp -99.19 117.94 45.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 12.5 m-85 -131.54 112.8 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -102.84 122.55 44.76 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.53 113.07 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.915 HD11 HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.93 99.34 9.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.337 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.9 mp -102.45 163.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.601 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.544 ' CG ' HD22 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -94.59 111.59 23.35 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.4 p30 -88.06 24.5 1.81 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.282 0.989 . . . . 0.0 112.524 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 15.7 pt-20 -111.13 -45.24 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 45' ' ' VAL . 25.9 mmtm -132.8 118.38 18.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.95 86.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.672 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 43' ' ' LYS . 46.1 t -135.08 112.39 14.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 120.86 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.5 mp -101.86 -62.45 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -122.09 143.74 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.344 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 p -150.24 114.98 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -126.47 145.43 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 55.7 p -150.22 134.96 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.791 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.631 ' H ' HG23 ' A' ' 34' ' ' ILE . 8.4 t . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.92 0.39 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 67' ' ' GLN . 59.7 t -92.33 -16.11 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.99 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.03 -41.55 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.01 0.434 . . . . 0.0 111.689 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.79 -61.03 2.3 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.433 0.635 . . . . 0.0 109.346 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.5 mt-30 -50.22 -24.86 3.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.514 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.99 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -78.73 -32.31 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.65 -25.16 65.76 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.214 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -78.73 -37.48 41.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -68.35 -38.9 81.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.953 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.0 tt -72.88 -46.53 52.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.64 -25.02 67.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -79.71 -30.08 40.86 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 21.6 mttt -69.47 -69.09 0.36 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.173 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.6 -44.92 9.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.785 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.4 mt -54.53 -39.08 67.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.152 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.24 -24.45 18.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.865 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.61 -26.1 20.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.51 13.47 16.79 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.076 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.508 HG12 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -75.1 102.62 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -104.43 -24.76 13.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.77 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -127.47 136.42 51.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.125 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -136.67 163.74 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.374 0.607 . . . . 0.0 112.191 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -101.52 98.5 8.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.774 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -80.92 111.73 17.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.599 . . . . 0.0 111.776 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.1 61.18 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.938 ' HG2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -48.9 -28.42 3.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.644 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.41 -117.81 3.33 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.73 38.0 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.758 2.305 . . . . 0.0 111.663 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.483 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 3.5 m-30 -98.61 144.9 27.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.28 155.01 49.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.4 t80 -39.83 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.168 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 2.0 t-160 -115.44 -109.87 0.36 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.151 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.523 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -131.25 -17.16 1.46 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.714 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.601 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -95.38 -71.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG22 HG11 ' A' ' 27' ' ' VAL . 48.3 t -32.94 -37.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.523 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -64.65 -78.85 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.301 0.572 . . . . 0.0 110.429 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -46.26 -42.88 15.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.314 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 34' ' ' ILE . 1.1 tt -67.51 -45.72 74.99 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.05 -35.76 79.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.362 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.705 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -63.45 -49.9 71.85 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.05 -56.21 6.08 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -56.43 -46.93 80.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 112.792 -1.704 . . . . 0.0 111.816 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.6 mmm-85 -78.84 -47.29 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.139 0.495 . . . . 0.0 109.976 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.705 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -53.4 -35.4 60.33 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -74.24 -49.19 12.81 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.499 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.785 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.33 -24.04 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 C-N-CA 119.737 -1.22 . . . . 0.0 115.405 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 38' ' ' ILE . 6.9 mp -71.17 146.2 49.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.204 1.002 . . . . 0.0 113.598 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.37 97.16 4.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.208 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.609 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.741 HD13 HG13 ' A' ' 81' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.992 0.425 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.4 ttt180 -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.334 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.831 HD23 ' N ' ' A' ' 26' ' ' SER . 2.9 tt -89.58 142.19 27.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.831 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.1 m -144.94 108.59 4.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 100' ' ' LEU . 8.8 p -94.2 117.73 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 111.749 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -99.26 146.95 25.67 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NH1' ' CG2' ' A' ' 97' ' ' VAL . 22.9 mtm-85 -150.14 122.34 8.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.996 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.9 p -89.66 -72.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.411 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 -58.26 0.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.566 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.23 2.56 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -101.82 155.57 18.05 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.177 0.513 . . . . 0.0 111.427 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.888 HD11 HD13 ' A' ' 100' ' ' LEU . 5.5 tp -142.63 119.74 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.573 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 14.1 m-85 -137.05 112.86 9.54 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.74 121.05 34.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.61 113.32 26.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.693 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.1 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.78 99.52 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.261 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -98.7 163.09 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.008 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -93.29 115.32 27.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.608 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.3 t0 -90.64 22.8 3.33 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.428 1.08 . . . . 0.0 112.354 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -110.15 -46.38 3.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.6 mmmt -134.02 118.28 17.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.99 87.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.778 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.4 t -137.53 112.32 9.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -71.57 117.68 13.43 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.568 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.3 mp -95.34 -63.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -121.11 147.75 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.794 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.4 p -150.17 114.83 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.063 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.38 158.29 33.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.707 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 79.5 p -150.18 143.02 24.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.973 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.654 ' N ' HG21 ' A' ' 68' ' ' VAL . 11.8 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.104 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 67' ' ' GLN . 58.2 t -94.13 -16.49 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.066 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.65 -41.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.882 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.83 -59.21 3.73 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.702 0.763 . . . . 0.0 109.035 178.354 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.599 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.1 mt-30 -49.78 -23.27 1.75 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.442 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.066 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.29 -33.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.91 -28.91 59.88 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.4 ppt_? -76.67 -37.24 56.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.08 73.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.1 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.63 -54.51 13.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.704 178.127 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.001 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.8 -25.68 65.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.8 mt-10 -78.18 -31.01 49.35 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 23.2 mttt -71.67 -69.14 0.4 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.497 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.68 -43.48 8.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.126 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.801 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -56.11 -39.67 72.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.041 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.5 -23.78 11.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.559 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.59 -27.7 20.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.7 8.08 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.071 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.21 105.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.536 0.684 . . . . 0.0 110.478 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 110' ' ' GLU . 8.1 ttmt -92.44 -59.49 2.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.8 138.63 44.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.6 164.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 111.901 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.93 103.26 12.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.795 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.44 116.49 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 111.616 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -145.54 47.59 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 6.9 ptt-85 -37.64 -37.58 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.762 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.27 -112.58 3.61 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.631 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -88.72 23.56 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.83 2.353 . . . . 0.0 112.767 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.533 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.8 m-30 -93.26 131.84 38.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.31 148.4 25.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.474 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -46.69 109.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.524 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -126.54 165.99 18.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.28 -40.41 7.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.79 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.802 ' HD2' HD13 ' A' ' 34' ' ' ILE . 15.0 mmt-85 -57.36 -70.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.572 0.225 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 37.2 t -38.39 -37.8 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.35 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.72 -76.71 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.029 0.442 . . . . 0.0 110.965 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.31 -36.4 68.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.732 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -68.96 -49.1 60.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.216 0.531 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -60.9 -32.1 71.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.42 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -68.54 -46.23 70.08 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.523 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.61 -57.15 8.69 Favored Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.001 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.03 -33.21 73.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.512 -1.344 . . . . 0.0 111.327 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.6 tpp85 -90.08 -25.06 20.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.1 pt-20 -81.02 -33.17 33.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -72.38 -46.78 31.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.858 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.801 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.73 -29.7 0.08 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.036 -1.078 . . . . 0.0 114.76 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.806 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.33 142.77 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.81 94.88 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.469 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.687 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.964 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.679 HD13 HG13 ' A' ' 81' ' ' ILE . 3.0 mp . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.69 126.33 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.38 -178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 4.1 tt -89.29 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.693 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.06 108.82 4.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 111.318 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.812 HG12 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -97.02 126.97 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.46 145.72 37.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.453 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 13.5 mtm105 -150.12 120.67 7.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.749 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 m -89.59 -81.04 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.684 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -139.86 -56.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.717 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -119.12 18.73 13.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.212 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.54 167.67 11.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.162 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 100' ' ' LEU . 3.3 tp -153.3 130.96 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.551 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.529 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 32.9 m-85 -150.01 152.18 34.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.243 0.544 . . . . 0.0 112.171 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -136.83 120.96 17.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.692 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.76 113.22 25.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.019 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.72 98.84 8.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.4 mp -98.8 160.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.165 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -93.1 115.63 28.27 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.603 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -90.75 26.16 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.297 0.998 . . . . 0.0 112.403 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.46 -47.97 3.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.39 118.04 14.97 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.96 90.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.448 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 43' ' ' LYS . 93.9 t -137.68 112.57 9.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 m -73.92 119.72 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.635 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.6 mp -98.87 -58.28 1.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.0 t -124.36 147.3 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 112.239 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 82.5 p -150.28 115.02 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.946 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.26 150.77 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.919 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 3.1 t -150.46 141.94 23.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.512 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.491 ' H ' HG23 ' A' ' 34' ' ' ILE . 32.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.689 0.281 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 67' ' ' GLN . 75.6 t -94.05 -17.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.693 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.036 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.89 -39.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.991 0.425 . . . . 0.0 111.414 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.73 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.29 -59.28 3.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.56 ' HB2' HG13 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -50.98 -22.95 2.55 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.408 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.036 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.53 -31.76 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.253 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.73 -30.86 51.53 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.26 -38.46 68.85 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.57 -39.39 88.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.019 HD21 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -65.54 -54.98 20.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.985 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.57 -24.99 35.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.99 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -73.18 -35.59 66.42 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.3 mttt -71.58 -67.4 0.53 Allowed 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.921 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.93 -41.28 5.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.623 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.753 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.67 -40.23 82.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.226 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.44 -23.89 6.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.075 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.33 -27.82 20.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.66 18.04 9.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.136 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.679 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.73 106.87 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.505 0.669 . . . . 0.0 110.338 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 18.9 ttmt -91.1 -58.14 2.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.393 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -111.86 147.58 35.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.463 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -134.33 161.15 41.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.319 0.58 . . . . 0.0 111.775 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -96.41 103.64 15.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.254 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.676 ' CE2' ' CZ ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -81.17 106.34 13.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.255 0.55 . . . . 0.0 112.071 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.76 72.16 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.983 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.812 ' NH1' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -52.19 -42.9 63.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.27 -117.35 3.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -90.35 35.95 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.746 2.298 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.3 m-30 -100.65 162.59 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 111.469 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.33 148.93 50.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.013 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -46.7 103.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.736 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -122.3 165.22 16.58 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.88 -42.46 11.4 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.983 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.453 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 55.4 mmt-85 -55.76 -71.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.704 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 t -38.92 -43.57 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.635 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.2 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.023 0.439 . . . . 0.0 111.133 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -59.24 -40.0 84.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 34' ' ' ILE . 1.5 tt -65.04 -47.29 77.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.351 0.596 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.26 -38.09 85.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -66.75 -39.71 88.01 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -52.49 -59.35 9.19 Favored Glycine 0 CA--C 1.501 -0.789 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.985 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.04 -28.81 69.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.831 -1.185 . . . . 0.0 110.559 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.7 mmm-85 -89.11 -30.48 18.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 110.917 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.795 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.9 pt-20 -78.84 -36.9 41.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.672 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -66.67 -46.38 76.36 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.773 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.753 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.42 -31.33 0.07 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.032 -1.08 . . . . 0.0 114.754 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.7 mp -71.28 147.05 48.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -128.23 91.68 3.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.348 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.727 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.7 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.063 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -101.18 126.96 47.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.078 -178.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.1 tt -93.39 145.1 24.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.939 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.764 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.03 108.43 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.415 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.851 HG11 HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -96.18 129.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.023 0.44 . . . . 0.0 111.313 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -114.78 125.92 54.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -129.52 118.6 22.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.57 178.126 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.2 m -90.03 -45.14 9.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD12 ' HG3' ' A' ' 32' ' ' LYS . 0.3 OUTLIER 179.78 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.171 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HG3' HD12 ' A' ' 31' ' ' LEU . 29.5 mtmt -119.35 -0.93 10.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.344 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -110.71 111.07 22.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 111.572 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.643 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -99.93 131.28 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 40.7 m-85 -149.08 147.76 28.89 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.146 0.498 . . . . 0.0 112.085 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -132.46 128.28 37.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -117.83 113.06 21.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.205 0.526 . . . . 0.0 110.767 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -100.13 102.23 13.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -104.91 160.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.977 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.28 118.03 30.48 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.818 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.441 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 13.6 t0 -91.82 20.61 5.48 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.44 1.088 . . . . 0.0 112.217 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.49 -48.62 3.4 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mmtp -131.11 118.15 20.1 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.82 89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.841 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.8 t -136.09 112.61 13.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 m -77.42 109.6 11.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -91.53 -53.07 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.833 HG21 ' HB2' ' A' ' 75' ' ' LYS . 1.4 t -124.16 145.84 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.571 0.701 . . . . 0.0 112.791 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 78.3 p -150.22 115.02 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.313 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -125.92 162.94 24.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 126.91 10.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.007 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.568 ' N ' HG21 ' A' ' 68' ' ' VAL . 1.1 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 0.0 111.24 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 67' ' ' GLN . 39.6 t -94.05 -13.78 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.058 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.104 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.26 -43.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -65.96 -60.83 2.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.378 0.608 . . . . 0.0 109.46 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -48.12 -28.19 2.77 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.292 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.104 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -71.88 -38.44 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.2 178.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -67.64 -56.78 10.29 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 5.5 ppt_? -44.95 -35.33 2.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -64.12 -50.19 69.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.08 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.617 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.2 mt -62.96 -52.62 62.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -53.51 -27.3 24.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.063 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -75.09 -32.89 61.57 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.833 ' HB2' HG21 ' A' ' 48' ' ' VAL . 33.0 mttm -76.79 -63.69 1.29 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.59 -43.19 11.97 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.792 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -56.2 -40.03 73.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.977 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.59 -24.33 13.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.952 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.42 -28.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.051 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.78 13.55 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.254 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.4 111.03 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 110.126 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 23.6 ttpp -95.89 -57.48 2.35 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.787 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -110.75 148.67 31.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.65 164.93 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 0.0 112.182 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.02 87.87 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.944 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 t80 -81.17 112.37 18.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.93 111.02 4.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HD3' ' N ' ' A' ' 27' ' ' VAL . 3.1 tpt85 -99.82 -21.11 15.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.28 -97.83 1.04 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.81 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.42 33.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.903 2.402 . . . . 0.0 112.197 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 4.3 m-85 -99.93 135.7 40.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.95 154.78 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.7 t80 -46.86 97.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 110.35 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.453 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 1.9 t60 -105.35 -99.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.901 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.478 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . . . -142.52 -30.94 0.12 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HG3' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mmt85 -85.87 -71.14 0.55 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 27' ' ' VAL . 55.4 t -33.07 -35.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HZ1' ' HB ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -62.14 -76.42 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.667 0.746 . . . . 0.0 109.551 179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.32 -44.51 11.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.655 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -68.12 -49.24 62.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 110.221 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.709 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.61 -32.49 63.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -68.79 -41.95 78.01 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.13 -57.48 8.88 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.971 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.45 -34.63 77.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.477 -1.362 . . . . 0.0 110.986 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.33 -26.61 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.411 . . . . 0.0 110.887 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.837 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -78.08 -36.57 48.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.19 -43.84 69.37 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.725 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.36 -31.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 119.999 -1.096 . . . . 0.0 114.904 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.891 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.42 151.1 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.76 96.01 4.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.713 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.07 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttt-85 -102.73 126.46 49.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.49 145.61 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.58 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.811 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -147.4 108.88 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.468 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 HD13 ' A' ' 100' ' ' LEU . 9.6 p -100.59 132.18 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.006 0.432 . . . . 0.0 111.761 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -113.35 143.99 43.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.278 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' CZ ' HG23 ' A' ' 97' ' ' VAL . 19.9 ptt-85 -151.53 118.76 5.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.093 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.78 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 110.788 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tt -177.36 -68.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.94 14.16 18.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.905 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 1.7 m-70 -127.33 150.18 49.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.655 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.72 HG21 ' HD2' ' A' ' 96' ' ' ARG . 22.5 pt -139.16 142.35 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -142.04 108.39 5.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.158 -177.279 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.003 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.73 121.01 34.73 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -114.75 118.64 34.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.847 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.99 103.82 15.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 46' ' ' THR . 3.5 mp -108.16 162.46 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.709 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.537 ' N ' HG22 ' A' ' 39' ' ' ILE . 3.0 t70 -92.87 113.58 25.9 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.039 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -92.97 24.82 3.48 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.253 0.971 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.8 -47.85 3.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mtpt -132.19 118.12 19.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.77 90.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.453 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 43' ' ' LYS . 91.5 t -141.05 112.2 3.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 39' ' ' ILE . 1.6 m -78.83 117.48 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -95.65 -56.87 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.78 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -128.57 145.12 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 111.986 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 p -150.19 114.53 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.422 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.659 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -127.03 148.78 50.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.631 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.499 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 15.2 p -150.22 136.14 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.821 178.848 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.732 0.301 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 67' ' ' GLN . 99.5 t -94.0 -20.09 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.685 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.037 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.18 -39.55 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 111.551 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.77 -60.21 2.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.8 mt-30 -49.36 -24.59 1.97 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.572 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.037 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.98 -36.14 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.806 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -77.06 -35.8 37.53 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.941 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 4.3 ppt_? -65.03 -36.12 83.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.47 -55.13 26.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.003 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -62.69 -44.58 95.88 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.83 -27.8 60.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.742 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.6 tt0 -72.94 -34.35 66.5 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.78 ' CB ' HG21 ' A' ' 48' ' ' VAL . 14.2 mttt -76.64 -63.19 1.4 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.072 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.688 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.29 -42.05 6.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.346 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.0 -40.38 80.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.184 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.08 -23.63 8.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.41 -28.44 19.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.46 15.69 12.05 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.197 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -69.29 104.47 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.589 0.709 . . . . 0.0 110.152 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 110' ' ' GLU . 14.6 tttt -92.51 -56.38 3.05 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.388 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.43 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -110.0 145.03 37.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.384 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.757 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.1 164.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.469 0.652 . . . . 0.0 112.048 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.02 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.746 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.791 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.02 106.32 13.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.105 0.479 . . . . 0.0 111.373 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 45.0 2.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.176 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.7 ptt180 -41.51 -32.47 0.34 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.582 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.91 -121.46 6.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.433 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -88.99 36.33 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -95.55 150.97 19.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.989 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -116.91 147.0 42.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -49.31 100.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.056 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -120.07 168.46 11.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.456 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.46 -38.16 3.86 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.912 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.72 ' HD2' HG21 ' A' ' 34' ' ' ILE . 45.1 mmt-85 -61.72 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.567 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 33.1 t -38.67 -40.97 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.57 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.4 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 0.0 111.001 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.28 -37.27 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.896 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD13 HG21 ' A' ' 27' ' ' VAL . 2.2 tt -67.48 -48.21 67.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 111.167 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.21 -33.4 70.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.17 -43.79 81.34 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.01 -62.06 5.27 Favored Glycine 0 CA--C 1.506 -0.517 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.925 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.98 -38.93 68.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 113.821 -1.19 . . . . 0.0 110.571 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.4 mmm-85 -79.79 -60.17 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -43.59 -43.15 5.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.158 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -62.01 -50.51 64.82 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.995 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -26.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.125 -1.036 . . . . 0.0 114.808 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.847 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.4 mp -71.49 147.77 47.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.28 92.24 3.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.25 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.724 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.038 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.844 0.354 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.36 125.26 50.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.694 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 26' ' ' SER . 5.1 tt -89.74 142.32 27.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.682 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.923 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.0 m -142.21 134.84 28.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.609 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.841 HG11 HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -119.79 134.58 62.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 0.0 110.831 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -122.92 132.31 54.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' CZ ' ' HD2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -137.32 118.83 14.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.214 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -89.24 -38.91 13.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.007 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tt -179.87 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -119.03 3.87 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.31 154.82 23.98 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 100' ' ' LEU . 3.8 tp -141.34 123.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.83 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 16.9 m-85 -139.22 110.72 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.73 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -100.17 121.45 41.45 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.22 113.47 26.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.321 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.685 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.78 101.71 12.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -104.84 164.03 4.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.573 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -94.44 113.98 25.93 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.809 178.126 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.3 t70 -91.38 25.54 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.335 1.022 . . . . 0.0 112.359 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -109.61 -48.15 3.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.71 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.8 mttp -135.64 118.09 15.79 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.3 89.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.546 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 43' ' ' LYS . 66.3 t -137.86 112.49 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -75.5 114.54 14.18 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -93.11 -60.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.75 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -125.21 147.25 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 111.882 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 p -150.23 114.91 5.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -124.89 151.89 44.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.5 p -150.22 127.14 11.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.892 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.514 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.2 m . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 76.1 t -94.18 -26.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.049 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.83 -40.75 0.06 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.634 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.49 -60.02 3.12 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.768 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 28.3 mt-30 -48.24 -27.14 2.29 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.248 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.049 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.06 -36.24 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.98 -29.74 62.36 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.27 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 6.5 ppt_? -69.51 -36.17 76.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -73.94 -38.07 64.36 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 7.2 mt -65.4 -43.58 90.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.419 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -75.51 -30.97 60.0 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.085 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 21.2 mt-10 -75.65 -28.46 58.77 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.804 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 8.3 mtmm -76.12 -67.79 0.65 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.399 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.44 -40.89 8.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.795 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.79 -39.02 76.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.718 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.5 -22.88 14.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.937 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.75 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.44 -27.38 20.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.21 19.69 9.26 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.077 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.736 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.92 103.79 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.588 0.708 . . . . 0.0 110.449 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLU . 19.1 tttp -91.54 -56.92 2.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.363 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.68 146.91 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -134.07 167.16 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.458 0.647 . . . . 0.0 112.169 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -102.21 103.74 14.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.255 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.731 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.5 t80 -80.75 110.58 16.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 112.723 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.0 106.36 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.066 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -92.34 -33.91 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.058 0.456 . . . . 0.0 110.304 -178.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.76 -110.22 2.76 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -90.31 32.7 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.849 2.366 . . . . 0.0 112.262 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 3.4 m-30 -102.27 152.79 20.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.131 0.491 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.26 148.91 52.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.446 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.503 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -44.75 111.83 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.979 0.419 . . . . 0.0 110.334 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -124.01 -122.69 0.26 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.639 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.04 -12.4 3.21 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.964 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HD2' ' CZ ' ' A' ' 29' ' ' ARG . 1.7 mmt85 -87.95 -70.77 0.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.851 0.325 . . . . 0.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.841 HG22 HG11 ' A' ' 27' ' ' VAL . 55.8 t -36.14 -32.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 123.035 0.534 . . . . 0.0 111.672 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.14 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.969 0.414 . . . . 0.0 110.96 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -44.25 -40.84 5.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -67.73 -45.77 74.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 110.214 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.84 -30.63 70.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.772 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -69.91 -49.0 56.41 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.74 -55.21 7.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.873 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.17 -45.04 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.772 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -56.63 -35.2 68.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.835 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.34 -49.08 16.55 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.119 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.795 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -179.53 -29.99 0.05 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.728 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 8.0 mp -71.15 146.86 48.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -128.04 91.71 3.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.104 178.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.669 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.026 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD13 HG13 ' A' ' 81' ' ' ILE . 1.4 mp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.914 0.388 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -104.59 126.93 52.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.705 -178.467 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.84 141.53 28.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.836 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.21 108.72 5.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.692 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 100' ' ' LEU . 4.7 p -95.78 125.45 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.16 144.15 40.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.83 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 26.2 tpt180 -150.12 118.63 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.765 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.9 p -89.93 -42.97 10.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.657 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -178.61 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 13.5 mtmt -119.27 -1.67 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.649 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -112.15 116.96 31.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.036 0.446 . . . . 0.0 111.492 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.788 HD11 HD13 ' A' ' 100' ' ' LEU . 5.8 tp -106.94 112.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' CD1' ' HB3' ' A' ' 51' ' ' SER . 8.9 m-85 -127.87 110.69 12.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.924 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -96.04 124.84 40.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.78 113.4 25.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.515 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.792 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.09 99.16 8.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.119 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.7 mp -99.84 163.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.127 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -93.95 114.08 26.22 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.754 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 22.0 t70 -91.5 25.47 2.62 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.438 1.086 . . . . 0.0 112.303 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -109.46 -47.92 3.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.89 118.25 15.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 90.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.613 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.6 t -139.99 112.32 5.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -73.31 114.13 11.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.624 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -91.58 -64.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -121.7 145.87 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 111.792 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.9 p -150.36 114.82 5.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.041 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.73 156.25 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.547 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.1 145.56 26.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.237 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.603 ' N ' HG21 ' A' ' 68' ' ' VAL . 34.7 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.689 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 67' ' ' GLN . 68.8 t -83.94 -19.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.075 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.83 -42.14 0.05 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.962 0.411 . . . . 0.0 111.965 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.76 -61.04 2.3 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.521 0.676 . . . . 0.0 109.301 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -48.67 -25.08 1.6 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.3 177.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.075 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.97 -33.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.671 178.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.77 -27.28 54.31 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.357 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -73.61 -38.37 65.12 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.38 -34.8 70.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.924 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -69.21 -49.6 54.98 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.322 178.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.986 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -67.46 -25.4 65.87 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.896 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -77.91 -31.28 51.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 13.5 mttt -71.95 -69.34 0.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.515 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.28 -43.38 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.136 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.774 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -55.52 -39.23 70.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.052 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.28 -23.56 15.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.58 -27.16 20.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.29 16.69 10.83 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.156 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.737 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.7 103.02 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.725 0.774 . . . . 0.0 110.307 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -94.44 -51.93 4.55 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.75 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 135.16 54.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.02 165.1 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.4 0.619 . . . . 0.0 111.769 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -109.85 105.4 14.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.379 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.34 106.31 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.529 -178.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -129.73 44.08 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.008 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 16.3 ptt-85 -39.4 -47.84 1.84 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.827 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.93 -114.68 2.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.15 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.03 -13.53 21.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.426 2.084 . . . . 0.0 112.275 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.5 m-85 -60.63 138.11 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.02 0.438 . . . . 0.0 111.159 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 154.11 49.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.999 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 1.3 t80 -42.4 113.56 0.47 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -128.89 -77.95 0.56 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' NZ ' ' A' ' 98' ' ' LYS . . . -155.37 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.167 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.716 ' HB3' HD13 ' A' ' 34' ' ' ILE . 37.0 mmt-85 -65.55 -60.85 2.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 42.1 t -35.97 -39.18 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.994 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.543 ' CE ' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.65 -80.16 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.391 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -53.77 -36.39 62.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.015 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.788 HD13 HD11 ' A' ' 34' ' ' ILE . 2.4 tt -68.98 -48.23 63.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.149 0.5 . . . . 0.0 110.972 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.79 -30.79 71.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.323 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.21 -45.04 70.85 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.77 -57.24 9.92 Favored Glycine 0 CA--C 1.508 -0.375 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.986 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.92 -33.12 74.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.357 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.1 mtm180 -88.46 -30.05 19.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.749 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.793 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -76.94 -34.36 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.17 -47.38 37.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.106 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.46 -29.47 0.07 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.878 -1.153 . . . . 0.0 114.942 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.792 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.9 mp -71.25 147.14 48.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -127.85 91.84 3.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.413 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.684 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.935 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 HG13 ' A' ' 81' ' ' ILE . 3.6 mp . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.926 0.393 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttp180 -103.85 125.34 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.442 -178.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.6 tt -89.81 143.81 26.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 25' ' ' LEU . 50.9 m -145.43 108.69 4.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 0.0 111.343 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 97' ' ' VAL . 8.0 p -101.99 121.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -103.64 129.39 50.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.603 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -136.69 118.55 15.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -89.75 -77.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.476 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -134.33 -61.24 0.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.828 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.29 18.32 12.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.557 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -117.71 164.05 15.56 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.997 0.427 . . . . 0.0 111.25 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.721 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.5 tp -155.8 126.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' CE2' ' CB ' ' A' ' 51' ' ' SER . 18.8 m-85 -140.86 110.2 6.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.078 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -94.04 121.46 35.55 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.33 117.4 30.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.205 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.791 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -100.24 103.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.479 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -105.95 161.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.449 -177.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 39' ' ' ILE . 16.2 t0 -92.7 114.32 26.84 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.962 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 25.4 t0 -92.05 23.58 3.69 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.277 0.985 . . . . 0.0 112.148 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.25 -47.82 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.6 mppt? -133.31 118.09 18.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.68 90.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.432 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.4 t -139.61 112.28 5.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.15 114.79 16.33 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -94.19 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.345 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.2 t -123.67 144.51 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.338 0.59 . . . . 0.0 112.093 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -150.24 114.78 5.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.826 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.06 161.98 27.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.804 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.486 ' CB ' ' CE2' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -150.06 144.36 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.875 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.5 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 67' ' ' GLN . 40.7 t -94.2 -16.3 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.56 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.059 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.5 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.26 -60.53 2.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.807 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.6 mt-30 -48.01 -26.11 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.419 178.087 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.059 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.66 -39.27 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.992 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.508 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -70.5 -37.42 69.01 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.815 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 16.1 ptt85 -64.27 -36.88 85.56 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.727 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.97 -54.95 26.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.097 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.79 -42.15 97.8 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.46 -27.7 69.3 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.715 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.3 tt0 -78.04 -25.52 47.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.466 178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.838 ' HB2' HG21 ' A' ' 48' ' ' VAL . 2.4 mttp -82.4 -62.11 1.71 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.08 -43.28 14.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.407 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.738 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -55.97 -39.65 72.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.107 178.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.54 -23.95 12.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.878 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.38 -27.14 20.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.59 17.7 10.27 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.961 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.674 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.1 106.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.513 0.673 . . . . 0.0 110.346 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLU . 1.5 ttpt -92.45 -61.07 1.68 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.207 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.39 146.32 34.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.356 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -131.72 165.78 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.205 0.526 . . . . 0.0 111.776 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.17 104.75 14.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.838 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.133 0.492 . . . . 0.0 111.741 -178.8 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -122.26 38.89 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.957 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.41 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 20.6 ptt180 -40.45 -33.38 0.26 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.516 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.77 -129.38 8.62 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.306 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.93 44.99 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.777 2.318 . . . . 0.0 112.298 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 29' ' ' ARG . 4.6 m-30 -97.38 153.71 17.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.007 0.432 . . . . 0.0 111.114 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.34 154.66 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.884 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.636 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -49.29 101.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 110.201 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.418 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 31.4 t-80 -111.92 -112.38 0.33 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.002 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.29 -37.12 0.31 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.672 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.721 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.4 mpt_? -67.96 -71.06 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 27' ' ' VAL . 70.8 t -36.41 -32.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.968 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -63.74 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.037 0.446 . . . . 0.0 110.893 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -43.2 -40.79 3.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.334 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -69.81 -48.77 57.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.757 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.635 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.35 -30.69 60.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.52 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.849 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.68 -47.0 57.11 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.764 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.19 -57.27 7.23 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -37.87 88.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.517 -1.342 . . . . 0.0 111.599 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -85.4 -33.16 22.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.068 0.461 . . . . 0.0 110.487 179.549 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.849 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.8 pt-20 -70.0 -37.53 75.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.24 -50.13 41.28 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.375 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.92 -26.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.945 -1.121 . . . . 0.0 114.978 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.1 mp -71.34 144.68 49.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.95 96.75 4.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.47 178.992 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.715 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.093 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.33 129.13 53.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.546 -179.108 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.861 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.2 tt -89.47 141.27 28.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.392 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.837 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.7 108.37 4.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.777 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG21 ' NH2' ' A' ' 29' ' ' ARG . 14.9 p -97.06 126.98 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.765 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.76 141.56 42.22 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.679 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HG2' HD12 ' A' ' 34' ' ' ILE . 35.7 mtt85 -150.11 118.69 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 p -89.91 -42.51 11.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.166 0.508 . . . . 0.0 110.416 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tt -179.98 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.723 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -119.29 -6.7 10.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.07 116.4 31.89 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.885 0.374 . . . . 0.0 111.617 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.892 HD11 HD13 ' A' ' 100' ' ' LEU . 2.0 tp -105.25 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.034 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 27.5 m-85 -146.93 109.24 4.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.842 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.45 125.47 38.08 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -113.85 113.45 24.91 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.837 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.87 102.98 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.905 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -107.68 161.27 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.084 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.3 t0 -89.44 115.14 26.65 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.779 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 4.0 t70 -92.3 24.08 3.57 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.376 1.048 . . . . 0.0 112.274 -178.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -109.49 -47.63 3.35 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 177.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.5 mttp -133.54 118.12 17.92 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.95 89.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.301 -177.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' LYS . 98.6 t -137.88 112.52 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -76.38 119.19 19.91 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD22 HD13 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -100.84 -56.81 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.466 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.871 HG12 HD23 ' A' ' 72' ' ' LEU . 2.1 t -126.62 142.1 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.211 0.529 . . . . 0.0 112.208 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.4 115.21 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.997 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -122.98 163.76 19.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.059 0.457 . . . . 0.0 111.963 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.501 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 18.2 p -146.06 126.9 14.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.046 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.588 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.1 p . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 67' ' ' GLN . 95.0 t -94.06 -17.19 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.621 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.94 -40.45 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.602 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.43 -60.13 2.82 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.47 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.507 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.9 mt-30 -49.34 -23.53 1.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.645 177.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.53 -35.5 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.524 178.573 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.48 -34.79 34.78 Favored Glycine 0 C--O 1.218 -0.901 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -64.77 -37.23 86.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -46.41 76.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.6 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -61.55 -51.18 69.65 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.315 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.869 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.04 -25.87 64.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.745 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 18.2 tt0 -72.0 -35.59 69.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.467 0.651 . . . . 0.0 109.37 178.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 9.1 mttt -78.81 -63.76 1.34 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.994 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -42.96 -42.45 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.706 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.7 mt -58.45 -41.2 84.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.387 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -50.28 -25.86 4.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.319 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.189 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 113.94 15.12 8.77 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.855 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.83 102.66 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.13 0.491 . . . . 0.0 110.187 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -106.3 -23.37 12.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.841 -179.564 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -129.84 125.29 35.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.284 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.797 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.09 165.41 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.435 0.636 . . . . 0.0 111.839 -179.5 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -112.14 111.63 22.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.754 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.861 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -80.95 111.41 17.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 111.789 -178.219 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.03 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 9.4 ptt-85 -41.82 -37.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.01 -125.41 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.47 0.26 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.521 2.147 . . . . 0.0 112.877 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.5 ' HD2' ' CE1' ' A' ' 94' ' ' HIS . 4.4 m-85 -58.71 144.03 44.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.97 109.57 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.544 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER 0.11 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.123 0.569 . . . . 0.0 112.103 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.5 ' CE1' ' HD2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -131.02 173.42 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.468 -179.009 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -36.58 -67.81 0.37 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.741 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -47.34 -66.36 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.593 0.235 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 89.9 t -29.61 -45.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.022 0.529 . . . . 0.0 112.014 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.486 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.43 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.031 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.38 -37.6 75.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.075 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 34' ' ' ILE . 4.8 tt -64.68 -47.77 77.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.389 0.614 . . . . 0.0 111.238 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.08 -31.6 72.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.694 -178.338 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.767 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -66.58 -46.31 76.37 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.31 -59.4 5.83 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.958 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -57.74 -43.19 85.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.609 -1.295 . . . . 0.0 111.405 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.93 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -80.99 -48.14 12.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.302 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.3 pt-20 -52.89 -43.75 66.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.698 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.82 -48.39 86.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.19 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.648 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.46 -27.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.609 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.64 149.64 45.37 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -129.14 91.82 3.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.091 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.731 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.027 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.135 0 CA-C-O 120.688 0.28 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.8 ttp180 -100.53 125.36 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.948 0.404 . . . . 0.0 111.067 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tt -89.53 141.47 28.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.959 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.849 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -150.33 108.86 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.141 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.664 HG12 ' HZ ' ' A' ' 86' ' ' PHE . 5.0 p -102.48 120.45 52.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.215 0.531 . . . . 0.0 111.661 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.5 OUTLIER -97.38 144.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.683 -179.405 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.65 ' NH2' HG11 ' A' ' 27' ' ' VAL . 16.3 mtt85 -150.61 118.53 6.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.219 178.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.24 -35.85 12.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.671 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.93 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.459 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -119.3 6.59 11.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.485 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 2.9 m-70 -115.89 103.14 10.33 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.467 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' CD1' ' A' ' 100' ' ' LEU . 9.5 tt -99.34 133.91 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.968 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 33.3 m-85 -147.3 110.2 4.73 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.291 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.01 120.91 33.79 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.42 113.03 25.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.011 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -95.83 98.76 8.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.221 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.6 mp -100.62 166.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.574 -177.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -99.34 111.92 24.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.238 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.77 26.55 1.75 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.127 0.892 . . . . 0.0 112.304 -178.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -110.03 -47.45 3.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.692 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.0 mttp -135.11 118.13 16.38 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 174.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.19 90.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.439 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.2 t -137.92 112.62 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -78.38 119.64 22.0 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -102.92 -58.56 1.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.331 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.548 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.4 t -120.55 146.73 24.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.313 0.578 . . . . 0.0 111.916 -178.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -150.13 114.74 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.883 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -121.89 156.41 33.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.14 126.75 10.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.553 ' H ' HG23 ' A' ' 34' ' ' ILE . 4.4 p . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 75.8 t -94.16 -20.83 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.65 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.039 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -43.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.109 0.48 . . . . 0.0 111.759 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -65.48 -59.08 4.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.532 0.682 . . . . 0.0 109.413 178.938 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 16.1 mt-30 -50.35 -23.66 2.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.473 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.039 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.61 -32.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.52 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.03 -29.88 52.86 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.9 178.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.16 -40.11 71.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.24 -40.31 90.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.011 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -63.76 -55.41 23.36 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.942 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.1 -24.93 28.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.04 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -71.37 -37.51 71.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 18.2 mttt -71.82 -64.52 0.91 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.018 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.837 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.03 -41.02 7.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.536 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.729 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -59.74 -40.18 87.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.243 178.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.26 -24.21 7.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.28 -28.06 20.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.236 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.08 13.27 16.02 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.532 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -65.66 109.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 110.193 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.6 tttm -93.58 -56.23 2.99 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.39 -178.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.471 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -112.93 151.1 30.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.272 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -135.33 161.53 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.509 0.671 . . . . 0.0 112.132 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 87.79 2.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 19.9 t80 -80.7 108.33 14.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -176.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.37 98.58 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.685 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 7.3 tpt180 -90.42 11.66 20.89 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.467 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 90' ' ' PRO . . . 87.19 -113.94 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.147 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 2.3 Cg_endo -81.06 45.12 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.803 2.335 . . . . 0.0 112.122 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 3.2 m-85 -112.19 133.15 54.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 111.011 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.6 155.04 48.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.3 t80 -33.06 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -103.82 -166.34 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -178.752 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.717 ' C ' ' HE2' ' A' ' 98' ' ' LYS . . . -76.18 -17.14 80.2 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.235 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' CB ' ' NE ' ' A' ' 29' ' ' ARG . 3.8 mmt85 -97.92 -64.55 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.484 ' O ' ' C ' ' A' ' 98' ' ' LYS . 13.6 t -28.84 -70.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.717 ' HE2' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -29.47 -60.18 0.15 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.223 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.666 ' N ' ' HG2' ' A' ' 98' ' ' LYS . . . -69.99 -46.89 64.19 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.398 -177.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -61.41 -47.69 84.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.814 0.816 . . . . 0.0 109.422 179.247 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.534 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.07 -40.36 76.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.64 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -62.58 -38.85 91.72 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.79 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.87 -59.34 8.15 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.89 -31.03 70.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.812 -1.194 . . . . 0.0 110.598 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.893 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 3.2 tpp85 -88.77 -25.52 22.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -82.7 -38.45 23.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.676 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -64.35 -46.35 90.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.638 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.729 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.81 -30.67 0.08 OUTLIER Glycine 0 C--N 1.341 0.835 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.556 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.57 146.56 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -128.32 99.7 5.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.127 178.328 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.721 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.064 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.604 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.224 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.356 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 13.6 ttp180 -93.36 124.5 37.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.908 -178.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.5 tt -89.66 145.99 24.85 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.255 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.802 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -150.38 119.06 6.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.212 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.775 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.8 t -101.29 139.99 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.863 0.363 . . . . 0.0 111.664 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HA ' ' OH ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -125.67 112.5 16.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.68 118.66 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.814 177.48 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -89.5 -78.88 0.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.55 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -131.58 -61.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.682 179.276 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -119.25 20.06 12.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.231 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -117.77 161.64 19.38 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.332 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.84 HD11 ' CD1' ' A' ' 100' ' ' LEU . 2.4 tp -151.37 128.05 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.939 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' O ' HG13 ' A' ' 27' ' ' VAL . 29.4 m-85 -145.42 150.83 37.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.153 0.502 . . . . 0.0 111.8 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -132.67 121.11 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.26 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 113.13 24.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.187 0.518 . . . . 0.0 110.22 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -96.21 96.31 5.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.5 mp -98.24 163.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.921 -177.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.574 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.5 t0 -96.9 109.31 22.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.574 177.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 18.2 p-10 -89.05 26.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.158 0.911 . . . . 0.0 112.273 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -110.67 -47.15 3.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mppp? -133.26 118.17 18.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 174.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.43 89.72 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.418 -177.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.8 t -139.59 112.45 5.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.47 119.48 21.12 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -99.56 -59.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.193 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 1.9 t -121.91 146.17 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.344 0.592 . . . . 0.0 112.004 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 88.3 p -150.18 114.86 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.943 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.37 158.3 33.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.844 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.22 134.14 16.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.562 ' N ' HG21 ' A' ' 68' ' ' VAL . 9.0 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 111.053 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.832 0.349 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.87 -19.81 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.291 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.28 -38.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.794 -179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.628 0.728 . . . . 0.0 109.157 178.603 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 10.6 mt-30 -49.68 -24.11 2.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.299 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.03 -32.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.99 -31.77 51.91 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.242 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.42 -42.59 68.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.62 -38.02 88.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -65.48 -54.57 26.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.226 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.79 -24.22 48.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.938 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.27 -37.79 68.97 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 21.9 mttt -70.75 -67.12 0.53 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.095 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.825 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.6 -41.96 4.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.685 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.794 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -59.3 -40.52 86.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.052 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.53 -23.92 7.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.526 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.46 -27.97 20.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.129 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.38 14.31 14.88 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.273 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.526 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.77 106.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.556 0.693 . . . . 0.0 110.019 179.722 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' GLU . 5.0 tttp -93.17 -54.55 3.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.493 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.73 144.2 41.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -130.73 159.89 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.5 0.667 . . . . 0.0 112.028 -179.643 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.92 ' CE2' HD22 ' A' ' 25' ' ' LEU . 17.1 t80 -80.39 106.51 12.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.635 0.731 . . . . 0.0 112.548 -176.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.95 97.78 2.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.362 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.4 tpt85 -83.55 -7.07 59.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.52 -110.21 2.0 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.24 34.94 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.021 2.48 . . . . 0.0 112.092 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 88' ' ' ARG . 2.9 m-30 -77.1 138.28 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.823 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 93' ' ' TYR . 9.4 tptt -121.28 99.49 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.796 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER 0.61 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.676 0.61 . . . . 0.0 112.236 -179.313 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -116.77 163.55 15.98 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.338 -179.301 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -39.53 -60.64 1.69 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.55 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.421 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 33.6 mmt180 -47.72 -69.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.675 0.274 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.6 t -33.98 -38.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.809 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.64 -79.06 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.607 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.9 -34.45 65.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.542 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.84 ' CD1' HD11 ' A' ' 34' ' ' ILE . 3.8 tt -68.17 -51.83 41.37 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.297 0.57 . . . . 0.0 110.969 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -62.38 -29.63 70.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.671 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.02 -44.95 71.69 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.287 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.33 -57.66 7.96 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.25 -33.67 75.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.534 -1.333 . . . . 0.0 110.875 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 -22.84 23.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -85.2 -34.87 21.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.41 -44.63 63.98 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.655 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.794 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.14 -31.03 0.08 OUTLIER Glycine 0 C--N 1.341 0.828 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.632 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.4 mp -71.42 147.01 48.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.32 96.71 4.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.412 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.1 p90 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.139 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.83 122.73 37.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.501 -178.933 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.43 143.02 27.14 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.518 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.806 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.3 m -146.23 108.55 4.44 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.008 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 6.7 p -97.03 119.23 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.321 0.582 . . . . 0.0 112.132 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.3 t80 -105.62 140.84 38.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.702 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 10.2 ptt85 -150.46 126.32 10.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.782 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 t -89.65 -85.78 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.924 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.87 -58.28 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.002 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.47 19.24 13.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.336 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -119.04 156.92 28.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.905 HD11 HD13 ' A' ' 100' ' ' LEU . 2.7 tp -142.76 132.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' H ' HD12 ' A' ' 34' ' ' ILE . 39.1 m-85 -149.55 149.97 31.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 111.963 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -133.74 128.4 34.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.317 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG2' HD11 ' A' ' 39' ' ' ILE . 2.8 tt0 -117.24 113.26 21.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.722 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -99.55 99.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.32 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.0 mp -104.32 160.05 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.794 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.699 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.0 t0 -91.36 114.19 26.65 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.51 22.74 2.85 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.077 0.861 . . . . 0.0 112.508 -178.216 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.67 -48.92 3.42 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.65 118.01 19.45 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.503 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.06 90.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.341 -177.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.2 t -136.1 112.58 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -77.87 118.48 20.23 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 47' ' ' LEU . 1.1 mp -103.67 -50.85 3.32 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.859 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.0 t -126.86 142.59 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.442 0.639 . . . . 0.0 112.385 -178.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 80.8 p -150.08 115.01 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.498 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.0 161.78 26.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.32 127.06 10.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 179.527 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 10.3 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.203 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.787 0.327 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 67' ' ' GLN . 79.2 t -93.99 -24.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.469 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.078 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -40.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.961 0.41 . . . . 0.0 111.748 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.06 -60.36 2.69 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.385 0.612 . . . . 0.0 109.376 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.0 mt-30 -48.66 -27.04 2.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.194 178.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.078 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -74.63 -35.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.57 178.616 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.38 -36.93 43.01 Favored Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.068 178.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -62.14 -35.72 79.63 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -67.27 -45.93 75.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.067 178.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.659 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.5 mt -63.55 -53.95 43.8 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.666 0.746 . . . . 0.0 109.019 178.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -57.91 -25.75 61.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.905 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -76.66 -26.92 55.37 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.108 178.183 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.859 ' HB2' HG21 ' A' ' 48' ' ' VAL . 27.2 mttm -82.9 -63.01 1.45 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.536 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.57 -42.6 11.24 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.02 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.6 mt -55.84 -40.15 72.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.127 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.63 -24.98 9.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.04 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.596 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.29 19.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.32 15.43 11.49 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.352 -179.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -66.52 106.21 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.519 0.676 . . . . 0.0 110.192 179.865 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.17 -56.78 3.03 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.165 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -113.73 144.72 42.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.261 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.16 161.7 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.651 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 103.28 12.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.999 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.762 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.56 108.42 15.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.124 0.487 . . . . 0.0 111.592 -179.078 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.41 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -129.24 45.81 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.115 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 1.3 ptt180 -41.53 -33.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.611 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.45 -117.96 5.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -88.74 20.07 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.771 2.314 . . . . 0.0 112.705 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.2 m-85 -80.92 138.74 36.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 0.0 111.214 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.02 151.34 25.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.6 106.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.649 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.32 164.57 18.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.85 -42.6 7.87 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.134 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HD2' HD13 ' A' ' 34' ' ' ILE . 1.1 mtt-85 -57.89 -70.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 0.0 110.668 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.0 t -37.45 -40.49 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.952 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.91 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.569 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.62 -35.36 70.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.699 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.905 HD13 HD11 ' A' ' 34' ' ' ILE . 3.4 tt -67.34 -49.6 63.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.084 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.17 -29.57 69.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.172 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.854 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -69.88 -44.26 70.16 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.369 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.77 -56.96 9.05 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.87 -31.43 72.66 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 113.578 -1.311 . . . . 0.0 111.013 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -89.97 -25.7 20.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.022 0.439 . . . . 0.0 110.726 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.1 pt-20 -80.48 -37.66 31.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.68 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.8 -48.32 62.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.493 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.01 -29.16 0.07 OUTLIER Glycine 0 C--N 1.343 0.949 0 C-N-CA 119.905 -1.14 . . . . 0.0 115.023 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.5 mp -71.48 146.54 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -128.24 96.31 4.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.379 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.708 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.004 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 HG13 ' A' ' 81' ' ' ILE . 1.7 mp . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 120.815 0.341 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 23.1 ttp85 -102.71 126.82 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.176 -179.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.941 HD23 ' N ' ' A' ' 26' ' ' SER . 5.3 tt -89.74 147.15 24.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.818 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.941 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.1 m -139.16 158.58 43.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.581 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.09 127.45 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.967 0.413 . . . . 0.0 110.265 179.219 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -128.68 122.49 30.91 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.912 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 96' ' ' ARG . 3.4 ptt-85 -130.81 123.55 29.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.639 178.01 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.09 -91.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.833 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.39 -64.76 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 109.829 179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 27.99 8.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.794 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -119.69 161.87 19.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.439 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.5 tp -149.34 128.23 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.513 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 27' ' ' VAL . 27.4 m-85 -144.02 160.15 41.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.312 0.577 . . . . 0.0 111.839 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -145.77 126.97 14.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.006 177.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -115.33 113.18 23.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 110.679 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.2 92.34 3.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.575 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.0 mp -96.58 161.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.533 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -94.53 115.44 27.6 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.826 177.953 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.7 t0 -92.42 28.67 1.89 Allowed 'General case' 0 N--CA 1.464 0.239 0 O-C-N 124.289 0.993 . . . . 0.0 112.22 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.45 -47.72 3.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.081 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mptt -136.78 118.25 14.77 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 174.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.37 89.16 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.545 -177.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.8 t -137.43 112.61 10.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.194 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -74.86 119.26 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 79' ' ' LEU . 1.8 mp -98.23 -63.63 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.48 HG13 ' HD3' ' A' ' 75' ' ' LYS . 2.2 t -120.23 147.51 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.402 0.62 . . . . 0.0 112.4 -178.305 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 p -150.27 129.44 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.82 179.161 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -141.75 157.61 44.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.494 . . . . 0.0 112.32 -179.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.39 129.19 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.515 179.594 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.45 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 m . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.769 179.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.754 0.312 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 73.2 t -94.06 -23.14 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.074 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.33 -41.66 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.735 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.01 -60.82 2.46 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.475 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.4 mt-30 -48.14 -26.19 1.78 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.241 177.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.074 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.49 -34.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.586 178.597 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.51 -31.33 54.68 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -67.94 -34.96 77.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.943 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.52 -41.48 65.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.151 177.706 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.795 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 5.1 mt -63.68 -46.33 86.02 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.36 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.91 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -68.32 -27.18 66.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -67.43 -37.16 82.58 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 109.298 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 3.2 mttt -81.34 -63.96 1.29 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.068 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -41.21 -42.34 2.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.135 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -61.15 -40.33 93.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.963 179.4 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.9 -22.57 5.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.17 -27.09 20.92 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.028 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.33 17.08 11.05 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.068 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.684 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -70.84 103.91 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.694 0.759 . . . . 0.0 110.312 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLU . 10.2 ttpt -95.75 -46.71 6.48 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.07 -178.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 140.63 52.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.379 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -127.89 167.45 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.473 0.654 . . . . 0.0 111.975 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.74 105.17 15.31 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.871 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.752 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.6 t80 -80.67 106.24 12.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.823 0.82 . . . . 0.0 112.597 -177.291 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.41 105.46 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.834 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -90.39 -48.06 7.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.675 -178.029 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.3 -112.48 2.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.163 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.16 26.84 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.834 2.356 . . . . 0.0 112.59 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 m-30 -99.66 162.54 12.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 111.368 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -132.01 148.07 52.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.886 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -44.61 103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.609 -179.858 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.06 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.142 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.31 -42.51 25.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.129 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.451 ' HB3' HD13 ' A' ' 34' ' ' ILE . 12.8 mmt-85 -56.27 -71.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.537 0.208 . . . . 0.0 110.985 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -39.46 -43.12 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.742 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.04 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.041 0.448 . . . . 0.0 111.067 -179.643 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -57.36 -36.84 71.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.213 -179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -68.32 -49.11 62.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 110.82 -179.606 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.583 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -58.65 -32.99 69.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.333 -178.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.74 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.75 -47.83 65.28 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.599 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.04 -58.32 6.37 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 177.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.91 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.36 -42.55 87.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.363 -1.419 . . . . 0.0 111.354 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -79.55 -53.77 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -48.35 -41.25 28.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.258 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.665 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.14 -49.58 61.35 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.842 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.66 -27.89 0.06 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.16 -1.019 . . . . 0.0 114.522 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.5 147.73 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.118 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.35 91.91 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 178.64 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.011 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.755 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.907 0.384 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -105.28 124.64 49.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.771 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.813 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.1 tt -90.54 143.02 27.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.257 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.774 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -145.14 110.17 5.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.165 -179.816 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 2.2 p -100.83 123.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.072 0.463 . . . . 0.0 111.921 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.504 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -100.5 154.24 18.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 112.316 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 18.1 mtm105 -150.29 118.81 6.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.32 179.133 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 -45.28 9.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.054 0.454 . . . . 0.0 110.994 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tp 179.89 -63.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -115.29 22.2 13.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.285 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -122.2 173.15 7.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.958 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 100' ' ' LEU . 5.2 tp -158.4 132.69 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 30.8 m-85 -148.21 148.69 30.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -134.23 121.29 21.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.876 177.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -111.76 112.88 24.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -98.31 105.3 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.106 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -108.26 160.08 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -88.83 116.33 27.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.831 178.109 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.4 t0 -91.74 22.38 4.18 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.415 1.072 . . . . 0.0 112.256 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.04 -46.67 3.43 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.8 mmmt -133.16 118.31 18.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 174.705 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.56 86.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 43' ' ' LYS . 61.7 t -134.89 112.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -72.4 113.87 9.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.644 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -89.9 -57.29 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.713 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.675 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -131.62 152.76 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.234 0.54 . . . . 0.0 111.902 -178.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -150.31 119.61 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.934 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -129.66 148.56 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 112.128 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.39 139.97 21.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.641 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.426 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 111.469 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 67' ' ' GLN . 63.9 t -94.03 -18.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.924 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.007 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.11 -42.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 111.95 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.03 -60.41 2.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.584 0.707 . . . . 0.0 109.205 178.648 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 25.2 mt-30 -49.18 -24.14 1.59 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.368 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.007 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.17 -32.37 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.268 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.44 -26.82 60.57 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.276 178.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 7.5 ppt_? -77.31 -38.45 50.55 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.346 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.37 72.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.77 ' CD1' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.21 -52.12 17.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.981 178.428 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.85 -23.67 67.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.532 178.385 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 42.7 mt-10 -77.79 -30.04 51.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB3' HG21 ' A' ' 48' ' ' VAL . 16.5 mttt -73.82 -68.29 0.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.416 177.361 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.45 -42.44 7.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.104 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -57.12 -38.89 74.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.823 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.55 -23.07 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.932 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.903 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 18.97 9.53 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.109 -178.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.41 104.93 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.559 0.695 . . . . 0.0 110.356 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 4.1 tttt -90.99 -57.22 2.88 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.372 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.91 146.91 35.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.421 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.83 165.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.5 0.667 . . . . 0.0 112.023 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.38 97.3 7.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.324 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.813 ' CE1' HD22 ' A' ' 25' ' ' LEU . 5.3 t80 -81.12 109.68 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.394 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.28 86.48 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.651 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.0 tpt180 -77.66 -27.7 50.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.046 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.29 -109.31 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.226 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.19 34.2 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.823 2.348 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 2.7 m-85 -96.34 138.11 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.124 0.488 . . . . 0.0 111.558 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 149.54 30.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.932 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.511 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -45.51 97.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.779 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.5 t-160 -110.5 159.11 17.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.459 -179.308 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -40.17 -51.44 3.55 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.492 -179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.4 mtt-85 -55.0 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.636 0.255 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -40.28 -38.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.273 179.363 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -61.16 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.012 0.434 . . . . 0.0 110.592 -179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -54.73 -36.08 64.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.99 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 34' ' ' ILE . 1.3 tt -70.35 -52.68 20.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.204 0.526 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.6 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -56.41 -32.32 64.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.319 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.794 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.6 -44.6 70.39 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.043 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.79 -57.09 8.92 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.106 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.78 -33.69 74.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.49 -1.355 . . . . 0.0 110.93 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.86 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.5 tpp85 -88.97 -24.11 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.794 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -83.6 -34.94 25.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.3 -45.35 61.41 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.921 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.03 -30.64 0.08 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.178 -1.011 . . . . 0.0 114.454 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.86 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.36 142.81 50.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.193 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 2.0 mp0 -127.7 99.8 5.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.066 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.091 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HD3' ' CA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.54 0.21 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -43.37 124.02 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.724 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -92.84 125.52 37.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.635 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.869 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.45 144.03 26.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.869 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 m -145.82 108.53 4.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.85 HG11 HG23 ' A' ' 97' ' ' VAL . 4.5 p -98.3 123.43 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.177 0.513 . . . . 0.0 111.882 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -106.98 145.26 32.48 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -150.29 119.17 6.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.74 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.66 -69.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.072 0.463 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.6 mt -147.6 -59.16 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.441 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -119.37 4.36 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.379 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.1 116.25 31.59 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.994 0.426 . . . . 0.0 111.356 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.636 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.0 tp -104.09 129.09 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 20.3 m-85 -143.16 151.21 40.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.215 0.531 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -137.61 122.52 18.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.397 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.63 113.26 25.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.0 110.547 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.02 100.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -102.02 163.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.892 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 t0 -93.63 114.03 26.26 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' CG ' ' A' ' 22' ' ' ARG . 7.1 t0 -90.26 26.65 1.86 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.331 1.019 . . . . 0.0 112.419 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' CA ' ' HD3' ' A' ' 22' ' ' ARG . 35.8 tt0 -110.67 -47.64 3.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.29 118.22 17.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.82 89.25 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.374 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.5 t -138.3 112.41 8.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -76.94 119.35 20.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.4 mp -102.32 -57.57 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -122.69 146.12 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 0.0 111.907 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -150.16 114.91 5.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -120.98 148.4 44.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.886 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.472 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.43 136.77 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.978 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 16.3 m -60.39 -57.49 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.0 tm? -64.09 -15.39 59.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.58 -62.02 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mp -52.45 -52.07 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.642 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.12 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.812 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 75.5 mt -51.86 115.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.755 ' HG2' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -121.45 24.69 9.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.02 -116.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m120 -77.77 178.02 7.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.747 0.308 . . . . 0.0 110.828 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -108.4 -38.77 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.487 HG23 ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -93.07 -28.09 16.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -58.2 -54.12 50.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.739 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 69.0 t -86.08 -21.46 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.198 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.067 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.6 -43.98 0.05 Allowed 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -64.12 -60.94 2.61 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.517 0.675 . . . . 0.0 109.398 178.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -48.45 -25.28 1.58 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.23 177.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.067 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.13 -33.16 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.639 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.52 -27.91 58.44 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.161 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.7 ppt_? -74.77 -38.61 62.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -70.27 -34.94 73.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 38' ' ' ILE . 1.8 tp -68.98 -54.29 16.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.82 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -61.94 -25.31 67.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.913 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.9 mt-10 -77.88 -30.22 50.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.3 mttt -72.77 -69.27 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.518 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.72 -42.55 7.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -55.85 -39.1 70.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.023 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.79 -24.01 13.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.54 -27.77 20.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.28 14.93 12.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.297 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.88 107.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.496 0.665 . . . . 0.0 110.237 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 110' ' ' GLU . 24.4 ttpt -94.53 -52.45 4.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.361 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.44 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -114.85 142.61 46.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.204 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.643 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.04 161.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.414 0.626 . . . . 0.0 112.058 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -102.02 100.88 11.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.282 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 1.9 t80 -81.06 106.25 12.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.155 0.502 . . . . 0.0 111.216 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -137.16 43.16 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.155 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' NH1' HG21 ' A' ' 97' ' ' VAL . 7.2 ptt180 -37.71 -39.18 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.809 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.72 -117.32 5.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.734 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.15 50.62 3.6 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 111.979 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.46 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 5.9 m-85 -123.22 102.23 7.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -71.52 139.33 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.881 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -52.11 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -103.73 -165.12 1.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.148 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.82 -55.81 9.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.987 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.636 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -45.77 -71.25 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.653 0.263 . . . . 0.0 110.586 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.85 HG23 HG11 ' A' ' 27' ' ' VAL . 8.8 p -42.59 -32.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -66.37 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.96 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -47.28 -35.87 8.4 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.772 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -70.18 -41.24 74.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.07 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -66.65 -34.93 78.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.461 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.742 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -66.25 -44.2 84.35 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.32 -57.0 10.93 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.97 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.26 -33.02 72.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.552 -1.324 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.1 tpp180 -90.05 -26.25 20.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.721 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.742 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.3 pt-20 -80.82 -33.33 34.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.65 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.91 -46.68 35.86 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.946 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.9 -31.42 0.07 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 119.989 -1.101 . . . . 0.0 114.731 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.835 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.3 mp -71.36 143.99 50.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' CB ' ' HG3' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -127.9 95.15 4.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.136 178.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.663 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.2 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.56 ' C ' HD23 ' A' ' 23' ' ' LEU . 17.2 ttm105 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.07 135.48 48.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.5 ttp85 -101.12 127.16 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.42 140.87 29.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.757 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.15 112.34 7.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.24 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -92.74 135.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.564 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 1.4 t80 -123.93 115.64 21.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.102 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -126.27 118.72 25.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.542 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.25 -48.58 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -170.52 -64.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -117.27 20.81 13.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.405 178.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 1.5 m80 -127.74 132.68 49.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.032 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 100' ' ' LEU . 4.0 tp -121.85 118.47 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.303 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 9.2 m-85 -136.5 108.39 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.706 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -97.54 126.03 42.58 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 116.07 29.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.321 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.81 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -97.43 98.35 7.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.169 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.2 mp -100.71 165.45 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.039 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -97.16 112.07 24.02 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.721 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.1 p30 -91.12 27.04 1.97 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.15 0.906 . . . . 0.0 112.252 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -110.15 -46.9 3.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.3 mptt -134.62 118.25 17.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.83 90.33 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.341 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.6 t -140.98 112.53 3.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -76.48 123.12 25.55 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -104.02 -61.78 1.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -120.59 144.9 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.224 0.535 . . . . 0.0 111.952 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.4 p -150.21 116.06 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.175 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.859 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.54 151.22 48.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.212 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.56 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 7.1 t -150.44 134.88 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.884 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.663 ' H ' HG23 ' A' ' 34' ' ' ILE . 5.4 t -52.67 -26.25 13.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.035 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.495 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.2 tm? -56.51 -62.48 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.728 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.4 -25.9 51.5 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.424 0.631 . . . . 0.0 109.946 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.6 mp -90.14 12.49 17.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.881 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 3.09 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.64 0.776 . . . . 0.0 112.804 -177.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.804 ' HB2' HG21 ' A' ' 64' ' ' VAL . 1.9 pt? -46.75 171.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.332 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 32.6 6.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.36 -155.8 9.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.13 -71.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -175.95 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 p -93.11 -10.24 36.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.33 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -68.15 -42.34 80.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' A' ' 57' ' ' LEU . 53.0 t -93.99 -18.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.722 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.025 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.43 -39.32 0.12 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.8 -59.96 3.09 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.7 mt-30 -49.58 -27.28 4.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.297 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -75.01 -33.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.78 -27.26 61.07 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.7 -33.58 72.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.9 -36.62 56.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.859 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -65.39 -45.54 83.61 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -73.06 -33.27 65.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.845 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 46.4 mt-10 -71.34 -33.22 69.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 48' ' ' VAL . 19.7 mttt -70.17 -67.65 0.48 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.79 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.37 -41.08 13.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.963 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.719 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.97 -38.97 77.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.023 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.52 -23.61 10.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.946 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.53 -27.38 20.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.5 16.59 10.81 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.206 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -72.16 107.96 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.516 0.674 . . . . 0.0 110.393 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -95.15 -53.45 3.8 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.442 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -115.14 142.57 46.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.44 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.55 163.47 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.496 0.665 . . . . 0.0 111.884 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.11 98.8 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.169 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.749 ' CE1' HD22 ' A' ' 25' ' ' LEU . 2.1 t80 -81.15 113.89 19.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.459 0.647 . . . . 0.0 111.806 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.442 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -150.17 33.7 0.66 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.677 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.667 ' C ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -43.31 -41.6 4.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.795 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' N ' ' HD3' ' A' ' 88' ' ' ARG . . . 156.28 -136.61 5.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -95.73 37.85 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.193 2.595 . . . . 0.0 112.736 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' NH2' ' A' ' 88' ' ' ARG . 4.7 m-30 -88.62 84.94 6.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.339 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -71.85 133.62 45.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.559 ' C ' ' O ' ' A' ' 92' ' ' LYS . 1.4 t80 0.69 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.533 0.521 . . . . 0.0 112.304 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.536 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -94.18 148.31 22.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.216 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.432 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -29.01 -39.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.095 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.6 mmt180 -79.49 -65.43 1.0 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.678 0.275 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 31.8 t -30.48 -49.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -53.99 -72.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.495 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.56 -40.94 96.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.476 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 34' ' ' ILE . 2.4 tt -63.19 -45.71 90.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.473 0.654 . . . . 0.0 110.446 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.528 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -67.58 -30.32 69.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.291 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.02 -46.74 70.4 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.25 -54.71 9.69 Favored Glycine 0 CA--C 1.508 -0.393 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.965 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.83 -36.15 83.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.269 -1.465 . . . . 0.0 111.469 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -87.48 -24.25 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.412 . . . . 0.0 110.764 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -82.59 -37.47 24.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.78 -47.98 64.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.002 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.719 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -30.06 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.513 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.817 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.0 mp -71.41 143.7 50.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.444 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -127.69 99.38 5.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.881 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.895 . . . . 0.0 111.068 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' C ' HD23 ' A' ' 23' ' ' LEU . 9.6 ptp85 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.816 0.341 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -102.34 132.4 48.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.411 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -101.54 125.16 48.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.55 143.42 26.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.821 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 m -146.97 108.76 4.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.966 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG21 HD13 ' A' ' 100' ' ' LEU . 7.7 p -93.39 119.77 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.07 140.22 37.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.785 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 34' ' ' ILE . 3.2 mmm180 -150.08 118.92 6.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.951 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.74 -64.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.21 0.529 . . . . 0.0 110.291 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 -58.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -119.71 2.28 11.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.634 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.634 ' HA ' HD23 ' A' ' 53' ' ' LEU . 1.8 m-70 -110.33 117.66 34.22 Favored 'General case' 0 N--CA 1.46 0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 112.089 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.86 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.8 tp -106.45 131.0 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.768 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.537 ' HE1' HD21 ' A' ' 53' ' ' LEU . 37.1 m-85 -148.98 111.97 4.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.721 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -93.72 123.59 37.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.56 113.52 26.38 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -99.04 96.51 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -98.4 164.7 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.306 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -95.61 113.19 24.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 10.0 t70 -88.35 21.83 2.72 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.376 1.048 . . . . 0.0 112.352 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.47 -48.85 3.18 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.3 mmtp -129.77 118.17 21.4 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.72 87.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.722 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 43' ' ' LYS . 53.0 t -136.39 112.5 12.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -75.86 117.81 17.99 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -101.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.07 143.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 112.238 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.03 114.69 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.36 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -120.81 159.18 25.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -144.89 126.86 15.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.49 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.628 ' N ' HG21 ' A' ' 68' ' ' VAL . 1.3 m -63.98 -34.09 77.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.35 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 33' ' ' HIS . 3.6 pp -70.39 -8.89 54.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.425 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.91 -53.55 5.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 55' ' ' LEU . 5.0 mp -52.37 -44.49 65.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 tttt 178.99 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.453 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.879 HD12 ' HB ' ' A' ' 64' ' ' VAL . 4.8 tt -40.11 133.91 1.64 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.941 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.801 ' N ' HD23 ' A' ' 57' ' ' LEU . 22.5 tttp -132.05 -45.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.26 -80.42 1.33 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.598 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' O ' HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -57.42 120.57 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.748 ' HA ' HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -93.65 -60.23 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.675 HG23 ' NH2' ' A' ' 96' ' ' ARG . 1.1 p -55.41 -23.55 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.322 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.56 -66.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.879 ' HB ' HD12 ' A' ' 57' ' ' LEU . 97.9 t -80.73 -19.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.662 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.052 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.22 -37.96 0.08 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.904 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -69.66 -58.9 3.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.4 mt-30 -49.84 -22.63 1.53 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.488 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.052 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.23 -33.63 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -76.64 -33.6 46.75 Favored Glycine 0 C--O 1.217 -0.93 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.131 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -72.31 -41.78 66.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.95 -40.58 91.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -64.34 -54.49 32.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.2 -25.25 31.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.8 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.8 tt0 -72.14 -36.85 69.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 10.2 mttp -71.85 -64.49 0.92 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.843 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.821 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.88 -42.65 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.318 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.772 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -59.23 -40.8 87.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.257 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -51.44 -25.66 6.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.417 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.42 -28.0 20.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 12.9 13.18 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.627 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.78 104.1 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.649 0.738 . . . . 0.0 110.036 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 110' ' ' GLU . 21.2 ttpp -92.79 -49.75 5.91 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.147 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -117.43 136.31 53.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.362 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.533 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.89 162.93 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.376 0.608 . . . . 0.0 111.838 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.2 102.55 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.47 121.19 25.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.49 . . . . 0.0 111.549 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 1.3 t70 -148.48 45.88 1.04 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.162 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.9 ptt-85 -40.39 -31.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.661 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.48 -125.01 7.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.5 59.84 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.418 2.078 . . . . 0.0 111.754 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 8.4 m-85 -131.66 157.51 43.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 111.391 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -132.21 140.78 48.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.357 178.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.508 ' CZ ' ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -41.0 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.917 ' CE1' HG23 ' A' ' 97' ' ' VAL . 18.8 p80 -112.88 151.16 30.79 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.525 ' C ' HG22 ' A' ' 62' ' ' THR . . . -20.88 -55.97 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.164 -0.925 . . . . 0.0 114.039 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.86 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.9 mmp_? -57.63 -64.54 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.917 HG23 ' CE1' ' A' ' 94' ' ' HIS . 88.7 t -35.41 -46.65 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.567 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HD3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.36 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.44 -43.27 62.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.889 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -61.62 -45.22 95.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.347 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.564 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -65.72 -37.63 86.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.805 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.809 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -67.42 -42.65 82.86 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.14 -58.94 8.07 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.972 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.92 -35.13 74.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.82 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -87.92 -30.43 20.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.418 . . . . 0.0 110.692 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.809 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.0 pt-20 -74.22 -35.15 63.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.659 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.72 -46.26 54.69 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.458 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.772 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.42 -27.76 0.08 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.941 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.3 mp -71.46 145.24 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER -128.16 93.98 3.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.504 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.696 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.938 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.633 ' C ' HD23 ' A' ' 23' ' ' LEU . 10.8 tpt180 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -104.22 133.83 48.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.428 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 16.3 ttp-105 -101.28 125.0 47.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.11 141.76 28.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.938 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.27 107.95 5.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.084 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.6 p -95.53 116.5 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.263 0.554 . . . . 0.0 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -93.61 134.98 35.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.972 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.71 ' NH2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -123.34 118.12 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 t -90.25 -79.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.06 -58.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.36 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.27 1.85 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.182 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.15 174.57 6.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.342 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.71 HD12 ' NH2' ' A' ' 29' ' ' ARG . 2.8 tp -150.45 111.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -136.56 140.67 43.1 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -128.54 127.95 43.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.257 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.05 114.02 25.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.038 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -98.19 95.2 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.317 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -95.84 163.89 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.858 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.4 t0 -95.19 114.71 26.53 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.711 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.6 t70 -90.28 23.53 2.87 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.405 1.065 . . . . 0.0 112.311 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.13 -47.77 3.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.19 118.17 16.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 174.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.95 89.97 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.28 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.0 t -139.63 112.42 5.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -72.1 113.6 9.31 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.9 mp -92.86 -65.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.91 148.33 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.266 0.555 . . . . 0.0 111.63 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -150.14 114.84 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.654 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -123.62 138.98 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 111.853 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 36.9 p -150.3 132.63 15.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.595 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.8 m -51.39 -33.2 29.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 53' ' ' LEU . 1.4 tm? -59.71 -63.62 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.334 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.97 62.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.534 . . . . 0.0 110.174 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 mp -89.07 11.37 18.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.278 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.5 tttt 2.17 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.33 0.652 . . . . 0.0 112.463 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.838 HD11 HG11 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -100.66 176.1 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.037 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -80.19 74.38 7.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.624 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.851 ' HA3' HG21 ' A' ' 64' ' ' VAL . . . -136.25 -168.46 11.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.781 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -133.31 -55.92 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.576 0.227 . . . . 0.0 110.995 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -175.54 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.681 0.277 . . . . 0.0 111.619 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -74.6 -43.0 57.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.749 0.309 . . . . 0.0 111.614 -179.293 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -50.76 -39.02 51.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.313 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.851 HG21 ' HA3' ' A' ' 59' ' ' GLY . 73.9 t -94.26 -22.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.766 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.035 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.92 -39.8 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.673 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.35 -59.55 3.32 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.525 0.678 . . . . 0.0 109.172 178.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.5 mt-30 -49.66 -26.56 3.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.205 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.035 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.43 -32.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.38 -26.39 63.72 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 8.2 ptt85 -73.47 -39.83 64.61 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 70' ' ' ARG . . . -68.57 -36.23 78.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.038 HD21 HD11 ' A' ' 38' ' ' ILE . 1.1 tp -68.69 -53.48 21.97 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.015 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -63.35 -25.12 68.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.528 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 15.8 mt-10 -78.2 -29.98 48.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mttt -71.82 -69.16 0.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.403 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.84 -42.84 8.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.181 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.697 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.5 mt -56.02 -39.16 71.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.71 -24.58 8.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.071 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.71 -27.04 20.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.62 21.82 7.0 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.061 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' CG1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.53 102.84 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.136 0.494 . . . . 0.0 110.771 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.652 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.97 -25.62 12.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -125.27 125.24 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.187 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.12 164.54 23.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 112.06 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.31 105.51 15.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.391 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.37 118.01 22.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.394 0.616 . . . . 0.0 112.011 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.03 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.644 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.43 -29.57 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 88' ' ' ARG . . . 123.12 -151.43 16.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.94 55.99 4.63 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.927 2.418 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.484 ' CG ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m-30 -100.18 166.52 10.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.024 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.91 153.51 50.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -47.33 109.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.502 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.496 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -126.25 156.53 40.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 62' ' ' THR . . . -38.44 -30.01 0.08 OUTLIER Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.633 ' CD ' HD13 ' A' ' 34' ' ' ILE . 1.2 mmt85 -76.7 -70.97 0.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.598 0.237 . . . . 0.0 111.606 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 60.0 t -31.01 -50.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -57.96 -75.06 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.864 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.58 -37.67 68.37 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.172 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.1 tt -67.66 -49.16 64.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.3 -33.16 73.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.402 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.758 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -66.53 -46.54 75.81 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.08 -57.91 7.52 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.949 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.15 -39.95 80.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.354 -1.423 . . . . 0.0 111.428 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.841 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -82.58 -51.42 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -49.44 -40.57 37.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.58 -48.81 64.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.359 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.14 -26.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.092 -1.051 . . . . 0.0 114.713 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.841 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.37 145.98 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -128.2 91.99 3.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.455 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.3 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.955 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HD3' ' HB2' ' A' ' 42' ' ' GLU . 7.7 ptm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -33.86 137.62 0.1 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.198 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -93.02 124.32 36.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.35 143.54 26.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.832 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -144.61 108.48 4.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.753 0.311 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.629 HG21 HH22 ' A' ' 29' ' ' ARG . 2.8 p -97.68 121.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.872 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.26 139.54 41.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.831 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.629 HH22 HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -150.31 126.25 10.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.518 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -80.73 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.765 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.9 -51.25 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -119.1 23.18 11.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.904 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -123.91 172.44 8.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.133 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -160.22 126.95 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.996 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.792 ' N ' HD12 ' A' ' 34' ' ' ILE . 41.9 m-85 -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.056 0.455 . . . . 0.0 112.024 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -134.75 121.36 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.14 113.36 25.58 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 110.485 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.78 99.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.3 mp -101.37 161.81 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.197 -0.911 . . . . 0.0 113.315 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -93.79 110.5 22.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.443 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -88.32 27.43 1.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.235 0.959 . . . . 0.0 112.552 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 32.0 tt0 -111.35 -48.54 3.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.62 118.32 19.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 174.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.22 88.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' LYS . 95.8 t -136.81 112.67 11.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -76.55 119.33 20.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.505 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.8 mp -98.84 -62.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.42 148.63 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 112.302 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 14.1 p -150.21 131.01 14.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.064 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.01 165.74 24.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 0.0 111.755 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.568 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -150.15 126.86 10.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.075 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.678 ' HB3' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -62.9 -65.47 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.514 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.5 tm? -43.57 -36.94 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.573 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.01 -48.71 11.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.496 0.665 . . . . 0.0 111.197 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 51' ' ' SER . 0.1 OUTLIER -52.75 -34.63 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt 179.79 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.9 mt -46.39 154.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 111.571 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -127.05 -56.03 1.35 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.413 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.48 18.58 3.65 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.28 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.489 ' CB ' HD21 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.26 -168.77 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.792 0.296 . . . . 0.0 110.653 179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -155.38 -51.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.458 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.5 p -91.77 15.39 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.535 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -94.21 -57.34 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 67' ' ' GLN . 89.6 t -94.16 -15.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.862 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.36 -41.5 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.897 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.65 -59.48 3.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.8 mt-30 -49.7 -23.41 1.75 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.478 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.38 -32.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.04 -28.4 56.45 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -73.88 -37.95 64.55 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.04 -35.41 69.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -67.68 -53.79 24.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.74 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.83 -26.26 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -75.89 -33.0 59.92 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 14.9 mttt -72.15 -68.97 0.42 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.816 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.73 -42.22 5.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.274 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.786 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -56.81 -40.03 75.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.062 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.14 -23.85 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.13 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.45 18.9 9.21 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.193 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.43 102.98 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.58 0.705 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.4 tttt -88.13 -59.37 2.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.705 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.408 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -107.25 148.24 29.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.398 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.56 158.91 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.369 0.604 . . . . 0.0 112.107 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.77 101.9 12.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.77 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.707 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.47 114.92 20.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.149 0.499 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.79 56.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -44.57 -40.2 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.47 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.32 -111.79 3.15 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.686 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.09 28.15 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.907 2.405 . . . . 0.0 112.693 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.0 m-30 -96.58 164.08 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -131.92 150.31 52.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -51.18 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.223 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -115.43 169.58 9.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.3 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.25 -38.27 4.93 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.759 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 7.1 mmt180 -62.54 -70.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 44.1 t -37.94 -41.74 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 110.887 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.58 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.116 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -58.88 -37.04 75.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.092 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.76 -47.83 68.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.223 0.535 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.54 -31.64 72.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.508 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.07 -44.02 73.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.35 -57.65 10.04 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.995 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.88 -31.53 72.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.71 -1.245 . . . . 0.0 111.187 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.7 mtm-85 -89.83 -25.68 20.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -82.46 -33.87 28.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.657 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.93 -47.38 39.21 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.992 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.786 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.87 -29.25 0.07 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 119.857 -1.164 . . . . 0.0 114.867 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.822 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.6 mp -71.1 146.19 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.8 mp0 -127.72 91.82 3.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.417 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.649 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.4 p90 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.894 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.656 ' C ' HD23 ' A' ' 23' ' ' LEU . 18.7 ttp-105 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -106.68 137.55 44.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.616 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -101.29 126.52 48.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.02 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.856 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.7 tt -89.69 142.53 27.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.82 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -146.47 108.7 4.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 100' ' ' LEU . 11.9 p -96.77 117.16 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.256 0.551 . . . . 0.0 111.748 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.02 137.22 38.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.834 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -143.35 118.85 10.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.934 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.75 -80.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.877 0.37 . . . . 0.0 110.717 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -127.37 -65.38 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 17.46 13.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.113 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -117.05 140.36 49.58 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 121.123 0.487 . . . . 0.0 111.6 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.808 HD11 HD13 ' A' ' 100' ' ' LEU . 6.5 tp -127.97 129.46 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 30.0 m-85 -144.92 112.21 6.07 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.25 120.93 34.09 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.8 113.01 25.28 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.486 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.935 HD11 ' CD2' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.75 102.27 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.323 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -99.2 161.41 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.686 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 t70 -92.36 117.86 30.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.986 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.7 t0 -91.95 22.72 4.09 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 124.411 1.069 . . . . 0.0 112.198 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -107.23 -47.47 3.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.04 118.1 15.39 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.04 90.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.173 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.3 t -137.93 112.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -73.43 116.73 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -99.66 -58.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.83 142.48 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.324 0.583 . . . . 0.0 112.226 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -150.17 114.86 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.876 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -125.3 161.9 25.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 111.796 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -143.76 137.52 28.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.798 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.823 ' OG ' HD13 ' A' ' 57' ' ' LEU . 9.2 p -59.51 -33.94 71.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' C ' HD12 ' A' ' 53' ' ' LEU . 4.0 pp -72.76 -7.76 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.295 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -81.44 -60.28 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.401 0.62 . . . . 0.0 111.729 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.665 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.64 -41.51 63.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.3 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.81 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 58' ' ' LYS . 4.6 tt -42.43 145.34 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 111.792 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.881 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -132.08 -53.51 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.13 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.13 -21.85 3.34 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.13 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 8.0 m120 -51.19 169.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.137 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -125.48 -84.85 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -93.35 32.16 1.39 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -55.15 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.874 ' HB ' HD12 ' A' ' 57' ' ' LEU . 84.4 t -94.18 -18.58 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.6 -38.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.848 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.68 -58.59 3.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -50.27 -23.06 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.473 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.03 -34.52 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.57 -33.28 48.14 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.155 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -71.71 -42.27 67.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.652 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.77 -42.62 90.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.935 ' CD2' HD11 ' A' ' 38' ' ' ILE . 4.3 tp -65.06 -51.71 59.93 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.79 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.88 -26.21 46.15 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.403 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -71.88 -35.94 69.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.821 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.6 mttt -73.19 -63.6 1.15 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.801 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.91 -41.95 7.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.285 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -60.62 -41.02 94.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.18 -25.9 6.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.38 -27.29 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 10.06 19.23 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.251 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.489 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.1 103.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.586 0.708 . . . . 0.0 110.192 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 110' ' ' GLU . 7.5 tttm -92.8 -55.5 3.34 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.044 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.2 OUTLIER -111.07 139.13 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.362 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.56 163.76 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 111.762 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.16 104.95 14.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.639 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.856 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.48 113.46 19.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.787 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -137.32 44.22 2.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.952 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 17.4 ptt-85 -40.57 -32.07 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.44 -128.67 9.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.273 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.79 52.66 3.02 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.654 2.236 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 4.4 m-85 -117.34 142.11 47.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -115.01 149.76 36.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.13 105.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.529 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -123.87 163.97 20.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.0 -27.97 3.74 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.869 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 34' ' ' ILE . 16.1 mmt180 -68.88 -70.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.399 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 24.7 t -39.43 -38.4 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.42 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.4 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.965 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.91 -36.54 70.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.816 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 34' ' ' ILE . 2.1 tt -68.47 -48.96 63.12 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 111.155 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.93 -31.02 69.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.178 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.97 -46.46 68.05 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.17 -58.47 7.12 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.944 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.59 -37.81 82.57 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.574 -1.313 . . . . 0.0 111.387 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -86.43 -29.34 22.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 110.92 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.7 pt-20 -74.15 -37.55 63.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.668 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.23 -47.17 73.97 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.103 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 173.52 -26.31 0.08 OUTLIER Glycine 0 C--N 1.342 0.901 0 C-N-CA 120.173 -1.013 . . . . 0.0 114.72 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.49 145.0 49.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.23 95.95 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.42 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.021 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' C ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -106.93 132.46 52.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.41 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp85 -101.15 125.36 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.57 143.32 26.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.852 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.887 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -136.5 147.9 47.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.734 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HE ' ' A' ' 88' ' ' ARG . 2.6 p -140.59 118.65 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.361 0.6 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -108.68 142.16 39.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.739 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 32.8 mtm180 -142.7 122.38 13.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.143 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 t -89.36 -78.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.331 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.29 -58.54 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -119.32 23.21 11.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.941 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -119.51 169.84 9.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.873 HD11 HD13 ' A' ' 100' ' ' LEU . 2.1 tp -156.35 131.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.555 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 51' ' ' SER . 30.8 m-85 -147.3 148.29 31.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.978 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.89 121.17 19.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.04 112.97 24.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.21 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.089 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -94.52 92.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.4 mp -96.55 162.09 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.741 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' N ' HG22 ' A' ' 39' ' ' ILE . 2.0 t0 -96.83 108.76 21.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.4 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.91 26.85 1.45 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.163 0.914 . . . . 0.0 112.242 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.02 -47.34 3.22 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mttt -133.12 118.17 18.38 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.16 90.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.588 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' LYS . 63.0 t -139.1 112.62 6.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -78.65 118.94 21.22 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 79' ' ' LEU . 1.1 mp -102.64 -56.96 2.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' HD3' ' A' ' 75' ' ' LYS . 1.9 t -117.14 144.84 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.641 . . . . 0.0 112.287 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -150.33 114.6 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.342 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -134.32 153.09 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.042 0.449 . . . . 0.0 112.106 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 2.4 t -150.42 131.12 14.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 34' ' ' ILE . 20.1 m -58.71 -29.57 66.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.409 . . . . 0.0 110.382 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.2 tm? -66.75 -48.1 70.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.787 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.09 70.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.221 0.534 . . . . 0.0 110.064 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.9 mp -91.83 10.91 26.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.968 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 2.29 63.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.562 0.745 . . . . 0.0 112.994 -178.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.99 HD12 HG11 ' A' ' 64' ' ' VAL . 9.4 mt -81.46 176.16 9.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.669 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -77.66 67.06 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.823 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.669 ' HA3' HG23 ' A' ' 64' ' ' VAL . . . -136.89 -150.25 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.544 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.24 -68.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -144.76 -78.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' C ' ' A' ' 95' ' ' GLY . 71.8 p -84.96 3.31 38.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.284 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.6 -46.19 17.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.293 . . . . 0.0 110.922 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.99 HG11 HD12 ' A' ' 57' ' ' LEU . 72.1 t -94.07 -24.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.062 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.59 -42.44 0.05 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.017 0.437 . . . . 0.0 111.724 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.65 -60.25 3.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.501 ' HB2' HG13 ' A' ' 64' ' ' VAL . 3.6 mp0 -47.55 -26.43 1.43 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.247 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.062 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.93 -32.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.977 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.38 -30.18 46.48 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.464 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.94 -39.9 65.85 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -69.15 -37.55 78.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.089 HD21 HD11 ' A' ' 38' ' ' ILE . 1.4 tp -65.9 -53.42 39.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.305 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.69 -23.36 67.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.153 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.61 -29.76 56.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.5 -47.73 7.79 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -51.58 -40.21 59.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.765 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -60.11 -38.56 83.38 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.781 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.18 -22.96 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.44 -26.89 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 16.0 13.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.058 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.577 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.55 0.691 . . . . 0.0 110.251 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.5 tttt -89.78 -57.72 2.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.216 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.47 147.41 35.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.293 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -134.58 164.05 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.358 0.599 . . . . 0.0 112.058 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.53 101.75 12.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.192 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.663 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -81.04 106.01 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.349 0.595 . . . . 0.0 112.37 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' N ' ' NH1' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -142.8 75.25 1.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.237 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -57.39 -38.02 73.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.095 0.474 . . . . 0.0 110.584 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.04 -110.79 2.59 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -90.09 31.15 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.833 2.355 . . . . 0.0 112.334 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 2.8 m-85 -103.06 154.91 18.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.2 150.8 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.222 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -47.82 109.68 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.414 ' O ' ' NZ ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -121.27 -77.78 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.413 ' C ' HG22 ' A' ' 62' ' ' THR . . . -155.66 -54.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.784 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.454 ' HD2' HD13 ' A' ' 34' ' ' ILE . 3.2 mtt180 -54.53 -59.59 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 27.2 t -40.1 -40.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.952 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.91 -76.33 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.935 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -61.1 -34.77 75.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.831 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 34' ' ' ILE . 2.7 tt -66.57 -48.39 69.75 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.769 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.14 -33.41 74.44 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.239 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.804 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.73 -45.41 75.1 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.3 -57.02 8.51 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.96 -36.3 81.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.465 -1.368 . . . . 0.0 111.341 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 2.5 tpp85 -87.13 -28.52 22.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.932 0.396 . . . . 0.0 110.683 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -76.6 -35.69 57.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.655 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.64 -48.16 51.8 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.554 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.765 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.42 -27.74 0.07 OUTLIER Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.657 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.837 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.2 mp -71.22 143.34 50.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -127.74 93.83 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.375 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.119 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 42' ' ' GLU . 4.2 tpp180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -44.76 125.32 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.793 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -95.4 126.28 40.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.467 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.844 HD23 ' N ' ' A' ' 26' ' ' SER . 3.3 tt -89.47 142.75 27.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.1 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.844 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.67 108.82 5.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.128 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.802 HG11 HG22 ' A' ' 97' ' ' VAL . 3.3 p -98.29 125.28 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.615 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.76 143.19 41.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.11 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.4 tpt180 -150.19 119.01 6.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.999 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -89.81 -44.07 10.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.459 . . . . 0.0 110.757 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER 179.92 -54.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.737 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.0 tttt -119.28 7.57 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.648 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 m80 -125.97 131.05 52.33 Favored 'General case' 0 N--CA 1.46 0.042 0 CA-C-O 120.959 0.409 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.748 HD11 HD13 ' A' ' 100' ' ' LEU . 2.9 tp -118.24 132.21 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.621 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CE1' HD11 ' A' ' 53' ' ' LEU . 29.9 m-85 -145.82 111.04 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -96.21 122.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 113.26 25.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.734 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.34 98.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -99.51 162.67 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.148 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 t0 -93.38 114.02 26.33 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -91.75 25.98 2.54 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.17 0.919 . . . . 0.0 112.189 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 35.2 tt0 -109.48 -48.13 3.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.79 118.18 17.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 174.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.8 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.31 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.0 t -138.85 112.56 7.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.81 122.57 23.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.483 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.6 mp -104.43 -64.2 1.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.49 144.4 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 111.96 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -150.2 125.16 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -131.05 160.91 33.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.749 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.72 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -146.27 126.42 13.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.286 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -57.82 -51.34 70.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.406 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.642 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -61.06 -10.22 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -84.96 -50.69 7.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 51' ' ' SER . 4.0 mp -52.6 -38.64 60.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 111.281 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.8 pttp 179.35 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.725 HD22 ' HB2' ' A' ' 60' ' ' ASN . 9.3 mt -47.79 140.48 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -132.11 -40.58 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.222 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.18 -47.94 0.63 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.864 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.725 ' HB2' HD22 ' A' ' 57' ' ' LEU . 9.9 m120 -51.5 177.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.322 . . . . 0.0 111.065 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.85 -68.23 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.385 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 p -93.17 27.93 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.457 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.09 -53.35 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.703 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 67' ' ' GLN . 48.4 t -94.06 -14.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.072 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -29.93 -44.11 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.66 -61.03 2.32 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.583 0.706 . . . . 0.0 109.368 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 1.5 mp0 -48.27 -25.88 1.74 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.154 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.072 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.86 -36.39 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.8 -28.23 65.41 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.796 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 11.7 ptt180 -70.04 -36.49 75.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.31 -37.77 68.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.751 ' CD2' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -67.1 -45.69 76.46 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.52 0.676 . . . . 0.0 109.436 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.99 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -72.35 -27.78 62.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.829 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 41.1 mt-10 -78.5 -29.67 46.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 15.4 mttt -72.79 -69.23 0.42 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.474 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.63 -43.42 12.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.316 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.747 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.1 mt -55.76 -39.74 71.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.84 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.84 -24.5 9.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.73 -29.38 18.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.53 15.8 8.59 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.635 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.586 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.99 106.98 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.616 0.722 . . . . 0.0 110.307 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -97.03 -48.32 5.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.427 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.376 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -117.0 163.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.317 0.579 . . . . 0.0 111.785 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.37 105.99 15.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.738 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.46 113.68 19.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.178 0.513 . . . . 0.0 111.602 -178.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.57 44.36 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.118 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 12.8 ptt-85 -40.71 -48.01 2.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.54 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.47 -114.08 2.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.64 -10.66 13.08 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.2 m-85 -57.25 132.63 53.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.02 154.88 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.105 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.528 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -45.21 108.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.04 0.448 . . . . 0.0 110.629 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -119.25 -125.69 0.28 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.394 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.61 -12.24 3.8 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.902 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mmt-85 -89.4 -68.97 0.74 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.926 0.363 . . . . 0.0 110.746 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.802 HG22 HG11 ' A' ' 27' ' ' VAL . 57.4 t -38.81 -28.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.658 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.121 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.01 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.83 -38.96 7.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.178 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -67.91 -46.67 70.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.162 0.506 . . . . 0.0 110.608 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -63.95 -33.22 75.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.081 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.806 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.47 -45.61 75.44 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.547 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.32 -56.8 8.8 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.99 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -34.39 77.16 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 113.507 -1.346 . . . . 0.0 111.543 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.867 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -90.09 -26.45 20.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 0.0 110.809 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.806 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.4 pt-20 -78.07 -32.1 50.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -75.37 -45.43 18.89 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.747 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.54 -32.43 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 119.935 -1.126 . . . . 0.0 114.87 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.867 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.33 146.17 49.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.26 93.19 3.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.484 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.982 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' C ' HD23 ' A' ' 23' ' ' LEU . 10.9 tpp180 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -101.95 131.62 48.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.332 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 37.0 ttp85 -100.43 123.76 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.86 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.46 144.67 25.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.428 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.846 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -148.71 108.04 3.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.094 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 7.2 p -92.99 115.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.385 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 139.26 31.59 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.929 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' NH2' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -140.02 118.17 11.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.93 -155.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -71.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -120.12 35.39 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.39 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -115.33 132.9 56.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.18 0.515 . . . . 0.0 112.305 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -121.2 111.6 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.666 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 38.4 m-85 -146.42 154.07 41.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.412 0.625 . . . . 0.0 112.675 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -135.21 129.82 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.946 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.97 115.0 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.114 0.483 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -99.72 94.07 3.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.316 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -94.43 164.62 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.659 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.2 t0 -96.75 115.27 27.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 7.9 t0 -90.89 23.72 3.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.346 1.028 . . . . 0.0 112.319 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -108.09 -47.37 3.57 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mptp? -135.4 118.16 16.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.12 90.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.343 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.4 t -140.69 112.29 4.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.7 119.82 17.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -99.97 -63.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -118.08 148.68 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 112.153 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -150.11 129.98 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.72 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.95 162.48 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 112.147 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.451 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.31 134.83 17.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.436 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -65.76 -53.0 46.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.573 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.4 tm? -53.89 -33.05 55.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.238 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.5 -48.6 8.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.425 0.631 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 51' ' ' SER . 0.1 OUTLIER -52.73 -36.87 58.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.614 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tttm 179.6 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -45.02 140.77 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.666 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 -39.7 1.61 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.022 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.55 76.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.779 ' HB2' HD21 ' A' ' 57' ' ' LEU . 4.1 m-80 -174.52 -173.14 0.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -142.88 -67.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 95' ' ' GLY . 33.0 p -93.19 25.03 3.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.289 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.96 -59.14 2.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 0.0 110.81 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 57' ' ' LEU . 57.4 t -94.15 -15.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.695 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.012 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.58 -38.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 111.932 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.36 -59.59 2.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.0 mt-30 -49.46 -22.74 1.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.374 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.012 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -82.69 -32.79 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -77.23 -28.37 58.25 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.216 -0.992 . . . . 0.0 111.005 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 3.5 ppt_? -76.74 -38.75 53.65 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.42 -34.38 74.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 38' ' ' ILE . 1.1 tm? -69.45 -56.26 7.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.593 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.007 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.37 -24.77 63.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.989 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 51.6 mt-10 -79.14 -30.95 43.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.6 mttt -70.27 -68.91 0.39 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.271 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.38 -44.04 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.2 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -55.4 -40.11 71.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.975 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.68 -24.93 9.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.032 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.72 -28.73 19.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.0 18.02 8.56 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.575 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.28 105.68 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 110.52 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 110' ' ' GLU . 28.7 tttp -90.32 -59.39 2.2 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.204 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -109.02 140.82 42.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.24 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.79 162.52 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 111.949 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.84 103.42 13.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.841 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.86 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.45 111.38 17.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.21 0.529 . . . . 0.0 111.666 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.48 44.45 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.111 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 ptt-85 -42.09 -46.14 4.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.489 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.38 -131.92 7.58 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.184 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.46 48.97 2.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.595 2.197 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.4 m-30 -100.49 155.75 17.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.91 154.76 48.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.279 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.6 109.67 0.27 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.979 0.418 . . . . 0.0 110.55 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -115.99 -124.29 0.29 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.409 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.808 ' O ' HG22 ' A' ' 62' ' ' THR . . . -125.13 -27.46 1.22 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.866 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 34' ' ' ILE . 8.5 mtt-85 -78.07 -67.24 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.606 0.241 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.9 t -37.74 -29.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.019 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.46 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -49.39 -41.11 38.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -64.94 -46.15 82.78 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.198 0.523 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.66 -35.25 79.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.603 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.826 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.34 -46.86 59.52 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -46.9 -54.69 9.05 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -65.59 -33.91 77.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.238 -1.481 . . . . 0.0 111.382 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -90.09 -22.47 21.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.573 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -84.34 -32.34 24.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.85 -45.79 25.96 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.91 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.813 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.77 -30.69 0.08 OUTLIER Glycine 0 C--N 1.342 0.875 0 C-N-CA 120.012 -1.089 . . . . 0.0 114.833 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 76' ' ' ALA . 7.7 mp -71.11 142.87 50.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.75 93.76 3.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.533 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.657 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.999 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 23' ' ' LEU . 21.7 ttp-105 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp -119.76 138.02 53.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.651 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp180 -104.37 126.41 51.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.78 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.853 HD23 ' N ' ' A' ' 26' ' ' SER . 3.6 tt -89.7 143.69 26.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.976 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.853 ' N ' HD23 ' A' ' 25' ' ' LEU . 16.0 m -144.79 108.31 4.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.728 0.299 . . . . 0.0 110.675 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 100' ' ' LEU . 5.8 p -97.07 120.7 46.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.193 0.52 . . . . 0.0 111.802 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -100.75 148.9 24.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.781 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' NH1' ' A' ' 29' ' ' ARG . 15.1 mtm105 -150.4 120.68 7.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -89.71 -84.64 0.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.671 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -61.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.13 21.62 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.8 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 1.7 m-70 -116.95 156.71 26.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.194 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 100' ' ' LEU . 4.3 tp -141.75 130.98 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.757 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.816 ' OH ' HD11 ' A' ' 53' ' ' LEU . 38.4 m-85 -148.95 150.33 32.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 0.0 111.845 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.937 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -133.27 121.41 22.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.414 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.76 113.34 25.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.487 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.063 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.12 105.14 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.369 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -102.44 158.73 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' N ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -89.61 119.55 30.13 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.877 178.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -93.19 23.56 4.31 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.432 1.082 . . . . 0.0 112.294 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -106.86 -47.64 3.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.258 -2.126 . . . . 0.0 105.258 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mttt -137.95 118.1 13.53 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.5 90.46 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.489 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' LYS . 87.3 t -138.59 112.5 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -69.93 113.12 6.85 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -90.56 -57.5 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 75' ' ' LYS . 1.8 t -127.56 148.96 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.299 0.571 . . . . 0.0 112.123 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 58.5 p -150.21 114.9 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.786 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.86 ' HB2' ' CE ' ' A' ' 75' ' ' LYS . . . -129.62 150.93 50.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 112.028 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.509 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.4 t -150.42 149.97 30.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.606 ' N ' HG21 ' A' ' 68' ' ' VAL . 37.2 m -60.66 -53.69 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD11 ' OH ' ' A' ' 35' ' ' TYR . 3.1 pp -68.01 -9.49 46.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.557 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -75.81 -64.75 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mp -53.67 -52.16 60.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.592 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 177.35 -41.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 HG11 ' A' ' 64' ' ' VAL . 54.2 mt -54.41 115.46 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.05 10.23 4.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.159 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.52 -83.55 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -68.17 175.33 3.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -130.71 -54.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.849 HG22 ' O ' ' A' ' 95' ' ' GLY . 3.3 p -89.98 -24.8 21.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -66.51 -40.58 89.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.139 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG11 HD13 ' A' ' 57' ' ' LEU . 78.8 t -92.22 -25.73 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.59 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.04 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.66 -40.69 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.999 0.428 . . . . 0.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.03 -59.56 3.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.484 0.659 . . . . 0.0 109.278 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 12.9 mt-30 -49.41 -26.15 3.05 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.225 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.04 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -76.8 -32.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.425 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.9 -26.33 60.6 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.838 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 10.3 ptt180 -72.22 -39.21 68.7 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.47 -38.93 77.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.063 HD21 HD11 ' A' ' 38' ' ' ILE . 1.5 tp -66.14 -52.34 49.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.171 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.37 -27.17 68.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.57 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 29.6 mt-10 -77.13 -32.48 56.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.86 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 11.8 mtmm -71.48 -68.69 0.43 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.726 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.01 -43.12 6.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.19 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.11 -38.28 70.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.027 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.78 -23.11 16.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.899 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.561 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.43 -26.5 20.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.33 17.35 10.08 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.138 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.715 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.25 102.91 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.686 0.755 . . . . 0.0 110.271 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -97.02 -46.78 6.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.954 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.03 134.86 54.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -126.22 165.85 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.965 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.47 106.12 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.63 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.756 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.4 120.45 24.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.267 0.556 . . . . 0.0 111.73 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.05 51.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.067 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.2 -31.33 0.37 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.523 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.17 -119.06 5.59 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.99 20.63 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.734 2.29 . . . . 0.0 112.426 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.597 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.6 m-30 -80.81 159.45 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 154.81 48.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.369 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.468 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -43.77 109.35 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.571 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.497 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.2 t-80 -124.67 157.96 34.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.477 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.849 ' O ' HG22 ' A' ' 62' ' ' THR . . . -41.13 -26.7 0.18 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.689 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -82.09 -67.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.689 0.244 . . . . 0.0 111.182 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 90.0 t -29.83 -50.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -57.72 -75.37 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.801 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.75 -38.15 66.81 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.228 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.51 -47.26 70.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.447 0.641 . . . . 0.0 110.428 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.1 -32.13 72.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.384 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.785 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -68.12 -44.65 75.66 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.369 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.67 -58.41 8.38 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.942 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.75 -35.35 74.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.621 -1.289 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.866 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.99 -30.65 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.861 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.785 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -72.2 -34.91 68.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.627 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -70.52 -46.91 45.18 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.797 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.26 -29.07 0.07 OUTLIER Glycine 0 C--N 1.341 0.831 0 C-N-CA 120.052 -1.07 . . . . 0.0 114.752 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.866 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.45 145.52 49.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -128.12 92.58 3.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.296 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.997 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.756 0.312 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.806 HD22 HG13 ' A' ' 81' ' ' ILE . 3.7 mp -42.67 130.6 4.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.305 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 4.7 ttp180 -98.83 124.87 44.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.289 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.33 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.359 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.814 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.76 108.73 4.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.153 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.553 HG21 HD13 ' A' ' 100' ' ' LEU . 9.2 p -99.19 115.48 39.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -93.02 152.06 19.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 55.6 mtm-85 -149.15 118.91 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.916 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -46.4 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.994 0.426 . . . . 0.0 111.066 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.34 -59.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -116.73 12.68 14.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.323 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.646 ' NE2' HD23 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -116.3 174.36 6.1 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.779 HD11 HD13 ' A' ' 100' ' ' LEU . 6.9 tp -159.99 115.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 5.3 m-85 -129.68 111.21 12.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.996 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.79 123.32 37.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.59 117.02 29.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.448 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -98.87 101.77 12.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.2 mp -101.52 161.61 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.966 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.42 117.27 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.715 177.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 5.6 t0 -93.3 27.45 2.54 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.278 0.986 . . . . 0.0 112.282 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HG2' ' HD3' ' A' ' 43' ' ' LYS . 2.6 tt0 -108.8 -46.48 3.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -137.94 118.14 13.58 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.32 89.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.503 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.5 t -137.89 112.53 9.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -75.65 124.54 27.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 23' ' ' LEU . 1.2 mp -107.35 -58.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.724 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.1 t -120.06 141.71 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 112.076 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.23 114.79 5.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.5 151.89 48.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.02 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.0 p -150.58 142.74 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.602 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -54.0 -24.87 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.93 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.646 HD23 ' NE2' ' A' ' 33' ' ' HIS . 2.6 tm? -49.72 -65.72 0.52 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.31 -24.4 54.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.385 0.612 . . . . 0.0 109.83 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.2 mp -89.62 11.83 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.825 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 55' ' ' LEU . 19.7 mtpp 2.58 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.85 0.86 . . . . 0.0 113.025 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD13 ' HB ' ' A' ' 64' ' ' VAL . 2.1 pt? -58.05 176.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.936 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -80.48 114.53 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.37 106.91 0.18 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -69.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.784 0.326 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.81 -150.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.727 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.431 HG21 ' CA ' ' A' ' 95' ' ' GLY . 15.3 p -69.7 61.34 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.895 0.379 . . . . 0.0 110.8 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.43 -52.5 4.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.633 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' A' ' 57' ' ' LEU . 94.3 t -94.05 -21.73 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.081 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -36.92 -38.21 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 0.0 110.855 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.5 -58.96 3.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 12.7 mt-30 -49.81 -23.02 1.64 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.667 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.081 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -78.29 -37.01 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -75.63 -36.21 43.94 Favored Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -66.43 -36.55 83.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -62.75 -53.87 47.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.776 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.66 -46.04 87.43 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.906 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.46 -27.15 46.39 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.689 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.4 tt0 -73.61 -35.34 65.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.724 ' HB2' HG21 ' A' ' 48' ' ' VAL . 7.5 mttt -74.79 -63.7 1.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.907 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.89 -42.55 5.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.2 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -58.54 -40.68 83.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.4 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.01 -24.81 7.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.491 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.28 -27.13 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.32 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.57 11.57 19.11 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.15 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.806 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -64.02 103.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.616 0.722 . . . . 0.0 110.142 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -91.7 -57.47 2.74 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.345 -178.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -109.52 143.19 39.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.387 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.668 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -130.49 162.91 37.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.636 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.38 103.6 13.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.808 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.48 112.48 18.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -142.65 51.44 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.668 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -41.21 -38.37 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.651 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.09 -124.93 6.25 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.34 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -90.05 42.87 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.873 2.382 . . . . 0.0 112.066 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.668 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.7 m-30 -99.56 163.6 12.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.229 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 154.64 49.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -46.88 112.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.593 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.3 t60 -133.43 154.04 51.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.301 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -33.47 -37.04 0.06 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.851 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.736 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.0 mmt85 -70.74 -70.86 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.586 0.193 . . . . 0.0 111.407 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 98.5 t -29.91 -51.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.551 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -56.75 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 110.292 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.92 -43.0 49.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.14 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -66.66 -49.09 67.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.458 0.646 . . . . 0.0 110.649 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.559 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.08 -34.82 68.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.081 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.761 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.32 -43.3 81.95 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.06 -61.5 5.72 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.906 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.12 -41.83 68.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.932 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -79.21 -55.68 4.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.761 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.6 pt-20 -46.58 -43.33 17.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.689 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.84 -50.01 72.3 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.994 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.16 -25.48 0.07 OUTLIER Glycine 0 C--N 1.341 0.859 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.667 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.84 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.48 146.41 48.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.18 93.08 3.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.215 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.018 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.81 0.338 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 81' ' ' ILE . 3.7 mp -32.07 132.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.555 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 7.0 ptt180 -96.18 126.86 41.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.0 tt -89.43 140.79 29.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.554 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.829 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.0 t -142.3 114.07 8.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 110.996 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 100' ' ' LEU . 4.0 p -101.53 120.35 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.215 0.531 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.466 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -99.14 148.97 23.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.964 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HD2' ' CG ' ' A' ' 96' ' ' ARG . 15.8 mtm-85 -146.72 119.76 8.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.584 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.79 -50.64 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tt -179.24 -54.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.362 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 10.12 12.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.885 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -119.55 148.15 43.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 100' ' ' LEU . 4.1 tp -131.18 131.61 63.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.704 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 29.6 m-85 -146.95 149.93 34.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.832 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.933 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.18 120.93 19.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.221 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.816 ' HG3' HD11 ' A' ' 39' ' ' ILE . 4.8 pt20 -113.63 113.06 24.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.316 0.579 . . . . 0.0 109.921 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.081 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -90.92 97.15 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.85 164.26 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.283 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -99.53 103.16 14.88 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.485 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -86.65 27.16 1.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.172 0.92 . . . . 0.0 112.328 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -113.09 -47.9 3.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -129.33 118.5 22.35 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 174.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.63 86.29 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.725 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 43' ' ' LYS . 47.3 t -137.51 112.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.421 ' HA ' HG23 ' A' ' 39' ' ' ILE . 22.5 m -77.11 122.66 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.626 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.4 mp -103.19 -64.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -123.12 147.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 111.876 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 21.8 p -150.6 117.36 5.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.729 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.12 151.23 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.237 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.8 t -150.3 147.24 27.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.751 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' HG21 ' A' ' 68' ' ' VAL . 5.9 m -62.48 -68.41 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.811 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.6 tm? -60.29 -16.49 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.623 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 51' ' ' SER . . . -77.05 -64.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mp -54.05 -52.3 61.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.06 0.457 . . . . 0.0 111.492 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 177.21 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.445 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' CD1' ' CG1' ' A' ' 64' ' ' VAL . 16.4 mt -51.14 121.06 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.736 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 58.68 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.727 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.19 133.65 33.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.601 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.01 -51.05 5.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 110.794 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -153.61 -96.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.671 HG22 ' C ' ' A' ' 95' ' ' GLY . 34.6 p -93.61 30.96 1.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.668 0.271 . . . . 0.0 111.182 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -94.05 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.206 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 67' ' ' GLN . 72.8 t -91.93 -19.0 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.683 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.74 -43.75 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -64.74 -61.34 2.25 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.499 0.666 . . . . 0.0 109.365 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 23.5 mt-30 -48.47 -24.56 1.32 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.4 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.32 -33.41 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.653 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.89 -27.43 58.54 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.167 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -75.01 -39.53 61.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.05 -34.39 71.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -68.91 -54.44 15.49 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.845 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.016 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.04 -26.11 68.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.974 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 48.3 mt-10 -77.49 -31.18 53.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 21.0 mttt -72.51 -68.74 0.45 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.523 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.25 -43.21 7.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.828 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.04 -39.86 72.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.942 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.9 -23.81 14.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.43 -27.89 20.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.82 15.51 13.07 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.252 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -72.98 102.98 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 110.202 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -91.24 -57.3 2.83 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.423 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.11 137.97 46.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.84 166.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.368 0.604 . . . . 0.0 111.666 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -115.33 109.41 17.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.834 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -80.53 106.36 12.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.299 0.571 . . . . 0.0 111.919 -177.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.6 46.09 2.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.277 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.29 -45.49 5.91 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.26 -112.83 3.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.54 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.95 25.08 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.772 2.315 . . . . 0.0 112.863 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -93.97 157.13 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 111.056 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 151.53 49.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.675 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.21 94.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.416 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -114.21 170.93 7.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.384 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.671 ' C ' HG22 ' A' ' 62' ' ' THR . . . -41.94 -47.94 5.21 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.203 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.3 mtt85 -57.01 -68.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.64 0.257 . . . . 0.0 110.506 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.6 t -38.32 -39.96 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.567 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.33 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -56.8 -34.31 67.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.858 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.875 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -70.11 -48.37 57.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.213 0.53 . . . . 0.0 110.959 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.02 -28.7 69.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -71.5 -46.44 59.72 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.178 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.53 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.67 -56.17 8.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.016 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.24 -34.6 78.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.41 -1.395 . . . . 0.0 111.111 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.3 mmm180 -87.14 -24.42 24.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.2 pt-20 -84.45 -33.36 23.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.8 -46.47 45.69 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.074 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.828 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.94 -28.64 0.07 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 120.031 -1.08 . . . . 0.0 114.597 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.816 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.21 146.61 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -127.73 94.39 3.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.374 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.638 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' NE ' ' HB2' ' A' ' 85' ' ' ALA . 26.4 ptt180 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.838 0.351 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.768 HD22 HG13 ' A' ' 81' ' ' ILE . 4.9 mp -102.84 134.8 45.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 25.4 ttp85 -103.0 123.31 46.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.225 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.17 143.79 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.602 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.812 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -146.72 108.8 4.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.454 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.7 p -102.48 116.71 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.91 136.25 35.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.445 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.598 ' HD3' HG23 ' A' ' 97' ' ' VAL . 22.9 mtm105 -132.81 118.71 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.978 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.58 -70.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -148.86 -62.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.773 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -119.13 20.19 12.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.197 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.42 175.62 5.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.166 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.899 HD11 HD13 ' A' ' 100' ' ' LEU . 6.6 tp -160.03 122.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.93 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -137.79 111.56 8.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -97.09 125.57 41.66 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 113.27 21.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.169 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.657 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.76 100.95 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.512 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -102.61 160.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.805 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -92.15 116.96 29.4 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.856 178.09 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 1.7 t70 -93.38 28.11 2.35 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 124.281 0.988 . . . . 0.0 112.185 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -109.76 -47.42 3.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.2 mttp -136.49 118.14 14.96 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.11 90.58 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.532 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 80.6 t -139.62 112.47 5.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.402 HG23 HG13 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -77.75 121.09 23.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.477 HD21 ' OD1' ' A' ' 40' ' ' ASP . 1.1 mp -103.59 -59.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' CG1' HD23 ' A' ' 72' ' ' LEU . 2.1 t -115.81 140.36 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.175 0.512 . . . . 0.0 111.971 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -150.27 114.93 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.266 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -133.51 151.4 51.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.245 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 43.6 p -150.54 139.6 21.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 34' ' ' ILE . 68.2 m -47.2 -29.11 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.0 tm? -61.22 -50.84 71.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.659 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 -25.73 65.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.118 0.485 . . . . 0.0 110.401 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.9 mp -88.46 11.26 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.383 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mtmp? 1.73 63.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.468 0.707 . . . . 0.0 112.807 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 55' ' ' LEU . 11.6 mt -61.43 176.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.118 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.19 -29.59 57.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.02 67.98 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.384 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.585 ' HB3' HG23 ' A' ' 64' ' ' VAL . 36.5 m-20 -149.04 106.36 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -84.77 -70.27 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -85.92 -24.19 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.53 -45.57 81.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB3' ' A' ' 60' ' ' ASN . 95.5 t -94.14 -20.01 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.761 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.051 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.48 -38.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 3.7 ttm180 -67.59 -59.13 3.6 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -50.89 -24.31 3.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.533 178.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.54 -33.23 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.36 -32.37 43.09 Favored Glycine 0 C--O 1.218 -0.854 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.71 -36.79 83.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.779 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -45.59 78.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.409 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.864 HD23 ' CG1' ' A' ' 48' ' ' VAL . 1.1 mt -62.58 -50.04 72.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.56 -26.1 65.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 12.4 tt0 -72.04 -34.66 68.95 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.1 mttp -77.08 -64.12 1.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.862 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.96 -42.6 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.639 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -58.76 -40.51 84.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.373 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.55 -25.18 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.227 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.47 -26.51 20.91 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.2 13.81 14.62 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.198 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.768 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.43 102.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.016 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -103.87 -27.89 11.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.853 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -126.11 140.51 52.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.035 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -135.27 164.49 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.507 0.67 . . . . 0.0 112.345 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.43 103.82 13.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.835 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.72 106.35 13.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 111.509 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.09 43.69 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.231 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 21.0 ptt-85 -43.48 -48.76 7.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.502 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.59 -126.37 5.5 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -89.9 48.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.859 2.373 . . . . 0.0 112.125 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.1 m-30 -99.99 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.436 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 154.75 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.608 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.69 106.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.019 0.438 . . . . 0.0 110.681 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -110.63 -125.08 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.56 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 62' ' ' THR . . . -125.14 -26.83 1.29 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.276 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.848 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.2 mmt85 -79.77 -69.65 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.937 0.369 . . . . 0.0 110.941 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 ' HD3' ' A' ' 29' ' ' ARG . 47.4 t -35.03 -31.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.79 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.868 0.366 . . . . 0.0 110.992 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.85 -43.23 63.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.192 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -60.53 -40.94 93.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.235 0.541 . . . . 0.0 110.639 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.96 -35.73 78.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.267 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 106' ' ' GLU . 1.3 mt-10 -69.55 -46.59 66.07 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.554 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.42 -58.27 5.31 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.932 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.56 -46.47 88.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.242 -1.479 . . . . 0.0 111.14 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 mtm180 -74.92 -55.48 5.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.175 0.512 . . . . 0.0 109.663 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.797 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -47.81 -44.43 28.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.664 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -61.16 -47.59 90.24 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.352 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.72 -25.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.623 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.828 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.2 mp -71.46 150.17 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -128.38 91.49 3.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.583 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 6.0 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.959 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.663 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.4 tpt180 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.907 0.384 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -108.65 133.89 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.208 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -102.52 126.27 49.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 26' ' ' SER . 2.0 tt -89.56 143.49 26.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.217 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.799 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -143.27 111.97 6.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 88' ' ' ARG . 1.4 p -98.22 153.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.381 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.17 114.81 5.25 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -129.24 118.92 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -33.03 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.232 0.539 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.65 -61.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.471 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 9.64 11.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.595 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.0 m-70 -121.99 100.05 6.77 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.823 HD11 HD13 ' A' ' 100' ' ' LEU . 4.5 tp -99.19 117.94 45.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 12.5 m-85 -131.54 112.8 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -102.84 122.55 44.76 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.53 113.07 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.915 HD11 HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.93 99.34 9.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.337 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.9 mp -102.45 163.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.601 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' CG ' HD22 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -94.59 111.59 23.35 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.4 p30 -88.06 24.5 1.81 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.282 0.989 . . . . 0.0 112.524 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 15.7 pt-20 -111.13 -45.24 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 45' ' ' VAL . 25.9 mmtm -132.8 118.38 18.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.95 86.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.672 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 43' ' ' LYS . 46.1 t -135.08 112.39 14.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 120.86 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.5 mp -101.86 -62.45 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -122.09 143.74 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.344 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 p -150.24 114.98 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -126.47 145.43 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 55.7 p -150.22 134.96 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.791 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.631 ' H ' HG23 ' A' ' 34' ' ' ILE . 8.4 t -52.62 -38.5 60.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.511 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.0 tm? -62.05 -52.35 64.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.107 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.02 -30.37 67.96 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.366 0.603 . . . . 0.0 109.768 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.0 mp -87.06 12.12 12.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.933 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER 3.03 63.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.528 0.68 . . . . 0.0 112.534 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.742 HD13 HG11 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -80.8 176.21 10.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.723 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -99.34 43.15 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.64 -143.08 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.695 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -126.28 -70.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.652 0.263 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -160.92 -83.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 32.2 p -88.55 -4.32 58.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -44.9 95.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.92 0.39 . . . . 0.0 110.251 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.742 HG11 HD13 ' A' ' 57' ' ' LEU . 59.7 t -92.33 -16.11 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.99 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.03 -41.55 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.01 0.434 . . . . 0.0 111.689 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.79 -61.03 2.3 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.433 0.635 . . . . 0.0 109.346 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.5 mt-30 -50.22 -24.86 3.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.514 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.99 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -78.73 -32.31 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.65 -25.16 65.76 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.214 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -78.73 -37.48 41.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -68.35 -38.9 81.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.953 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.0 tt -72.88 -46.53 52.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.64 -25.02 67.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -79.71 -30.08 40.86 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 21.6 mttt -69.47 -69.09 0.36 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.173 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.6 -44.92 9.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.785 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.4 mt -54.53 -39.08 67.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.152 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.24 -24.45 18.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.865 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.61 -26.1 20.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.51 13.47 16.79 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.076 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.508 HG12 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -75.1 102.62 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -104.43 -24.76 13.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.77 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -127.47 136.42 51.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.125 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -136.67 163.74 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.374 0.607 . . . . 0.0 112.191 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -101.52 98.5 8.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.774 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -80.92 111.73 17.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.599 . . . . 0.0 111.776 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.1 61.18 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.938 ' HG2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -48.9 -28.42 3.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.644 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.41 -117.81 3.33 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.73 38.0 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.758 2.305 . . . . 0.0 111.663 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.483 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 3.5 m-30 -98.61 144.9 27.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.28 155.01 49.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.4 t80 -39.83 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.168 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 2.0 t-160 -115.44 -109.87 0.36 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.151 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.523 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -131.25 -17.16 1.46 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.714 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.601 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -95.38 -71.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG22 HG11 ' A' ' 27' ' ' VAL . 48.3 t -32.94 -37.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.523 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -64.65 -78.85 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.301 0.572 . . . . 0.0 110.429 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -46.26 -42.88 15.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.314 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 34' ' ' ILE . 1.1 tt -67.51 -45.72 74.99 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.05 -35.76 79.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.362 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.705 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -63.45 -49.9 71.85 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.05 -56.21 6.08 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -56.43 -46.93 80.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 112.792 -1.704 . . . . 0.0 111.816 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.6 mmm-85 -78.84 -47.29 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.139 0.495 . . . . 0.0 109.976 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.705 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -53.4 -35.4 60.33 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -74.24 -49.19 12.81 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.499 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.785 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.33 -24.04 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 C-N-CA 119.737 -1.22 . . . . 0.0 115.405 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 38' ' ' ILE . 6.9 mp -71.17 146.2 49.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.204 1.002 . . . . 0.0 113.598 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.37 97.16 4.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.208 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.609 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.867 0.365 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.741 HD13 HG13 ' A' ' 81' ' ' ILE . 2.8 mp -113.09 134.22 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.79 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.4 ttt180 -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.334 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.831 HD23 ' N ' ' A' ' 26' ' ' SER . 2.9 tt -89.58 142.19 27.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.831 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.1 m -144.94 108.59 4.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 100' ' ' LEU . 8.8 p -94.2 117.73 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 111.749 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -99.26 146.95 25.67 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NH1' ' CG2' ' A' ' 97' ' ' VAL . 22.9 mtm-85 -150.14 122.34 8.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.996 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.9 p -89.66 -72.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.411 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 -58.26 0.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.566 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.23 2.56 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -101.82 155.57 18.05 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.177 0.513 . . . . 0.0 111.427 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.888 HD11 HD13 ' A' ' 100' ' ' LEU . 5.5 tp -142.63 119.74 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.573 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 14.1 m-85 -137.05 112.86 9.54 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.74 121.05 34.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.61 113.32 26.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.693 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.1 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.78 99.52 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.261 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -98.7 163.09 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.008 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -93.29 115.32 27.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.608 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.3 t0 -90.64 22.8 3.33 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.428 1.08 . . . . 0.0 112.354 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -110.15 -46.38 3.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.6 mmmt -134.02 118.28 17.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.99 87.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.778 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.4 t -137.53 112.32 9.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -71.57 117.68 13.43 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.3 mp -95.34 -63.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -121.11 147.75 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.794 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.4 p -150.17 114.83 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.063 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.38 158.29 33.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.707 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 79.5 p -150.18 143.02 24.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.973 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.654 ' N ' HG21 ' A' ' 68' ' ' VAL . 11.8 p -55.46 -44.92 76.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.104 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.18 -7.74 25.99 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -75.39 -59.75 2.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.0 110.948 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.78 -42.51 65.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.911 -178.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 64' ' ' VAL . 1.4 mt -46.99 171.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -131.56 -42.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.55 78.39 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.428 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -122.86 -175.4 3.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -166.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.418 HG21 ' C ' ' A' ' 95' ' ' GLY . 21.5 p -70.99 60.82 0.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.4 -57.68 2.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.692 ' HB ' HD12 ' A' ' 57' ' ' LEU . 58.2 t -94.13 -16.49 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.066 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.65 -41.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.882 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.83 -59.21 3.73 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.702 0.763 . . . . 0.0 109.035 178.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.599 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.1 mt-30 -49.78 -23.27 1.75 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.442 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.066 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.29 -33.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.91 -28.91 59.88 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.4 ppt_? -76.67 -37.24 56.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.08 73.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.1 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.63 -54.51 13.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.704 178.127 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.001 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.8 -25.68 65.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.8 mt-10 -78.18 -31.01 49.35 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 23.2 mttt -71.67 -69.14 0.4 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.497 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.68 -43.48 8.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.126 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.801 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -56.11 -39.67 72.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.041 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.5 -23.78 11.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.559 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.59 -27.7 20.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.7 8.08 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.071 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.21 105.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.536 0.684 . . . . 0.0 110.478 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 110' ' ' GLU . 8.1 ttmt -92.44 -59.49 2.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.8 138.63 44.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.6 164.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 111.901 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.93 103.26 12.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.795 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.44 116.49 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 111.616 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -145.54 47.59 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 6.9 ptt-85 -37.64 -37.58 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.762 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.27 -112.58 3.61 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.631 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -88.72 23.56 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.83 2.353 . . . . 0.0 112.767 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.533 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.8 m-30 -93.26 131.84 38.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.31 148.4 25.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.474 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -46.69 109.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.524 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -126.54 165.99 18.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.418 ' C ' HG21 ' A' ' 62' ' ' THR . . . -45.28 -40.41 7.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.79 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.802 ' HD2' HD13 ' A' ' 34' ' ' ILE . 15.0 mmt-85 -57.36 -70.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.572 0.225 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 37.2 t -38.39 -37.8 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.35 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.72 -76.71 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.029 0.442 . . . . 0.0 110.965 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.31 -36.4 68.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.732 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -68.96 -49.1 60.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.216 0.531 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -60.9 -32.1 71.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.42 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -68.54 -46.23 70.08 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.523 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.61 -57.15 8.69 Favored Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.001 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.03 -33.21 73.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.512 -1.344 . . . . 0.0 111.327 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.6 tpp85 -90.08 -25.06 20.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.1 pt-20 -81.02 -33.17 33.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -72.38 -46.78 31.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.858 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.801 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.73 -29.7 0.08 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.036 -1.078 . . . . 0.0 114.76 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.806 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.33 142.77 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.81 94.88 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.469 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.687 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.964 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.679 HD13 HG13 ' A' ' 81' ' ' ILE . 3.0 mp -43.42 128.21 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.258 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.69 126.33 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.38 -178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 4.1 tt -89.29 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.693 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.06 108.82 4.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 111.318 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.812 HG12 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -97.02 126.97 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.46 145.72 37.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 13.5 mtm105 -150.12 120.67 7.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.749 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 m -89.59 -81.04 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.684 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -139.86 -56.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.717 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -119.12 18.73 13.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.212 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.54 167.67 11.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.162 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 100' ' ' LEU . 3.3 tp -153.3 130.96 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.551 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.529 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 32.9 m-85 -150.01 152.18 34.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.243 0.544 . . . . 0.0 112.171 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -136.83 120.96 17.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.692 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.76 113.22 25.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.019 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.72 98.84 8.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.4 mp -98.8 160.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.165 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -93.1 115.63 28.27 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.603 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -90.75 26.16 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.297 0.998 . . . . 0.0 112.403 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.46 -47.97 3.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.39 118.04 14.97 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.96 90.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.448 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 43' ' ' LYS . 93.9 t -137.68 112.57 9.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 m -73.92 119.72 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.635 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.6 mp -98.87 -58.28 1.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.0 t -124.36 147.3 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 112.239 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 82.5 p -150.28 115.02 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.946 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.26 150.77 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.919 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 3.1 t -150.46 141.94 23.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.512 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.491 ' H ' HG23 ' A' ' 34' ' ' ILE . 32.1 m -57.72 -40.76 80.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 54' ' ' ALA . 1.3 pp -64.26 -46.48 83.54 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.882 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.659 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -56.66 -30.8 63.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.516 0.674 . . . . 0.0 109.487 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -92.34 13.11 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.64 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 55' ' ' LEU . 2.6 mtpt 3.67 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.782 0.801 . . . . 0.0 112.366 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.942 HD13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -64.56 176.1 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.505 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -118.71 46.84 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.05 2.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -170.67 1.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -92.6 -48.31 6.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -93.13 -25.91 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.87 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -57.63 -42.04 82.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.159 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.942 HG11 HD13 ' A' ' 57' ' ' LEU . 75.6 t -94.05 -17.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.693 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.036 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.89 -39.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.991 0.425 . . . . 0.0 111.414 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.73 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.29 -59.28 3.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.56 ' HB2' HG13 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -50.98 -22.95 2.55 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.408 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.036 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.53 -31.76 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.253 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.73 -30.86 51.53 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.26 -38.46 68.85 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.57 -39.39 88.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.019 HD21 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -65.54 -54.98 20.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.985 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.57 -24.99 35.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.99 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -73.18 -35.59 66.42 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.3 mttt -71.58 -67.4 0.53 Allowed 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.921 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.93 -41.28 5.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.623 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.753 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.67 -40.23 82.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.226 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.44 -23.89 6.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.075 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.33 -27.82 20.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.66 18.04 9.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.136 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.679 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.73 106.87 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.505 0.669 . . . . 0.0 110.338 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 18.9 ttmt -91.1 -58.14 2.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.393 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -111.86 147.58 35.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.463 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -134.33 161.15 41.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.319 0.58 . . . . 0.0 111.775 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -96.41 103.64 15.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.254 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.676 ' CE2' ' CZ ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -81.17 106.34 13.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.255 0.55 . . . . 0.0 112.071 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.76 72.16 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.983 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.812 ' NH1' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -52.19 -42.9 63.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.27 -117.35 3.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -90.35 35.95 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.746 2.298 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.3 m-30 -100.65 162.59 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 111.469 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.33 148.93 50.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.013 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -46.7 103.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.736 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -122.3 165.22 16.58 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.88 -42.46 11.4 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.983 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.453 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 55.4 mmt-85 -55.76 -71.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.704 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 t -38.92 -43.57 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.635 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.2 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.023 0.439 . . . . 0.0 111.133 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -59.24 -40.0 84.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 34' ' ' ILE . 1.5 tt -65.04 -47.29 77.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.351 0.596 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.26 -38.09 85.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -66.75 -39.71 88.01 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -52.49 -59.35 9.19 Favored Glycine 0 CA--C 1.501 -0.789 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.985 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.04 -28.81 69.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.831 -1.185 . . . . 0.0 110.559 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.7 mmm-85 -89.11 -30.48 18.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 110.917 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.795 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.9 pt-20 -78.84 -36.9 41.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.672 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -66.67 -46.38 76.36 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.773 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.753 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.42 -31.33 0.07 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.032 -1.08 . . . . 0.0 114.754 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.7 mp -71.28 147.05 48.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -128.23 91.68 3.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.348 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.727 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.7 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.063 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 2.9 mp -113.5 133.83 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -101.18 126.96 47.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.078 -178.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.1 tt -93.39 145.1 24.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.939 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.764 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.03 108.43 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.415 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.851 HG11 HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -96.18 129.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.023 0.44 . . . . 0.0 111.313 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -114.78 125.92 54.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -129.52 118.6 22.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.57 178.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.2 m -90.03 -45.14 9.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD12 ' HG3' ' A' ' 32' ' ' LYS . 0.3 OUTLIER 179.78 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.171 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HG3' HD12 ' A' ' 31' ' ' LEU . 29.5 mtmt -119.35 -0.93 10.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.344 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.54 ' HA ' HD23 ' A' ' 53' ' ' LEU . 2.2 m-70 -110.71 111.07 22.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 111.572 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.643 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -99.93 131.28 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 40.7 m-85 -149.08 147.76 28.89 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.146 0.498 . . . . 0.0 112.085 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -132.46 128.28 37.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -117.83 113.06 21.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.205 0.526 . . . . 0.0 110.767 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -100.13 102.23 13.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -104.91 160.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.977 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.28 118.03 30.48 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.818 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.441 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 13.6 t0 -91.82 20.61 5.48 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.44 1.088 . . . . 0.0 112.217 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.49 -48.62 3.4 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mmtp -131.11 118.15 20.1 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.82 89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.841 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.8 t -136.09 112.61 13.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 m -77.42 109.6 11.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -91.53 -53.07 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.833 HG21 ' HB2' ' A' ' 75' ' ' LYS . 1.4 t -124.16 145.84 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.571 0.701 . . . . 0.0 112.791 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 78.3 p -150.22 115.02 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.313 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -125.92 162.94 24.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 126.91 10.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.007 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.573 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.1 m -61.79 -39.54 92.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 0.0 111.24 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 33' ' ' HIS . 4.0 pp -57.7 -18.52 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.41 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.31 -49.09 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.846 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.594 HD12 ' H ' ' A' ' 55' ' ' LEU . 5.5 mp -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.24 -31.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.953 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD12 ' HB3' ' A' ' 52' ' ' SER . 8.8 mt -52.69 160.75 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -36.04 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.8 51.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.57 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' HB2' HD22 ' A' ' 57' ' ' LEU . 1.1 t-20 -83.42 -168.61 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.82 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.657 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.3 ttmm -109.21 -110.65 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.697 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.657 HG23 ' HG2' ' A' ' 61' ' ' LYS . 4.2 p -93.63 52.25 1.68 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -75.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.51 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 67' ' ' GLN . 39.6 t -94.05 -13.78 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.058 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.104 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.26 -43.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -65.96 -60.83 2.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.378 0.608 . . . . 0.0 109.46 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -48.12 -28.19 2.77 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.292 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.104 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -71.88 -38.44 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.2 178.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -67.64 -56.78 10.29 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 5.5 ppt_? -44.95 -35.33 2.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -64.12 -50.19 69.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.08 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.617 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.2 mt -62.96 -52.62 62.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -53.51 -27.3 24.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.063 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -75.09 -32.89 61.57 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.833 ' HB2' HG21 ' A' ' 48' ' ' VAL . 33.0 mttm -76.79 -63.69 1.29 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.59 -43.19 11.97 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.792 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -56.2 -40.03 73.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.977 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.59 -24.33 13.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.952 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.42 -28.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.78 13.55 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.254 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.4 111.03 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 110.126 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 23.6 ttpp -95.89 -57.48 2.35 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.787 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -110.75 148.67 31.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.65 164.93 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 0.0 112.182 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.02 87.87 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.944 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 t80 -81.17 112.37 18.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.93 111.02 4.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HD3' ' N ' ' A' ' 27' ' ' VAL . 3.1 tpt85 -99.82 -21.11 15.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.28 -97.83 1.04 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.81 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.42 33.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.903 2.402 . . . . 0.0 112.197 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 4.3 m-85 -99.93 135.7 40.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.95 154.78 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.7 t80 -46.86 97.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 110.35 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.453 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 1.9 t60 -105.35 -99.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.901 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 62' ' ' THR . . . -142.52 -30.94 0.12 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HG3' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mmt85 -85.87 -71.14 0.55 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 27' ' ' VAL . 55.4 t -33.07 -35.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HZ1' ' HB ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -62.14 -76.42 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.667 0.746 . . . . 0.0 109.551 179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.32 -44.51 11.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.655 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -68.12 -49.24 62.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 110.221 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.709 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.61 -32.49 63.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -68.79 -41.95 78.01 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.13 -57.48 8.88 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.971 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.45 -34.63 77.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.477 -1.362 . . . . 0.0 110.986 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.33 -26.61 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.411 . . . . 0.0 110.887 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.837 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -78.08 -36.57 48.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.19 -43.84 69.37 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.725 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.36 -31.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 119.999 -1.096 . . . . 0.0 114.904 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.891 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.42 151.1 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.76 96.01 4.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.713 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.07 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp -117.28 131.96 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttt-85 -102.73 126.46 49.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.49 145.61 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.58 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.811 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -147.4 108.88 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.468 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 HD13 ' A' ' 100' ' ' LEU . 9.6 p -100.59 132.18 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.006 0.432 . . . . 0.0 111.761 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -113.35 143.99 43.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.278 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' CZ ' HG23 ' A' ' 97' ' ' VAL . 19.9 ptt-85 -151.53 118.76 5.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.093 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.78 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 110.788 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tt -177.36 -68.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.94 14.16 18.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.905 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.855 ' NE2' HD23 ' A' ' 53' ' ' LEU . 1.7 m-70 -127.33 150.18 49.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.655 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.72 HG21 ' HD2' ' A' ' 96' ' ' ARG . 22.5 pt -139.16 142.35 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -142.04 108.39 5.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.158 -177.279 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.003 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.73 121.01 34.73 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -114.75 118.64 34.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.201 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.847 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.99 103.82 15.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 46' ' ' THR . 3.5 mp -108.16 162.46 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.709 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.537 ' N ' HG22 ' A' ' 39' ' ' ILE . 3.0 t70 -92.87 113.58 25.9 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.039 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -92.97 24.82 3.48 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.253 0.971 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.8 -47.85 3.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mtpt -132.19 118.12 19.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.77 90.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.453 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 43' ' ' LYS . 91.5 t -141.05 112.2 3.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 39' ' ' ILE . 1.6 m -78.83 117.48 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -95.65 -56.87 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.78 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -128.57 145.12 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 111.986 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 p -150.19 114.53 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.422 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.659 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -127.03 148.78 50.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.631 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.499 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 15.2 p -150.22 136.14 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.726 ' CB ' HD21 ' A' ' 57' ' ' LEU . 19.1 m -44.62 -31.27 1.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.821 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.855 HD23 ' NE2' ' A' ' 33' ' ' HIS . 3.0 tm? -56.92 -61.95 2.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.602 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.42 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -58.4 -27.23 64.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.26 0.552 . . . . 0.0 110.043 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.4 mp -90.67 11.57 21.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.083 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 55' ' ' LEU . 7.5 mttm 2.07 63.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.617 0.767 . . . . 0.0 112.785 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.927 HD13 ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -57.6 156.51 8.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.542 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.23 88.61 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.68 -100.97 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -117.49 -169.77 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 0.0 110.824 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.79 -67.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.414 HG22 ' HD3' ' A' ' 96' ' ' ARG . 77.1 p -66.85 -17.64 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -49.74 70.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.927 ' HB ' HD13 ' A' ' 57' ' ' LEU . 99.5 t -94.0 -20.09 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.685 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.037 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.18 -39.55 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 111.551 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.77 -60.21 2.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.8 mt-30 -49.36 -24.59 1.97 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.572 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.037 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.98 -36.14 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.806 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -77.06 -35.8 37.53 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.941 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 4.3 ppt_? -65.03 -36.12 83.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.47 -55.13 26.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.003 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -62.69 -44.58 95.88 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.83 -27.8 60.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.742 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.6 tt0 -72.94 -34.35 66.5 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.78 ' CB ' HG21 ' A' ' 48' ' ' VAL . 14.2 mttt -76.64 -63.19 1.4 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.072 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.688 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.29 -42.05 6.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.346 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.0 -40.38 80.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.184 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.08 -23.63 8.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.41 -28.44 19.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.46 15.69 12.05 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.197 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -69.29 104.47 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.589 0.709 . . . . 0.0 110.152 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 110' ' ' GLU . 14.6 tttt -92.51 -56.38 3.05 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.388 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.43 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -110.0 145.03 37.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.384 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.757 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.1 164.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.469 0.652 . . . . 0.0 112.048 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.02 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.746 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.791 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.02 106.32 13.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.105 0.479 . . . . 0.0 111.373 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 45.0 2.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.176 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.7 ptt180 -41.51 -32.47 0.34 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.582 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.91 -121.46 6.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.433 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -88.99 36.33 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -95.55 150.97 19.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.989 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -116.91 147.0 42.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -49.31 100.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.056 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -120.07 168.46 11.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.456 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.46 -38.16 3.86 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.912 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.72 ' HD2' HG21 ' A' ' 34' ' ' ILE . 45.1 mmt-85 -61.72 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.567 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 33.1 t -38.67 -40.97 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.57 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.4 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 0.0 111.001 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.28 -37.27 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.896 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD13 HG21 ' A' ' 27' ' ' VAL . 2.2 tt -67.48 -48.21 67.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 111.167 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.21 -33.4 70.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.17 -43.79 81.34 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.01 -62.06 5.27 Favored Glycine 0 CA--C 1.506 -0.517 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.925 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.98 -38.93 68.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 113.821 -1.19 . . . . 0.0 110.571 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.4 mmm-85 -79.79 -60.17 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -43.59 -43.15 5.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.158 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -62.01 -50.51 64.82 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.995 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -26.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.125 -1.036 . . . . 0.0 114.808 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.847 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.4 mp -71.49 147.77 47.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.28 92.24 3.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.25 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.724 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.038 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp -120.42 133.56 55.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.36 125.26 50.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.694 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 26' ' ' SER . 5.1 tt -89.74 142.32 27.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.682 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.923 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.0 m -142.21 134.84 28.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.609 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.841 HG11 HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -119.79 134.58 62.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 0.0 110.831 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -122.92 132.31 54.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' CZ ' ' HD2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -137.32 118.83 14.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.214 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -89.24 -38.91 13.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.007 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tt -179.87 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -119.03 3.87 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.4 ' NE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -111.31 154.82 23.98 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 100' ' ' LEU . 3.8 tp -141.34 123.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.83 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 16.9 m-85 -139.22 110.72 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.73 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -100.17 121.45 41.45 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.22 113.47 26.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.321 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.685 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.78 101.71 12.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -104.84 164.03 4.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.573 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -94.44 113.98 25.93 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.809 178.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.3 t70 -91.38 25.54 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.335 1.022 . . . . 0.0 112.359 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -109.61 -48.15 3.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.71 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.8 mttp -135.64 118.09 15.79 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.3 89.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.546 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 43' ' ' LYS . 66.3 t -137.86 112.49 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -75.5 114.54 14.18 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -93.11 -60.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.75 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -125.21 147.25 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 111.882 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 p -150.23 114.91 5.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -124.89 151.89 44.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.5 p -150.22 127.14 11.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.892 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.514 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.2 m -53.05 -25.84 13.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.4 tm? -63.82 -52.21 61.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.014 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.25 -29.23 68.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.077 0.465 . . . . 0.0 110.47 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -91.4 10.58 26.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.9 mtmp? 1.77 63.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.468 0.707 . . . . 0.0 112.878 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.96 HD12 HG11 ' A' ' 64' ' ' VAL . 10.9 mt -80.99 176.16 10.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.852 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 68.29 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 64' ' ' VAL . . . -129.98 -159.01 9.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.84 -73.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -74.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 95' ' ' GLY . 60.6 p -91.69 14.72 14.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.255 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.81 -43.38 11.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 110.856 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.96 HG11 HD12 ' A' ' 57' ' ' LEU . 76.1 t -94.18 -26.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.049 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.83 -40.75 0.06 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.634 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.49 -60.02 3.12 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.768 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 28.3 mt-30 -48.24 -27.14 2.29 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.248 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.049 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.06 -36.24 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.98 -29.74 62.36 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.27 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 6.5 ppt_? -69.51 -36.17 76.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -73.94 -38.07 64.36 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 7.2 mt -65.4 -43.58 90.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.419 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -75.51 -30.97 60.0 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.085 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 21.2 mt-10 -75.65 -28.46 58.77 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.804 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 8.3 mtmm -76.12 -67.79 0.65 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.399 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.44 -40.89 8.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.795 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.79 -39.02 76.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.718 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.5 -22.88 14.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.937 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.75 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.44 -27.38 20.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.21 19.69 9.26 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.077 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.736 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.92 103.79 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.588 0.708 . . . . 0.0 110.449 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLU . 19.1 tttp -91.54 -56.92 2.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.363 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.68 146.91 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -134.07 167.16 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.458 0.647 . . . . 0.0 112.169 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -102.21 103.74 14.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.255 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.731 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.5 t80 -80.75 110.58 16.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 112.723 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.0 106.36 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.066 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -92.34 -33.91 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.058 0.456 . . . . 0.0 110.304 -178.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.76 -110.22 2.76 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -90.31 32.7 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.849 2.366 . . . . 0.0 112.262 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 3.4 m-30 -102.27 152.79 20.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.131 0.491 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.26 148.91 52.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.446 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.503 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -44.75 111.83 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.979 0.419 . . . . 0.0 110.334 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -124.01 -122.69 0.26 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.639 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 62' ' ' THR . . . -127.04 -12.4 3.21 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.964 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HD2' ' CZ ' ' A' ' 29' ' ' ARG . 1.7 mmt85 -87.95 -70.77 0.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.851 0.325 . . . . 0.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.841 HG22 HG11 ' A' ' 27' ' ' VAL . 55.8 t -36.14 -32.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 123.035 0.534 . . . . 0.0 111.672 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.14 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.969 0.414 . . . . 0.0 110.96 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -44.25 -40.84 5.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -67.73 -45.77 74.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 110.214 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.84 -30.63 70.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.772 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -69.91 -49.0 56.41 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.74 -55.21 7.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.873 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.17 -45.04 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.772 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -56.63 -35.2 68.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.835 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.34 -49.08 16.55 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.119 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.795 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -179.53 -29.99 0.05 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.728 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 8.0 mp -71.15 146.86 48.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -128.04 91.71 3.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.104 178.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.669 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.026 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.853 0.358 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD13 HG13 ' A' ' 81' ' ' ILE . 1.4 mp -122.12 134.09 54.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.72 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -104.59 126.93 52.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.705 -178.467 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.84 141.53 28.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.836 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.21 108.72 5.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.692 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 100' ' ' LEU . 4.7 p -95.78 125.45 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.16 144.15 40.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.83 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 26.2 tpt180 -150.12 118.63 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.765 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.9 p -89.93 -42.97 10.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.657 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -178.61 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 13.5 mtmt -119.27 -1.67 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.649 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -112.15 116.96 31.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.036 0.446 . . . . 0.0 111.492 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.788 HD11 HD13 ' A' ' 100' ' ' LEU . 5.8 tp -106.94 112.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.547 ' CD1' ' HB3' ' A' ' 51' ' ' SER . 8.9 m-85 -127.87 110.69 12.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.924 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -96.04 124.84 40.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.78 113.4 25.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.515 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.792 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.09 99.16 8.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.119 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.7 mp -99.84 163.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.127 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -93.95 114.08 26.22 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.754 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 22.0 t70 -91.5 25.47 2.62 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.438 1.086 . . . . 0.0 112.303 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -109.46 -47.92 3.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.89 118.25 15.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 90.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.613 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.6 t -139.99 112.32 5.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -73.31 114.13 11.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.624 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -91.58 -64.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -121.7 145.87 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 111.792 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.9 p -150.36 114.82 5.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.041 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.73 156.25 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.547 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.1 145.56 26.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.237 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.603 ' N ' HG21 ' A' ' 68' ' ' VAL . 34.7 m -53.56 -82.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.689 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.656 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -59.14 -10.23 2.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.88 -64.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.689 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mp -55.79 -51.94 65.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.63 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 mt -56.8 115.35 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.278 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -109.38 85.51 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.19 175.39 28.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -101.58 -76.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 -155.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 95' ' ' GLY . 17.8 p -74.48 57.35 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.0 110.957 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -94.34 -59.18 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.814 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 67' ' ' GLN . 68.8 t -83.94 -19.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.075 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.83 -42.14 0.05 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.962 0.411 . . . . 0.0 111.965 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.76 -61.04 2.3 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.521 0.676 . . . . 0.0 109.301 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -48.67 -25.08 1.6 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.3 177.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.075 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.97 -33.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.671 178.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.77 -27.28 54.31 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.357 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -73.61 -38.37 65.12 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.38 -34.8 70.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.924 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -69.21 -49.6 54.98 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.322 178.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.986 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -67.46 -25.4 65.87 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.896 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -77.91 -31.28 51.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 13.5 mttt -71.95 -69.34 0.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.515 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.28 -43.38 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.136 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.774 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -55.52 -39.23 70.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.052 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.28 -23.56 15.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.58 -27.16 20.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.29 16.69 10.83 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.156 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.737 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.7 103.02 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.725 0.774 . . . . 0.0 110.307 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -94.44 -51.93 4.55 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.75 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 135.16 54.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.02 165.1 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.4 0.619 . . . . 0.0 111.769 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -109.85 105.4 14.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.379 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.34 106.31 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.529 -178.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -129.73 44.08 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.008 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 16.3 ptt-85 -39.4 -47.84 1.84 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.827 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.93 -114.68 2.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.15 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.03 -13.53 21.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.426 2.084 . . . . 0.0 112.275 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.5 m-85 -60.63 138.11 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.02 0.438 . . . . 0.0 111.159 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 154.11 49.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.999 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 1.3 t80 -42.4 113.56 0.47 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -128.89 -77.95 0.56 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' O ' HG21 ' A' ' 62' ' ' THR . . . -155.37 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.167 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.716 ' HB3' HD13 ' A' ' 34' ' ' ILE . 37.0 mmt-85 -65.55 -60.85 2.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 42.1 t -35.97 -39.18 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.994 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' CE ' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.65 -80.16 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.391 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -53.77 -36.39 62.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.015 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.788 HD13 HD11 ' A' ' 34' ' ' ILE . 2.4 tt -68.98 -48.23 63.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.149 0.5 . . . . 0.0 110.972 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.79 -30.79 71.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.323 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.21 -45.04 70.85 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.77 -57.24 9.92 Favored Glycine 0 CA--C 1.508 -0.375 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.986 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.92 -33.12 74.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.357 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.1 mtm180 -88.46 -30.05 19.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.749 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.793 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -76.94 -34.36 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.17 -47.38 37.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.106 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.46 -29.47 0.07 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.878 -1.153 . . . . 0.0 114.942 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.792 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.9 mp -71.25 147.14 48.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -127.85 91.84 3.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.413 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.684 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.935 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 HG13 ' A' ' 81' ' ' ILE . 3.6 mp -110.63 134.89 52.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.761 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttp180 -103.85 125.34 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.442 -178.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.6 tt -89.81 143.81 26.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 25' ' ' LEU . 50.9 m -145.43 108.69 4.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 0.0 111.343 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 97' ' ' VAL . 8.0 p -101.99 121.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -103.64 129.39 50.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.603 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -136.69 118.55 15.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -89.75 -77.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.476 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -134.33 -61.24 0.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.828 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.29 18.32 12.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.557 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -117.71 164.05 15.56 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.997 0.427 . . . . 0.0 111.25 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.721 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.5 tp -155.8 126.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.6 ' OH ' HD11 ' A' ' 53' ' ' LEU . 18.8 m-85 -140.86 110.2 6.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.078 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -94.04 121.46 35.55 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.33 117.4 30.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.205 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.791 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -100.24 103.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.479 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -105.95 161.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.449 -177.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 39' ' ' ILE . 16.2 t0 -92.7 114.32 26.84 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.962 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 25.4 t0 -92.05 23.58 3.69 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.277 0.985 . . . . 0.0 112.148 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.25 -47.82 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.6 mppt? -133.31 118.09 18.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.68 90.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.432 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.4 t -139.61 112.28 5.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.15 114.79 16.33 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -94.19 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.345 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.2 t -123.67 144.51 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.338 0.59 . . . . 0.0 112.093 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -150.24 114.78 5.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.826 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.06 161.98 27.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.804 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.679 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -150.06 144.36 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.875 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 p -56.33 -48.43 76.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.5 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD11 ' OH ' ' A' ' 35' ' ' TYR . 3.7 pp -71.13 -7.91 49.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.76 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.41 -54.27 5.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 111.696 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 51' ' ' SER . 5.7 mp -52.48 -46.85 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.173 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 36.4 ttmt 179.2 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.527 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.89 HD23 ' N ' ' A' ' 58' ' ' LYS . 5.1 tt -41.62 137.73 1.54 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.656 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.89 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -132.12 -44.58 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.902 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.35 72.69 0.38 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.67 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 57' ' ' LEU . 14.0 m-20 -169.42 160.3 9.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.75 0.309 . . . . 0.0 110.73 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CB ' ' NH2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -109.88 -88.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 9.3 p -93.19 11.89 26.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.65 0.262 . . . . 0.0 111.079 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -58.67 -53.24 60.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 67' ' ' GLN . 40.7 t -94.2 -16.3 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.56 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.059 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.5 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.26 -60.53 2.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.807 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.6 mt-30 -48.01 -26.11 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.419 178.087 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.059 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.66 -39.27 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.992 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.508 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -70.5 -37.42 69.01 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.815 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 16.1 ptt85 -64.27 -36.88 85.56 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.727 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.97 -54.95 26.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.097 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.79 -42.15 97.8 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.46 -27.7 69.3 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.715 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.3 tt0 -78.04 -25.52 47.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.466 178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.838 ' HB2' HG21 ' A' ' 48' ' ' VAL . 2.4 mttp -82.4 -62.11 1.71 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.08 -43.28 14.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.407 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.738 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -55.97 -39.65 72.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.107 178.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.54 -23.95 12.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.878 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.38 -27.14 20.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.59 17.7 10.27 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.961 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.674 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.1 106.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.513 0.673 . . . . 0.0 110.346 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLU . 1.5 ttpt -92.45 -61.07 1.68 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.207 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.39 146.32 34.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.356 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -131.72 165.78 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.205 0.526 . . . . 0.0 111.776 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.17 104.75 14.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.838 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.133 0.492 . . . . 0.0 111.741 -178.8 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -122.26 38.89 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.957 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.41 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 20.6 ptt180 -40.45 -33.38 0.26 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.516 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.77 -129.38 8.62 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.306 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.93 44.99 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.777 2.318 . . . . 0.0 112.298 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 29' ' ' ARG . 4.6 m-30 -97.38 153.71 17.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.007 0.432 . . . . 0.0 111.114 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.34 154.66 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.884 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.636 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -49.29 101.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 110.201 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.418 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 31.4 t-80 -111.92 -112.38 0.33 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.002 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.29 -37.12 0.31 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.672 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.721 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.4 mpt_? -67.96 -71.06 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 27' ' ' VAL . 70.8 t -36.41 -32.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.968 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -63.74 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.037 0.446 . . . . 0.0 110.893 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -43.2 -40.79 3.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.334 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -69.81 -48.77 57.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.757 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.635 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.35 -30.69 60.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.52 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.849 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.68 -47.0 57.11 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.764 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.19 -57.27 7.23 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -37.87 88.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.517 -1.342 . . . . 0.0 111.599 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -85.4 -33.16 22.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.068 0.461 . . . . 0.0 110.487 179.549 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.849 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.8 pt-20 -70.0 -37.53 75.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.24 -50.13 41.28 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.375 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.92 -26.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.945 -1.121 . . . . 0.0 114.978 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.1 mp -71.34 144.68 49.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.95 96.75 4.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.47 178.992 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.715 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.093 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 7.8 tpp85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.895 0.379 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -104.71 134.05 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.229 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.33 129.13 53.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.546 -179.108 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.861 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.2 tt -89.47 141.27 28.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.392 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.837 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.7 108.37 4.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.777 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG21 ' NH2' ' A' ' 29' ' ' ARG . 14.9 p -97.06 126.98 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.765 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.76 141.56 42.22 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.679 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HG2' HD12 ' A' ' 34' ' ' ILE . 35.7 mtt85 -150.11 118.69 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 p -89.91 -42.51 11.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.166 0.508 . . . . 0.0 110.416 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tt -179.98 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.723 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' CG ' ' HA3' ' A' ' 59' ' ' GLY . 1.4 ttpt -119.29 -6.7 10.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.973 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.07 116.4 31.89 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.885 0.374 . . . . 0.0 111.617 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.892 HD11 HD13 ' A' ' 100' ' ' LEU . 2.0 tp -105.25 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.034 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 27.5 m-85 -146.93 109.24 4.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.842 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.45 125.47 38.08 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -113.85 113.45 24.91 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.837 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.87 102.98 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.905 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -107.68 161.27 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.084 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.3 t0 -89.44 115.14 26.65 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.779 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 4.0 t70 -92.3 24.08 3.57 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.376 1.048 . . . . 0.0 112.274 -178.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -109.49 -47.63 3.35 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 177.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.5 mttp -133.54 118.12 17.92 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.95 89.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.301 -177.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' LYS . 98.6 t -137.88 112.52 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -76.38 119.19 19.91 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD22 HD13 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -100.84 -56.81 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.466 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.871 HG12 HD23 ' A' ' 72' ' ' LEU . 2.1 t -126.62 142.1 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.211 0.529 . . . . 0.0 112.208 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.4 115.21 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.997 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -122.98 163.76 19.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.059 0.457 . . . . 0.0 111.963 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.501 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 18.2 p -146.06 126.9 14.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.046 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.588 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.1 p -56.35 -43.82 79.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.434 -179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -62.52 -10.28 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.089 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -84.16 -54.65 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.752 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 55' ' ' LEU . 4.8 mp -52.64 -44.81 66.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.191 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tttp 179.21 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.513 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -43.79 154.32 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.65 25.03 4.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 32' ' ' LYS . . . 69.0 63.97 3.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.622 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -102.96 -48.15 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.97 -163.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 p -82.48 57.52 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.785 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -94.17 -58.19 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.074 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 67' ' ' GLN . 95.0 t -94.06 -17.19 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.621 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.94 -40.45 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.602 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.43 -60.13 2.82 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.47 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.507 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.9 mt-30 -49.34 -23.53 1.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.645 177.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.53 -35.5 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.524 178.573 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.48 -34.79 34.78 Favored Glycine 0 C--O 1.218 -0.901 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -64.77 -37.23 86.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -46.41 76.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.6 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -61.55 -51.18 69.65 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.315 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.869 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.04 -25.87 64.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.745 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 18.2 tt0 -72.0 -35.59 69.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.467 0.651 . . . . 0.0 109.37 178.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 9.1 mttt -78.81 -63.76 1.34 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.994 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -42.96 -42.45 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.706 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.7 mt -58.45 -41.2 84.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.387 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -50.28 -25.86 4.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.319 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.189 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 113.94 15.12 8.77 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.855 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.83 102.66 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.13 0.491 . . . . 0.0 110.187 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -106.3 -23.37 12.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.841 -179.564 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -129.84 125.29 35.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.284 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.797 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.09 165.41 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.435 0.636 . . . . 0.0 111.839 -179.5 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -112.14 111.63 22.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.754 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.861 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -80.95 111.41 17.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 111.789 -178.219 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.03 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 9.4 ptt-85 -41.82 -37.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.01 -125.41 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.47 0.26 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.521 2.147 . . . . 0.0 112.877 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.5 ' HD2' ' CE1' ' A' ' 94' ' ' HIS . 4.4 m-85 -58.71 144.03 44.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.97 109.57 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.544 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER 0.11 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.123 0.569 . . . . 0.0 112.103 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.5 ' CE1' ' HD2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -131.02 173.42 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.468 -179.009 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -36.58 -67.81 0.37 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.741 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -47.34 -66.36 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.593 0.235 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 89.9 t -29.61 -45.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.022 0.529 . . . . 0.0 112.014 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.486 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.43 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.031 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.38 -37.6 75.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.075 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 34' ' ' ILE . 4.8 tt -64.68 -47.77 77.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.389 0.614 . . . . 0.0 111.238 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.08 -31.6 72.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.694 -178.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.767 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -66.58 -46.31 76.37 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.31 -59.4 5.83 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.958 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -57.74 -43.19 85.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.609 -1.295 . . . . 0.0 111.405 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.93 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -80.99 -48.14 12.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.302 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.3 pt-20 -52.89 -43.75 66.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.698 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.82 -48.39 86.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.19 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.648 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.46 -27.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.609 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.64 149.64 45.37 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -129.14 91.82 3.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.091 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.731 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.027 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 35.8 ttm180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.15 134.98 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.42 179.774 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.8 ttp180 -100.53 125.36 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.948 0.404 . . . . 0.0 111.067 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tt -89.53 141.47 28.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.959 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.849 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -150.33 108.86 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.141 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.664 HG12 ' HZ ' ' A' ' 86' ' ' PHE . 5.0 p -102.48 120.45 52.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.215 0.531 . . . . 0.0 111.661 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.5 OUTLIER -97.38 144.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.683 -179.405 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.65 ' NH2' HG11 ' A' ' 27' ' ' VAL . 16.3 mtt85 -150.61 118.53 6.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.219 178.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.24 -35.85 12.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.671 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.93 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.459 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -119.3 6.59 11.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.485 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 2.9 m-70 -115.89 103.14 10.33 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.467 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' CD1' ' A' ' 100' ' ' LEU . 9.5 tt -99.34 133.91 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.968 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 33.3 m-85 -147.3 110.2 4.73 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.291 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.01 120.91 33.79 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.42 113.03 25.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.011 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -95.83 98.76 8.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.221 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.6 mp -100.62 166.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.574 -177.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -99.34 111.92 24.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.238 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.77 26.55 1.75 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.127 0.892 . . . . 0.0 112.304 -178.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -110.03 -47.45 3.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.692 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.0 mttp -135.11 118.13 16.38 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 174.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.19 90.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.439 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.2 t -137.92 112.62 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -78.38 119.64 22.0 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -102.92 -58.56 1.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.331 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.548 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.4 t -120.55 146.73 24.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.313 0.578 . . . . 0.0 111.916 -178.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -150.13 114.74 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.883 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -121.89 156.41 33.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.14 126.75 10.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.635 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.4 p -56.76 -57.67 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 53' ' ' LEU . 3.0 tm? -58.82 -21.5 56.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -76.98 -55.08 5.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.074 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.16 -50.29 62.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.19 -33.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.18 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.734 HD11 ' HA ' ' A' ' 61' ' ' LYS . 6.5 tt -37.28 124.76 0.98 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.958 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.544 ' N ' HD23 ' A' ' 57' ' ' LEU . 3.3 tttm -131.96 -6.94 3.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.31 -107.2 1.53 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -56.45 106.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.734 ' HA ' HD11 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -82.9 -47.72 11.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.161 -179.718 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 95' ' ' GLY . 13.2 p -66.75 -38.0 85.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -54.18 -45.1 72.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.784 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' HB ' HD12 ' A' ' 57' ' ' LEU . 75.8 t -94.16 -20.83 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.65 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.039 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -43.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.109 0.48 . . . . 0.0 111.759 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -65.48 -59.08 4.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.532 0.682 . . . . 0.0 109.413 178.938 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 16.1 mt-30 -50.35 -23.66 2.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.473 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.039 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.61 -32.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.52 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.03 -29.88 52.86 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.9 178.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.16 -40.11 71.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.24 -40.31 90.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.011 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -63.76 -55.41 23.36 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.942 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.1 -24.93 28.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.04 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -71.37 -37.51 71.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 18.2 mttt -71.82 -64.52 0.91 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.018 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.837 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.03 -41.02 7.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.536 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.729 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -59.74 -40.18 87.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.243 178.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.26 -24.21 7.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.28 -28.06 20.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.236 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.08 13.27 16.02 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.532 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -65.66 109.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 110.193 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.6 tttm -93.58 -56.23 2.99 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.39 -178.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.471 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -112.93 151.1 30.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.272 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -135.33 161.53 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.509 0.671 . . . . 0.0 112.132 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 87.79 2.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 19.9 t80 -80.7 108.33 14.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -176.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.37 98.58 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.685 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 7.3 tpt180 -90.42 11.66 20.89 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.467 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 90' ' ' PRO . . . 87.19 -113.94 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.147 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 2.3 Cg_endo -81.06 45.12 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.803 2.335 . . . . 0.0 112.122 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 3.2 m-85 -112.19 133.15 54.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 111.011 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.6 155.04 48.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.3 t80 -33.06 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -103.82 -166.34 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -178.752 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.717 ' C ' ' HE2' ' A' ' 98' ' ' LYS . . . -76.18 -17.14 80.2 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.235 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' CB ' ' NE ' ' A' ' 29' ' ' ARG . 3.8 mmt85 -97.92 -64.55 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.484 ' O ' ' C ' ' A' ' 98' ' ' LYS . 13.6 t -28.84 -70.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.717 ' HE2' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -29.47 -60.18 0.15 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.223 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.666 ' N ' ' HG2' ' A' ' 98' ' ' LYS . . . -69.99 -46.89 64.19 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.398 -177.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -61.41 -47.69 84.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.814 0.816 . . . . 0.0 109.422 179.247 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.534 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.07 -40.36 76.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.64 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -62.58 -38.85 91.72 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.79 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.87 -59.34 8.15 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.89 -31.03 70.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.812 -1.194 . . . . 0.0 110.598 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.893 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 3.2 tpp85 -88.77 -25.52 22.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -82.7 -38.45 23.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.676 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -64.35 -46.35 90.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.638 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.729 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.81 -30.67 0.08 OUTLIER Glycine 0 C--N 1.341 0.835 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.556 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.57 146.56 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -128.32 99.7 5.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.127 178.328 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.721 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.064 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 tpp180 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.769 0.319 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.615 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -30.87 134.1 0.07 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.356 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 13.6 ttp180 -93.36 124.5 37.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.908 -178.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.5 tt -89.66 145.99 24.85 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.255 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.802 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -150.38 119.06 6.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.212 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.775 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.8 t -101.29 139.99 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.863 0.363 . . . . 0.0 111.664 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HA ' ' OH ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -125.67 112.5 16.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.68 118.66 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.814 177.48 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -89.5 -78.88 0.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.55 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -131.58 -61.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.682 179.276 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -119.25 20.06 12.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.231 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.502 ' HA ' HD23 ' A' ' 53' ' ' LEU . 2.4 m-70 -117.77 161.64 19.38 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.84 HD11 ' CD1' ' A' ' 100' ' ' LEU . 2.4 tp -151.37 128.05 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.939 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 53' ' ' LEU . 29.4 m-85 -145.42 150.83 37.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.153 0.502 . . . . 0.0 111.8 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -132.67 121.11 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.26 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 113.13 24.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.187 0.518 . . . . 0.0 110.22 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -96.21 96.31 5.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.5 mp -98.24 163.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.921 -177.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.574 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.5 t0 -96.9 109.31 22.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.574 177.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 18.2 p-10 -89.05 26.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.158 0.911 . . . . 0.0 112.273 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -110.67 -47.15 3.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mppp? -133.26 118.17 18.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 174.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.43 89.72 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.418 -177.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.8 t -139.59 112.45 5.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.47 119.48 21.12 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -99.56 -59.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.193 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 1.9 t -121.91 146.17 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.344 0.592 . . . . 0.0 112.004 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 88.3 p -150.18 114.86 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.943 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.37 158.3 33.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.844 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -150.22 134.14 16.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.653 ' OG ' HD12 ' A' ' 57' ' ' LEU . 9.0 t -54.5 -45.3 73.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 111.053 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD11 ' OH ' ' A' ' 35' ' ' TYR . 4.5 pp -74.39 -7.86 54.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -69.09 -54.36 15.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.466 . . . . 0.0 111.401 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mp -52.52 -48.85 65.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.805 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.89 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.639 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.653 HD12 ' OG ' ' A' ' 52' ' ' SER . 25.8 mt -49.39 176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.5 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -123.47 -43.26 2.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.66 99.75 1.04 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.433 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -116.73 -41.19 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.983 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -176.3 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.483 HG21 ' C ' ' A' ' 95' ' ' GLY . 15.1 p -86.22 51.4 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 -49.1 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.614 HG21 ' CD1' ' A' ' 57' ' ' LEU . 93.8 t -93.87 -19.81 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.291 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.28 -38.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.794 -179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.628 0.728 . . . . 0.0 109.157 178.603 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 10.6 mt-30 -49.68 -24.11 2.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.299 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.03 -32.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.99 -31.77 51.91 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.242 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.42 -42.59 68.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.62 -38.02 88.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -65.48 -54.57 26.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.226 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.79 -24.22 48.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.938 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.27 -37.79 68.97 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 21.9 mttt -70.75 -67.12 0.53 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.095 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.825 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.6 -41.96 4.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.685 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.794 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -59.3 -40.52 86.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.052 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.53 -23.92 7.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.526 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.46 -27.97 20.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.129 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.38 14.31 14.88 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.273 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.526 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.77 106.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.556 0.693 . . . . 0.0 110.019 179.722 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' GLU . 5.0 tttp -93.17 -54.55 3.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.493 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.73 144.2 41.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -130.73 159.89 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.5 0.667 . . . . 0.0 112.028 -179.643 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.92 ' CE2' HD22 ' A' ' 25' ' ' LEU . 17.1 t80 -80.39 106.51 12.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.635 0.731 . . . . 0.0 112.548 -176.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.95 97.78 2.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.362 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.4 tpt85 -83.55 -7.07 59.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.52 -110.21 2.0 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.24 34.94 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.021 2.48 . . . . 0.0 112.092 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 88' ' ' ARG . 2.9 m-30 -77.1 138.28 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.823 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 93' ' ' TYR . 9.4 tptt -121.28 99.49 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.796 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER 0.61 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.676 0.61 . . . . 0.0 112.236 -179.313 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -116.77 163.55 15.98 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.338 -179.301 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' C ' HG21 ' A' ' 62' ' ' THR . . . -39.53 -60.64 1.69 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.55 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.421 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 33.6 mmt180 -47.72 -69.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.675 0.274 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.6 t -33.98 -38.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.809 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.64 -79.06 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.607 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.9 -34.45 65.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.542 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.84 ' CD1' HD11 ' A' ' 34' ' ' ILE . 3.8 tt -68.17 -51.83 41.37 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.297 0.57 . . . . 0.0 110.969 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -62.38 -29.63 70.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.671 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.02 -44.95 71.69 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.287 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.33 -57.66 7.96 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.25 -33.67 75.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.534 -1.333 . . . . 0.0 110.875 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 -22.84 23.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -85.2 -34.87 21.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.41 -44.63 63.98 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.655 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.794 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.14 -31.03 0.08 OUTLIER Glycine 0 C--N 1.341 0.828 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.632 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.4 mp -71.42 147.01 48.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.32 96.71 4.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.412 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.1 p90 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.842 0.353 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -43.32 125.06 3.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.843 -179.401 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.83 122.73 37.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.501 -178.933 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.43 143.02 27.14 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.518 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.806 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.3 m -146.23 108.55 4.44 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.008 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 6.7 p -97.03 119.23 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.321 0.582 . . . . 0.0 112.132 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.3 t80 -105.62 140.84 38.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.702 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 10.2 ptt85 -150.46 126.32 10.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.782 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 t -89.65 -85.78 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.924 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.87 -58.28 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.002 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.47 19.24 13.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.336 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -119.04 156.92 28.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.905 HD11 HD13 ' A' ' 100' ' ' LEU . 2.7 tp -142.76 132.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' HD21 ' A' ' 53' ' ' LEU . 39.1 m-85 -149.55 149.97 31.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 111.963 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -133.74 128.4 34.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG2' HD11 ' A' ' 39' ' ' ILE . 2.8 tt0 -117.24 113.26 21.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.722 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -99.55 99.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.32 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.0 mp -104.32 160.05 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.794 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.699 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.0 t0 -91.36 114.19 26.65 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.51 22.74 2.85 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.077 0.861 . . . . 0.0 112.508 -178.216 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.67 -48.92 3.42 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.65 118.01 19.45 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.503 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.06 90.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.341 -177.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.2 t -136.1 112.58 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -77.87 118.48 20.23 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 47' ' ' LEU . 1.1 mp -103.67 -50.85 3.32 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.859 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.0 t -126.86 142.59 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.442 0.639 . . . . 0.0 112.385 -178.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 80.8 p -150.08 115.01 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.498 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.0 161.78 26.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.32 127.06 10.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 179.527 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 10.3 m -56.96 -26.93 60.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD21 ' CE1' ' A' ' 35' ' ' TYR . 2.9 pp -75.12 -39.51 60.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.02 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.55 69.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -92.17 11.34 25.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.032 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.4 tptp 2.35 63.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.443 0.697 . . . . 0.0 112.618 -178.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.939 HD12 HG11 ' A' ' 64' ' ' VAL . 8.5 mt -79.08 176.08 9.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 61.84 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.4 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.42 -160.21 9.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.543 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.91 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.353 . . . . 0.0 110.96 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.05 -77.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.23 -23.98 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -38.56 71.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.939 HG11 HD12 ' A' ' 57' ' ' LEU . 79.2 t -93.99 -24.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.469 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.078 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -40.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.961 0.41 . . . . 0.0 111.748 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.06 -60.36 2.69 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.385 0.612 . . . . 0.0 109.376 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.0 mt-30 -48.66 -27.04 2.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.194 178.097 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.078 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -74.63 -35.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.57 178.616 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.38 -36.93 43.01 Favored Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.068 178.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -62.14 -35.72 79.63 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -67.27 -45.93 75.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.067 178.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.659 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.5 mt -63.55 -53.95 43.8 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.666 0.746 . . . . 0.0 109.019 178.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -57.91 -25.75 61.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.905 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -76.66 -26.92 55.37 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.108 178.183 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.859 ' HB2' HG21 ' A' ' 48' ' ' VAL . 27.2 mttm -82.9 -63.01 1.45 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.536 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.57 -42.6 11.24 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.02 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.6 mt -55.84 -40.15 72.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.127 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.63 -24.98 9.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.04 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.596 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.29 19.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.32 15.43 11.49 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.352 -179.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -66.52 106.21 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.519 0.676 . . . . 0.0 110.192 179.865 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.17 -56.78 3.03 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.165 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -113.73 144.72 42.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.261 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.16 161.7 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.651 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 103.28 12.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.999 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.762 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.56 108.42 15.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.124 0.487 . . . . 0.0 111.592 -179.078 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.41 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -129.24 45.81 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.115 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 1.3 ptt180 -41.53 -33.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.611 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.45 -117.96 5.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -88.74 20.07 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.771 2.314 . . . . 0.0 112.705 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.2 m-85 -80.92 138.74 36.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 0.0 111.214 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.02 151.34 25.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.6 106.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.649 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.32 164.57 18.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.85 -42.6 7.87 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.134 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HD2' HD13 ' A' ' 34' ' ' ILE . 1.1 mtt-85 -57.89 -70.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 0.0 110.668 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.0 t -37.45 -40.49 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.952 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.91 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.569 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.62 -35.36 70.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.699 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.905 HD13 HD11 ' A' ' 34' ' ' ILE . 3.4 tt -67.34 -49.6 63.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.084 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.17 -29.57 69.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.172 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.854 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -69.88 -44.26 70.16 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.369 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.77 -56.96 9.05 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.87 -31.43 72.66 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 113.578 -1.311 . . . . 0.0 111.013 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -89.97 -25.7 20.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.022 0.439 . . . . 0.0 110.726 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.1 pt-20 -80.48 -37.66 31.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.68 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.8 -48.32 62.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.493 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.01 -29.16 0.07 OUTLIER Glycine 0 C--N 1.343 0.949 0 C-N-CA 119.905 -1.14 . . . . 0.0 115.023 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.5 mp -71.48 146.54 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -128.24 96.31 4.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.379 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.708 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.004 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.796 0.331 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -121.25 132.18 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 23.1 ttp85 -102.71 126.82 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.176 -179.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.941 HD23 ' N ' ' A' ' 26' ' ' SER . 5.3 tt -89.74 147.15 24.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.818 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.941 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.1 m -139.16 158.58 43.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.581 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.09 127.45 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.967 0.413 . . . . 0.0 110.265 179.219 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -128.68 122.49 30.91 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.912 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 96' ' ' ARG . 3.4 ptt-85 -130.81 123.55 29.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.639 178.01 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.09 -91.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.833 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.39 -64.76 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 109.829 179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 27.99 8.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.794 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -119.69 161.87 19.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.439 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.5 tp -149.34 128.23 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.513 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 27' ' ' VAL . 27.4 m-85 -144.02 160.15 41.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.312 0.577 . . . . 0.0 111.839 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -145.77 126.97 14.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.006 177.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -115.33 113.18 23.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 110.679 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.2 92.34 3.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.575 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.0 mp -96.58 161.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -94.53 115.44 27.6 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.826 177.953 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.7 t0 -92.42 28.67 1.89 Allowed 'General case' 0 N--CA 1.464 0.239 0 O-C-N 124.289 0.993 . . . . 0.0 112.22 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.45 -47.72 3.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.081 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mptt -136.78 118.25 14.77 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 174.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.37 89.16 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.545 -177.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.8 t -137.43 112.61 10.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.194 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -74.86 119.26 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 79' ' ' LEU . 1.8 mp -98.23 -63.63 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.48 HG13 ' HD3' ' A' ' 75' ' ' LYS . 2.2 t -120.23 147.51 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.402 0.62 . . . . 0.0 112.4 -178.305 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 p -150.27 129.44 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.82 179.161 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -141.75 157.61 44.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.494 . . . . 0.0 112.32 -179.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.39 129.19 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.515 179.594 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.45 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 m -53.84 -25.13 18.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.7 tm? -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.77 -28.4 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.115 0.483 . . . . 0.0 110.411 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.6 mp -91.28 10.74 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.306 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 1.66 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.137 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.931 HD12 HG11 ' A' ' 64' ' ' VAL . 12.6 mt -79.26 176.04 10.04 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.723 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -93.04 69.8 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.4 -136.41 2.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.582 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.1 t-20 -140.33 -168.09 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.931 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.966 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 p -75.8 -25.14 56.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -40.42 72.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.138 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.931 HG11 HD12 ' A' ' 57' ' ' LEU . 73.2 t -94.06 -23.14 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.074 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.33 -41.66 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.735 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.01 -60.82 2.46 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.475 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.4 mt-30 -48.14 -26.19 1.78 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.241 177.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.074 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.49 -34.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.586 178.597 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.51 -31.33 54.68 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -67.94 -34.96 77.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.943 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.52 -41.48 65.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.151 177.706 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.795 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 5.1 mt -63.68 -46.33 86.02 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.91 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -68.32 -27.18 66.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -67.43 -37.16 82.58 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 109.298 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 3.2 mttt -81.34 -63.96 1.29 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.068 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -41.21 -42.34 2.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.135 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -61.15 -40.33 93.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.963 179.4 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.9 -22.57 5.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.17 -27.09 20.92 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.028 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.33 17.08 11.05 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.068 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.684 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -70.84 103.91 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.694 0.759 . . . . 0.0 110.312 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLU . 10.2 ttpt -95.75 -46.71 6.48 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.07 -178.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 140.63 52.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.379 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -127.89 167.45 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.473 0.654 . . . . 0.0 111.975 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.74 105.17 15.31 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.871 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.752 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.6 t80 -80.67 106.24 12.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.823 0.82 . . . . 0.0 112.597 -177.291 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.41 105.46 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.834 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -90.39 -48.06 7.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.675 -178.029 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.3 -112.48 2.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.163 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.16 26.84 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.834 2.356 . . . . 0.0 112.59 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 m-30 -99.66 162.54 12.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 111.368 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -132.01 148.07 52.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.886 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -44.61 103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.609 -179.858 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.06 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.142 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.31 -42.51 25.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.129 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.451 ' HB3' HD13 ' A' ' 34' ' ' ILE . 12.8 mmt-85 -56.27 -71.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.537 0.208 . . . . 0.0 110.985 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -39.46 -43.12 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.742 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.04 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.041 0.448 . . . . 0.0 111.067 -179.643 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -57.36 -36.84 71.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.213 -179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -68.32 -49.11 62.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 110.82 -179.606 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.583 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -58.65 -32.99 69.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.333 -178.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.74 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.75 -47.83 65.28 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.599 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.04 -58.32 6.37 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 177.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.91 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.36 -42.55 87.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.363 -1.419 . . . . 0.0 111.354 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -79.55 -53.77 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -48.35 -41.25 28.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.258 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.665 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.14 -49.58 61.35 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.842 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.66 -27.89 0.06 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.16 -1.019 . . . . 0.0 114.522 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.5 147.73 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.118 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.35 91.91 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 178.64 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.011 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.875 0.369 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.755 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp -126.64 134.99 50.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -105.28 124.64 49.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.771 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.813 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.1 tt -90.54 143.02 27.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.257 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.774 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -145.14 110.17 5.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.165 -179.816 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 2.2 p -100.83 123.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.072 0.463 . . . . 0.0 111.921 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.504 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -100.5 154.24 18.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 112.316 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 18.1 mtm105 -150.29 118.81 6.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.32 179.133 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 -45.28 9.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.054 0.454 . . . . 0.0 110.994 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tp 179.89 -63.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -115.29 22.2 13.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.285 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -122.2 173.15 7.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.958 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 100' ' ' LEU . 5.2 tp -158.4 132.69 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 30.8 m-85 -148.21 148.69 30.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -134.23 121.29 21.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.876 177.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -111.76 112.88 24.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -98.31 105.3 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.106 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -108.26 160.08 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -88.83 116.33 27.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.831 178.109 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.4 t0 -91.74 22.38 4.18 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.415 1.072 . . . . 0.0 112.256 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.04 -46.67 3.43 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.8 mmmt -133.16 118.31 18.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 174.705 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.56 86.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 43' ' ' LYS . 61.7 t -134.89 112.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -72.4 113.87 9.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.644 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -89.9 -57.29 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.713 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -131.62 152.76 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.234 0.54 . . . . 0.0 111.902 -178.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -150.31 119.61 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.934 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -129.66 148.56 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 112.128 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.669 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -150.39 139.97 21.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.641 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.426 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -50.96 -67.41 0.25 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 111.469 -179.737 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -58.22 -9.69 1.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -69.05 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.032 0.444 . . . . 0.0 111.668 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mp -52.59 -51.95 57.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.639 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tttt 177.5 -37.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -83.36 117.62 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.704 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HA ' ' CB ' ' A' ' 53' ' ' LEU . 17.0 tttm -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.847 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.63 106.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.699 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.22 -30.03 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.621 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.04 -161.73 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.381 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -86.73 48.97 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -94.23 -55.01 3.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 67' ' ' GLN . 63.9 t -94.03 -18.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.924 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.007 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.11 -42.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 111.95 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.03 -60.41 2.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.584 0.707 . . . . 0.0 109.205 178.648 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 25.2 mt-30 -49.18 -24.14 1.59 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.368 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.007 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.17 -32.37 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.268 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.44 -26.82 60.57 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.276 178.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 7.5 ppt_? -77.31 -38.45 50.55 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.346 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.37 72.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.77 ' CD1' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.21 -52.12 17.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.981 178.428 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.85 -23.67 67.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.532 178.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 42.7 mt-10 -77.79 -30.04 51.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB3' HG21 ' A' ' 48' ' ' VAL . 16.5 mttt -73.82 -68.29 0.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.416 177.361 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.45 -42.44 7.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.104 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -57.12 -38.89 74.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.823 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.55 -23.07 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.932 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.903 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 18.97 9.53 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.109 -178.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.41 104.93 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.559 0.695 . . . . 0.0 110.356 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 4.1 tttt -90.99 -57.22 2.88 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.372 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.91 146.91 35.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.421 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.83 165.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.5 0.667 . . . . 0.0 112.023 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.38 97.3 7.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.324 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.813 ' CE1' HD22 ' A' ' 25' ' ' LEU . 5.3 t80 -81.12 109.68 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.394 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.28 86.48 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.651 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.0 tpt180 -77.66 -27.7 50.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.046 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.29 -109.31 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.226 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.19 34.2 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.823 2.348 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 2.7 m-85 -96.34 138.11 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.124 0.488 . . . . 0.0 111.558 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 149.54 30.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.932 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.511 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -45.51 97.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.779 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.5 t-160 -110.5 159.11 17.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.459 -179.308 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -40.17 -51.44 3.55 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.492 -179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.4 mtt-85 -55.0 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.636 0.255 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -40.28 -38.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.273 179.363 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -61.16 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.012 0.434 . . . . 0.0 110.592 -179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -54.73 -36.08 64.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.99 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 34' ' ' ILE . 1.3 tt -70.35 -52.68 20.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.204 0.526 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.6 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -56.41 -32.32 64.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.319 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.794 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.6 -44.6 70.39 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.043 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.79 -57.09 8.92 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.106 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.78 -33.69 74.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.49 -1.355 . . . . 0.0 110.93 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.86 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.5 tpp85 -88.97 -24.11 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.794 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -83.6 -34.94 25.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.3 -45.35 61.41 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.921 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.03 -30.64 0.08 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.178 -1.011 . . . . 0.0 114.454 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.86 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.36 142.81 50.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.193 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 2.0 mp0 -127.7 99.8 5.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.066 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.091 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.734 0.302 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -92.84 125.52 37.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.635 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.869 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.45 144.03 26.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.869 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 m -145.82 108.53 4.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.85 HG11 HG23 ' A' ' 97' ' ' VAL . 4.5 p -98.3 123.43 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.177 0.513 . . . . 0.0 111.882 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -106.98 145.26 32.48 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -150.29 119.17 6.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.74 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.66 -69.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.072 0.463 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.6 mt -147.6 -59.16 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.441 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -119.37 4.36 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.379 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -109.1 116.25 31.59 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.994 0.426 . . . . 0.0 111.356 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.636 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.0 tp -104.09 129.09 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 20.3 m-85 -143.16 151.21 40.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.215 0.531 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -137.61 122.52 18.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.397 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 113.26 25.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.0 110.547 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.02 100.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -102.02 163.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.892 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 t0 -93.63 114.03 26.26 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -90.26 26.65 1.86 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.331 1.019 . . . . 0.0 112.419 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.67 -47.64 3.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.29 118.22 17.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.82 89.25 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.374 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.5 t -138.3 112.41 8.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -76.94 119.35 20.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.4 mp -102.32 -57.57 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -122.69 146.12 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 0.0 111.907 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -150.16 114.91 5.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -120.98 148.4 44.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.886 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.472 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.43 136.77 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.978 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 16.3 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.007 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.812 0.339 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 69.0 t -86.08 -21.46 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.198 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.067 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.6 -43.98 0.05 Allowed 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -64.12 -60.94 2.61 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.517 0.675 . . . . 0.0 109.398 178.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -48.45 -25.28 1.58 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.23 177.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.067 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.13 -33.16 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.639 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.52 -27.91 58.44 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.161 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.7 ppt_? -74.77 -38.61 62.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -70.27 -34.94 73.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 38' ' ' ILE . 1.8 tp -68.98 -54.29 16.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.82 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -61.94 -25.31 67.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.913 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.9 mt-10 -77.88 -30.22 50.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.3 mttt -72.77 -69.27 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.518 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.72 -42.55 7.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -55.85 -39.1 70.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.023 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.79 -24.01 13.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.54 -27.77 20.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.28 14.93 12.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.297 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.88 107.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.496 0.665 . . . . 0.0 110.237 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 110' ' ' GLU . 24.4 ttpt -94.53 -52.45 4.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.361 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.44 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -114.85 142.61 46.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.204 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.643 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.04 161.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.414 0.626 . . . . 0.0 112.058 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -102.02 100.88 11.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.282 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 1.9 t80 -81.06 106.25 12.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.155 0.502 . . . . 0.0 111.216 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -137.16 43.16 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.155 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' NH1' HG21 ' A' ' 97' ' ' VAL . 7.2 ptt180 -37.71 -39.18 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.809 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.72 -117.32 5.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.734 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.15 50.62 3.6 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 111.979 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.46 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 5.9 m-85 -123.22 102.23 7.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -71.52 139.33 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.881 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -52.11 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -103.73 -165.12 1.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.148 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.82 -55.81 9.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.987 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.636 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -45.77 -71.25 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.653 0.263 . . . . 0.0 110.586 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.85 HG23 HG11 ' A' ' 27' ' ' VAL . 8.8 p -42.59 -32.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -66.37 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.96 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -47.28 -35.87 8.4 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.772 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -70.18 -41.24 74.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.07 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -66.65 -34.93 78.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.461 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.742 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -66.25 -44.2 84.35 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.32 -57.0 10.93 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.97 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.26 -33.02 72.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.552 -1.324 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.1 tpp180 -90.05 -26.25 20.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.721 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.742 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.3 pt-20 -80.82 -33.33 34.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.65 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.91 -46.68 35.86 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.946 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.9 -31.42 0.07 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 119.989 -1.101 . . . . 0.0 114.731 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.835 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.3 mp -71.36 143.99 50.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' CB ' ' HG3' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -127.9 95.15 4.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.136 178.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.663 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.2 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.754 0.312 . . . . 0.0 110.585 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.5 ttp85 -101.12 127.16 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.42 140.87 29.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.757 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.15 112.34 7.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.24 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -92.74 135.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.564 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 1.4 t80 -123.93 115.64 21.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.102 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -126.27 118.72 25.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.542 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.25 -48.58 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -170.52 -64.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -117.27 20.81 13.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.405 178.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 1.5 m80 -127.74 132.68 49.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.032 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 100' ' ' LEU . 4.0 tp -121.85 118.47 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.303 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 9.2 m-85 -136.5 108.39 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.706 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -97.54 126.03 42.58 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 116.07 29.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.321 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.81 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -97.43 98.35 7.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.169 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.2 mp -100.71 165.45 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.039 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -97.16 112.07 24.02 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.721 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.1 p30 -91.12 27.04 1.97 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.15 0.906 . . . . 0.0 112.252 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -110.15 -46.9 3.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.3 mptt -134.62 118.25 17.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.83 90.33 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.341 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.6 t -140.98 112.53 3.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -76.48 123.12 25.55 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -104.02 -61.78 1.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -120.59 144.9 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.224 0.535 . . . . 0.0 111.952 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.4 p -150.21 116.06 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.175 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.859 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.54 151.22 48.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.212 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.56 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 7.1 t -150.44 134.88 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.884 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.663 ' H ' HG23 ' A' ' 34' ' ' ILE . 5.4 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.035 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 67' ' ' GLN . 53.0 t -93.99 -18.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.722 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.025 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.43 -39.32 0.12 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.8 -59.96 3.09 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.7 mt-30 -49.58 -27.28 4.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.297 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -75.01 -33.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.78 -27.26 61.07 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.7 -33.58 72.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.9 -36.62 56.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.859 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -65.39 -45.54 83.61 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -73.06 -33.27 65.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.845 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 46.4 mt-10 -71.34 -33.22 69.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 48' ' ' VAL . 19.7 mttt -70.17 -67.65 0.48 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.79 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.37 -41.08 13.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.963 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.719 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.97 -38.97 77.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.023 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.52 -23.61 10.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.946 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.53 -27.38 20.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.5 16.59 10.81 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.206 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -72.16 107.96 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.516 0.674 . . . . 0.0 110.393 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -95.15 -53.45 3.8 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.442 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -115.14 142.57 46.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.44 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.55 163.47 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.496 0.665 . . . . 0.0 111.884 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.11 98.8 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.169 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.749 ' CE1' HD22 ' A' ' 25' ' ' LEU . 2.1 t80 -81.15 113.89 19.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.459 0.647 . . . . 0.0 111.806 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.442 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -150.17 33.7 0.66 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.677 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.667 ' C ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -43.31 -41.6 4.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.795 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.465 ' N ' ' HD3' ' A' ' 88' ' ' ARG . . . 156.28 -136.61 5.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -95.73 37.85 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.193 2.595 . . . . 0.0 112.736 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' NH2' ' A' ' 88' ' ' ARG . 4.7 m-30 -88.62 84.94 6.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.339 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -71.85 133.62 45.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.559 ' C ' ' O ' ' A' ' 92' ' ' LYS . 1.4 t80 0.69 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.533 0.521 . . . . 0.0 112.304 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.536 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.1 m170 -94.18 148.31 22.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.216 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.432 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -29.01 -39.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.095 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.6 mmt180 -79.49 -65.43 1.0 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.678 0.275 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 31.8 t -30.48 -49.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -53.99 -72.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.495 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.56 -40.94 96.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.476 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 34' ' ' ILE . 2.4 tt -63.19 -45.71 90.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.473 0.654 . . . . 0.0 110.446 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.528 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -67.58 -30.32 69.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.291 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.02 -46.74 70.4 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.25 -54.71 9.69 Favored Glycine 0 CA--C 1.508 -0.393 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.965 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.83 -36.15 83.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.269 -1.465 . . . . 0.0 111.469 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -87.48 -24.25 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.412 . . . . 0.0 110.764 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -82.59 -37.47 24.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.78 -47.98 64.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.002 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.719 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -30.06 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.513 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.817 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.0 mp -71.41 143.7 50.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.444 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -127.69 99.38 5.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.881 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.895 . . . . 0.0 111.068 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.799 0.333 . . . . 0.0 110.411 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -101.54 125.16 48.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.55 143.42 26.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.821 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 m -146.97 108.76 4.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.966 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG21 HD13 ' A' ' 100' ' ' LEU . 7.7 p -93.39 119.77 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.07 140.22 37.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.785 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 34' ' ' ILE . 3.2 mmm180 -150.08 118.92 6.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.951 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.74 -64.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.21 0.529 . . . . 0.0 110.291 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 -58.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -119.71 2.28 11.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.634 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -110.33 117.66 34.22 Favored 'General case' 0 N--CA 1.46 0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 112.089 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.86 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.8 tp -106.45 131.0 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.768 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' A' ' 34' ' ' ILE . 37.1 m-85 -148.98 111.97 4.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.721 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -93.72 123.59 37.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.56 113.52 26.38 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -99.04 96.51 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -98.4 164.7 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.306 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -95.61 113.19 24.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 10.0 t70 -88.35 21.83 2.72 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.376 1.048 . . . . 0.0 112.352 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.47 -48.85 3.18 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.3 mmtp -129.77 118.17 21.4 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.72 87.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.722 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 43' ' ' LYS . 53.0 t -136.39 112.5 12.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -75.86 117.81 17.99 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -101.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.07 143.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 112.238 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.03 114.69 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.36 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -120.81 159.18 25.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -144.89 126.86 15.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.49 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.628 ' N ' HG21 ' A' ' 68' ' ' VAL . 1.3 m . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.35 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.751 0.31 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 67' ' ' GLN . 97.9 t -80.73 -19.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.662 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.052 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.22 -37.96 0.08 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.904 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -69.66 -58.9 3.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.4 mt-30 -49.84 -22.63 1.53 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.488 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.052 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.23 -33.63 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -76.64 -33.6 46.75 Favored Glycine 0 C--O 1.217 -0.93 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.131 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -72.31 -41.78 66.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.95 -40.58 91.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -64.34 -54.49 32.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.2 -25.25 31.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.8 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.8 tt0 -72.14 -36.85 69.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 10.2 mttp -71.85 -64.49 0.92 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.843 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.821 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.88 -42.65 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.318 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.772 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -59.23 -40.8 87.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.257 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -51.44 -25.66 6.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.417 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.42 -28.0 20.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 12.9 13.18 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.627 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.78 104.1 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.649 0.738 . . . . 0.0 110.036 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 110' ' ' GLU . 21.2 ttpp -92.79 -49.75 5.91 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.147 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -117.43 136.31 53.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.362 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.533 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.89 162.93 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.376 0.608 . . . . 0.0 111.838 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.2 102.55 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.47 121.19 25.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.49 . . . . 0.0 111.549 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 1.3 t70 -148.48 45.88 1.04 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.162 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.9 ptt-85 -40.39 -31.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.661 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.48 -125.01 7.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.5 59.84 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.418 2.078 . . . . 0.0 111.754 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 8.4 m-85 -131.66 157.51 43.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 111.391 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -132.21 140.78 48.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.357 178.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.508 ' CZ ' ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -41.0 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.917 ' CE1' HG23 ' A' ' 97' ' ' VAL . 18.8 p80 -112.88 151.16 30.79 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 94' ' ' HIS . . . -20.88 -55.97 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.164 -0.925 . . . . 0.0 114.039 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.86 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.9 mmp_? -57.63 -64.54 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.917 HG23 ' CE1' ' A' ' 94' ' ' HIS . 88.7 t -35.41 -46.65 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.567 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HD3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.36 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.44 -43.27 62.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.889 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -61.62 -45.22 95.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.347 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.564 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -65.72 -37.63 86.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.805 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.809 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -67.42 -42.65 82.86 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.14 -58.94 8.07 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.972 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.92 -35.13 74.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.82 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -87.92 -30.43 20.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.418 . . . . 0.0 110.692 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.809 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.0 pt-20 -74.22 -35.15 63.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.659 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.72 -46.26 54.69 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.458 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.772 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.42 -27.76 0.08 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.941 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.3 mp -71.46 145.24 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER -128.16 93.98 3.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.504 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.696 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.938 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.428 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 16.3 ttp-105 -101.28 125.0 47.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.11 141.76 28.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.938 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.27 107.95 5.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.084 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.6 p -95.53 116.5 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.263 0.554 . . . . 0.0 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -93.61 134.98 35.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.972 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.71 ' NH2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -123.34 118.12 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 t -90.25 -79.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.06 -58.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.36 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.27 1.85 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.182 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.15 174.57 6.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.342 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.71 HD12 ' NH2' ' A' ' 29' ' ' ARG . 2.8 tp -150.45 111.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -136.56 140.67 43.1 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -128.54 127.95 43.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.257 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.05 114.02 25.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.038 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -98.19 95.2 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.317 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -95.84 163.89 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.858 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.4 t0 -95.19 114.71 26.53 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.711 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.6 t70 -90.28 23.53 2.87 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.405 1.065 . . . . 0.0 112.311 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.13 -47.77 3.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.19 118.17 16.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 174.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.95 89.97 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.28 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.0 t -139.63 112.42 5.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -72.1 113.6 9.31 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.9 mp -92.86 -65.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.91 148.33 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.266 0.555 . . . . 0.0 111.63 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -150.14 114.84 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.654 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -123.62 138.98 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 111.853 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 36.9 p -150.3 132.63 15.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.595 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.8 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 67' ' ' GLN . 73.9 t -94.26 -22.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.766 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.035 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.92 -39.8 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.673 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.35 -59.55 3.32 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.525 0.678 . . . . 0.0 109.172 178.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.5 mt-30 -49.66 -26.56 3.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.205 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.035 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.43 -32.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.38 -26.39 63.72 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 8.2 ptt85 -73.47 -39.83 64.61 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 70' ' ' ARG . . . -68.57 -36.23 78.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.038 HD21 HD11 ' A' ' 38' ' ' ILE . 1.1 tp -68.69 -53.48 21.97 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.015 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -63.35 -25.12 68.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.528 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 15.8 mt-10 -78.2 -29.98 48.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mttt -71.82 -69.16 0.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.403 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.84 -42.84 8.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.181 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.697 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.5 mt -56.02 -39.16 71.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.71 -24.58 8.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.071 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.71 -27.04 20.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.62 21.82 7.0 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.061 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' CG1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.53 102.84 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.136 0.494 . . . . 0.0 110.771 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.652 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.97 -25.62 12.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -125.27 125.24 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.187 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.12 164.54 23.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 112.06 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.31 105.51 15.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.391 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.37 118.01 22.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.394 0.616 . . . . 0.0 112.011 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.03 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.644 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.43 -29.57 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 88' ' ' ARG . . . 123.12 -151.43 16.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.94 55.99 4.63 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.927 2.418 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.484 ' CG ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m-30 -100.18 166.52 10.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.024 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.91 153.51 50.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -47.33 109.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.502 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.496 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -126.25 156.53 40.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -38.44 -30.01 0.08 OUTLIER Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.633 ' CD ' HD13 ' A' ' 34' ' ' ILE . 1.2 mmt85 -76.7 -70.97 0.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.598 0.237 . . . . 0.0 111.606 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 60.0 t -31.01 -50.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -57.96 -75.06 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.864 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.58 -37.67 68.37 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.172 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.1 tt -67.66 -49.16 64.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.3 -33.16 73.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.402 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.758 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -66.53 -46.54 75.81 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.08 -57.91 7.52 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.949 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.15 -39.95 80.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.354 -1.423 . . . . 0.0 111.428 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.841 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -82.58 -51.42 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -49.44 -40.57 37.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.58 -48.81 64.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.359 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.14 -26.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.092 -1.051 . . . . 0.0 114.713 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.841 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.37 145.98 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -128.2 91.99 3.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.455 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.3 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.955 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 120.837 0.351 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -93.02 124.32 36.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.35 143.54 26.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.832 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -144.61 108.48 4.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.753 0.311 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.629 HG21 HH22 ' A' ' 29' ' ' ARG . 2.8 p -97.68 121.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.872 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.26 139.54 41.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.831 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.629 HH22 HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -150.31 126.25 10.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.518 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -80.73 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.765 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.9 -51.25 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -119.1 23.18 11.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.904 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -123.91 172.44 8.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.133 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -160.22 126.95 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.996 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.792 ' N ' HD12 ' A' ' 34' ' ' ILE . 41.9 m-85 -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.056 0.455 . . . . 0.0 112.024 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -134.75 121.36 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.14 113.36 25.58 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 110.485 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.78 99.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.3 mp -101.37 161.81 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.197 -0.911 . . . . 0.0 113.315 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -93.79 110.5 22.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.443 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -88.32 27.43 1.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.235 0.959 . . . . 0.0 112.552 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.35 -48.54 3.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.62 118.32 19.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 174.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.22 88.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' LYS . 95.8 t -136.81 112.67 11.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -76.55 119.33 20.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.505 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.8 mp -98.84 -62.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.42 148.63 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 112.302 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 14.1 p -150.21 131.01 14.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.064 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.01 165.74 24.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 0.0 111.755 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.15 126.86 10.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.075 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.612 ' N ' HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.514 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.876 0.369 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 67' ' ' GLN . 89.6 t -94.16 -15.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.862 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.36 -41.5 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.897 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.65 -59.48 3.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.8 mt-30 -49.7 -23.41 1.75 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.478 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.38 -32.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.04 -28.4 56.45 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -73.88 -37.95 64.55 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.04 -35.41 69.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -67.68 -53.79 24.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.74 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.83 -26.26 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -75.89 -33.0 59.92 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 14.9 mttt -72.15 -68.97 0.42 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.816 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.73 -42.22 5.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.274 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.786 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -56.81 -40.03 75.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.062 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.14 -23.85 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.13 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.45 18.9 9.21 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.193 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.43 102.98 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.58 0.705 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.4 tttt -88.13 -59.37 2.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.705 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.408 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -107.25 148.24 29.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.398 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.56 158.91 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.369 0.604 . . . . 0.0 112.107 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.77 101.9 12.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.77 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.707 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.47 114.92 20.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.149 0.499 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.79 56.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -44.57 -40.2 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.47 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.32 -111.79 3.15 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.686 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.09 28.15 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.907 2.405 . . . . 0.0 112.693 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.0 m-30 -96.58 164.08 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -131.92 150.31 52.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -51.18 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.223 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -115.43 169.58 9.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.3 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.25 -38.27 4.93 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.759 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 7.1 mmt180 -62.54 -70.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 44.1 t -37.94 -41.74 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 110.887 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.58 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.116 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -58.88 -37.04 75.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.092 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.76 -47.83 68.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.223 0.535 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.54 -31.64 72.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.508 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.07 -44.02 73.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.35 -57.65 10.04 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.995 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.88 -31.53 72.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.71 -1.245 . . . . 0.0 111.187 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.7 mtm-85 -89.83 -25.68 20.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -82.46 -33.87 28.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.657 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.93 -47.38 39.21 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.992 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.786 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.87 -29.25 0.07 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 119.857 -1.164 . . . . 0.0 114.867 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.822 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.6 mp -71.1 146.19 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.8 mp0 -127.72 91.82 3.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.417 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.649 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.4 p90 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.894 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.945 0.402 . . . . 0.0 110.616 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -101.29 126.52 48.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.02 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.856 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.7 tt -89.69 142.53 27.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.82 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -146.47 108.7 4.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 100' ' ' LEU . 11.9 p -96.77 117.16 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.256 0.551 . . . . 0.0 111.748 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.02 137.22 38.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.834 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -143.35 118.85 10.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.934 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.75 -80.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.877 0.37 . . . . 0.0 110.717 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -127.37 -65.38 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 17.46 13.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.113 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -117.05 140.36 49.58 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 121.123 0.487 . . . . 0.0 111.6 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.808 HD11 HD13 ' A' ' 100' ' ' LEU . 6.5 tp -127.97 129.46 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 30.0 m-85 -144.92 112.21 6.07 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.25 120.93 34.09 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.8 113.01 25.28 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.486 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.935 HD11 ' CD2' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.75 102.27 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.323 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -99.2 161.41 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.686 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 t70 -92.36 117.86 30.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.986 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.7 t0 -91.95 22.72 4.09 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 124.411 1.069 . . . . 0.0 112.198 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -107.23 -47.47 3.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.04 118.1 15.39 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.04 90.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.173 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.3 t -137.93 112.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -73.43 116.73 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -99.66 -58.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.83 142.48 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.324 0.583 . . . . 0.0 112.226 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -150.17 114.86 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.876 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -125.3 161.9 25.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 111.796 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -143.76 137.52 28.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.798 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.686 ' N ' HG21 ' A' ' 68' ' ' VAL . 9.2 p . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.72 0.295 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 67' ' ' GLN . 84.4 t -94.18 -18.58 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.6 -38.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.848 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.68 -58.59 3.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -50.27 -23.06 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.473 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.03 -34.52 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.57 -33.28 48.14 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.155 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -71.71 -42.27 67.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.652 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.77 -42.62 90.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.935 ' CD2' HD11 ' A' ' 38' ' ' ILE . 4.3 tp -65.06 -51.71 59.93 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.79 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.88 -26.21 46.15 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.403 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -71.88 -35.94 69.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.821 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.6 mttt -73.19 -63.6 1.15 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.801 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.91 -41.95 7.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.285 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -60.62 -41.02 94.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.18 -25.9 6.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.38 -27.29 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 10.06 19.23 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.251 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.489 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.1 103.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.586 0.708 . . . . 0.0 110.192 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 110' ' ' GLU . 7.5 tttm -92.8 -55.5 3.34 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.044 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.2 OUTLIER -111.07 139.13 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.362 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.56 163.76 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 111.762 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.16 104.95 14.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.639 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.856 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.48 113.46 19.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.787 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -137.32 44.22 2.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.952 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 17.4 ptt-85 -40.57 -32.07 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.44 -128.67 9.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.273 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.79 52.66 3.02 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.654 2.236 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 4.4 m-85 -117.34 142.11 47.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -115.01 149.76 36.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.13 105.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.529 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -123.87 163.97 20.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.0 -27.97 3.74 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.869 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 34' ' ' ILE . 16.1 mmt180 -68.88 -70.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.399 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 24.7 t -39.43 -38.4 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.42 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.4 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.965 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.91 -36.54 70.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.816 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 34' ' ' ILE . 2.1 tt -68.47 -48.96 63.12 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 111.155 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.93 -31.02 69.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.178 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.97 -46.46 68.05 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.17 -58.47 7.12 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.944 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.59 -37.81 82.57 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.574 -1.313 . . . . 0.0 111.387 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -86.43 -29.34 22.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 110.92 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.7 pt-20 -74.15 -37.55 63.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.668 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.23 -47.17 73.97 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.103 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 173.52 -26.31 0.08 OUTLIER Glycine 0 C--N 1.342 0.901 0 C-N-CA 120.173 -1.013 . . . . 0.0 114.72 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.49 145.0 49.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.23 95.95 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.42 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.021 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 110.41 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp85 -101.15 125.36 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.57 143.32 26.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.852 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.887 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -136.5 147.9 47.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.734 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HE ' ' A' ' 88' ' ' ARG . 2.6 p -140.59 118.65 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.361 0.6 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -108.68 142.16 39.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.739 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 32.8 mtm180 -142.7 122.38 13.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.143 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 t -89.36 -78.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.331 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.29 -58.54 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -119.32 23.21 11.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.941 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.51 169.84 9.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.873 HD11 HD13 ' A' ' 100' ' ' LEU . 2.1 tp -156.35 131.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.555 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 51' ' ' SER . 30.8 m-85 -147.3 148.29 31.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.978 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.89 121.17 19.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.04 112.97 24.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.21 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.089 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -94.52 92.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.4 mp -96.55 162.09 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.741 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.493 ' N ' HG22 ' A' ' 39' ' ' ILE . 2.0 t0 -96.83 108.76 21.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.4 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.91 26.85 1.45 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.163 0.914 . . . . 0.0 112.242 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.02 -47.34 3.22 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mttt -133.12 118.17 18.38 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.16 90.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.588 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' LYS . 63.0 t -139.1 112.62 6.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -78.65 118.94 21.22 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 79' ' ' LEU . 1.1 mp -102.64 -56.96 2.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' HD3' ' A' ' 75' ' ' LYS . 1.9 t -117.14 144.84 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.641 . . . . 0.0 112.287 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -150.33 114.6 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.342 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -134.32 153.09 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.042 0.449 . . . . 0.0 112.106 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 2.4 t -150.42 131.12 14.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 34' ' ' ILE . 20.1 m . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.409 . . . . 0.0 110.382 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.293 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 67' ' ' GLN . 72.1 t -94.07 -24.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.062 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.59 -42.44 0.05 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.017 0.437 . . . . 0.0 111.724 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.65 -60.25 3.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.501 ' HB2' HG13 ' A' ' 64' ' ' VAL . 3.6 mp0 -47.55 -26.43 1.43 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.247 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.062 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.93 -32.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.977 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.38 -30.18 46.48 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.464 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.94 -39.9 65.85 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -69.15 -37.55 78.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.089 HD21 HD11 ' A' ' 38' ' ' ILE . 1.4 tp -65.9 -53.42 39.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.305 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.69 -23.36 67.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.153 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.61 -29.76 56.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.5 -47.73 7.79 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -51.58 -40.21 59.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.765 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -60.11 -38.56 83.38 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.781 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.18 -22.96 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.44 -26.89 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 16.0 13.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.058 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.577 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.55 0.691 . . . . 0.0 110.251 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.5 tttt -89.78 -57.72 2.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.216 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -111.47 147.41 35.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.293 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -134.58 164.05 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.358 0.599 . . . . 0.0 112.058 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.53 101.75 12.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.192 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.663 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -81.04 106.01 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.349 0.595 . . . . 0.0 112.37 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' N ' ' NH1' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -142.8 75.25 1.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.237 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -57.39 -38.02 73.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.095 0.474 . . . . 0.0 110.584 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.04 -110.79 2.59 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -90.09 31.15 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.833 2.355 . . . . 0.0 112.334 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 2.8 m-85 -103.06 154.91 18.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.2 150.8 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.222 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -47.82 109.68 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.414 ' O ' ' NZ ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -121.27 -77.78 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.66 -54.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.784 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.454 ' HD2' HD13 ' A' ' 34' ' ' ILE . 3.2 mtt180 -54.53 -59.59 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 27.2 t -40.1 -40.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.952 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.91 -76.33 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.935 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -61.1 -34.77 75.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.831 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 34' ' ' ILE . 2.7 tt -66.57 -48.39 69.75 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.769 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.14 -33.41 74.44 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.239 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.804 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.73 -45.41 75.1 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.3 -57.02 8.51 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.96 -36.3 81.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.465 -1.368 . . . . 0.0 111.341 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 2.5 tpp85 -87.13 -28.52 22.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.932 0.396 . . . . 0.0 110.683 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -76.6 -35.69 57.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.655 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.64 -48.16 51.8 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.554 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.765 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.42 -27.74 0.07 OUTLIER Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.657 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.837 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.2 mp -71.22 143.34 50.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -127.74 93.83 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.375 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.119 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 120.72 0.295 . . . . 0.0 110.793 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -95.4 126.28 40.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.467 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.844 HD23 ' N ' ' A' ' 26' ' ' SER . 3.3 tt -89.47 142.75 27.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.1 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.844 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.67 108.82 5.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.128 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.802 HG11 HG22 ' A' ' 97' ' ' VAL . 3.3 p -98.29 125.28 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.615 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.76 143.19 41.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.11 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.4 tpt180 -150.19 119.01 6.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.999 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -89.81 -44.07 10.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.459 . . . . 0.0 110.757 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER 179.92 -54.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.737 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.0 tttt -119.28 7.57 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.648 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 9.0 m170 -125.97 131.05 52.33 Favored 'General case' 0 N--CA 1.46 0.042 0 CA-C-O 120.959 0.409 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.748 HD11 HD13 ' A' ' 100' ' ' LEU . 2.9 tp -118.24 132.21 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.621 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 34' ' ' ILE . 29.9 m-85 -145.82 111.04 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -96.21 122.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 113.26 25.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.734 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.34 98.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -99.51 162.67 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.148 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 t0 -93.38 114.02 26.33 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.75 25.98 2.54 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.17 0.919 . . . . 0.0 112.189 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -109.48 -48.13 3.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.79 118.18 17.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 174.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.8 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.31 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.0 t -138.85 112.56 7.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.81 122.57 23.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.483 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.6 mp -104.43 -64.2 1.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.49 144.4 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 111.96 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -150.2 125.16 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -131.05 160.91 33.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.749 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 126.42 13.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.286 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.406 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 67' ' ' GLN . 48.4 t -94.06 -14.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.072 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -29.93 -44.11 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.66 -61.03 2.32 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.583 0.706 . . . . 0.0 109.368 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -48.27 -25.88 1.74 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.154 177.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.072 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.86 -36.39 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.8 -28.23 65.41 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.796 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 11.7 ptt180 -70.04 -36.49 75.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.31 -37.77 68.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.751 ' CD2' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -67.1 -45.69 76.46 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.52 0.676 . . . . 0.0 109.436 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.99 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -72.35 -27.78 62.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.829 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 41.1 mt-10 -78.5 -29.67 46.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 15.4 mttt -72.79 -69.23 0.42 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.474 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.63 -43.42 12.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.316 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.747 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.1 mt -55.76 -39.74 71.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.84 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.84 -24.5 9.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.73 -29.38 18.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.53 15.8 8.59 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.635 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.586 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.99 106.98 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.616 0.722 . . . . 0.0 110.307 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -97.03 -48.32 5.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.427 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.376 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -117.0 163.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.317 0.579 . . . . 0.0 111.785 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.37 105.99 15.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.738 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.46 113.68 19.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.178 0.513 . . . . 0.0 111.602 -178.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.57 44.36 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.118 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 12.8 ptt-85 -40.71 -48.01 2.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.54 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.47 -114.08 2.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.64 -10.66 13.08 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.2 m-85 -57.25 132.63 53.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.02 154.88 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.105 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.528 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -45.21 108.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.04 0.448 . . . . 0.0 110.629 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -119.25 -125.69 0.28 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.394 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.61 -12.24 3.8 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.902 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mmt-85 -89.4 -68.97 0.74 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.926 0.363 . . . . 0.0 110.746 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.802 HG22 HG11 ' A' ' 27' ' ' VAL . 57.4 t -38.81 -28.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.658 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.121 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.01 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.83 -38.96 7.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.178 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -67.91 -46.67 70.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.162 0.506 . . . . 0.0 110.608 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -63.95 -33.22 75.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.081 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.806 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.47 -45.61 75.44 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.547 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.32 -56.8 8.8 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.99 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -34.39 77.16 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 113.507 -1.346 . . . . 0.0 111.543 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.867 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -90.09 -26.45 20.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 0.0 110.809 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.806 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.4 pt-20 -78.07 -32.1 50.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -75.37 -45.43 18.89 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.747 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.54 -32.43 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 119.935 -1.126 . . . . 0.0 114.87 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.867 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.33 146.17 49.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.26 93.19 3.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.484 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.982 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 37.0 ttp85 -100.43 123.76 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.86 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.46 144.67 25.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.428 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.846 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -148.71 108.04 3.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.094 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 7.2 p -92.99 115.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.385 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 139.26 31.59 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.929 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' NH2' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -140.02 118.17 11.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.93 -155.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -71.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -120.12 35.39 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.39 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -115.33 132.9 56.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.18 0.515 . . . . 0.0 112.305 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -121.2 111.6 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.666 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 38.4 m-85 -146.42 154.07 41.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.412 0.625 . . . . 0.0 112.675 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -135.21 129.82 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.946 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.97 115.0 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.114 0.483 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -99.72 94.07 3.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.316 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -94.43 164.62 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.659 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.2 t0 -96.75 115.27 27.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 7.9 t0 -90.89 23.72 3.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.346 1.028 . . . . 0.0 112.319 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -108.09 -47.37 3.57 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mptp? -135.4 118.16 16.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.12 90.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.343 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.4 t -140.69 112.29 4.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.7 119.82 17.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -99.97 -63.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -118.08 148.68 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 112.153 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -150.11 129.98 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.72 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.95 162.48 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 112.147 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.31 134.83 17.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.436 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.573 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.83 0.347 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 67' ' ' GLN . 57.4 t -94.15 -15.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.695 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.012 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.58 -38.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 111.932 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.36 -59.59 2.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.0 mt-30 -49.46 -22.74 1.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.374 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.012 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -82.69 -32.79 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -77.23 -28.37 58.25 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.216 -0.992 . . . . 0.0 111.005 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 3.5 ppt_? -76.74 -38.75 53.65 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.42 -34.38 74.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 38' ' ' ILE . 1.1 tm? -69.45 -56.26 7.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.593 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.007 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.37 -24.77 63.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.989 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 51.6 mt-10 -79.14 -30.95 43.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.6 mttt -70.27 -68.91 0.39 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.271 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.38 -44.04 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.2 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -55.4 -40.11 71.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.975 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.68 -24.93 9.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.032 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.72 -28.73 19.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.0 18.02 8.56 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.575 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.28 105.68 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 110.52 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 110' ' ' GLU . 28.7 tttp -90.32 -59.39 2.2 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.204 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -109.02 140.82 42.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.24 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.79 162.52 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 111.949 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.84 103.42 13.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.841 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.86 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.45 111.38 17.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.21 0.529 . . . . 0.0 111.666 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.48 44.45 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.111 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 ptt-85 -42.09 -46.14 4.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.489 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.38 -131.92 7.58 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.184 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.46 48.97 2.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.595 2.197 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.4 m-30 -100.49 155.75 17.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.91 154.76 48.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.279 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.6 109.67 0.27 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.979 0.418 . . . . 0.0 110.55 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -115.99 -124.29 0.29 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.409 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.13 -27.46 1.22 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 34' ' ' ILE . 8.5 mtt-85 -78.07 -67.24 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.606 0.241 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.9 t -37.74 -29.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.019 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.46 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -49.39 -41.11 38.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -64.94 -46.15 82.78 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.198 0.523 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.66 -35.25 79.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.603 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.826 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.34 -46.86 59.52 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -46.9 -54.69 9.05 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -65.59 -33.91 77.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.238 -1.481 . . . . 0.0 111.382 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -90.09 -22.47 21.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.573 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -84.34 -32.34 24.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.85 -45.79 25.96 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.91 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.813 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.77 -30.69 0.08 OUTLIER Glycine 0 C--N 1.342 0.875 0 C-N-CA 120.012 -1.089 . . . . 0.0 114.833 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 76' ' ' ALA . 7.7 mp -71.11 142.87 50.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.75 93.76 3.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.533 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.657 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.999 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp . . . . . 0 CA--C 1.52 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp180 -104.37 126.41 51.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.78 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.853 HD23 ' N ' ' A' ' 26' ' ' SER . 3.6 tt -89.7 143.69 26.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.976 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.853 ' N ' HD23 ' A' ' 25' ' ' LEU . 16.0 m -144.79 108.31 4.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.728 0.299 . . . . 0.0 110.675 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 100' ' ' LEU . 5.8 p -97.07 120.7 46.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.193 0.52 . . . . 0.0 111.802 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -100.75 148.9 24.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.781 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' NH1' ' A' ' 29' ' ' ARG . 15.1 mtm105 -150.4 120.68 7.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -89.71 -84.64 0.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.671 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -61.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.13 21.62 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.8 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -116.95 156.71 26.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 100' ' ' LEU . 4.3 tp -141.75 130.98 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.757 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.509 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 38.4 m-85 -148.95 150.33 32.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 0.0 111.845 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.937 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -133.27 121.41 22.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.414 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.76 113.34 25.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.487 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.063 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.12 105.14 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.369 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -102.44 158.73 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' N ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -89.61 119.55 30.13 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.877 178.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -93.19 23.56 4.31 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.432 1.082 . . . . 0.0 112.294 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -106.86 -47.64 3.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.258 -2.126 . . . . 0.0 105.258 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mttt -137.95 118.1 13.53 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.5 90.46 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.489 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' LYS . 87.3 t -138.59 112.5 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -69.93 113.12 6.85 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -90.56 -57.5 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 75' ' ' LYS . 1.8 t -127.56 148.96 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.299 0.571 . . . . 0.0 112.123 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 58.5 p -150.21 114.9 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.786 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.86 ' HB2' ' CE ' ' A' ' 75' ' ' LYS . . . -129.62 150.93 50.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 112.028 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.509 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.4 t -150.42 149.97 30.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.606 ' N ' HG21 ' A' ' 68' ' ' VAL . 37.2 m . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.688 0.28 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 67' ' ' GLN . 78.8 t -92.22 -25.73 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.59 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.04 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.66 -40.69 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.999 0.428 . . . . 0.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.03 -59.56 3.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.484 0.659 . . . . 0.0 109.278 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 12.9 mt-30 -49.41 -26.15 3.05 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.225 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.04 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -76.8 -32.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.425 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.9 -26.33 60.6 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.838 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 10.3 ptt180 -72.22 -39.21 68.7 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.47 -38.93 77.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.063 HD21 HD11 ' A' ' 38' ' ' ILE . 1.5 tp -66.14 -52.34 49.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.171 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.37 -27.17 68.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.57 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 29.6 mt-10 -77.13 -32.48 56.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.86 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 11.8 mtmm -71.48 -68.69 0.43 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.726 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.01 -43.12 6.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.19 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.11 -38.28 70.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.027 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.78 -23.11 16.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.899 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.561 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.43 -26.5 20.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.33 17.35 10.08 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.138 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.715 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.25 102.91 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.686 0.755 . . . . 0.0 110.271 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -97.02 -46.78 6.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.954 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.03 134.86 54.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -126.22 165.85 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.965 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.47 106.12 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.63 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.756 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.4 120.45 24.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.267 0.556 . . . . 0.0 111.73 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.05 51.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.067 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.2 -31.33 0.37 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.523 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.17 -119.06 5.59 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.99 20.63 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.734 2.29 . . . . 0.0 112.426 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.597 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.6 m-30 -80.81 159.45 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 154.81 48.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.369 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.468 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -43.77 109.35 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.571 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.497 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.2 t-80 -124.67 157.96 34.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.477 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -41.13 -26.7 0.18 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.689 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -82.09 -67.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.689 0.244 . . . . 0.0 111.182 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 90.0 t -29.83 -50.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -57.72 -75.37 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.801 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.75 -38.15 66.81 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.228 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.51 -47.26 70.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.447 0.641 . . . . 0.0 110.428 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.1 -32.13 72.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.384 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.785 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -68.12 -44.65 75.66 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.67 -58.41 8.38 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.942 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.75 -35.35 74.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.621 -1.289 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.866 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.99 -30.65 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.861 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.785 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -72.2 -34.91 68.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.627 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -70.52 -46.91 45.18 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.797 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.26 -29.07 0.07 OUTLIER Glycine 0 C--N 1.341 0.831 0 C-N-CA 120.052 -1.07 . . . . 0.0 114.752 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.866 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.45 145.52 49.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -128.12 92.58 3.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.296 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.997 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.806 HD22 HG13 ' A' ' 81' ' ' ILE . 3.7 mp . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.99 0.424 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 4.7 ttp180 -98.83 124.87 44.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.289 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.33 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.359 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.814 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.76 108.73 4.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.153 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.553 HG21 HD13 ' A' ' 100' ' ' LEU . 9.2 p -99.19 115.48 39.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -93.02 152.06 19.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 55.6 mtm-85 -149.15 118.91 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.916 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -46.4 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.994 0.426 . . . . 0.0 111.066 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.34 -59.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -116.73 12.68 14.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.323 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.3 174.36 6.1 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.779 HD11 HD13 ' A' ' 100' ' ' LEU . 6.9 tp -159.99 115.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 5.3 m-85 -129.68 111.21 12.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.996 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.79 123.32 37.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -115.59 117.02 29.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.448 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -98.87 101.77 12.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.2 mp -101.52 161.61 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.966 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.528 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.42 117.27 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.715 177.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 5.6 t0 -93.3 27.45 2.54 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.278 0.986 . . . . 0.0 112.282 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HG2' ' HD3' ' A' ' 43' ' ' LYS . 2.6 tt0 -108.8 -46.48 3.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -137.94 118.14 13.58 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.32 89.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.503 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.5 t -137.89 112.53 9.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -75.65 124.54 27.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 23' ' ' LEU . 1.2 mp -107.35 -58.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.724 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.1 t -120.06 141.71 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 112.076 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' NE2' ' A' ' 37' ' ' GLN . 80.6 p -150.23 114.79 5.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.5 151.89 48.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.02 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.0 p -150.58 142.74 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.602 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.468 ' HB2' ' CG2' ' A' ' 34' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.93 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.617 0.246 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 67' ' ' GLN . 94.3 t -94.05 -21.73 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.081 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -36.92 -38.21 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 0.0 110.855 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.5 -58.96 3.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 12.7 mt-30 -49.81 -23.02 1.64 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.667 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.081 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -78.29 -37.01 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -75.63 -36.21 43.94 Favored Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -66.43 -36.55 83.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -62.75 -53.87 47.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.776 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.66 -46.04 87.43 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.906 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.46 -27.15 46.39 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.689 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.4 tt0 -73.61 -35.34 65.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.724 ' HB2' HG21 ' A' ' 48' ' ' VAL . 7.5 mttt -74.79 -63.7 1.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.907 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.89 -42.55 5.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.2 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -58.54 -40.68 83.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.4 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.01 -24.81 7.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.491 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.28 -27.13 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.57 11.57 19.11 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.15 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.806 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -64.02 103.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.616 0.722 . . . . 0.0 110.142 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -91.7 -57.47 2.74 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.345 -178.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -109.52 143.19 39.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.387 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.668 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -130.49 162.91 37.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.636 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.38 103.6 13.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.808 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.48 112.48 18.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -142.65 51.44 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.668 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -41.21 -38.37 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.651 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.09 -124.93 6.25 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.34 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -90.05 42.87 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.873 2.382 . . . . 0.0 112.066 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.668 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.7 m-30 -99.56 163.6 12.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.229 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 154.64 49.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -46.88 112.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.593 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.3 t60 -133.43 154.04 51.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.301 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -33.47 -37.04 0.06 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.851 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.736 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.0 mmt85 -70.74 -70.86 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.586 0.193 . . . . 0.0 111.407 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 98.5 t -29.91 -51.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.551 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -56.75 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 110.292 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.92 -43.0 49.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.14 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -66.66 -49.09 67.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.458 0.646 . . . . 0.0 110.649 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.559 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.08 -34.82 68.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.081 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.761 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.32 -43.3 81.95 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.06 -61.5 5.72 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.906 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.12 -41.83 68.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.932 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -79.21 -55.68 4.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.761 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.6 pt-20 -46.58 -43.33 17.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.689 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.84 -50.01 72.3 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.994 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.16 -25.48 0.07 OUTLIER Glycine 0 C--N 1.341 0.859 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.667 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.84 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.48 146.41 48.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.18 93.08 3.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.215 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.018 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 81' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.747 0.308 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 7.0 ptt180 -96.18 126.86 41.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.0 tt -89.43 140.79 29.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.554 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.829 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.0 t -142.3 114.07 8.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 110.996 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 100' ' ' LEU . 4.0 p -101.53 120.35 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.215 0.531 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.466 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -99.14 148.97 23.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.964 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HD2' ' CG ' ' A' ' 96' ' ' ARG . 15.8 mtm-85 -146.72 119.76 8.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.584 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.79 -50.64 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tt -179.24 -54.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.362 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 10.12 12.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.885 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -119.55 148.15 43.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 100' ' ' LEU . 4.1 tp -131.18 131.61 63.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.704 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 29.6 m-85 -146.95 149.93 34.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.832 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.933 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.18 120.93 19.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.221 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.816 ' HG3' HD11 ' A' ' 39' ' ' ILE . 4.8 pt20 -113.63 113.06 24.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.316 0.579 . . . . 0.0 109.921 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.081 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -90.92 97.15 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.85 164.26 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.283 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -99.53 103.16 14.88 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.485 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -86.65 27.16 1.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.172 0.92 . . . . 0.0 112.328 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -113.09 -47.9 3.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -129.33 118.5 22.35 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 174.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.63 86.29 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.725 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 43' ' ' LYS . 47.3 t -137.51 112.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.421 ' HA ' HG23 ' A' ' 39' ' ' ILE . 22.5 m -77.11 122.66 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.626 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.4 mp -103.19 -64.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -123.12 147.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 111.876 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 21.8 p -150.6 117.36 5.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.729 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.12 151.23 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.237 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.8 t -150.3 147.24 27.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.751 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' HG21 ' A' ' 68' ' ' VAL . 5.9 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.25 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.771 0.32 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 67' ' ' GLN . 72.8 t -91.93 -19.0 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.683 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.74 -43.75 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -64.74 -61.34 2.25 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.499 0.666 . . . . 0.0 109.365 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 23.5 mt-30 -48.47 -24.56 1.32 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.4 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.32 -33.41 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.653 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.89 -27.43 58.54 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.167 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -75.01 -39.53 61.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.05 -34.39 71.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -68.91 -54.44 15.49 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.845 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.016 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.04 -26.11 68.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.974 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 48.3 mt-10 -77.49 -31.18 53.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 21.0 mttt -72.51 -68.74 0.45 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.523 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.25 -43.21 7.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.828 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.04 -39.86 72.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.942 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.9 -23.81 14.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.43 -27.89 20.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.82 15.51 13.07 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.252 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -72.98 102.98 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 110.202 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -91.24 -57.3 2.83 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.423 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.11 137.97 46.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.84 166.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.368 0.604 . . . . 0.0 111.666 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -115.33 109.41 17.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.834 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -80.53 106.36 12.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.299 0.571 . . . . 0.0 111.919 -177.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.6 46.09 2.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.277 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.29 -45.49 5.91 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.26 -112.83 3.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.54 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.95 25.08 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.772 2.315 . . . . 0.0 112.863 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -93.97 157.13 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 111.056 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 151.53 49.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.675 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.21 94.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.416 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -114.21 170.93 7.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.384 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -41.94 -47.94 5.21 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.203 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.3 mtt85 -57.01 -68.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.64 0.257 . . . . 0.0 110.506 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.6 t -38.32 -39.96 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.567 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.33 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -56.8 -34.31 67.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.858 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.875 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -70.11 -48.37 57.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.213 0.53 . . . . 0.0 110.959 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.02 -28.7 69.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -71.5 -46.44 59.72 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.53 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.67 -56.17 8.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.016 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.24 -34.6 78.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.41 -1.395 . . . . 0.0 111.111 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.3 mmm180 -87.14 -24.42 24.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.2 pt-20 -84.45 -33.36 23.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.8 -46.47 45.69 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.074 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.828 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.94 -28.64 0.07 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 120.031 -1.08 . . . . 0.0 114.597 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.816 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.21 146.61 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -127.73 94.39 3.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.374 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.638 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.768 HD22 HG13 ' A' ' 81' ' ' ILE . 4.9 mp . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.014 0.435 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 25.4 ttp85 -103.0 123.31 46.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.225 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.17 143.79 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.602 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.812 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -146.72 108.8 4.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.454 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.7 p -102.48 116.71 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.91 136.25 35.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.445 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.598 ' HD3' HG23 ' A' ' 97' ' ' VAL . 22.9 mtm105 -132.81 118.71 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.978 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.58 -70.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -148.86 -62.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.773 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -119.13 20.19 12.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.197 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.42 175.62 5.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.166 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.899 HD11 HD13 ' A' ' 100' ' ' LEU . 6.6 tp -160.03 122.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.93 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -137.79 111.56 8.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -97.09 125.57 41.66 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 113.27 21.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.169 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.657 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.76 100.95 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.512 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -102.61 160.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.805 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -92.15 116.96 29.4 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.856 178.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 1.7 t70 -93.38 28.11 2.35 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 124.281 0.988 . . . . 0.0 112.185 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -109.76 -47.42 3.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.2 mttp -136.49 118.14 14.96 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.11 90.58 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.532 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 80.6 t -139.62 112.47 5.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.402 HG23 HG13 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -77.75 121.09 23.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.477 HD21 ' OD1' ' A' ' 40' ' ' ASP . 1.1 mp -103.59 -59.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' CG1' HD23 ' A' ' 72' ' ' LEU . 2.1 t -115.81 140.36 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.175 0.512 . . . . 0.0 111.971 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -150.27 114.93 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.266 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -133.51 151.4 51.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.245 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 43.6 p -150.54 139.6 21.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 34' ' ' ILE . 68.2 m . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.708 0.289 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 67' ' ' GLN . 95.5 t -94.14 -20.01 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.761 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.051 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.48 -38.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 3.7 ttm180 -67.59 -59.13 3.6 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -50.89 -24.31 3.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.533 178.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.54 -33.23 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.36 -32.37 43.09 Favored Glycine 0 C--O 1.218 -0.854 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.71 -36.79 83.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.779 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -45.59 78.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.409 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.864 HD23 ' CG1' ' A' ' 48' ' ' VAL . 1.1 mt -62.58 -50.04 72.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.56 -26.1 65.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 12.4 tt0 -72.04 -34.66 68.95 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.1 mttp -77.08 -64.12 1.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.862 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.96 -42.6 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.639 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -58.76 -40.51 84.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.373 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.55 -25.18 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.227 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.47 -26.51 20.91 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.2 13.81 14.62 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.198 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.768 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.43 102.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.016 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -103.87 -27.89 11.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.853 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -126.11 140.51 52.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.035 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -135.27 164.49 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.507 0.67 . . . . 0.0 112.345 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.43 103.82 13.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.835 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.72 106.35 13.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 111.509 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.09 43.69 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.231 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 21.0 ptt-85 -43.48 -48.76 7.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.502 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.59 -126.37 5.5 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -89.9 48.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.859 2.373 . . . . 0.0 112.125 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.1 m-30 -99.99 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.436 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 154.75 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.608 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.69 106.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.019 0.438 . . . . 0.0 110.681 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -110.63 -125.08 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.56 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.83 1.29 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.276 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.848 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.2 mmt85 -79.77 -69.65 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.937 0.369 . . . . 0.0 110.941 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 ' HD3' ' A' ' 29' ' ' ARG . 47.4 t -35.03 -31.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.79 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.868 0.366 . . . . 0.0 110.992 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.85 -43.23 63.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.192 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -60.53 -40.94 93.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.235 0.541 . . . . 0.0 110.639 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.96 -35.73 78.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.267 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 106' ' ' GLU . 1.3 mt-10 -69.55 -46.59 66.07 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.554 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.42 -58.27 5.31 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.932 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.56 -46.47 88.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.242 -1.479 . . . . 0.0 111.14 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 mtm180 -74.92 -55.48 5.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.175 0.512 . . . . 0.0 109.663 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.797 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -47.81 -44.43 28.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.664 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -61.16 -47.59 90.24 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.352 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.72 -25.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.623 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.828 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.2 mp -71.46 150.17 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -128.38 91.49 3.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.583 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 6.0 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.959 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -102.52 126.27 49.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 26' ' ' SER . 2.0 tt -89.56 143.49 26.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.217 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.799 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -143.27 111.97 6.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 88' ' ' ARG . 1.4 p -98.22 153.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.381 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.17 114.81 5.25 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -129.24 118.92 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -33.03 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.232 0.539 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.65 -61.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.471 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 9.64 11.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.595 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 7.4 m170 -121.99 100.05 6.77 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.823 HD11 HD13 ' A' ' 100' ' ' LEU . 4.5 tp -99.19 117.94 45.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 12.5 m-85 -131.54 112.8 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -102.84 122.55 44.76 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.53 113.07 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.915 HD11 HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.93 99.34 9.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.337 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.9 mp -102.45 163.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.601 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.544 ' CG ' HD22 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -94.59 111.59 23.35 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.4 p30 -88.06 24.5 1.81 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.282 0.989 . . . . 0.0 112.524 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 15.7 pt-20 -111.13 -45.24 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 45' ' ' VAL . 25.9 mmtm -132.8 118.38 18.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.95 86.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.672 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 43' ' ' LYS . 46.1 t -135.08 112.39 14.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 120.86 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.5 mp -101.86 -62.45 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -122.09 143.74 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.344 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 p -150.24 114.98 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -126.47 145.43 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 55.7 p -150.22 134.96 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.791 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.631 ' H ' HG23 ' A' ' 34' ' ' ILE . 8.4 t . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.92 0.39 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 67' ' ' GLN . 59.7 t -92.33 -16.11 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.99 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.03 -41.55 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.01 0.434 . . . . 0.0 111.689 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.79 -61.03 2.3 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.433 0.635 . . . . 0.0 109.346 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.5 mt-30 -50.22 -24.86 3.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.514 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.99 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -78.73 -32.31 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.65 -25.16 65.76 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.214 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -78.73 -37.48 41.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -68.35 -38.9 81.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.953 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.0 tt -72.88 -46.53 52.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.64 -25.02 67.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -79.71 -30.08 40.86 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 21.6 mttt -69.47 -69.09 0.36 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.173 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.6 -44.92 9.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.785 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.4 mt -54.53 -39.08 67.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.152 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.24 -24.45 18.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.865 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.61 -26.1 20.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.51 13.47 16.79 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.076 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.508 HG12 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -75.1 102.62 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -104.43 -24.76 13.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.77 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -127.47 136.42 51.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.125 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -136.67 163.74 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.374 0.607 . . . . 0.0 112.191 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -101.52 98.5 8.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.774 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -80.92 111.73 17.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.599 . . . . 0.0 111.776 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.1 61.18 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.938 ' HG2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -48.9 -28.42 3.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.644 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.41 -117.81 3.33 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.73 38.0 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.758 2.305 . . . . 0.0 111.663 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.483 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 3.5 m-30 -98.61 144.9 27.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.28 155.01 49.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.4 t80 -39.83 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.168 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 2.0 t-160 -115.44 -109.87 0.36 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.151 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.523 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -131.25 -17.16 1.46 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.714 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.601 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -95.38 -71.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG22 HG11 ' A' ' 27' ' ' VAL . 48.3 t -32.94 -37.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.523 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -64.65 -78.85 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.301 0.572 . . . . 0.0 110.429 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -46.26 -42.88 15.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.314 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 34' ' ' ILE . 1.1 tt -67.51 -45.72 74.99 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.05 -35.76 79.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.362 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.705 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -63.45 -49.9 71.85 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.05 -56.21 6.08 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -56.43 -46.93 80.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 112.792 -1.704 . . . . 0.0 111.816 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.6 mmm-85 -78.84 -47.29 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.139 0.495 . . . . 0.0 109.976 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.705 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -53.4 -35.4 60.33 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -74.24 -49.19 12.81 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.499 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.785 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.33 -24.04 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 C-N-CA 119.737 -1.22 . . . . 0.0 115.405 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 38' ' ' ILE . 6.9 mp -71.17 146.2 49.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.204 1.002 . . . . 0.0 113.598 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.37 97.16 4.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.208 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.609 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.741 HD13 HG13 ' A' ' 81' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.992 0.425 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.4 ttt180 -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.334 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.831 HD23 ' N ' ' A' ' 26' ' ' SER . 2.9 tt -89.58 142.19 27.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.831 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.1 m -144.94 108.59 4.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 100' ' ' LEU . 8.8 p -94.2 117.73 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 111.749 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -99.26 146.95 25.67 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NH1' ' CG2' ' A' ' 97' ' ' VAL . 22.9 mtm-85 -150.14 122.34 8.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.996 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.9 p -89.66 -72.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.411 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 -58.26 0.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.566 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.23 2.56 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -101.82 155.57 18.05 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.177 0.513 . . . . 0.0 111.427 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.888 HD11 HD13 ' A' ' 100' ' ' LEU . 5.5 tp -142.63 119.74 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.573 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 14.1 m-85 -137.05 112.86 9.54 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.74 121.05 34.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.61 113.32 26.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.693 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.1 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.78 99.52 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.261 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -98.7 163.09 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.008 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -93.29 115.32 27.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.608 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.3 t0 -90.64 22.8 3.33 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.428 1.08 . . . . 0.0 112.354 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -110.15 -46.38 3.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.6 mmmt -134.02 118.28 17.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.99 87.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.778 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.4 t -137.53 112.32 9.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -71.57 117.68 13.43 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.568 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.3 mp -95.34 -63.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -121.11 147.75 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.794 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.4 p -150.17 114.83 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.063 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.38 158.29 33.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.707 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 79.5 p -150.18 143.02 24.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.973 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.654 ' N ' HG21 ' A' ' 68' ' ' VAL . 11.8 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.104 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 67' ' ' GLN . 58.2 t -94.13 -16.49 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.066 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.65 -41.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.882 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.83 -59.21 3.73 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.702 0.763 . . . . 0.0 109.035 178.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.599 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.1 mt-30 -49.78 -23.27 1.75 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.442 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.066 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.29 -33.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.91 -28.91 59.88 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.4 ppt_? -76.67 -37.24 56.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.08 73.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.1 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.63 -54.51 13.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.704 178.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.001 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.8 -25.68 65.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.8 mt-10 -78.18 -31.01 49.35 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 23.2 mttt -71.67 -69.14 0.4 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.497 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.68 -43.48 8.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.126 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.801 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -56.11 -39.67 72.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.041 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.5 -23.78 11.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.559 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.59 -27.7 20.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.7 8.08 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.071 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.21 105.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.536 0.684 . . . . 0.0 110.478 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 110' ' ' GLU . 8.1 ttmt -92.44 -59.49 2.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.8 138.63 44.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.6 164.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 111.901 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.93 103.26 12.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.795 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.44 116.49 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 111.616 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -145.54 47.59 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 6.9 ptt-85 -37.64 -37.58 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.762 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.27 -112.58 3.61 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.631 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -88.72 23.56 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.83 2.353 . . . . 0.0 112.767 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.533 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.8 m-30 -93.26 131.84 38.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.31 148.4 25.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.474 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -46.69 109.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.524 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -126.54 165.99 18.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.28 -40.41 7.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.79 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.802 ' HD2' HD13 ' A' ' 34' ' ' ILE . 15.0 mmt-85 -57.36 -70.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.572 0.225 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 37.2 t -38.39 -37.8 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.35 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.72 -76.71 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.029 0.442 . . . . 0.0 110.965 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.31 -36.4 68.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.732 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -68.96 -49.1 60.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.216 0.531 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -60.9 -32.1 71.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.42 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -68.54 -46.23 70.08 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.523 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.61 -57.15 8.69 Favored Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.001 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.03 -33.21 73.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.512 -1.344 . . . . 0.0 111.327 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.6 tpp85 -90.08 -25.06 20.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.1 pt-20 -81.02 -33.17 33.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -72.38 -46.78 31.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.858 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.801 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.73 -29.7 0.08 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.036 -1.078 . . . . 0.0 114.76 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.806 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.33 142.77 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.81 94.88 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.469 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.687 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.964 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.679 HD13 HG13 ' A' ' 81' ' ' ILE . 3.0 mp . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.69 126.33 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.38 -178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 4.1 tt -89.29 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.693 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.06 108.82 4.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 111.318 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.812 HG12 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -97.02 126.97 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.46 145.72 37.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.453 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 13.5 mtm105 -150.12 120.67 7.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.749 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 m -89.59 -81.04 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.684 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -139.86 -56.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.717 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -119.12 18.73 13.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.212 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -117.54 167.67 11.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.162 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 100' ' ' LEU . 3.3 tp -153.3 130.96 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.551 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.529 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 32.9 m-85 -150.01 152.18 34.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.243 0.544 . . . . 0.0 112.171 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -136.83 120.96 17.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.692 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.76 113.22 25.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.019 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.72 98.84 8.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.4 mp -98.8 160.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.165 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -93.1 115.63 28.27 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.603 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -90.75 26.16 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.297 0.998 . . . . 0.0 112.403 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.46 -47.97 3.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.39 118.04 14.97 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.96 90.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.448 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 43' ' ' LYS . 93.9 t -137.68 112.57 9.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 m -73.92 119.72 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.635 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.6 mp -98.87 -58.28 1.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.0 t -124.36 147.3 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 112.239 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 82.5 p -150.28 115.02 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.946 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.26 150.77 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.919 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 3.1 t -150.46 141.94 23.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.512 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.491 ' H ' HG23 ' A' ' 34' ' ' ILE . 32.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.689 0.281 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 67' ' ' GLN . 75.6 t -94.05 -17.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.693 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.036 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.89 -39.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.991 0.425 . . . . 0.0 111.414 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.73 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.29 -59.28 3.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.56 ' HB2' HG13 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -50.98 -22.95 2.55 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.408 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.036 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.53 -31.76 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.253 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.73 -30.86 51.53 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.26 -38.46 68.85 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.57 -39.39 88.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.019 HD21 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -65.54 -54.98 20.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.985 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.57 -24.99 35.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.99 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -73.18 -35.59 66.42 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.3 mttt -71.58 -67.4 0.53 Allowed 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.921 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.93 -41.28 5.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.623 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.753 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.67 -40.23 82.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.226 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.44 -23.89 6.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.075 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.33 -27.82 20.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.66 18.04 9.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.136 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.679 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.73 106.87 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.505 0.669 . . . . 0.0 110.338 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 18.9 ttmt -91.1 -58.14 2.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.393 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -111.86 147.58 35.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.463 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -134.33 161.15 41.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.319 0.58 . . . . 0.0 111.775 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -96.41 103.64 15.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.254 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.676 ' CE2' ' CZ ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -81.17 106.34 13.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.255 0.55 . . . . 0.0 112.071 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.76 72.16 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.983 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.812 ' NH1' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -52.19 -42.9 63.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.27 -117.35 3.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -90.35 35.95 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.746 2.298 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.3 m-30 -100.65 162.59 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 111.469 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.33 148.93 50.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.013 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -46.7 103.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.736 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -122.3 165.22 16.58 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.88 -42.46 11.4 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.983 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.453 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 55.4 mmt-85 -55.76 -71.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.704 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 t -38.92 -43.57 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.635 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.2 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.023 0.439 . . . . 0.0 111.133 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -59.24 -40.0 84.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 34' ' ' ILE . 1.5 tt -65.04 -47.29 77.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.351 0.596 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.26 -38.09 85.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -66.75 -39.71 88.01 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -52.49 -59.35 9.19 Favored Glycine 0 CA--C 1.501 -0.789 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.985 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.04 -28.81 69.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.831 -1.185 . . . . 0.0 110.559 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.7 mmm-85 -89.11 -30.48 18.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 110.917 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.795 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.9 pt-20 -78.84 -36.9 41.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.672 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -66.67 -46.38 76.36 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.773 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.753 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.42 -31.33 0.07 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.032 -1.08 . . . . 0.0 114.754 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.7 mp -71.28 147.05 48.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -128.23 91.68 3.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.348 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.727 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.7 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.063 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.801 0.334 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -101.18 126.96 47.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.078 -178.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.1 tt -93.39 145.1 24.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.939 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.764 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.03 108.43 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.415 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.851 HG11 HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -96.18 129.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.023 0.44 . . . . 0.0 111.313 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -114.78 125.92 54.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -129.52 118.6 22.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.57 178.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.2 m -90.03 -45.14 9.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD12 ' HG3' ' A' ' 32' ' ' LYS . 0.3 OUTLIER 179.78 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.171 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HG3' HD12 ' A' ' 31' ' ' LEU . 29.5 mtmt -119.35 -0.93 10.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.344 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -110.71 111.07 22.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 111.572 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.643 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -99.93 131.28 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 40.7 m-85 -149.08 147.76 28.89 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.146 0.498 . . . . 0.0 112.085 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -132.46 128.28 37.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -117.83 113.06 21.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.205 0.526 . . . . 0.0 110.767 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -100.13 102.23 13.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -104.91 160.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.977 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.28 118.03 30.48 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.818 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.441 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 13.6 t0 -91.82 20.61 5.48 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.44 1.088 . . . . 0.0 112.217 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.49 -48.62 3.4 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mmtp -131.11 118.15 20.1 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.82 89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.841 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.8 t -136.09 112.61 13.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 m -77.42 109.6 11.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -91.53 -53.07 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.833 HG21 ' HB2' ' A' ' 75' ' ' LYS . 1.4 t -124.16 145.84 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.571 0.701 . . . . 0.0 112.791 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 78.3 p -150.22 115.02 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.313 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -125.92 162.94 24.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 126.91 10.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.007 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.568 ' N ' HG21 ' A' ' 68' ' ' VAL . 1.1 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 0.0 111.24 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 67' ' ' GLN . 39.6 t -94.05 -13.78 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.058 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.104 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.26 -43.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -65.96 -60.83 2.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.378 0.608 . . . . 0.0 109.46 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -48.12 -28.19 2.77 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.292 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.104 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -71.88 -38.44 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.2 178.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -67.64 -56.78 10.29 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 5.5 ppt_? -44.95 -35.33 2.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -64.12 -50.19 69.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.08 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.617 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.2 mt -62.96 -52.62 62.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -53.51 -27.3 24.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.063 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -75.09 -32.89 61.57 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.833 ' HB2' HG21 ' A' ' 48' ' ' VAL . 33.0 mttm -76.79 -63.69 1.29 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.59 -43.19 11.97 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.792 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -56.2 -40.03 73.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.977 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.59 -24.33 13.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.952 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.42 -28.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.78 13.55 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.254 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.4 111.03 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 110.126 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 23.6 ttpp -95.89 -57.48 2.35 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.787 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -110.75 148.67 31.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.65 164.93 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 0.0 112.182 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.02 87.87 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.944 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 t80 -81.17 112.37 18.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.93 111.02 4.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HD3' ' N ' ' A' ' 27' ' ' VAL . 3.1 tpt85 -99.82 -21.11 15.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.28 -97.83 1.04 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.81 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.42 33.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.903 2.402 . . . . 0.0 112.197 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 4.3 m-85 -99.93 135.7 40.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.95 154.78 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.7 t80 -46.86 97.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 110.35 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.453 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 1.9 t60 -105.35 -99.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.901 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.478 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . . . -142.52 -30.94 0.12 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HG3' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mmt85 -85.87 -71.14 0.55 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 27' ' ' VAL . 55.4 t -33.07 -35.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HZ1' ' HB ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -62.14 -76.42 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.667 0.746 . . . . 0.0 109.551 179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.32 -44.51 11.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.655 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -68.12 -49.24 62.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 110.221 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.709 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.61 -32.49 63.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -68.79 -41.95 78.01 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.13 -57.48 8.88 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.971 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.45 -34.63 77.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.477 -1.362 . . . . 0.0 110.986 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.33 -26.61 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.411 . . . . 0.0 110.887 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.837 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -78.08 -36.57 48.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.19 -43.84 69.37 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.725 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.36 -31.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 119.999 -1.096 . . . . 0.0 114.904 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.891 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.42 151.1 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.76 96.01 4.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.713 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.07 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.928 0.394 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttt-85 -102.73 126.46 49.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.49 145.61 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.58 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.811 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -147.4 108.88 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.468 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 HD13 ' A' ' 100' ' ' LEU . 9.6 p -100.59 132.18 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.006 0.432 . . . . 0.0 111.761 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -113.35 143.99 43.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.278 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' CZ ' HG23 ' A' ' 97' ' ' VAL . 19.9 ptt-85 -151.53 118.76 5.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.093 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.78 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 110.788 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tt -177.36 -68.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.94 14.16 18.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.905 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 1.7 m-70 -127.33 150.18 49.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.655 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.72 HG21 ' HD2' ' A' ' 96' ' ' ARG . 22.5 pt -139.16 142.35 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -142.04 108.39 5.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.158 -177.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.003 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.73 121.01 34.73 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' NE2' HG21 ' A' ' 46' ' ' THR . 5.2 tt0 -114.75 118.64 34.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.847 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.99 103.82 15.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 46' ' ' THR . 3.5 mp -108.16 162.46 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.709 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.537 ' N ' HG22 ' A' ' 39' ' ' ILE . 3.0 t70 -92.87 113.58 25.9 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.039 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -92.97 24.82 3.48 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.253 0.971 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.8 -47.85 3.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mtpt -132.19 118.12 19.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.77 90.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.453 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 43' ' ' LYS . 91.5 t -141.05 112.2 3.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 39' ' ' ILE . 1.6 m -78.83 117.48 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -95.65 -56.87 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.78 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -128.57 145.12 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 111.986 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 p -150.19 114.53 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.422 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.659 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -127.03 148.78 50.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.631 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.499 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 15.2 p -150.22 136.14 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.821 178.848 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.732 0.301 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 67' ' ' GLN . 99.5 t -94.0 -20.09 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.685 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.037 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.18 -39.55 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 111.551 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.77 -60.21 2.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.8 mt-30 -49.36 -24.59 1.97 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.572 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.037 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.98 -36.14 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.806 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -77.06 -35.8 37.53 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.941 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 4.3 ppt_? -65.03 -36.12 83.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.47 -55.13 26.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.003 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -62.69 -44.58 95.88 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.83 -27.8 60.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.742 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.6 tt0 -72.94 -34.35 66.5 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.78 ' CB ' HG21 ' A' ' 48' ' ' VAL . 14.2 mttt -76.64 -63.19 1.4 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.072 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.688 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.29 -42.05 6.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.346 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.0 -40.38 80.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.184 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.08 -23.63 8.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.41 -28.44 19.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.46 15.69 12.05 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.197 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -69.29 104.47 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.589 0.709 . . . . 0.0 110.152 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 110' ' ' GLU . 14.6 tttt -92.51 -56.38 3.05 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.388 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.43 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -110.0 145.03 37.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.384 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.757 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.1 164.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.469 0.652 . . . . 0.0 112.048 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.02 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.746 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.791 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.02 106.32 13.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.105 0.479 . . . . 0.0 111.373 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 45.0 2.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.176 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.7 ptt180 -41.51 -32.47 0.34 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.582 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.91 -121.46 6.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.433 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -88.99 36.33 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -95.55 150.97 19.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.989 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -116.91 147.0 42.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -49.31 100.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.056 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -120.07 168.46 11.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.456 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.46 -38.16 3.86 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.912 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.72 ' HD2' HG21 ' A' ' 34' ' ' ILE . 45.1 mmt-85 -61.72 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.567 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 33.1 t -38.67 -40.97 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.57 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.4 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 0.0 111.001 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.28 -37.27 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.896 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD13 HG21 ' A' ' 27' ' ' VAL . 2.2 tt -67.48 -48.21 67.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 111.167 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.21 -33.4 70.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.17 -43.79 81.34 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.01 -62.06 5.27 Favored Glycine 0 CA--C 1.506 -0.517 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.925 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.98 -38.93 68.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 113.821 -1.19 . . . . 0.0 110.571 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.4 mmm-85 -79.79 -60.17 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -43.59 -43.15 5.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.158 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -62.01 -50.51 64.82 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.995 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -26.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.125 -1.036 . . . . 0.0 114.808 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.847 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.4 mp -71.49 147.77 47.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.28 92.24 3.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.25 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.724 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.038 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.844 0.354 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.36 125.26 50.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.694 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 26' ' ' SER . 5.1 tt -89.74 142.32 27.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.682 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.923 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.0 m -142.21 134.84 28.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.609 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.841 HG11 HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -119.79 134.58 62.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 0.0 110.831 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -122.92 132.31 54.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' CZ ' ' HD2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -137.32 118.83 14.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.214 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -89.24 -38.91 13.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.007 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tt -179.87 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -119.03 3.87 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.31 154.82 23.98 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 100' ' ' LEU . 3.8 tp -141.34 123.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.83 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 16.9 m-85 -139.22 110.72 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.73 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -100.17 121.45 41.45 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.22 113.47 26.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.321 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.685 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.78 101.71 12.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -104.84 164.03 4.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.573 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -94.44 113.98 25.93 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.809 178.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.3 t70 -91.38 25.54 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.335 1.022 . . . . 0.0 112.359 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -109.61 -48.15 3.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.71 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.8 mttp -135.64 118.09 15.79 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.3 89.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.546 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 43' ' ' LYS . 66.3 t -137.86 112.49 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -75.5 114.54 14.18 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -93.11 -60.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.75 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -125.21 147.25 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 111.882 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 p -150.23 114.91 5.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -124.89 151.89 44.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.5 p -150.22 127.14 11.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.892 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.514 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.2 m . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 76.1 t -94.18 -26.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.049 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.83 -40.75 0.06 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.634 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.49 -60.02 3.12 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.768 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 28.3 mt-30 -48.24 -27.14 2.29 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.248 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.049 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.06 -36.24 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.98 -29.74 62.36 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.27 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 6.5 ppt_? -69.51 -36.17 76.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -73.94 -38.07 64.36 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 7.2 mt -65.4 -43.58 90.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.419 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -75.51 -30.97 60.0 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.085 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 21.2 mt-10 -75.65 -28.46 58.77 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.804 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 8.3 mtmm -76.12 -67.79 0.65 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.399 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.44 -40.89 8.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.795 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.79 -39.02 76.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.718 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.5 -22.88 14.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.937 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.75 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.44 -27.38 20.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.21 19.69 9.26 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.077 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.736 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.92 103.79 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.588 0.708 . . . . 0.0 110.449 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLU . 19.1 tttp -91.54 -56.92 2.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.363 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.68 146.91 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -134.07 167.16 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.458 0.647 . . . . 0.0 112.169 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -102.21 103.74 14.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.255 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.731 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.5 t80 -80.75 110.58 16.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 112.723 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.0 106.36 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.066 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -92.34 -33.91 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.058 0.456 . . . . 0.0 110.304 -178.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.76 -110.22 2.76 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -90.31 32.7 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.849 2.366 . . . . 0.0 112.262 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 3.4 m-30 -102.27 152.79 20.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.131 0.491 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.26 148.91 52.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.446 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.503 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -44.75 111.83 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.979 0.419 . . . . 0.0 110.334 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -124.01 -122.69 0.26 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.639 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.04 -12.4 3.21 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.964 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HD2' ' CZ ' ' A' ' 29' ' ' ARG . 1.7 mmt85 -87.95 -70.77 0.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.851 0.325 . . . . 0.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.841 HG22 HG11 ' A' ' 27' ' ' VAL . 55.8 t -36.14 -32.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 123.035 0.534 . . . . 0.0 111.672 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.14 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.969 0.414 . . . . 0.0 110.96 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -44.25 -40.84 5.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -67.73 -45.77 74.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 110.214 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.84 -30.63 70.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.772 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -69.91 -49.0 56.41 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.74 -55.21 7.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.873 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.17 -45.04 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.772 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -56.63 -35.2 68.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.835 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.34 -49.08 16.55 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.119 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.795 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -179.53 -29.99 0.05 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.728 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 8.0 mp -71.15 146.86 48.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -128.04 91.71 3.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.104 178.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.669 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.026 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD13 HG13 ' A' ' 81' ' ' ILE . 1.4 mp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.914 0.388 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -104.59 126.93 52.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.705 -178.467 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.84 141.53 28.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.836 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.21 108.72 5.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.692 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 100' ' ' LEU . 4.7 p -95.78 125.45 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.16 144.15 40.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.83 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 26.2 tpt180 -150.12 118.63 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.765 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.9 p -89.93 -42.97 10.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.657 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -178.61 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 13.5 mtmt -119.27 -1.67 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.649 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 25.8 m170 -112.15 116.96 31.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.036 0.446 . . . . 0.0 111.492 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.788 HD11 HD13 ' A' ' 100' ' ' LEU . 5.8 tp -106.94 112.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' CD1' ' HB3' ' A' ' 51' ' ' SER . 8.9 m-85 -127.87 110.69 12.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.924 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -96.04 124.84 40.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.78 113.4 25.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.515 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.792 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.09 99.16 8.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.119 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.7 mp -99.84 163.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.127 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -93.95 114.08 26.22 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.754 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 22.0 t70 -91.5 25.47 2.62 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.438 1.086 . . . . 0.0 112.303 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -109.46 -47.92 3.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.89 118.25 15.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 90.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.613 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.6 t -139.99 112.32 5.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -73.31 114.13 11.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.624 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -91.58 -64.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -121.7 145.87 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 111.792 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.9 p -150.36 114.82 5.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.041 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.73 156.25 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.547 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.1 145.56 26.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.237 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.603 ' N ' HG21 ' A' ' 68' ' ' VAL . 34.7 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.689 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.824 0.345 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 67' ' ' GLN . 68.8 t -83.94 -19.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.075 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.83 -42.14 0.05 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.962 0.411 . . . . 0.0 111.965 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.76 -61.04 2.3 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.521 0.676 . . . . 0.0 109.301 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -48.67 -25.08 1.6 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.3 177.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.075 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.97 -33.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.671 178.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.77 -27.28 54.31 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.357 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -73.61 -38.37 65.12 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.38 -34.8 70.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.924 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -69.21 -49.6 54.98 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.322 178.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.986 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -67.46 -25.4 65.87 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.896 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -77.91 -31.28 51.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 13.5 mttt -71.95 -69.34 0.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.515 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.28 -43.38 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.136 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.774 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -55.52 -39.23 70.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.052 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.28 -23.56 15.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.58 -27.16 20.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.29 16.69 10.83 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.156 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.737 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.7 103.02 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.725 0.774 . . . . 0.0 110.307 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -94.44 -51.93 4.55 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.75 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 135.16 54.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.02 165.1 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.4 0.619 . . . . 0.0 111.769 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -109.85 105.4 14.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.379 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.34 106.31 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.529 -178.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -129.73 44.08 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.008 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 16.3 ptt-85 -39.4 -47.84 1.84 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.827 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.93 -114.68 2.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.15 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.03 -13.53 21.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.426 2.084 . . . . 0.0 112.275 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.5 m-85 -60.63 138.11 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.02 0.438 . . . . 0.0 111.159 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 154.11 49.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.999 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 1.3 t80 -42.4 113.56 0.47 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -128.89 -77.95 0.56 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' NZ ' ' A' ' 98' ' ' LYS . . . -155.37 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.167 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.716 ' HB3' HD13 ' A' ' 34' ' ' ILE . 37.0 mmt-85 -65.55 -60.85 2.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 42.1 t -35.97 -39.18 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.994 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.543 ' CE ' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.65 -80.16 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.391 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -53.77 -36.39 62.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.015 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.788 HD13 HD11 ' A' ' 34' ' ' ILE . 2.4 tt -68.98 -48.23 63.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.149 0.5 . . . . 0.0 110.972 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.79 -30.79 71.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.323 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.21 -45.04 70.85 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.77 -57.24 9.92 Favored Glycine 0 CA--C 1.508 -0.375 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.986 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.92 -33.12 74.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.357 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.1 mtm180 -88.46 -30.05 19.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.749 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.793 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -76.94 -34.36 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.17 -47.38 37.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.106 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.46 -29.47 0.07 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.878 -1.153 . . . . 0.0 114.942 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.792 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.9 mp -71.25 147.14 48.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -127.85 91.84 3.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.413 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.684 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.935 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 HG13 ' A' ' 81' ' ' ILE . 3.6 mp . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.926 0.393 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttp180 -103.85 125.34 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.442 -178.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.6 tt -89.81 143.81 26.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 25' ' ' LEU . 50.9 m -145.43 108.69 4.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 0.0 111.343 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 97' ' ' VAL . 8.0 p -101.99 121.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -103.64 129.39 50.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.603 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -136.69 118.55 15.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -89.75 -77.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.476 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -134.33 -61.24 0.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.828 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.29 18.32 12.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.557 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -117.71 164.05 15.56 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.997 0.427 . . . . 0.0 111.25 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.721 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.5 tp -155.8 126.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' CE2' ' CB ' ' A' ' 51' ' ' SER . 18.8 m-85 -140.86 110.2 6.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.078 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -94.04 121.46 35.55 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.33 117.4 30.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.205 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.791 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -100.24 103.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.479 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -105.95 161.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.449 -177.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 39' ' ' ILE . 16.2 t0 -92.7 114.32 26.84 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.962 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 25.4 t0 -92.05 23.58 3.69 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.277 0.985 . . . . 0.0 112.148 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.25 -47.82 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.6 mppt? -133.31 118.09 18.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.68 90.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.432 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.4 t -139.61 112.28 5.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.15 114.79 16.33 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -94.19 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.2 t -123.67 144.51 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.338 0.59 . . . . 0.0 112.093 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -150.24 114.78 5.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.826 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.06 161.98 27.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.804 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.486 ' CB ' ' CE2' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -150.06 144.36 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.875 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.5 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 67' ' ' GLN . 40.7 t -94.2 -16.3 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.56 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.059 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.5 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.26 -60.53 2.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.6 mt-30 -48.01 -26.11 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.419 178.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.059 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.66 -39.27 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.992 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.508 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -70.5 -37.42 69.01 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.815 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 16.1 ptt85 -64.27 -36.88 85.56 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.727 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.97 -54.95 26.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.097 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.79 -42.15 97.8 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.46 -27.7 69.3 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.715 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.3 tt0 -78.04 -25.52 47.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.466 178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.838 ' HB2' HG21 ' A' ' 48' ' ' VAL . 2.4 mttp -82.4 -62.11 1.71 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.08 -43.28 14.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.407 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.738 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -55.97 -39.65 72.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.107 178.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.54 -23.95 12.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.878 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.38 -27.14 20.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.59 17.7 10.27 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.961 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.674 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.1 106.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.513 0.673 . . . . 0.0 110.346 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLU . 1.5 ttpt -92.45 -61.07 1.68 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.207 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.39 146.32 34.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.356 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -131.72 165.78 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.205 0.526 . . . . 0.0 111.776 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.17 104.75 14.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.838 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.133 0.492 . . . . 0.0 111.741 -178.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -122.26 38.89 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.957 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.41 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 20.6 ptt180 -40.45 -33.38 0.26 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.516 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.77 -129.38 8.62 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.306 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.93 44.99 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.777 2.318 . . . . 0.0 112.298 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 29' ' ' ARG . 4.6 m-30 -97.38 153.71 17.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.007 0.432 . . . . 0.0 111.114 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.34 154.66 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.884 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.636 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -49.29 101.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 110.201 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.418 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 31.4 t-80 -111.92 -112.38 0.33 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.002 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.29 -37.12 0.31 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.672 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.721 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.4 mpt_? -67.96 -71.06 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 27' ' ' VAL . 70.8 t -36.41 -32.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.968 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -63.74 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.037 0.446 . . . . 0.0 110.893 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -43.2 -40.79 3.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.334 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -69.81 -48.77 57.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.757 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.635 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.35 -30.69 60.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.52 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.849 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.68 -47.0 57.11 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.764 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.19 -57.27 7.23 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -37.87 88.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.517 -1.342 . . . . 0.0 111.599 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -85.4 -33.16 22.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.068 0.461 . . . . 0.0 110.487 179.549 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.849 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.8 pt-20 -70.0 -37.53 75.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.24 -50.13 41.28 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.375 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.92 -26.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.945 -1.121 . . . . 0.0 114.978 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.1 mp -71.34 144.68 49.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.95 96.75 4.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.47 178.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.715 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.093 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.33 129.13 53.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.546 -179.108 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.861 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.2 tt -89.47 141.27 28.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.392 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.837 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.7 108.37 4.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.777 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG21 ' NH2' ' A' ' 29' ' ' ARG . 14.9 p -97.06 126.98 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.765 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.76 141.56 42.22 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.679 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HG2' HD12 ' A' ' 34' ' ' ILE . 35.7 mtt85 -150.11 118.69 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 p -89.91 -42.51 11.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.166 0.508 . . . . 0.0 110.416 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tt -179.98 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.723 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -119.29 -6.7 10.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -109.07 116.4 31.89 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.885 0.374 . . . . 0.0 111.617 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.892 HD11 HD13 ' A' ' 100' ' ' LEU . 2.0 tp -105.25 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.034 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 27.5 m-85 -146.93 109.24 4.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.842 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.45 125.47 38.08 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -113.85 113.45 24.91 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.837 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.87 102.98 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.905 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -107.68 161.27 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.3 t0 -89.44 115.14 26.65 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.779 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 4.0 t70 -92.3 24.08 3.57 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.376 1.048 . . . . 0.0 112.274 -178.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -109.49 -47.63 3.35 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 177.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.5 mttp -133.54 118.12 17.92 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.95 89.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.301 -177.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' LYS . 98.6 t -137.88 112.52 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -76.38 119.19 19.91 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD22 HD13 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -100.84 -56.81 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.466 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.871 HG12 HD23 ' A' ' 72' ' ' LEU . 2.1 t -126.62 142.1 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.211 0.529 . . . . 0.0 112.208 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.4 115.21 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.997 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -122.98 163.76 19.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.059 0.457 . . . . 0.0 111.963 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.501 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 18.2 p -146.06 126.9 14.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.046 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.588 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.1 p . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 67' ' ' GLN . 95.0 t -94.06 -17.19 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.621 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.94 -40.45 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.602 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.43 -60.13 2.82 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.47 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.507 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.9 mt-30 -49.34 -23.53 1.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.645 177.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.53 -35.5 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.524 178.573 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.48 -34.79 34.78 Favored Glycine 0 C--O 1.218 -0.901 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -64.77 -37.23 86.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -46.41 76.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.6 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -61.55 -51.18 69.65 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.315 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.869 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.04 -25.87 64.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.745 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 18.2 tt0 -72.0 -35.59 69.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.467 0.651 . . . . 0.0 109.37 178.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 9.1 mttt -78.81 -63.76 1.34 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.994 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -42.96 -42.45 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.706 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.7 mt -58.45 -41.2 84.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.387 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -50.28 -25.86 4.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.319 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.189 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 113.94 15.12 8.77 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.855 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.83 102.66 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.13 0.491 . . . . 0.0 110.187 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -106.3 -23.37 12.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.841 -179.564 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -129.84 125.29 35.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.284 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.797 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.09 165.41 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.435 0.636 . . . . 0.0 111.839 -179.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -112.14 111.63 22.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.754 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.861 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -80.95 111.41 17.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 111.789 -178.219 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.03 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 9.4 ptt-85 -41.82 -37.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.01 -125.41 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.47 0.26 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.521 2.147 . . . . 0.0 112.877 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CD2' ' CE1' ' A' ' 94' ' ' HIS . 4.4 m-85 -58.71 144.03 44.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.97 109.57 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.544 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER 0.11 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.123 0.569 . . . . 0.0 112.103 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -131.02 173.42 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.468 -179.009 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -36.58 -67.81 0.37 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.741 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -47.34 -66.36 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.593 0.235 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 94' ' ' HIS . 89.9 t -29.61 -45.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.022 0.529 . . . . 0.0 112.014 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.486 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.43 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.031 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.38 -37.6 75.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.075 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 34' ' ' ILE . 4.8 tt -64.68 -47.77 77.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.389 0.614 . . . . 0.0 111.238 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.08 -31.6 72.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.694 -178.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.767 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -66.58 -46.31 76.37 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.31 -59.4 5.83 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.958 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -57.74 -43.19 85.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.609 -1.295 . . . . 0.0 111.405 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.93 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -80.99 -48.14 12.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.302 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.3 pt-20 -52.89 -43.75 66.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.698 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.82 -48.39 86.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.19 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.648 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.46 -27.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.609 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.64 149.64 45.37 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -129.14 91.82 3.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.091 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.731 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.027 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.135 0 CA-C-O 120.688 0.28 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.8 ttp180 -100.53 125.36 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.948 0.404 . . . . 0.0 111.067 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tt -89.53 141.47 28.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.959 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.849 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -150.33 108.86 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.141 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.664 HG12 ' HZ ' ' A' ' 86' ' ' PHE . 5.0 p -102.48 120.45 52.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.215 0.531 . . . . 0.0 111.661 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.5 OUTLIER -97.38 144.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.683 -179.405 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.65 ' NH2' HG11 ' A' ' 27' ' ' VAL . 16.3 mtt85 -150.61 118.53 6.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.219 178.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.24 -35.85 12.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.671 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.93 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.459 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -119.3 6.59 11.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.485 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 33.5 m170 -115.89 103.14 10.33 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.467 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' CD1' ' A' ' 100' ' ' LEU . 9.5 tt -99.34 133.91 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.968 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 33.3 m-85 -147.3 110.2 4.73 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.01 120.91 33.79 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 113.03 25.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.011 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -95.83 98.76 8.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.221 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.6 mp -100.62 166.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.574 -177.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -99.34 111.92 24.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.238 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.77 26.55 1.75 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.127 0.892 . . . . 0.0 112.304 -178.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -110.03 -47.45 3.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.692 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.0 mttp -135.11 118.13 16.38 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 174.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.19 90.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.439 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.2 t -137.92 112.62 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -78.38 119.64 22.0 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -102.92 -58.56 1.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.331 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.548 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.4 t -120.55 146.73 24.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.313 0.578 . . . . 0.0 111.916 -178.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -150.13 114.74 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.883 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -121.89 156.41 33.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.14 126.75 10.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.553 ' H ' HG23 ' A' ' 34' ' ' ILE . 4.4 p . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 75.8 t -94.16 -20.83 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.65 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.039 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -43.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.109 0.48 . . . . 0.0 111.759 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -65.48 -59.08 4.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.532 0.682 . . . . 0.0 109.413 178.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 16.1 mt-30 -50.35 -23.66 2.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.473 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.039 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.61 -32.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.52 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.03 -29.88 52.86 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.9 178.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.16 -40.11 71.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.24 -40.31 90.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.011 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -63.76 -55.41 23.36 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.1 -24.93 28.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.04 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -71.37 -37.51 71.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 18.2 mttt -71.82 -64.52 0.91 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.018 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.837 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.03 -41.02 7.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.536 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.729 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -59.74 -40.18 87.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.243 178.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.26 -24.21 7.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.28 -28.06 20.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.236 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.08 13.27 16.02 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.532 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -65.66 109.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 110.193 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.6 tttm -93.58 -56.23 2.99 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.39 -178.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.471 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -112.93 151.1 30.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.272 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -135.33 161.53 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.509 0.671 . . . . 0.0 112.132 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 87.79 2.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 19.9 t80 -80.7 108.33 14.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -176.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.37 98.58 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.685 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 7.3 tpt180 -90.42 11.66 20.89 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.467 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 90' ' ' PRO . . . 87.19 -113.94 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.147 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 2.3 Cg_endo -81.06 45.12 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.803 2.335 . . . . 0.0 112.122 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 3.2 m-85 -112.19 133.15 54.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 111.011 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.6 155.04 48.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.3 t80 -33.06 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -103.82 -166.34 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -178.752 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.717 ' C ' ' HE2' ' A' ' 98' ' ' LYS . . . -76.18 -17.14 80.2 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.235 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' CB ' ' NE ' ' A' ' 29' ' ' ARG . 3.8 mmt85 -97.92 -64.55 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.484 ' O ' ' C ' ' A' ' 98' ' ' LYS . 13.6 t -28.84 -70.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.717 ' HE2' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -29.47 -60.18 0.15 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.223 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.666 ' N ' ' HG2' ' A' ' 98' ' ' LYS . . . -69.99 -46.89 64.19 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.398 -177.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -61.41 -47.69 84.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.814 0.816 . . . . 0.0 109.422 179.247 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.534 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.07 -40.36 76.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.64 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -62.58 -38.85 91.72 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.87 -59.34 8.15 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.89 -31.03 70.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.812 -1.194 . . . . 0.0 110.598 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.893 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 3.2 tpp85 -88.77 -25.52 22.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -82.7 -38.45 23.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.676 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -64.35 -46.35 90.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.638 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.729 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.81 -30.67 0.08 OUTLIER Glycine 0 C--N 1.341 0.835 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.556 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.57 146.56 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -128.32 99.7 5.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.127 178.328 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.721 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.064 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.604 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.224 -0.282 0 CA-C-O 120.698 0.285 . . . . 0.0 111.356 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 13.6 ttp180 -93.36 124.5 37.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.908 -178.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.5 tt -89.66 145.99 24.85 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.255 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.802 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -150.38 119.06 6.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.212 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.775 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.8 t -101.29 139.99 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.863 0.363 . . . . 0.0 111.664 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HA ' ' OH ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -125.67 112.5 16.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.68 118.66 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.814 177.48 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -89.5 -78.88 0.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.55 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -131.58 -61.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.682 179.276 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -119.25 20.06 12.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.231 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -117.77 161.64 19.38 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.332 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.84 HD11 ' CD1' ' A' ' 100' ' ' LEU . 2.4 tp -151.37 128.05 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.939 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' O ' HG13 ' A' ' 27' ' ' VAL . 29.4 m-85 -145.42 150.83 37.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.153 0.502 . . . . 0.0 111.8 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -132.67 121.11 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 113.13 24.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.187 0.518 . . . . 0.0 110.22 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -96.21 96.31 5.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.5 mp -98.24 163.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.921 -177.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.574 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.5 t0 -96.9 109.31 22.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.574 177.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 18.2 p-10 -89.05 26.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.158 0.911 . . . . 0.0 112.273 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -110.67 -47.15 3.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mppp? -133.26 118.17 18.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 174.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.43 89.72 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.418 -177.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.8 t -139.59 112.45 5.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.47 119.48 21.12 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -99.56 -59.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 1.9 t -121.91 146.17 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.344 0.592 . . . . 0.0 112.004 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 88.3 p -150.18 114.86 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.943 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.37 158.3 33.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.844 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.22 134.14 16.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.562 ' N ' HG21 ' A' ' 68' ' ' VAL . 9.0 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 111.053 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.832 0.349 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.87 -19.81 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.291 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.28 -38.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.794 -179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.628 0.728 . . . . 0.0 109.157 178.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 10.6 mt-30 -49.68 -24.11 2.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.299 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.03 -32.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.99 -31.77 51.91 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.242 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.42 -42.59 68.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.62 -38.02 88.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -65.48 -54.57 26.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.226 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.79 -24.22 48.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.938 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.27 -37.79 68.97 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 21.9 mttt -70.75 -67.12 0.53 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.095 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.825 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.6 -41.96 4.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.685 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.794 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -59.3 -40.52 86.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.052 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.53 -23.92 7.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.526 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.46 -27.97 20.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.129 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.38 14.31 14.88 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.273 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.526 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.77 106.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.556 0.693 . . . . 0.0 110.019 179.722 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' GLU . 5.0 tttp -93.17 -54.55 3.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.493 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.73 144.2 41.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -130.73 159.89 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.5 0.667 . . . . 0.0 112.028 -179.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.92 ' CE2' HD22 ' A' ' 25' ' ' LEU . 17.1 t80 -80.39 106.51 12.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.635 0.731 . . . . 0.0 112.548 -176.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.95 97.78 2.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.362 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.4 tpt85 -83.55 -7.07 59.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.52 -110.21 2.0 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.24 34.94 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.021 2.48 . . . . 0.0 112.092 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 88' ' ' ARG . 2.9 m-30 -77.1 138.28 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.823 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 93' ' ' TYR . 9.4 tptt -121.28 99.49 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.796 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER 0.61 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.676 0.61 . . . . 0.0 112.236 -179.313 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -116.77 163.55 15.98 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.338 -179.301 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -39.53 -60.64 1.69 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.55 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.421 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 33.6 mmt180 -47.72 -69.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.675 0.274 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.6 t -33.98 -38.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.809 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.64 -79.06 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.607 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.9 -34.45 65.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.542 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.84 ' CD1' HD11 ' A' ' 34' ' ' ILE . 3.8 tt -68.17 -51.83 41.37 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.297 0.57 . . . . 0.0 110.969 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -62.38 -29.63 70.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.671 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.02 -44.95 71.69 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.33 -57.66 7.96 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.25 -33.67 75.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.534 -1.333 . . . . 0.0 110.875 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 -22.84 23.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -85.2 -34.87 21.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.41 -44.63 63.98 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.655 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.794 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.14 -31.03 0.08 OUTLIER Glycine 0 C--N 1.341 0.828 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.632 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.4 mp -71.42 147.01 48.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.32 96.71 4.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.412 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.1 p90 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.139 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.83 122.73 37.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.501 -178.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.43 143.02 27.14 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.518 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.806 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.3 m -146.23 108.55 4.44 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.008 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 6.7 p -97.03 119.23 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.321 0.582 . . . . 0.0 112.132 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.3 t80 -105.62 140.84 38.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.702 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 10.2 ptt85 -150.46 126.32 10.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.782 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 t -89.65 -85.78 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.924 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.87 -58.28 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.002 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.47 19.24 13.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.336 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -119.04 156.92 28.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.905 HD11 HD13 ' A' ' 100' ' ' LEU . 2.7 tp -142.76 132.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' H ' HD12 ' A' ' 34' ' ' ILE . 39.1 m-85 -149.55 149.97 31.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 111.963 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -133.74 128.4 34.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG2' HD11 ' A' ' 39' ' ' ILE . 2.1 tt0 -117.24 113.26 21.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.722 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -99.55 99.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.32 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.0 mp -104.32 160.05 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.794 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.699 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.0 t0 -91.36 114.19 26.65 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.51 22.74 2.85 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.077 0.861 . . . . 0.0 112.508 -178.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.67 -48.92 3.42 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.65 118.01 19.45 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.503 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.06 90.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.341 -177.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.2 t -136.1 112.58 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -77.87 118.48 20.23 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 47' ' ' LEU . 1.1 mp -103.67 -50.85 3.32 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.859 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.0 t -126.86 142.59 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.442 0.639 . . . . 0.0 112.385 -178.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 80.8 p -150.08 115.01 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.498 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.0 161.78 26.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.32 127.06 10.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 179.527 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 10.3 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.203 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.787 0.327 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 67' ' ' GLN . 79.2 t -93.99 -24.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.469 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.078 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -40.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.961 0.41 . . . . 0.0 111.748 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.06 -60.36 2.69 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.385 0.612 . . . . 0.0 109.376 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.0 mt-30 -48.66 -27.04 2.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.194 178.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.078 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -74.63 -35.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.57 178.616 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.38 -36.93 43.01 Favored Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.068 178.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -62.14 -35.72 79.63 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -67.27 -45.93 75.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.067 178.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.659 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.5 mt -63.55 -53.95 43.8 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.666 0.746 . . . . 0.0 109.019 178.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -57.91 -25.75 61.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.905 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -76.66 -26.92 55.37 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.108 178.183 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.859 ' HB2' HG21 ' A' ' 48' ' ' VAL . 27.2 mttm -82.9 -63.01 1.45 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.536 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.57 -42.6 11.24 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.02 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.6 mt -55.84 -40.15 72.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.127 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.63 -24.98 9.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.04 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.596 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.29 19.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.32 15.43 11.49 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.352 -179.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -66.52 106.21 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.519 0.676 . . . . 0.0 110.192 179.865 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.17 -56.78 3.03 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.165 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -113.73 144.72 42.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.261 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.16 161.7 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.651 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 103.28 12.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.999 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.762 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.56 108.42 15.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.124 0.487 . . . . 0.0 111.592 -179.078 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.41 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -129.24 45.81 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.115 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 1.3 ptt180 -41.53 -33.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.611 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.45 -117.96 5.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -88.74 20.07 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.771 2.314 . . . . 0.0 112.705 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.2 m-85 -80.92 138.74 36.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 0.0 111.214 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.02 151.34 25.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.6 106.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.649 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.32 164.57 18.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.85 -42.6 7.87 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.134 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HD2' HD13 ' A' ' 34' ' ' ILE . 1.1 mtt-85 -57.89 -70.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 0.0 110.668 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.0 t -37.45 -40.49 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.952 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.91 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.62 -35.36 70.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.699 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.905 HD13 HD11 ' A' ' 34' ' ' ILE . 3.4 tt -67.34 -49.6 63.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.084 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.17 -29.57 69.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.172 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.854 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -69.88 -44.26 70.16 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.369 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.77 -56.96 9.05 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.87 -31.43 72.66 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 113.578 -1.311 . . . . 0.0 111.013 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -89.97 -25.7 20.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.022 0.439 . . . . 0.0 110.726 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.1 pt-20 -80.48 -37.66 31.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.68 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.8 -48.32 62.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.493 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.01 -29.16 0.07 OUTLIER Glycine 0 C--N 1.343 0.949 0 C-N-CA 119.905 -1.14 . . . . 0.0 115.023 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.5 mp -71.48 146.54 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -128.24 96.31 4.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.379 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.708 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.004 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 HG13 ' A' ' 81' ' ' ILE . 1.7 mp . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 120.815 0.341 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 23.1 ttp85 -102.71 126.82 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.176 -179.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.941 HD23 ' N ' ' A' ' 26' ' ' SER . 5.3 tt -89.74 147.15 24.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.818 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.941 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.1 m -139.16 158.58 43.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.581 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.09 127.45 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.967 0.413 . . . . 0.0 110.265 179.219 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -128.68 122.49 30.91 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.912 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 96' ' ' ARG . 3.4 ptt-85 -130.81 123.55 29.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.639 178.01 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.09 -91.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.833 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.39 -64.76 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 109.829 179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 27.99 8.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.794 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -119.69 161.87 19.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.439 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.5 tp -149.34 128.23 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.513 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 27' ' ' VAL . 27.4 m-85 -144.02 160.15 41.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.312 0.577 . . . . 0.0 111.839 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -145.77 126.97 14.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.006 177.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -115.33 113.18 23.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 110.679 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.2 92.34 3.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.575 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.0 mp -96.58 161.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.533 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -94.53 115.44 27.6 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.826 177.953 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.7 t0 -92.42 28.67 1.89 Allowed 'General case' 0 N--CA 1.464 0.239 0 O-C-N 124.289 0.993 . . . . 0.0 112.22 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.45 -47.72 3.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mptt -136.78 118.25 14.77 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 174.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.37 89.16 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.545 -177.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.8 t -137.43 112.61 10.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.194 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -74.86 119.26 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 79' ' ' LEU . 1.8 mp -98.23 -63.63 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.48 HG13 ' HD3' ' A' ' 75' ' ' LYS . 2.2 t -120.23 147.51 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.402 0.62 . . . . 0.0 112.4 -178.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 p -150.27 129.44 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.82 179.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -141.75 157.61 44.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.494 . . . . 0.0 112.32 -179.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.39 129.19 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.515 179.594 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.45 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 m . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.769 179.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.754 0.312 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 65' ' ' ALA . 73.2 t -94.06 -23.14 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.074 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.33 -41.66 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.735 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.01 -60.82 2.46 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.475 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.4 mt-30 -48.14 -26.19 1.78 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.241 177.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.074 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.49 -34.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.586 178.597 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.51 -31.33 54.68 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -67.94 -34.96 77.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.943 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.52 -41.48 65.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.151 177.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.795 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 5.1 mt -63.68 -46.33 86.02 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.91 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -68.32 -27.18 66.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -67.43 -37.16 82.58 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 109.298 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 3.2 mttt -81.34 -63.96 1.29 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.068 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -41.21 -42.34 2.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.135 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -61.15 -40.33 93.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.963 179.4 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.9 -22.57 5.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.17 -27.09 20.92 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.028 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.33 17.08 11.05 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.068 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.684 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -70.84 103.91 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.694 0.759 . . . . 0.0 110.312 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLU . 10.2 ttpt -95.75 -46.71 6.48 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.07 -178.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 140.63 52.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.379 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -127.89 167.45 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.473 0.654 . . . . 0.0 111.975 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.74 105.17 15.31 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.752 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.6 t80 -80.67 106.24 12.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.823 0.82 . . . . 0.0 112.597 -177.291 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.41 105.46 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.834 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -90.39 -48.06 7.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.675 -178.029 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.3 -112.48 2.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.163 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.16 26.84 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.834 2.356 . . . . 0.0 112.59 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 m-30 -99.66 162.54 12.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 111.368 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -132.01 148.07 52.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.886 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -44.61 103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.609 -179.858 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.06 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.142 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.31 -42.51 25.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.129 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.451 ' HB3' HD13 ' A' ' 34' ' ' ILE . 12.8 mmt-85 -56.27 -71.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.537 0.208 . . . . 0.0 110.985 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -39.46 -43.12 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.742 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.04 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.041 0.448 . . . . 0.0 111.067 -179.643 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -57.36 -36.84 71.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.213 -179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -68.32 -49.11 62.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 110.82 -179.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.583 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -58.65 -32.99 69.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.333 -178.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.74 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.75 -47.83 65.28 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.599 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.04 -58.32 6.37 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 177.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.91 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.36 -42.55 87.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.363 -1.419 . . . . 0.0 111.354 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -79.55 -53.77 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -48.35 -41.25 28.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.258 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.665 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.14 -49.58 61.35 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.842 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.66 -27.89 0.06 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.16 -1.019 . . . . 0.0 114.522 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.5 147.73 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.35 91.91 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 178.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.011 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.755 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.907 0.384 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -105.28 124.64 49.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.771 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.813 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.1 tt -90.54 143.02 27.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.257 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.774 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -145.14 110.17 5.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.165 -179.816 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 2.2 p -100.83 123.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.072 0.463 . . . . 0.0 111.921 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.504 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -100.5 154.24 18.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 112.316 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 18.1 mtm105 -150.29 118.81 6.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.32 179.133 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 -45.28 9.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.054 0.454 . . . . 0.0 110.994 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tp 179.89 -63.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -115.29 22.2 13.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.285 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -122.2 173.15 7.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.958 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 100' ' ' LEU . 5.2 tp -158.4 132.69 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 30.8 m-85 -148.21 148.69 30.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -134.23 121.29 21.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.876 177.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -111.76 112.88 24.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -98.31 105.3 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.106 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -108.26 160.08 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -88.83 116.33 27.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.831 178.109 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.4 t0 -91.74 22.38 4.18 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.415 1.072 . . . . 0.0 112.256 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.04 -46.67 3.43 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.8 mmmt -133.16 118.31 18.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 174.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.56 86.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 43' ' ' LYS . 61.7 t -134.89 112.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -72.4 113.87 9.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.644 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -89.9 -57.29 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.713 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.675 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -131.62 152.76 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.234 0.54 . . . . 0.0 111.902 -178.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -150.31 119.61 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.934 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -129.66 148.56 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 112.128 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.39 139.97 21.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.641 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.426 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 111.469 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 67' ' ' GLN . 63.9 t -94.03 -18.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.924 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.007 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.11 -42.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 111.95 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.03 -60.41 2.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.584 0.707 . . . . 0.0 109.205 178.648 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 25.2 mt-30 -49.18 -24.14 1.59 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.368 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.007 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.17 -32.37 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.268 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.44 -26.82 60.57 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.276 178.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 7.5 ppt_? -77.31 -38.45 50.55 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.346 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.37 72.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.77 ' CD1' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.21 -52.12 17.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.981 178.428 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.85 -23.67 67.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.532 178.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 42.7 mt-10 -77.79 -30.04 51.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB3' HG21 ' A' ' 48' ' ' VAL . 16.5 mttt -73.82 -68.29 0.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.416 177.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.45 -42.44 7.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.104 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -57.12 -38.89 74.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.823 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.55 -23.07 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.932 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.903 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 18.97 9.53 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.109 -178.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.41 104.93 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.559 0.695 . . . . 0.0 110.356 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 4.1 tttt -90.99 -57.22 2.88 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.372 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.91 146.91 35.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.421 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.83 165.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.5 0.667 . . . . 0.0 112.023 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.38 97.3 7.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.324 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.813 ' CE1' HD22 ' A' ' 25' ' ' LEU . 5.3 t80 -81.12 109.68 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.28 86.48 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.651 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.0 tpt180 -77.66 -27.7 50.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.046 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.29 -109.31 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.226 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.19 34.2 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.823 2.348 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 2.7 m-85 -96.34 138.11 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.124 0.488 . . . . 0.0 111.558 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 149.54 30.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.932 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.511 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -45.51 97.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.779 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.5 t-160 -110.5 159.11 17.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.459 -179.308 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -40.17 -51.44 3.55 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.492 -179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.4 mtt-85 -55.0 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.636 0.255 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -40.28 -38.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.273 179.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -61.16 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.012 0.434 . . . . 0.0 110.592 -179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -54.73 -36.08 64.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.99 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 34' ' ' ILE . 1.3 tt -70.35 -52.68 20.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.204 0.526 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.6 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -56.41 -32.32 64.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.319 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.794 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.6 -44.6 70.39 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.043 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.79 -57.09 8.92 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.78 -33.69 74.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.49 -1.355 . . . . 0.0 110.93 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.86 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.5 tpp85 -88.97 -24.11 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.794 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -83.6 -34.94 25.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.3 -45.35 61.41 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.921 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.03 -30.64 0.08 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.178 -1.011 . . . . 0.0 114.454 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.86 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.36 142.81 50.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.193 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 2.0 mp0 -127.7 99.8 5.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.066 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.091 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HD3' ' CA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.54 0.21 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -43.37 124.02 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.724 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -92.84 125.52 37.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.635 -178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.869 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.45 144.03 26.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.869 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.4 m -145.82 108.53 4.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.85 HG11 HG23 ' A' ' 97' ' ' VAL . 4.5 p -98.3 123.43 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.177 0.513 . . . . 0.0 111.882 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' OH ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -106.98 145.26 32.48 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -150.29 119.17 6.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.74 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.66 -69.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.072 0.463 . . . . 0.0 110.423 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.6 mt -147.6 -59.16 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.441 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -119.37 4.36 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.379 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -109.1 116.25 31.59 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.994 0.426 . . . . 0.0 111.356 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.636 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.0 tp -104.09 129.09 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.777 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 20.3 m-85 -143.16 151.21 40.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.215 0.531 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -137.61 122.52 18.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.397 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 113.26 25.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.0 110.547 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.02 100.44 10.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -102.02 163.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.892 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.2 t0 -93.63 114.03 26.26 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' CG ' ' A' ' 22' ' ' ARG . 7.1 t0 -90.26 26.65 1.86 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.331 1.019 . . . . 0.0 112.419 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' CA ' ' HD3' ' A' ' 22' ' ' ARG . 35.8 tt0 -110.67 -47.64 3.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.29 118.22 17.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.82 89.25 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.374 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' LYS . 93.5 t -138.3 112.41 8.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -76.94 119.35 20.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.4 mp -102.32 -57.57 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -122.69 146.12 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 0.0 111.907 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -150.16 114.91 5.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -120.98 148.4 44.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.886 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.472 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.43 136.77 18.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.978 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 16.3 m -60.39 -57.49 12.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.007 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.0 tm? -64.09 -15.39 59.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.58 -62.02 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mp -52.45 -52.07 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.642 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.12 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.812 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 75.5 mt -51.86 115.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.553 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.755 ' HG2' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -121.45 24.69 9.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.02 -116.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.324 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 63' ' ' GLU . 3.1 m120 -77.77 178.02 7.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.747 0.308 . . . . 0.0 110.828 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -108.4 -38.77 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.487 HG23 ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -93.07 -28.09 16.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -58.2 -54.12 50.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.739 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 65' ' ' ALA . 69.0 t -86.08 -21.46 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.198 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.067 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.6 -43.98 0.05 Allowed 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -64.12 -60.94 2.61 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.517 0.675 . . . . 0.0 109.398 178.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -48.45 -25.28 1.58 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.23 177.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.067 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.13 -33.16 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.639 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.52 -27.91 58.44 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.161 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.7 ppt_? -74.77 -38.61 62.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -70.27 -34.94 73.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 38' ' ' ILE . 1.8 tp -68.98 -54.29 16.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.82 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -61.94 -25.31 67.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.913 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.9 mt-10 -77.88 -30.22 50.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.3 mttt -72.77 -69.27 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.518 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.72 -42.55 7.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.742 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -55.85 -39.1 70.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.023 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.79 -24.01 13.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.54 -27.77 20.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.28 14.93 12.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.297 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.88 107.21 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.496 0.665 . . . . 0.0 110.237 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 110' ' ' GLU . 24.4 ttpt -94.53 -52.45 4.31 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.361 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.44 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -114.85 142.61 46.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.204 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.643 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.04 161.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.414 0.626 . . . . 0.0 112.058 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -102.02 100.88 11.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.282 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 1.9 t80 -81.06 106.25 12.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.155 0.502 . . . . 0.0 111.216 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -137.16 43.16 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.155 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' NH1' HG21 ' A' ' 97' ' ' VAL . 7.2 ptt180 -37.71 -39.18 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.809 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.72 -117.32 5.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.734 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.15 50.62 3.6 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 111.979 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.46 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 5.9 m-85 -123.22 102.23 7.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.945 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -71.52 139.33 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.881 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.513 ' CD1' ' CE ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -52.11 88.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.505 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -103.73 -165.12 1.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.148 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.82 -55.81 9.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.987 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.636 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -45.77 -71.25 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.653 0.263 . . . . 0.0 110.586 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.85 HG23 HG11 ' A' ' 27' ' ' VAL . 8.8 p -42.59 -32.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CE ' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -66.37 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.96 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -47.28 -35.87 8.4 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.772 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -70.18 -41.24 74.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.07 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -66.65 -34.93 78.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.461 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.742 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -66.25 -44.2 84.35 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.32 -57.0 10.93 Favored Glycine 0 CA--C 1.508 -0.394 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.97 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.26 -33.02 72.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 113.552 -1.324 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.1 tpp180 -90.05 -26.25 20.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.721 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.742 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.3 pt-20 -80.82 -33.33 34.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.65 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.91 -46.68 35.86 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.946 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.9 -31.42 0.07 OUTLIER Glycine 0 C--N 1.34 0.803 0 C-N-CA 119.989 -1.101 . . . . 0.0 114.731 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.835 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.3 mp -71.36 143.99 50.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' CB ' ' HG3' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -127.9 95.15 4.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.136 178.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.663 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.2 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.095 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.56 ' C ' HD23 ' A' ' 23' ' ' LEU . 17.2 ttm105 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.877 0.37 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.07 135.48 48.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.5 ttp85 -101.12 127.16 47.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.42 140.87 29.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.757 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.15 112.34 7.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.24 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -92.74 135.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.564 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 1.4 t80 -123.93 115.64 21.6 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.102 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -126.27 118.72 25.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.542 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.25 -48.58 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -170.52 -64.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -117.27 20.81 13.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.405 178.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 1.5 m80 -127.74 132.68 49.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.032 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 100' ' ' LEU . 4.0 tp -121.85 118.47 55.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.303 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 9.2 m-85 -136.5 108.39 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.706 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -97.54 126.03 42.58 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 116.07 29.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.321 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.81 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -97.43 98.35 7.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.169 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.2 mp -100.71 165.45 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.039 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -97.16 112.07 24.02 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.721 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.1 p30 -91.12 27.04 1.97 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.15 0.906 . . . . 0.0 112.252 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -110.15 -46.9 3.38 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.3 mptt -134.62 118.25 17.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.83 90.33 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.341 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.6 t -140.98 112.53 3.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -76.48 123.12 25.55 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -104.02 -61.78 1.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -120.59 144.9 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.224 0.535 . . . . 0.0 111.952 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.4 p -150.21 116.06 5.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.175 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.859 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.54 151.22 48.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.212 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.56 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 7.1 t -150.44 134.88 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 0.0 111.884 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.663 ' H ' HG23 ' A' ' 34' ' ' ILE . 5.4 t -52.67 -26.25 13.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.035 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.495 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.2 tm? -56.51 -62.48 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.728 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.4 -25.9 51.5 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.424 0.631 . . . . 0.0 109.946 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.6 mp -90.14 12.49 17.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.881 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 3.09 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.64 0.776 . . . . 0.0 112.804 -177.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.804 ' HB2' HG21 ' A' ' 64' ' ' VAL . 1.9 pt? -46.75 171.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.332 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 32.6 6.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.36 -155.8 9.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.13 -71.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -175.95 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 p -93.11 -10.24 36.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.33 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -68.15 -42.34 80.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' A' ' 57' ' ' LEU . 53.0 t -93.99 -18.87 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.722 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.025 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.43 -39.32 0.12 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.8 -59.96 3.09 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.58 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.7 mt-30 -49.58 -27.28 4.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.297 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -75.01 -33.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.78 -27.26 61.07 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.7 -33.58 72.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.9 -36.62 56.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.859 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -65.39 -45.54 83.61 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.965 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -73.06 -33.27 65.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.845 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 46.4 mt-10 -71.34 -33.22 69.42 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 48' ' ' VAL . 19.7 mttt -70.17 -67.65 0.48 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.79 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.37 -41.08 13.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.963 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.719 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.97 -38.97 77.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.023 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.52 -23.61 10.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.946 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.53 -27.38 20.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.5 16.59 10.81 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.206 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -72.16 107.96 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.516 0.674 . . . . 0.0 110.393 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -95.15 -53.45 3.8 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.442 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -115.14 142.57 46.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.44 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -128.55 163.47 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.496 0.665 . . . . 0.0 111.884 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.11 98.8 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.169 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.749 ' CE1' HD22 ' A' ' 25' ' ' LEU . 2.1 t80 -81.15 113.89 19.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.459 0.647 . . . . 0.0 111.806 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.442 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -150.17 33.7 0.66 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.677 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.667 ' C ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -43.31 -41.6 4.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.795 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' N ' ' HD3' ' A' ' 88' ' ' ARG . . . 156.28 -136.61 5.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.303 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -95.73 37.85 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.193 2.595 . . . . 0.0 112.736 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' CE2' ' NH2' ' A' ' 88' ' ' ARG . 4.7 m-30 -88.62 84.94 6.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.339 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -71.85 133.62 45.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.559 ' C ' ' O ' ' A' ' 92' ' ' LYS . 1.4 t80 0.69 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.533 0.521 . . . . 0.0 112.304 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.536 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.1 m170 -94.18 148.31 22.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.216 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.432 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -29.01 -39.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.095 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 16.6 mmt180 -79.49 -65.43 1.0 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.678 0.275 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 31.8 t -30.48 -49.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -53.99 -72.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.495 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -61.56 -40.94 96.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.476 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 34' ' ' ILE . 2.4 tt -63.19 -45.71 90.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.473 0.654 . . . . 0.0 110.446 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.528 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -67.58 -30.32 69.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.291 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.02 -46.74 70.4 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.25 -54.71 9.69 Favored Glycine 0 CA--C 1.508 -0.393 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.965 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.83 -36.15 83.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 113.269 -1.465 . . . . 0.0 111.469 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -87.48 -24.25 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.412 . . . . 0.0 110.764 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -82.59 -37.47 24.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.78 -47.98 64.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.002 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.719 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -30.06 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.513 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.817 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.0 mp -71.41 143.7 50.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.444 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -127.69 99.38 5.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.881 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.895 . . . . 0.0 111.068 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' C ' HD23 ' A' ' 23' ' ' LEU . 9.6 ptp85 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.816 0.341 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -102.34 132.4 48.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.411 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HD2' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -101.54 125.16 48.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.55 143.42 26.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.037 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.821 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 m -146.97 108.76 4.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.966 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG21 HD13 ' A' ' 100' ' ' LEU . 7.7 p -93.39 119.77 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.07 140.22 37.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.785 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 34' ' ' ILE . 3.2 mmm180 -150.08 118.92 6.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.951 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.74 -64.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.21 0.529 . . . . 0.0 110.291 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 -58.16 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -119.71 2.28 11.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.634 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.634 ' HA ' HD23 ' A' ' 53' ' ' LEU . 32.5 m170 -110.33 117.66 34.22 Favored 'General case' 0 N--CA 1.46 0.05 0 CA-C-O 120.965 0.412 . . . . 0.0 112.089 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.86 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.8 tp -106.45 131.0 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.768 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.537 ' HE1' HD21 ' A' ' 53' ' ' LEU . 37.1 m-85 -148.98 111.97 4.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.721 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -93.72 123.59 37.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.56 113.52 26.38 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -99.04 96.51 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -98.4 164.7 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.306 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -95.61 113.19 24.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 10.0 t70 -88.35 21.83 2.72 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.376 1.048 . . . . 0.0 112.352 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.47 -48.85 3.18 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.3 mmtp -129.77 118.17 21.4 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.72 87.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.722 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 43' ' ' LYS . 53.0 t -136.39 112.5 12.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -75.86 117.81 17.99 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -101.31 -59.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.07 143.69 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 112.238 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.6 p -150.03 114.69 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.36 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' TYR . . . -120.81 159.18 25.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 112.098 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -144.89 126.86 15.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.49 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.628 ' N ' HG21 ' A' ' 68' ' ' VAL . 1.3 m -63.98 -34.09 77.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.35 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 33' ' ' HIS . 3.6 pp -70.39 -8.89 54.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.425 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.91 -53.55 5.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.672 HD12 ' H ' ' A' ' 55' ' ' LEU . 5.0 mp -52.37 -44.49 65.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 tttt 178.99 -31.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.453 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.879 HD12 ' HB ' ' A' ' 64' ' ' VAL . 4.8 tt -40.11 133.91 1.64 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.941 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.801 ' N ' HD23 ' A' ' 57' ' ' LEU . 22.5 tttp -132.05 -45.48 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.26 -80.42 1.33 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.598 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' O ' HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -57.42 120.57 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.748 ' HA ' HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -93.65 -60.23 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.675 HG23 ' NH2' ' A' ' 96' ' ' ARG . 1.1 p -55.41 -23.55 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.322 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.56 -66.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.179 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.879 ' HB ' HD12 ' A' ' 57' ' ' LEU . 97.9 t -80.73 -19.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.662 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.052 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.22 -37.96 0.08 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.904 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -69.66 -58.9 3.36 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 9.4 mt-30 -49.84 -22.63 1.53 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.488 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.052 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.23 -33.63 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -76.64 -33.6 46.75 Favored Glycine 0 C--O 1.217 -0.93 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.131 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -72.31 -41.78 66.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.95 -40.58 91.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -64.34 -54.49 32.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.2 -25.25 31.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.8 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.8 tt0 -72.14 -36.85 69.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 10.2 mttp -71.85 -64.49 0.92 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.843 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.821 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.88 -42.65 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.318 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.772 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -59.23 -40.8 87.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.257 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -51.44 -25.66 6.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.417 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.42 -28.0 20.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 12.9 13.18 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.627 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -67.78 104.1 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.649 0.738 . . . . 0.0 110.036 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 110' ' ' GLU . 21.2 ttpp -92.79 -49.75 5.91 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.147 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -117.43 136.31 53.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.362 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.533 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.89 162.93 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.376 0.608 . . . . 0.0 111.838 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.2 102.55 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.47 121.19 25.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.13 0.49 . . . . 0.0 111.549 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 1.3 t70 -148.48 45.88 1.04 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.162 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.9 ptt-85 -40.39 -31.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.661 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.48 -125.01 7.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.5 59.84 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.418 2.078 . . . . 0.0 111.754 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 8.4 m-85 -131.66 157.51 43.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 111.391 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -132.21 140.78 48.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.357 178.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.508 ' CZ ' ' HD3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -41.0 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.917 ' CE1' HG23 ' A' ' 97' ' ' VAL . 18.8 p80 -112.88 151.16 30.79 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.525 ' C ' HG22 ' A' ' 62' ' ' THR . . . -20.88 -55.97 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 115.164 -0.925 . . . . 0.0 114.039 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.86 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.9 mmp_? -57.63 -64.54 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.917 HG23 ' CE1' ' A' ' 94' ' ' HIS . 88.7 t -35.41 -46.65 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.567 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HD3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.36 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.44 -43.27 62.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.889 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -61.62 -45.22 95.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.347 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.564 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -65.72 -37.63 86.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.805 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.809 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -67.42 -42.65 82.86 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.14 -58.94 8.07 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.972 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.92 -35.13 74.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.82 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -87.92 -30.43 20.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.418 . . . . 0.0 110.692 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.809 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.0 pt-20 -74.22 -35.15 63.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.659 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.72 -46.26 54.69 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.458 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.772 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.42 -27.76 0.08 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.941 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.3 mp -71.46 145.24 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER -128.16 93.98 3.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.504 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.696 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.938 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.633 ' C ' HD23 ' A' ' 23' ' ' LEU . 10.8 tpt180 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -104.22 133.83 48.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.428 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 16.3 ttp-105 -101.28 125.0 47.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.11 141.76 28.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.938 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -142.27 107.95 5.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.084 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.6 p -95.53 116.5 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.263 0.554 . . . . 0.0 111.569 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -93.61 134.98 35.34 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.972 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.71 ' NH2' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -123.34 118.12 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 t -90.25 -79.33 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -153.06 -58.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.36 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.27 1.85 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.182 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.15 174.57 6.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.342 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.71 HD12 ' NH2' ' A' ' 29' ' ' ARG . 2.8 tp -150.45 111.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -136.56 140.67 43.1 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -128.54 127.95 43.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.257 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.05 114.02 25.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.038 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -98.19 95.2 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.317 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -95.84 163.89 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.858 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.4 t0 -95.19 114.71 26.53 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.711 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.6 t70 -90.28 23.53 2.87 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.405 1.065 . . . . 0.0 112.311 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.13 -47.77 3.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.19 118.17 16.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 174.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.95 89.97 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.28 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' LYS . 87.0 t -139.63 112.42 5.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 m -72.1 113.6 9.31 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.9 mp -92.86 -65.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.91 148.33 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.266 0.555 . . . . 0.0 111.63 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -150.14 114.84 5.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.654 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 72' ' ' LEU . . . -123.62 138.98 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 111.853 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 36.9 p -150.3 132.63 15.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.595 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.8 m -51.39 -33.2 29.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 53' ' ' LEU . 1.4 tm? -59.71 -63.62 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.334 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.97 62.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.534 . . . . 0.0 110.174 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.7 mp -89.07 11.37 18.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.278 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.5 tttt 2.17 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.33 0.652 . . . . 0.0 112.463 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.838 HD11 HG11 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -100.66 176.1 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.037 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -80.19 74.38 7.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.624 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.851 ' HA3' HG21 ' A' ' 64' ' ' VAL . . . -136.25 -168.46 11.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.781 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -133.31 -55.92 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.576 0.227 . . . . 0.0 110.995 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -175.54 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.681 0.277 . . . . 0.0 111.619 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -74.6 -43.0 57.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.749 0.309 . . . . 0.0 111.614 -179.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -50.76 -39.02 51.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.313 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.851 HG21 ' HA3' ' A' ' 59' ' ' GLY . 73.9 t -94.26 -22.91 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.766 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.035 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.92 -39.8 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.673 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.35 -59.55 3.32 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.525 0.678 . . . . 0.0 109.172 178.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.5 mt-30 -49.66 -26.56 3.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.205 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.035 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.43 -32.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.38 -26.39 63.72 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 8.2 ptt85 -73.47 -39.83 64.61 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 70' ' ' ARG . . . -68.57 -36.23 78.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.038 HD21 HD11 ' A' ' 38' ' ' ILE . 1.1 tp -68.69 -53.48 21.97 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.015 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.949 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -63.35 -25.12 68.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.528 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 15.8 mt-10 -78.2 -29.98 48.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.0 mttt -71.82 -69.16 0.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.403 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.84 -42.84 8.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.181 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.697 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.5 mt -56.02 -39.16 71.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.71 -24.58 8.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.071 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.71 -27.04 20.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.62 21.82 7.0 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.061 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' CG1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.53 102.84 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.136 0.494 . . . . 0.0 110.771 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.652 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.97 -25.62 12.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.576 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -125.27 125.24 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.187 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.12 164.54 23.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 112.06 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -105.31 105.51 15.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.391 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.37 118.01 22.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.394 0.616 . . . . 0.0 112.011 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.03 40.8 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.644 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.43 -29.57 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.752 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 88' ' ' ARG . . . 123.12 -151.43 16.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.94 55.99 4.63 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.927 2.418 . . . . 0.0 111.884 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.484 ' CG ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m-30 -100.18 166.52 10.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.024 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.91 153.51 50.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -47.33 109.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.502 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.496 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -126.25 156.53 40.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 62' ' ' THR . . . -38.44 -30.01 0.08 OUTLIER Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.602 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.633 ' CD ' HD13 ' A' ' 34' ' ' ILE . 1.2 mmt85 -76.7 -70.97 0.42 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.598 0.237 . . . . 0.0 111.606 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 60.0 t -31.01 -50.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -57.96 -75.06 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.864 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.58 -37.67 68.37 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.172 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 3.1 tt -67.66 -49.16 64.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.424 0.631 . . . . 0.0 110.625 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.3 -33.16 73.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.402 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.758 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -66.53 -46.54 75.81 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.08 -57.91 7.52 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.949 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.15 -39.95 80.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.354 -1.423 . . . . 0.0 111.428 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.841 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -82.58 -51.42 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -49.44 -40.57 37.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.58 -48.81 64.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.359 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.14 -26.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.092 -1.051 . . . . 0.0 114.713 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.841 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.37 145.98 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -128.2 91.99 3.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.455 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.3 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.955 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HD3' ' HB2' ' A' ' 42' ' ' GLU . 7.7 ptm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -33.86 137.62 0.1 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.198 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -93.02 124.32 36.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 26' ' ' SER . 3.4 tt -89.35 143.54 26.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.814 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.832 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -144.61 108.48 4.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.753 0.311 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.629 HG21 HH22 ' A' ' 29' ' ' ARG . 2.8 p -97.68 121.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.354 0.597 . . . . 0.0 111.872 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.26 139.54 41.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.831 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.629 HH22 HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -150.31 126.25 10.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.518 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -80.73 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.765 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.9 -51.25 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -119.1 23.18 11.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.904 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -123.91 172.44 8.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.133 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -160.22 126.95 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.996 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.792 ' N ' HD12 ' A' ' 34' ' ' ILE . 41.9 m-85 -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.056 0.455 . . . . 0.0 112.024 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -134.75 121.36 20.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.14 113.36 25.58 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.171 0.51 . . . . 0.0 110.485 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.78 99.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.3 mp -101.37 161.81 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.197 -0.911 . . . . 0.0 113.315 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -93.79 110.5 22.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.443 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -88.32 27.43 1.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.235 0.959 . . . . 0.0 112.552 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 22' ' ' ARG . 32.0 tt0 -111.35 -48.54 3.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.62 118.32 19.91 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 174.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.22 88.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' LYS . 95.8 t -136.81 112.67 11.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -76.55 119.33 20.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.505 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.8 mp -98.84 -62.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -122.42 148.63 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 112.302 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 14.1 p -150.21 131.01 14.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.064 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.01 165.74 24.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 0.0 111.755 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.568 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -150.15 126.86 10.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.075 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.678 ' HB3' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -62.9 -65.47 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.514 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.5 tm? -43.57 -36.94 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.573 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.01 -48.71 11.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.496 0.665 . . . . 0.0 111.197 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 51' ' ' SER . 0.1 OUTLIER -52.75 -34.63 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt 179.79 -37.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.9 mt -46.39 154.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 111.571 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -127.05 -56.03 1.35 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.413 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.48 18.58 3.65 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.28 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.489 ' CB ' HD21 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -113.26 -168.77 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.792 0.296 . . . . 0.0 110.653 179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -155.38 -51.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.458 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.5 p -91.77 15.39 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.535 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -94.21 -57.34 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.369 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 67' ' ' GLN . 89.6 t -94.16 -15.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.862 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.36 -41.5 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.897 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.65 -59.48 3.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.8 mt-30 -49.7 -23.41 1.75 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.478 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.38 -32.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.04 -28.4 56.45 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -73.88 -37.95 64.55 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.04 -35.41 69.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -67.68 -53.79 24.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.74 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.83 -26.26 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.074 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -75.89 -33.0 59.92 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 14.9 mttt -72.15 -68.97 0.42 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.816 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.73 -42.22 5.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.274 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.786 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -56.81 -40.03 75.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.062 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.14 -23.85 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.017 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.13 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.45 18.9 9.21 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.193 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.43 102.98 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.58 0.705 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.4 tttt -88.13 -59.37 2.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.705 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.408 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -107.25 148.24 29.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.398 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.56 158.91 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.369 0.604 . . . . 0.0 112.107 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.77 101.9 12.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.77 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.707 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.47 114.92 20.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.149 0.499 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.79 56.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -44.57 -40.2 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.47 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.32 -111.79 3.15 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.686 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.09 28.15 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.907 2.405 . . . . 0.0 112.693 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.0 m-30 -96.58 164.08 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -131.92 150.31 52.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.726 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -51.18 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.223 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -115.43 169.58 9.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.3 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.25 -38.27 4.93 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.759 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 7.1 mmt180 -62.54 -70.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.552 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 44.1 t -37.94 -41.74 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 110.887 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.58 -76.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.116 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -58.88 -37.04 75.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.092 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.76 -47.83 68.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.223 0.535 . . . . 0.0 111.029 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.54 -31.64 72.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.508 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.07 -44.02 73.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.35 -57.65 10.04 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.995 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.88 -31.53 72.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.71 -1.245 . . . . 0.0 111.187 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.7 mtm-85 -89.83 -25.68 20.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.786 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -82.46 -33.87 28.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.657 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.93 -47.38 39.21 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.992 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.786 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.87 -29.25 0.07 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 119.857 -1.164 . . . . 0.0 114.867 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.822 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.6 mp -71.1 146.19 49.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.8 mp0 -127.72 91.82 3.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.417 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.649 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.4 p90 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.894 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.656 ' C ' HD23 ' A' ' 23' ' ' LEU . 18.7 ttp-105 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -106.68 137.55 44.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.616 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -101.29 126.52 48.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.02 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.856 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.7 tt -89.69 142.53 27.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.82 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -146.47 108.7 4.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 100' ' ' LEU . 11.9 p -96.77 117.16 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.256 0.551 . . . . 0.0 111.748 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.02 137.22 38.77 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.834 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -143.35 118.85 10.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.934 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 t -89.75 -80.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.877 0.37 . . . . 0.0 110.717 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -127.37 -65.38 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 17.46 13.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.113 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -117.05 140.36 49.58 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 121.123 0.487 . . . . 0.0 111.6 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.808 HD11 HD13 ' A' ' 100' ' ' LEU . 6.5 tp -127.97 129.46 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 30.0 m-85 -144.92 112.21 6.07 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.25 120.93 34.09 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.8 113.01 25.28 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.486 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.935 HD11 ' CD2' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.75 102.27 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.323 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -99.2 161.41 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.686 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.7 t70 -92.36 117.86 30.33 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.986 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.7 t0 -91.95 22.72 4.09 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 124.411 1.069 . . . . 0.0 112.198 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -107.23 -47.47 3.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.04 118.1 15.39 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.04 90.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.058 -1.068 . . . . 0.0 112.173 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.3 t -137.93 112.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -73.43 116.73 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -99.66 -58.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.6 t -119.83 142.48 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.324 0.583 . . . . 0.0 112.226 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -150.17 114.86 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.876 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -125.3 161.9 25.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 111.796 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -143.76 137.52 28.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.798 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.823 ' OG ' HD13 ' A' ' 57' ' ' LEU . 9.2 p -59.51 -33.94 71.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' C ' HD12 ' A' ' 53' ' ' LEU . 4.0 pp -72.76 -7.76 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.295 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -81.44 -60.28 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.401 0.62 . . . . 0.0 111.729 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.665 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.64 -41.51 63.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.3 -178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.81 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 58' ' ' LYS . 4.6 tt -42.43 145.34 0.42 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.877 0.37 . . . . 0.0 111.792 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.881 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -132.08 -53.51 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.13 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.13 -21.85 3.34 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.13 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 8.0 m120 -51.19 169.7 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.137 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -125.48 -84.85 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -93.35 32.16 1.39 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.05 -55.15 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.874 ' HB ' HD12 ' A' ' 57' ' ' LEU . 84.4 t -94.18 -18.58 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.069 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.6 -38.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.848 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.68 -58.59 3.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -50.27 -23.06 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.473 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.069 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.03 -34.52 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.57 -33.28 48.14 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.155 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -71.71 -42.27 67.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.652 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.77 -42.62 90.64 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.935 ' CD2' HD11 ' A' ' 38' ' ' ILE . 4.3 tp -65.06 -51.71 59.93 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.79 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.944 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.88 -26.21 46.15 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.403 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -71.88 -35.94 69.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.821 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.6 mttt -73.19 -63.6 1.15 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.801 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.91 -41.95 7.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.285 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.752 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -60.62 -41.02 94.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.18 -25.9 6.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.38 -27.29 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 111.96 10.06 19.23 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.251 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.489 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -65.1 103.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.586 0.708 . . . . 0.0 110.192 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 110' ' ' GLU . 7.5 tttm -92.8 -55.5 3.34 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.044 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.2 OUTLIER -111.07 139.13 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.362 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.56 163.76 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 111.762 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.16 104.95 14.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.639 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.856 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.48 113.46 19.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.224 0.535 . . . . 0.0 111.787 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -137.32 44.22 2.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.952 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 17.4 ptt-85 -40.57 -32.07 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.44 -128.67 9.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.273 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.79 52.66 3.02 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.654 2.236 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' HB2' ' CG ' ' A' ' 88' ' ' ARG . 4.4 m-85 -117.34 142.11 47.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.876 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -115.01 149.76 36.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.13 105.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.529 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -123.87 163.97 20.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.164 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.0 -27.97 3.74 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.869 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 34' ' ' ILE . 16.1 mmt180 -68.88 -70.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.645 0.26 . . . . 0.0 110.399 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 24.7 t -39.43 -38.4 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.42 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.4 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.965 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.91 -36.54 70.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.816 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 34' ' ' ILE . 2.1 tt -68.47 -48.96 63.12 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 111.155 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.93 -31.02 69.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.178 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.97 -46.46 68.05 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.17 -58.47 7.12 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.944 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.59 -37.81 82.57 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.574 -1.313 . . . . 0.0 111.387 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -86.43 -29.34 22.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 110.92 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.7 pt-20 -74.15 -37.55 63.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.668 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.23 -47.17 73.97 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.103 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 173.52 -26.31 0.08 OUTLIER Glycine 0 C--N 1.342 0.901 0 C-N-CA 120.173 -1.013 . . . . 0.0 114.72 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.3 mp -71.49 145.0 49.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.23 95.95 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.42 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.021 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' C ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.866 0.365 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -106.93 132.46 52.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.41 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp85 -101.15 125.36 47.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 26' ' ' SER . 3.7 tt -89.57 143.32 26.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.852 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.887 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -136.5 147.9 47.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.734 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG12 ' HE ' ' A' ' 88' ' ' ARG . 2.6 p -140.59 118.65 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.361 0.6 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -108.68 142.16 39.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.739 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 32.8 mtm180 -142.7 122.38 13.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.143 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 t -89.36 -78.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.331 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.29 -58.54 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -119.32 23.21 11.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.941 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.51 169.84 9.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.873 HD11 HD13 ' A' ' 100' ' ' LEU . 2.1 tp -156.35 131.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.555 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 51' ' ' SER . 30.8 m-85 -147.3 148.29 31.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.978 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.901 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.89 121.17 19.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.04 112.97 24.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.21 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.089 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -94.52 92.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.4 mp -96.55 162.09 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.741 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' N ' HG22 ' A' ' 39' ' ' ILE . 2.0 t0 -96.83 108.76 21.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.4 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.91 26.85 1.45 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.163 0.914 . . . . 0.0 112.242 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -111.02 -47.34 3.22 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mttt -133.12 118.17 18.38 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.16 90.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.588 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' LYS . 63.0 t -139.1 112.62 6.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -78.65 118.94 21.22 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 79' ' ' LEU . 1.1 mp -102.64 -56.96 2.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' HD3' ' A' ' 75' ' ' LYS . 1.9 t -117.14 144.84 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.641 . . . . 0.0 112.287 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -150.33 114.6 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.342 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -134.32 153.09 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.042 0.449 . . . . 0.0 112.106 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 2.4 t -150.42 131.12 14.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 34' ' ' ILE . 20.1 m -58.71 -29.57 66.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.409 . . . . 0.0 110.382 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.2 tm? -66.75 -48.1 70.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.787 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.09 70.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.221 0.534 . . . . 0.0 110.064 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.9 mp -91.83 10.91 26.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.968 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 2.29 63.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.562 0.745 . . . . 0.0 112.994 -178.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.99 HD12 HG11 ' A' ' 64' ' ' VAL . 9.4 mt -81.46 176.16 9.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.669 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -77.66 67.06 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.823 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.669 ' HA3' HG23 ' A' ' 64' ' ' VAL . . . -136.89 -150.25 5.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.544 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.24 -68.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -144.76 -78.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' C ' ' A' ' 95' ' ' GLY . 71.8 p -84.96 3.31 38.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.284 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.6 -46.19 17.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.714 0.293 . . . . 0.0 110.922 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.99 HG11 HD12 ' A' ' 57' ' ' LEU . 72.1 t -94.07 -24.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.062 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.59 -42.44 0.05 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.017 0.437 . . . . 0.0 111.724 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.65 -60.25 3.1 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.501 ' HB2' HG13 ' A' ' 64' ' ' VAL . 3.6 mp0 -47.55 -26.43 1.43 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.247 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.062 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.93 -32.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.977 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.38 -30.18 46.48 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.464 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.94 -39.9 65.85 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -69.15 -37.55 78.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.089 HD21 HD11 ' A' ' 38' ' ' ILE . 1.4 tp -65.9 -53.42 39.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.305 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.69 -23.36 67.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.153 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.61 -29.76 56.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.5 -47.73 7.79 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -51.58 -40.21 59.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.765 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -60.11 -38.56 83.38 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.781 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.18 -22.96 12.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.44 -26.89 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 16.0 13.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.058 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.577 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -70.38 102.95 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.55 0.691 . . . . 0.0 110.251 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.5 tttt -89.78 -57.72 2.77 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.216 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -111.47 147.41 35.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.293 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -134.58 164.05 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.358 0.599 . . . . 0.0 112.058 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -100.53 101.75 12.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.192 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.663 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -81.04 106.01 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.349 0.595 . . . . 0.0 112.37 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' N ' ' NH1' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -142.8 75.25 1.48 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.237 178.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.594 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -57.39 -38.02 73.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.095 0.474 . . . . 0.0 110.584 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.04 -110.79 2.59 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -90.09 31.15 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.833 2.355 . . . . 0.0 112.334 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 2.8 m-85 -103.06 154.91 18.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.2 150.8 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.222 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -47.82 109.68 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.414 ' O ' ' NZ ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -121.27 -77.78 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.413 ' C ' HG22 ' A' ' 62' ' ' THR . . . -155.66 -54.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.784 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.454 ' HD2' HD13 ' A' ' 34' ' ' ILE . 3.2 mtt180 -54.53 -59.59 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 27.2 t -40.1 -40.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.952 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.91 -76.33 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.935 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -61.1 -34.77 75.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.831 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 34' ' ' ILE . 2.7 tt -66.57 -48.39 69.75 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.332 0.587 . . . . 0.0 110.769 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.14 -33.41 74.44 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.239 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.804 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.73 -45.41 75.1 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.3 -57.02 8.51 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.96 -36.3 81.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.465 -1.368 . . . . 0.0 111.341 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 2.5 tpp85 -87.13 -28.52 22.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.932 0.396 . . . . 0.0 110.683 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -76.6 -35.69 57.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.655 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.64 -48.16 51.8 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.554 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.765 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.42 -27.74 0.07 OUTLIER Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.657 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.837 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.2 mp -71.22 143.34 50.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -127.74 93.83 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.375 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.119 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 42' ' ' GLU . 4.2 tpp180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -44.76 125.32 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.793 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -95.4 126.28 40.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.467 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.844 HD23 ' N ' ' A' ' 26' ' ' SER . 3.3 tt -89.47 142.75 27.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.1 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.844 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.67 108.82 5.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.128 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.802 HG11 HG22 ' A' ' 97' ' ' VAL . 3.3 p -98.29 125.28 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.615 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.76 143.19 41.66 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.11 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.4 tpt180 -150.19 119.01 6.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.999 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -89.81 -44.07 10.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.065 0.459 . . . . 0.0 110.757 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER 179.92 -54.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.737 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.0 tttt -119.28 7.57 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.648 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 9.0 m170 -125.97 131.05 52.33 Favored 'General case' 0 N--CA 1.46 0.042 0 CA-C-O 120.959 0.409 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.748 HD11 HD13 ' A' ' 100' ' ' LEU . 2.9 tp -118.24 132.21 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.621 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' CE1' HD11 ' A' ' 53' ' ' LEU . 29.9 m-85 -145.82 111.04 5.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -96.21 122.83 39.5 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.13 113.26 25.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.734 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.34 98.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.3 mp -99.51 162.67 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.148 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' HA ' HD22 ' A' ' 23' ' ' LEU . 1.5 t0 -93.38 114.02 26.33 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.47 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -91.75 25.98 2.54 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.17 0.919 . . . . 0.0 112.189 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 35.2 tt0 -109.48 -48.13 3.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.79 118.18 17.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 174.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.8 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.31 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 43' ' ' LYS . 75.0 t -138.85 112.56 7.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.81 122.57 23.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.483 HD13 ' CD1' ' A' ' 23' ' ' LEU . 1.6 mp -104.43 -64.2 1.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.3 t -117.49 144.4 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 111.96 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -150.2 125.16 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -131.05 160.91 33.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 111.749 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.72 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -146.27 126.42 13.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.286 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.599 ' HB2' HG21 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -57.82 -51.34 70.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.406 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.642 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -61.06 -10.22 5.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -84.96 -50.69 7.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 51' ' ' SER . 4.0 mp -52.6 -38.64 60.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 111.281 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.8 pttp 179.35 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.545 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.725 HD22 ' HB2' ' A' ' 60' ' ' ASN . 9.3 mt -47.79 140.48 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -132.11 -40.58 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.222 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.18 -47.94 0.63 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.864 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.725 ' HB2' HD22 ' A' ' 57' ' ' LEU . 9.9 m120 -51.5 177.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.777 0.322 . . . . 0.0 111.065 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.85 -68.23 0.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.385 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 p -93.17 27.93 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.457 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.09 -53.35 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.703 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 67' ' ' GLN . 48.4 t -94.06 -14.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.072 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -29.93 -44.11 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.66 -61.03 2.32 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.583 0.706 . . . . 0.0 109.368 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -48.27 -25.88 1.74 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.154 177.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.072 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.86 -36.39 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.8 -28.23 65.41 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.796 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 11.7 ptt180 -70.04 -36.49 75.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.31 -37.77 68.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.751 ' CD2' ' HB3' ' A' ' 50' ' ' ALA . 6.3 mt -67.1 -45.69 76.46 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.52 0.676 . . . . 0.0 109.436 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.99 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -72.35 -27.78 62.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.829 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 41.1 mt-10 -78.5 -29.67 46.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 15.4 mttt -72.79 -69.23 0.42 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.474 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.63 -43.42 12.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.316 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.747 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.1 mt -55.76 -39.74 71.62 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.84 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.84 -24.5 9.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.73 -29.38 18.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.53 15.8 8.59 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.635 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.586 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.99 106.98 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.616 0.722 . . . . 0.0 110.307 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -97.03 -48.32 5.44 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.427 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.376 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -117.0 163.63 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.317 0.579 . . . . 0.0 111.785 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.37 105.99 15.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.738 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.46 113.68 19.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.178 0.513 . . . . 0.0 111.602 -178.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.57 44.36 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.118 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 12.8 ptt-85 -40.71 -48.01 2.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.54 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.47 -114.08 2.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.64 -10.66 13.08 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.531 2.154 . . . . 0.0 112.474 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.2 m-85 -57.25 132.63 53.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.218 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.02 154.88 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.105 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.528 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -45.21 108.76 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.04 0.448 . . . . 0.0 110.629 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -119.25 -125.69 0.28 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.394 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -125.61 -12.24 3.8 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.902 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mmt-85 -89.4 -68.97 0.74 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.926 0.363 . . . . 0.0 110.746 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.802 HG22 HG11 ' A' ' 27' ' ' VAL . 57.4 t -38.81 -28.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.658 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.121 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.01 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.83 -38.96 7.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.178 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -67.91 -46.67 70.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.162 0.506 . . . . 0.0 110.608 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -63.95 -33.22 75.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.081 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.806 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.47 -45.61 75.44 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.547 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.32 -56.8 8.8 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.99 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -34.39 77.16 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 113.507 -1.346 . . . . 0.0 111.543 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.867 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -90.09 -26.45 20.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 0.0 110.809 179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.806 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.4 pt-20 -78.07 -32.1 50.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -75.37 -45.43 18.89 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.747 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.54 -32.43 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 119.935 -1.126 . . . . 0.0 114.87 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.867 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.9 mp -71.33 146.17 49.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.26 93.19 3.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.484 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.706 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.982 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' C ' HD23 ' A' ' 23' ' ' LEU . 10.9 tpp180 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD13 ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -101.95 131.62 48.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.332 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 85' ' ' ALA . 37.0 ttp85 -100.43 123.76 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.86 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.9 tt -89.46 144.67 25.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.428 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.846 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -148.71 108.04 3.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.094 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 7.2 p -92.99 115.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.385 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 139.26 31.59 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.929 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' NH2' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -140.02 118.17 11.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.941 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.93 -155.3 0.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.12 -71.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -120.12 35.39 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.39 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -115.33 132.9 56.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.18 0.515 . . . . 0.0 112.305 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 52' ' ' SER . 0.5 OUTLIER -121.2 111.6 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.666 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 38.4 m-85 -146.42 154.07 41.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.412 0.625 . . . . 0.0 112.675 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -135.21 129.82 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.946 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.97 115.0 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.114 0.483 . . . . 0.0 110.702 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.847 HD11 HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -99.72 94.07 3.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.316 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.548 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.8 mp -94.43 164.62 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.659 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.2 t0 -96.75 115.27 27.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 7.9 t0 -90.89 23.72 3.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.346 1.028 . . . . 0.0 112.319 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -108.09 -47.37 3.57 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 45' ' ' VAL . 1.8 mptp? -135.4 118.16 16.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.12 90.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.343 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.4 t -140.69 112.29 4.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.7 119.82 17.45 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -99.97 -63.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 75' ' ' LYS . 2.2 t -118.08 148.68 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 0.0 112.153 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -150.11 129.98 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.72 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.95 162.48 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 112.147 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.451 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.31 134.83 17.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.436 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -65.76 -53.0 46.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.573 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.4 tm? -53.89 -33.05 55.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.238 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.5 -48.6 8.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.425 0.631 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 51' ' ' SER . 0.1 OUTLIER -52.73 -36.87 58.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.614 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tttm 179.6 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -45.02 140.77 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.666 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 -39.7 1.61 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.022 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.55 76.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.779 ' HB2' HD21 ' A' ' 57' ' ' LEU . 4.1 m-80 -174.52 -173.14 0.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -142.88 -67.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 95' ' ' GLY . 33.0 p -93.19 25.03 3.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.289 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.96 -59.14 2.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 0.0 110.81 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 57' ' ' LEU . 57.4 t -94.15 -15.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.695 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.012 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.58 -38.5 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 111.932 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -69.36 -59.59 2.9 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.57 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.0 mt-30 -49.46 -22.74 1.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.374 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.012 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -82.69 -32.79 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -77.23 -28.37 58.25 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.216 -0.992 . . . . 0.0 111.005 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 3.5 ppt_? -76.74 -38.75 53.65 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.42 -34.38 74.37 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 38' ' ' ILE . 1.1 tm? -69.45 -56.26 7.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.593 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.007 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.37 -24.77 63.69 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.989 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 51.6 mt-10 -79.14 -30.95 43.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 11.6 mttt -70.27 -68.91 0.39 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.271 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.842 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.38 -44.04 11.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.2 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -55.4 -40.11 71.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.975 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.68 -24.93 9.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.032 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.72 -28.73 19.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.0 18.02 8.56 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.575 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -75.28 105.68 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 110.52 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 110' ' ' GLU . 28.7 tttp -90.32 -59.39 2.2 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.204 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -109.02 140.82 42.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.24 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.79 162.52 33.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 111.949 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . . . -103.84 103.42 13.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.841 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.86 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.45 111.38 17.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.21 0.529 . . . . 0.0 111.666 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.48 44.45 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.111 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 ptt-85 -42.09 -46.14 4.19 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.489 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.38 -131.92 7.58 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.184 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.46 48.97 2.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.595 2.197 . . . . 0.0 112.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.4 m-30 -100.49 155.75 17.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.91 154.76 48.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.279 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.6 109.67 0.27 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.979 0.418 . . . . 0.0 110.55 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -115.99 -124.29 0.29 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.409 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.808 ' O ' HG22 ' A' ' 62' ' ' THR . . . -125.13 -27.46 1.22 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.866 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 34' ' ' ILE . 8.5 mtt-85 -78.07 -67.24 0.75 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.606 0.241 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 47.9 t -37.74 -29.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.019 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.46 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.921 0.391 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -49.39 -41.11 38.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -64.94 -46.15 82.78 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.198 0.523 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -63.66 -35.25 79.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.603 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.826 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.34 -46.86 59.52 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.54 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -46.9 -54.69 9.05 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.007 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -65.59 -33.91 77.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.238 -1.481 . . . . 0.0 111.382 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -90.09 -22.47 21.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.573 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -84.34 -32.34 24.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.85 -45.79 25.96 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.91 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.813 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.77 -30.69 0.08 OUTLIER Glycine 0 C--N 1.342 0.875 0 C-N-CA 120.012 -1.089 . . . . 0.0 114.833 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 76' ' ' ALA . 7.7 mp -71.11 142.87 50.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.75 93.76 3.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.533 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.657 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.999 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 23' ' ' LEU . 21.7 ttp-105 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp -119.76 138.02 53.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.651 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 2.6 ttp180 -104.37 126.41 51.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.78 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.853 HD23 ' N ' ' A' ' 26' ' ' SER . 3.6 tt -89.7 143.69 26.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.976 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.853 ' N ' HD23 ' A' ' 25' ' ' LEU . 16.0 m -144.79 108.31 4.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.728 0.299 . . . . 0.0 110.675 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 100' ' ' LEU . 5.8 p -97.07 120.7 46.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.193 0.52 . . . . 0.0 111.802 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -100.75 148.9 24.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.781 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' NH1' ' A' ' 29' ' ' ARG . 15.1 mtm105 -150.4 120.68 7.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.81 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -89.71 -84.64 0.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.671 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -61.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.13 21.62 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.8 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.534 ' CD2' HD22 ' A' ' 53' ' ' LEU . 38.7 m170 -116.95 156.71 26.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.194 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 100' ' ' LEU . 4.3 tp -141.75 130.98 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.757 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.816 ' OH ' HD11 ' A' ' 53' ' ' LEU . 38.4 m-85 -148.95 150.33 32.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 0.0 111.845 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.937 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -133.27 121.41 22.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.414 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.76 113.34 25.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.487 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.063 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -97.12 105.14 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.369 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -102.44 158.73 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' N ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -89.61 119.55 30.13 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.877 178.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -93.19 23.56 4.31 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.432 1.082 . . . . 0.0 112.294 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -106.86 -47.64 3.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.258 -2.126 . . . . 0.0 105.258 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mttt -137.95 118.1 13.53 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.5 90.46 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.489 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' LYS . 87.3 t -138.59 112.5 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -69.93 113.12 6.85 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -90.56 -57.5 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 75' ' ' LYS . 1.8 t -127.56 148.96 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.299 0.571 . . . . 0.0 112.123 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 58.5 p -150.21 114.9 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.786 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.86 ' HB2' ' CE ' ' A' ' 75' ' ' LYS . . . -129.62 150.93 50.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.984 0.421 . . . . 0.0 112.028 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.509 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.4 t -150.42 149.97 30.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.012 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.606 ' N ' HG21 ' A' ' 68' ' ' VAL . 37.2 m -60.66 -53.69 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD11 ' OH ' ' A' ' 35' ' ' TYR . 3.1 pp -68.01 -9.49 46.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.557 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -75.81 -64.75 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mp -53.67 -52.16 60.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.592 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 177.35 -41.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 HG11 ' A' ' 64' ' ' VAL . 54.2 mt -54.41 115.46 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.05 10.23 4.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.159 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.52 -83.55 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -68.17 175.33 3.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -130.71 -54.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.849 HG22 ' O ' ' A' ' 95' ' ' GLY . 3.3 p -89.98 -24.8 21.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -66.51 -40.58 89.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.139 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG11 HD13 ' A' ' 57' ' ' LEU . 78.8 t -92.22 -25.73 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.59 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.04 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.66 -40.69 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.999 0.428 . . . . 0.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.03 -59.56 3.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.484 0.659 . . . . 0.0 109.278 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 12.9 mt-30 -49.41 -26.15 3.05 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.225 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.04 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -76.8 -32.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.425 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.9 -26.33 60.6 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.838 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 67' ' ' GLN . 10.3 ptt180 -72.22 -39.21 68.7 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -69.47 -38.93 77.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.063 HD21 HD11 ' A' ' 38' ' ' ILE . 1.5 tp -66.14 -52.34 49.3 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.171 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.942 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -64.37 -27.17 68.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.57 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 29.6 mt-10 -77.13 -32.48 56.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.86 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 11.8 mtmm -71.48 -68.69 0.43 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.726 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.01 -43.12 6.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.19 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.773 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.11 -38.28 70.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.027 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.78 -23.11 16.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.899 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.561 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.43 -26.5 20.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.33 17.35 10.08 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.138 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.715 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.25 102.91 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.686 0.755 . . . . 0.0 110.271 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -97.02 -46.78 6.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.954 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.03 134.86 54.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -126.22 165.85 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.965 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -107.47 106.12 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.63 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.756 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.4 120.45 24.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.267 0.556 . . . . 0.0 111.73 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.05 51.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.067 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -42.2 -31.33 0.37 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.523 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.17 -119.06 5.59 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.442 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.99 20.63 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.734 2.29 . . . . 0.0 112.426 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.597 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.6 m-30 -80.81 159.45 25.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 154.81 48.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.369 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.468 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -43.77 109.35 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.571 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.497 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.2 t-80 -124.67 157.96 34.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.477 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.849 ' O ' HG22 ' A' ' 62' ' ' THR . . . -41.13 -26.7 0.18 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.871 -0.604 . . . . 0.0 113.689 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -82.09 -67.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.689 0.244 . . . . 0.0 111.182 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 90.0 t -29.83 -50.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -57.72 -75.37 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.801 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -54.75 -38.15 66.81 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.228 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -67.51 -47.26 70.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.447 0.641 . . . . 0.0 110.428 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.1 -32.13 72.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.384 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.785 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -68.12 -44.65 75.66 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.67 -58.41 8.38 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.942 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.75 -35.35 74.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.621 -1.289 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.866 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.99 -30.65 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.861 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.785 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -72.2 -34.91 68.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.627 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -70.52 -46.91 45.18 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.797 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.26 -29.07 0.07 OUTLIER Glycine 0 C--N 1.341 0.831 0 C-N-CA 120.052 -1.07 . . . . 0.0 114.752 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.866 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.5 mp -71.45 145.52 49.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -128.12 92.58 3.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.296 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.707 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.997 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.756 0.312 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.806 HD22 HG13 ' A' ' 81' ' ' ILE . 3.7 mp -42.67 130.6 4.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.305 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 4.7 ttp180 -98.83 124.87 44.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.289 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.814 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.33 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.359 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.814 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.76 108.73 4.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.153 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.553 HG21 HD13 ' A' ' 100' ' ' LEU . 9.2 p -99.19 115.48 39.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 111.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -93.02 152.06 19.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD2' ' HG3' ' A' ' 96' ' ' ARG . 55.6 mtm-85 -149.15 118.91 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.916 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -46.4 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.994 0.426 . . . . 0.0 111.066 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.34 -59.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.917 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -116.73 12.68 14.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.323 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.646 ' NE2' HD23 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -116.3 174.36 6.1 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.779 HD11 HD13 ' A' ' 100' ' ' LEU . 6.9 tp -159.99 115.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 5.3 m-85 -129.68 111.21 12.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.996 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.79 123.32 37.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -115.59 117.02 29.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.448 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.755 HD11 HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -98.87 101.77 12.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.2 mp -101.52 161.61 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.966 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.42 117.27 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.715 177.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 5.6 t0 -93.3 27.45 2.54 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.278 0.986 . . . . 0.0 112.282 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HG2' ' HD3' ' A' ' 43' ' ' LYS . 2.6 tt0 -108.8 -46.48 3.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -137.94 118.14 13.58 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.32 89.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.503 -177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.5 t -137.89 112.53 9.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -75.65 124.54 27.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 23' ' ' LEU . 1.2 mp -107.35 -58.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.724 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.1 t -120.06 141.71 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 112.076 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' NE2' ' A' ' 37' ' ' GLN . 80.6 p -150.23 114.79 5.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.5 151.89 48.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.02 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.0 p -150.58 142.74 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.602 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -54.0 -24.87 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.93 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.646 HD23 ' NE2' ' A' ' 33' ' ' HIS . 2.6 tm? -49.72 -65.72 0.52 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.31 -24.4 54.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.385 0.612 . . . . 0.0 109.83 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.2 mp -89.62 11.83 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.825 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 55' ' ' LEU . 19.7 mtpp 2.58 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.85 0.86 . . . . 0.0 113.025 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD13 ' HB ' ' A' ' 64' ' ' VAL . 2.1 pt? -58.05 176.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.936 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -80.48 114.53 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.37 106.91 0.18 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -69.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.784 0.326 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.81 -150.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.727 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.431 HG21 ' CA ' ' A' ' 95' ' ' GLY . 15.3 p -69.7 61.34 0.16 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.895 0.379 . . . . 0.0 110.8 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.43 -52.5 4.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.633 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' A' ' 57' ' ' LEU . 94.3 t -94.05 -21.73 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.081 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -36.92 -38.21 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.249 0.547 . . . . 0.0 110.855 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.5 -58.96 3.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 12.7 mt-30 -49.81 -23.02 1.64 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.667 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.081 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -78.29 -37.01 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -75.63 -36.21 43.94 Favored Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -66.43 -36.55 83.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -62.75 -53.87 47.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.776 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.66 -46.04 87.43 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.906 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.46 -27.15 46.39 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.689 177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.4 tt0 -73.61 -35.34 65.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.724 ' HB2' HG21 ' A' ' 48' ' ' VAL . 7.5 mttt -74.79 -63.7 1.2 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.907 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.89 -42.55 5.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.2 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -58.54 -40.68 83.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.4 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.01 -24.81 7.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.491 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -89.28 -27.13 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.57 11.57 19.11 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.15 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.806 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -64.02 103.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.616 0.722 . . . . 0.0 110.142 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -91.7 -57.47 2.74 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.345 -178.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -109.52 143.19 39.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.387 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.668 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -130.49 162.91 37.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.636 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.38 103.6 13.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.808 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.48 112.48 18.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -142.65 51.44 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.668 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -41.21 -38.37 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.651 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.09 -124.93 6.25 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.34 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -90.05 42.87 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.873 2.382 . . . . 0.0 112.066 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.668 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.7 m-30 -99.56 163.6 12.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.229 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 154.64 49.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 1.0 OUTLIER -46.88 112.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.593 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.457 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.3 t60 -133.43 154.04 51.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.301 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -33.47 -37.04 0.06 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.851 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.736 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.0 mmt85 -70.74 -70.86 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.586 0.193 . . . . 0.0 111.407 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 98.5 t -29.91 -51.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.551 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -56.75 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.381 0.61 . . . . 0.0 110.292 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -49.92 -43.0 49.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.14 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -66.66 -49.09 67.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.458 0.646 . . . . 0.0 110.649 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.559 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.08 -34.82 68.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.081 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.761 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -67.32 -43.3 81.95 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.543 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.06 -61.5 5.72 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.906 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.12 -41.83 68.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.653 -1.273 . . . . 0.0 110.932 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -79.21 -55.68 4.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.761 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.6 pt-20 -46.58 -43.33 17.13 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.689 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.84 -50.01 72.3 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.994 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.16 -25.48 0.07 OUTLIER Glycine 0 C--N 1.341 0.859 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.667 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.84 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.9 mp -71.48 146.41 48.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.18 93.08 3.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.215 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.018 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.81 0.338 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 81' ' ' ILE . 3.7 mp -32.07 132.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.555 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 7.0 ptt180 -96.18 126.86 41.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.487 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.843 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.0 tt -89.43 140.79 29.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.554 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.829 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.0 t -142.3 114.07 8.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.869 0.366 . . . . 0.0 110.996 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 100' ' ' LEU . 4.0 p -101.53 120.35 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.215 0.531 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.466 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -99.14 148.97 23.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.964 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HD2' ' CG ' ' A' ' 96' ' ' ARG . 15.8 mtm-85 -146.72 119.76 8.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.584 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.79 -50.64 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.992 0.425 . . . . 0.0 110.98 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tt -179.24 -54.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.362 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 10.12 12.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.885 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -119.55 148.15 43.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.975 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.875 HD11 HD13 ' A' ' 100' ' ' LEU . 4.1 tp -131.18 131.61 63.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.704 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 29.6 m-85 -146.95 149.93 34.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.832 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.933 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -135.18 120.93 19.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.221 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.816 ' HG3' HD11 ' A' ' 39' ' ' ILE . 4.8 pt20 -113.63 113.06 24.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.316 0.579 . . . . 0.0 109.921 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.081 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -90.92 97.15 6.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.816 HD11 ' HG3' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.85 164.26 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.283 -176.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' H ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -99.53 103.16 14.88 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.485 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -86.65 27.16 1.0 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.172 0.92 . . . . 0.0 112.328 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -113.09 -47.9 3.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -129.33 118.5 22.35 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 174.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.63 86.29 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.725 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 43' ' ' LYS . 47.3 t -137.51 112.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.421 ' HA ' HG23 ' A' ' 39' ' ' ILE . 22.5 m -77.11 122.66 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.626 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.4 mp -103.19 -64.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -123.12 147.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 111.876 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 21.8 p -150.6 117.36 5.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.729 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.12 151.23 51.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.237 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.544 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 1.8 t -150.3 147.24 27.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.751 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' HG21 ' A' ' 68' ' ' VAL . 5.9 m -62.48 -68.41 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.811 HD13 ' O ' ' A' ' 53' ' ' LEU . 2.6 tm? -60.29 -16.49 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.623 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 51' ' ' SER . . . -77.05 -64.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mp -54.05 -52.3 61.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.06 0.457 . . . . 0.0 111.492 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 177.21 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.445 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' CD1' ' CG1' ' A' ' 64' ' ' VAL . 16.4 mt -51.14 121.06 5.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.736 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.38 58.68 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.727 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.19 133.65 33.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.601 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.01 -51.05 5.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 110.794 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -153.61 -96.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.671 HG22 ' C ' ' A' ' 95' ' ' GLY . 34.6 p -93.61 30.96 1.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.668 0.271 . . . . 0.0 111.182 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -94.05 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.206 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 67' ' ' GLN . 72.8 t -91.93 -19.0 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.683 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.74 -43.75 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -64.74 -61.34 2.25 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.499 0.666 . . . . 0.0 109.365 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 23.5 mt-30 -48.47 -24.56 1.32 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.4 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -80.32 -33.41 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.653 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.89 -27.43 58.54 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.167 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -75.01 -39.53 61.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.05 -34.39 71.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.081 HD21 HD11 ' A' ' 38' ' ' ILE . 1.9 tp -68.91 -54.44 15.49 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.845 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.016 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.04 -26.11 68.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.974 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 48.3 mt-10 -77.49 -31.18 53.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 21.0 mttt -72.51 -68.74 0.45 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.523 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.25 -43.21 7.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.828 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -56.04 -39.86 72.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.942 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.9 -23.81 14.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.019 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.43 -27.89 20.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.82 15.51 13.07 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.252 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -72.98 102.98 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 110.202 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -91.24 -57.3 2.83 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.423 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.11 137.97 46.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.84 166.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.368 0.604 . . . . 0.0 111.666 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -115.33 109.41 17.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.834 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.843 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -80.53 106.36 12.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.299 0.571 . . . . 0.0 111.919 -177.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.6 46.09 2.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.277 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.29 -45.49 5.91 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.26 -112.83 3.26 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.54 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.95 25.08 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.772 2.315 . . . . 0.0 112.863 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -93.97 157.13 16.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.94 0.4 . . . . 0.0 111.056 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.47 151.53 49.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.675 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.21 94.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.416 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -114.21 170.93 7.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.384 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.671 ' C ' HG22 ' A' ' 62' ' ' THR . . . -41.94 -47.94 5.21 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.203 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 34' ' ' ILE . 1.3 mtt85 -57.01 -68.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.64 0.257 . . . . 0.0 110.506 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.6 t -38.32 -39.96 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.567 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.33 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -56.8 -34.31 67.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.858 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.875 HD13 HD11 ' A' ' 34' ' ' ILE . 2.0 tt -70.11 -48.37 57.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.213 0.53 . . . . 0.0 110.959 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.02 -28.7 69.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.816 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -71.5 -46.44 59.72 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.53 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.67 -56.17 8.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.016 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.24 -34.6 78.47 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.41 -1.395 . . . . 0.0 111.111 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.3 mmm180 -87.14 -24.42 24.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.816 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.2 pt-20 -84.45 -33.36 23.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -70.8 -46.47 45.69 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.074 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.828 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.94 -28.64 0.07 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 120.031 -1.08 . . . . 0.0 114.597 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.816 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.21 146.61 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -127.73 94.39 3.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.374 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.638 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' NE ' ' HB2' ' A' ' 85' ' ' ALA . 26.4 ptt180 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.838 0.351 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.768 HD22 HG13 ' A' ' 81' ' ' ILE . 4.9 mp -102.84 134.8 45.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 25.4 ttp85 -103.0 123.31 46.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.225 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.17 143.79 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.602 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.812 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -146.72 108.8 4.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.454 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.7 p -102.48 116.71 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 111.285 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -94.91 136.25 35.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.445 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.598 ' HD3' HG23 ' A' ' 97' ' ' VAL . 22.9 mtm105 -132.81 118.71 19.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.978 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.58 -70.25 0.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -148.86 -62.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.773 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -119.13 20.19 12.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.197 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.42 175.62 5.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.166 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.899 HD11 HD13 ' A' ' 100' ' ' LEU . 6.6 tp -160.03 122.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.93 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 13.6 m-85 -137.79 111.56 8.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -97.09 125.57 41.66 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.27 113.27 21.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.169 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.657 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.76 100.95 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.512 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.1 mp -102.61 160.14 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.805 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -92.15 116.96 29.4 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.856 178.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 1.7 t70 -93.38 28.11 2.35 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 124.281 0.988 . . . . 0.0 112.185 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -109.76 -47.42 3.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 45' ' ' VAL . 3.2 mttp -136.49 118.14 14.96 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.11 90.58 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.532 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' LYS . 80.6 t -139.62 112.47 5.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.402 HG23 HG13 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -77.75 121.09 23.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.477 HD21 ' OD1' ' A' ' 40' ' ' ASP . 1.1 mp -103.59 -59.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' CG1' HD23 ' A' ' 72' ' ' LEU . 2.1 t -115.81 140.36 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.175 0.512 . . . . 0.0 111.971 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -150.27 114.93 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.266 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -133.51 151.4 51.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.245 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 43.6 p -150.54 139.6 21.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 34' ' ' ILE . 68.2 m -47.2 -29.11 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.0 tm? -61.22 -50.84 71.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.659 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 -25.73 65.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.118 0.485 . . . . 0.0 110.401 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.9 mp -88.46 11.26 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.383 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mtmp? 1.73 63.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.468 0.707 . . . . 0.0 112.807 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 55' ' ' LEU . 11.6 mt -61.43 176.01 0.53 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.118 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.19 -29.59 57.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.02 67.98 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.384 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.585 ' HB3' HG23 ' A' ' 64' ' ' VAL . 36.5 m-20 -149.04 106.36 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -84.77 -70.27 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -85.92 -24.19 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.53 -45.57 81.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB3' ' A' ' 60' ' ' ASN . 95.5 t -94.14 -20.01 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.761 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.051 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -35.48 -38.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 3.7 ttm180 -67.59 -59.13 3.6 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -50.89 -24.31 3.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.533 178.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.051 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.54 -33.23 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.36 -32.37 43.09 Favored Glycine 0 C--O 1.218 -0.854 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.71 -36.79 83.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.779 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -45.59 78.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.409 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.864 HD23 ' CG1' ' A' ' 48' ' ' VAL . 1.1 mt -62.58 -50.04 72.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.56 -26.1 65.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 12.4 tt0 -72.04 -34.66 68.95 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.1 mttp -77.08 -64.12 1.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.862 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.96 -42.6 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.639 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -58.76 -40.51 84.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.373 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -51.55 -25.18 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.227 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.47 -26.51 20.91 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.2 13.81 14.62 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.198 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.768 HG13 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.43 102.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.016 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -103.87 -27.89 11.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.853 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -126.11 140.51 52.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.035 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -135.27 164.49 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.507 0.67 . . . . 0.0 112.345 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.43 103.82 13.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.835 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.72 106.35 13.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 111.509 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.09 43.69 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.231 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 21.0 ptt-85 -43.48 -48.76 7.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.502 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.59 -126.37 5.5 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -89.9 48.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.859 2.373 . . . . 0.0 112.125 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.1 m-30 -99.99 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.436 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 154.75 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.608 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -48.69 106.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.019 0.438 . . . . 0.0 110.681 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -110.63 -125.08 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.56 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 62' ' ' THR . . . -125.14 -26.83 1.29 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.276 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.848 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.2 mmt85 -79.77 -69.65 0.57 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.937 0.369 . . . . 0.0 110.941 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 ' HD3' ' A' ' 29' ' ' ARG . 47.4 t -35.03 -31.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.79 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.868 0.366 . . . . 0.0 110.992 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -51.85 -43.23 63.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.192 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -60.53 -40.94 93.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.235 0.541 . . . . 0.0 110.639 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -67.96 -35.73 78.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.267 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 106' ' ' GLU . 1.3 mt-10 -69.55 -46.59 66.07 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.554 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.42 -58.27 5.31 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.932 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -59.56 -46.47 88.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.242 -1.479 . . . . 0.0 111.14 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 mtm180 -74.92 -55.48 5.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.175 0.512 . . . . 0.0 109.663 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.797 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -47.81 -44.43 28.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.257 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.664 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -61.16 -47.59 90.24 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.352 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.72 -25.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.623 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.828 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.2 mp -71.46 150.17 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -128.38 91.49 3.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.583 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 6.0 p90 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.959 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.663 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.4 tpt180 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.907 0.384 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -108.65 133.89 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.208 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -102.52 126.27 49.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.746 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 26' ' ' SER . 2.0 tt -89.56 143.49 26.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.217 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.799 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -143.27 111.97 6.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 88' ' ' ARG . 1.4 p -98.22 153.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.381 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.17 114.81 5.25 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -129.24 118.92 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.5 -33.03 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.232 0.539 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -179.65 -61.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.471 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 9.64 11.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.595 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 7.4 m170 -121.99 100.05 6.77 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.823 HD11 HD13 ' A' ' 100' ' ' LEU . 4.5 tp -99.19 117.94 45.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 12.5 m-85 -131.54 112.8 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -102.84 122.55 44.76 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.53 113.07 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.915 HD11 HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.93 99.34 9.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.337 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.9 mp -102.45 163.78 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.601 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' CG ' HD22 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -94.59 111.59 23.35 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 24' ' ' ARG . 3.4 p30 -88.06 24.5 1.81 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.282 0.989 . . . . 0.0 112.524 -178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 15.7 pt-20 -111.13 -45.24 3.46 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 45' ' ' VAL . 25.9 mmtm -132.8 118.38 18.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.95 86.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.672 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 43' ' ' LYS . 46.1 t -135.08 112.39 14.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 120.86 21.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.5 mp -101.86 -62.45 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -122.09 143.74 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.344 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 p -150.24 114.98 5.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -126.47 145.43 50.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 55.7 p -150.22 134.96 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.791 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.631 ' H ' HG23 ' A' ' 34' ' ' ILE . 8.4 t -52.62 -38.5 60.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.511 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.0 tm? -62.05 -52.35 64.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.107 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.02 -30.37 67.96 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.366 0.603 . . . . 0.0 109.768 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 57' ' ' LEU . 2.0 mp -87.06 12.12 12.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.933 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER 3.03 63.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.528 0.68 . . . . 0.0 112.534 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.742 HD13 HG11 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -80.8 176.21 10.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.723 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -99.34 43.15 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.64 -143.08 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.695 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -126.28 -70.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.652 0.263 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -160.92 -83.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.982 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 32.2 p -88.55 -4.32 58.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -44.9 95.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.92 0.39 . . . . 0.0 110.251 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.742 HG11 HD13 ' A' ' 57' ' ' LEU . 59.7 t -92.33 -16.11 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.07 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.99 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.03 -41.55 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.01 0.434 . . . . 0.0 111.689 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.79 -61.03 2.3 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.433 0.635 . . . . 0.0 109.346 178.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.5 mt-30 -50.22 -24.86 3.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.514 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.99 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -78.73 -32.31 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.65 -25.16 65.76 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.214 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -78.73 -37.48 41.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -68.35 -38.9 81.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.953 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.0 tt -72.88 -46.53 52.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.64 -25.02 67.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -79.71 -30.08 40.86 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 21.6 mttt -69.47 -69.09 0.36 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.173 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.6 -44.92 9.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.785 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.4 mt -54.53 -39.08 67.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.152 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.24 -24.45 18.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.865 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.61 -26.1 20.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.51 13.47 16.79 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.076 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.508 HG12 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -75.1 102.62 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.119 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -104.43 -24.76 13.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.77 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -127.47 136.42 51.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.125 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.682 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -136.67 163.74 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.374 0.607 . . . . 0.0 112.191 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -101.52 98.5 8.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.774 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -80.92 111.73 17.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.599 . . . . 0.0 111.776 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.1 61.18 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.938 ' HG2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -48.9 -28.42 3.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.644 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.41 -117.81 3.33 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -89.73 38.0 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.758 2.305 . . . . 0.0 111.663 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.483 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 3.5 m-30 -98.61 144.9 27.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.28 155.01 49.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.707 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.4 t80 -39.83 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.168 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 98' ' ' LYS . 2.0 t-160 -115.44 -109.87 0.36 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.151 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.523 ' HA2' ' HD2' ' A' ' 98' ' ' LYS . . . -131.25 -17.16 1.46 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.714 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.601 ' HB3' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -95.38 -71.14 0.68 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG22 HG11 ' A' ' 27' ' ' VAL . 48.3 t -32.94 -37.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.523 ' HD2' ' HA2' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -64.65 -78.85 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.301 0.572 . . . . 0.0 110.429 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -46.26 -42.88 15.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.314 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.823 HD13 HD11 ' A' ' 34' ' ' ILE . 1.1 tt -67.51 -45.72 74.99 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.05 -35.76 79.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.362 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.705 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -63.45 -49.9 71.85 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.05 -56.21 6.08 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -56.43 -46.93 80.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 112.792 -1.704 . . . . 0.0 111.816 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.6 mmm-85 -78.84 -47.29 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.139 0.495 . . . . 0.0 109.976 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.705 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.5 pt-20 -53.4 -35.4 60.33 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -74.24 -49.19 12.81 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.499 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.785 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.33 -24.04 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 C-N-CA 119.737 -1.22 . . . . 0.0 115.405 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 38' ' ' ILE . 6.9 mp -71.17 146.2 49.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.204 1.002 . . . . 0.0 113.598 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.0 OUTLIER -127.37 97.16 4.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.208 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.609 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.867 0.365 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.741 HD13 HG13 ' A' ' 81' ' ' ILE . 2.8 mp -113.09 134.22 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.79 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 1.4 ttt180 -101.83 126.16 48.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.334 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.831 HD23 ' N ' ' A' ' 26' ' ' SER . 2.9 tt -89.58 142.19 27.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.831 ' N ' HD23 ' A' ' 25' ' ' LEU . 3.1 m -144.94 108.59 4.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 100' ' ' LEU . 8.8 p -94.2 117.73 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 111.749 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -99.26 146.95 25.67 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.789 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NH1' ' CG2' ' A' ' 97' ' ' VAL . 22.9 mtm-85 -150.14 122.34 8.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.996 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.9 p -89.66 -72.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.411 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 -58.26 0.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.566 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.23 2.56 11.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -101.82 155.57 18.05 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.177 0.513 . . . . 0.0 111.427 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.888 HD11 HD13 ' A' ' 100' ' ' LEU . 5.5 tp -142.63 119.74 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.573 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 14.1 m-85 -137.05 112.86 9.54 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.74 121.05 34.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.61 113.32 26.22 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.693 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.1 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -96.78 99.52 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.261 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -98.7 163.09 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.008 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -93.29 115.32 27.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.608 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 11.3 t0 -90.64 22.8 3.33 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.428 1.08 . . . . 0.0 112.354 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -110.15 -46.38 3.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.6 mmmt -134.02 118.28 17.63 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.99 87.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.778 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.4 t -137.53 112.32 9.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -71.57 117.68 13.43 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.3 mp -95.34 -63.17 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG23 HD21 ' A' ' 79' ' ' LEU . 2.2 t -121.11 147.75 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.163 0.506 . . . . 0.0 111.794 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.4 p -150.17 114.83 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.063 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.38 158.29 33.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.707 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 79.5 p -150.18 143.02 24.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.973 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.654 ' N ' HG21 ' A' ' 68' ' ' VAL . 11.8 p -55.46 -44.92 76.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.104 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.18 -7.74 25.99 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -75.39 -59.75 2.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.483 0.659 . . . . 0.0 110.948 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.78 -42.51 65.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.911 -178.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 64' ' ' VAL . 1.4 mt -46.99 171.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 111.624 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -131.56 -42.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.55 78.39 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.428 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -122.86 -175.4 3.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -166.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.843 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.418 HG21 ' C ' ' A' ' 95' ' ' GLY . 21.5 p -70.99 60.82 0.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.4 -57.68 2.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.094 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.692 ' HB ' HD12 ' A' ' 57' ' ' LEU . 58.2 t -94.13 -16.49 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.066 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.65 -41.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.882 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -66.83 -59.21 3.73 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.702 0.763 . . . . 0.0 109.035 178.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.599 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.1 mt-30 -49.78 -23.27 1.75 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.442 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.066 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -81.29 -33.54 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.91 -28.91 59.88 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 1.4 ppt_? -76.67 -37.24 56.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 -36.08 73.41 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.1 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.63 -54.51 13.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.704 178.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.001 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.8 -25.68 65.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 49.8 mt-10 -78.18 -31.01 49.35 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 23.2 mttt -71.67 -69.14 0.4 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.497 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.68 -43.48 8.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.126 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.801 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.9 mt -56.11 -39.67 72.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.041 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.5 -23.78 11.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.559 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.59 -27.7 20.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.7 8.08 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.071 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.21 105.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.536 0.684 . . . . 0.0 110.478 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 110' ' ' GLU . 8.1 ttmt -92.44 -59.49 2.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.8 138.63 44.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.41 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -126.6 164.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 111.901 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.93 103.26 12.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.795 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.798 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.44 116.49 21.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.128 0.49 . . . . 0.0 111.616 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -145.54 47.59 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 6.9 ptt-85 -37.64 -37.58 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.762 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.27 -112.58 3.61 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.631 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -88.72 23.56 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.83 2.353 . . . . 0.0 112.767 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.533 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 3.8 m-30 -93.26 131.84 38.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.31 148.4 25.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.474 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -46.69 109.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.524 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -126.54 165.99 18.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.418 ' C ' HG21 ' A' ' 62' ' ' THR . . . -45.28 -40.41 7.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.79 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.802 ' HD2' HD13 ' A' ' 34' ' ' ILE . 15.0 mmt-85 -57.36 -70.64 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.572 0.225 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 37.2 t -38.39 -37.8 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.35 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -60.72 -76.71 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.029 0.442 . . . . 0.0 110.965 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -56.31 -36.4 68.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.732 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.888 HD13 HD11 ' A' ' 34' ' ' ILE . 1.8 tt -68.96 -49.1 60.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.216 0.531 . . . . 0.0 111.038 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -60.9 -32.1 71.58 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.42 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -68.54 -46.23 70.08 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.523 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.61 -57.15 8.69 Favored Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.001 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.03 -33.21 73.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.512 -1.344 . . . . 0.0 111.327 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.6 tpp85 -90.08 -25.06 20.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.1 pt-20 -81.02 -33.17 33.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -72.38 -46.78 31.83 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.858 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.801 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 175.73 -29.7 0.08 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.036 -1.078 . . . . 0.0 114.76 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.806 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.1 mp -71.33 142.77 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.81 94.88 4.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.469 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.687 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.964 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.679 HD13 HG13 ' A' ' 81' ' ' ILE . 3.0 mp -43.42 128.21 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.258 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.69 126.33 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.38 -178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 26' ' ' SER . 4.1 tt -89.29 142.96 27.2 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.693 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.855 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -145.06 108.82 4.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.869 0.366 . . . . 0.0 111.318 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.812 HG12 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -97.02 126.97 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.215 0.531 . . . . 0.0 111.478 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.46 145.72 37.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.603 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 13.5 mtm105 -150.12 120.67 7.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.749 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 m -89.59 -81.04 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.684 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -139.86 -56.1 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.717 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -119.12 18.73 13.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.212 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -117.54 167.67 11.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.162 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 100' ' ' LEU . 3.3 tp -153.3 130.96 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.551 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.529 ' CG ' ' HB2' ' A' ' 51' ' ' SER . 32.9 m-85 -150.01 152.18 34.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.243 0.544 . . . . 0.0 112.171 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -136.83 120.96 17.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.692 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.76 113.22 25.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.019 HD11 HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -95.72 98.84 8.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.4 mp -98.8 160.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.165 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -93.1 115.63 28.27 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.603 177.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -90.75 26.16 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.297 0.998 . . . . 0.0 112.403 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.46 -47.97 3.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -136.39 118.04 14.97 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 174.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.96 90.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.448 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 43' ' ' LYS . 93.9 t -137.68 112.57 9.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 m -73.92 119.72 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.635 ' CD1' HD23 ' A' ' 23' ' ' LEU . 1.6 mp -98.87 -58.28 1.98 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 2.0 t -124.36 147.3 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 112.239 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 82.5 p -150.28 115.02 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.946 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.26 150.77 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.919 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . 3.1 t -150.46 141.94 23.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.512 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.491 ' H ' HG23 ' A' ' 34' ' ' ILE . 32.1 m -57.72 -40.76 80.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.132 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 54' ' ' ALA . 1.3 pp -64.26 -46.48 83.54 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.882 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.659 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -56.66 -30.8 63.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.516 0.674 . . . . 0.0 109.487 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -92.34 13.11 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.64 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 55' ' ' LEU . 2.6 mtpt 3.67 63.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.782 0.801 . . . . 0.0 112.366 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.942 HD13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -64.56 176.1 1.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.505 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -118.71 46.84 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.05 2.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -170.67 1.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -92.6 -48.31 6.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -93.13 -25.91 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.87 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -57.63 -42.04 82.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.159 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.942 HG11 HD13 ' A' ' 57' ' ' LEU . 75.6 t -94.05 -17.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.693 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.036 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.89 -39.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.991 0.425 . . . . 0.0 111.414 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.73 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.29 -59.28 3.54 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.56 ' HB2' HG13 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -50.98 -22.95 2.55 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.408 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.036 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -80.53 -31.76 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.253 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.73 -30.86 51.53 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -72.26 -38.46 68.85 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.57 -39.39 88.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.019 HD21 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -65.54 -54.98 20.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.985 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.57 -24.99 35.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.99 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -73.18 -35.59 66.42 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 13.3 mttt -71.58 -67.4 0.53 Allowed 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.921 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.93 -41.28 5.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.623 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.753 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.67 -40.23 82.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.226 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.44 -23.89 6.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.075 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.33 -27.82 20.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.66 18.04 9.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.136 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.679 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.73 106.87 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.505 0.669 . . . . 0.0 110.338 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 110' ' ' GLU . 18.9 ttmt -91.1 -58.14 2.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.393 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -111.86 147.58 35.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.463 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -134.33 161.15 41.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.319 0.58 . . . . 0.0 111.775 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -96.41 103.64 15.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.254 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.676 ' CE2' ' CZ ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -81.17 106.34 13.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.255 0.55 . . . . 0.0 112.071 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.76 72.16 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.983 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.812 ' NH1' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -52.19 -42.9 63.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.27 -117.35 3.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -90.35 35.95 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.746 2.298 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.3 m-30 -100.65 162.59 12.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 111.469 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.33 148.93 50.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.013 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -46.7 103.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.736 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -122.3 165.22 16.58 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.88 -42.46 11.4 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.983 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.453 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 55.4 mmt-85 -55.76 -71.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.704 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 t -38.92 -43.57 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.635 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -56.2 -75.32 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.023 0.439 . . . . 0.0 111.133 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -59.24 -40.0 84.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 34' ' ' ILE . 1.5 tt -65.04 -47.29 77.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.351 0.596 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.26 -38.09 85.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -66.75 -39.71 88.01 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -52.49 -59.35 9.19 Favored Glycine 0 CA--C 1.501 -0.789 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.985 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.04 -28.81 69.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.831 -1.185 . . . . 0.0 110.559 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.7 mmm-85 -89.11 -30.48 18.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 110.917 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.795 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.9 pt-20 -78.84 -36.9 41.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.672 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -66.67 -46.38 76.36 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.773 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.753 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.42 -31.33 0.07 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.032 -1.08 . . . . 0.0 114.754 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.7 mp -71.28 147.05 48.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.6 mp0 -128.23 91.68 3.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.348 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.727 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.7 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.063 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 2.9 mp -113.5 133.83 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -101.18 126.96 47.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.078 -178.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.1 tt -93.39 145.1 24.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.939 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.764 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.03 108.43 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.415 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.851 HG11 HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -96.18 129.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.023 0.44 . . . . 0.0 111.313 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -114.78 125.92 54.25 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -129.52 118.6 22.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.57 178.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.2 m -90.03 -45.14 9.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.326 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD12 ' HG3' ' A' ' 32' ' ' LYS . 0.3 OUTLIER 179.78 -55.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.171 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HG3' HD12 ' A' ' 31' ' ' LEU . 29.5 mtmt -119.35 -0.93 10.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.344 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.54 ' HA ' HD23 ' A' ' 53' ' ' LEU . 41.7 m170 -110.71 111.07 22.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 111.572 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.643 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -99.93 131.28 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 40.7 m-85 -149.08 147.76 28.89 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.146 0.498 . . . . 0.0 112.085 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -132.46 128.28 37.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -117.83 113.06 21.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.205 0.526 . . . . 0.0 110.767 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.718 ' O ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -100.13 102.23 13.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -104.91 160.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.977 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -92.28 118.03 30.48 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.818 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.441 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 13.6 t0 -91.82 20.61 5.48 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.44 1.088 . . . . 0.0 112.217 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.49 -48.62 3.4 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.3 mmtp -131.11 118.15 20.1 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.82 89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.82 -1.181 . . . . 0.0 111.841 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.8 t -136.09 112.61 13.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 m -77.42 109.6 11.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -91.53 -53.07 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.833 HG21 ' HB2' ' A' ' 75' ' ' LYS . 1.4 t -124.16 145.84 30.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.571 0.701 . . . . 0.0 112.791 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 78.3 p -150.22 115.02 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.313 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB3' ' CG ' ' A' ' 72' ' ' LEU . . . -125.92 162.94 24.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 126.91 10.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.007 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.573 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.1 m -61.79 -39.54 92.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 0.0 111.24 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 33' ' ' HIS . 4.0 pp -57.7 -18.52 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.41 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.31 -49.09 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.846 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.594 HD12 ' H ' ' A' ' 55' ' ' LEU . 5.5 mp -52.52 -40.77 62.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.24 -31.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.953 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD12 ' HB3' ' A' ' 52' ' ' SER . 8.8 mt -52.69 160.75 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.397 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 -36.04 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.8 51.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.57 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' HB2' HD22 ' A' ' 57' ' ' LEU . 1.1 t-20 -83.42 -168.61 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.82 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.657 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.3 ttmm -109.21 -110.65 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.697 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.657 HG23 ' HG2' ' A' ' 61' ' ' LYS . 4.2 p -93.63 52.25 1.68 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -75.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.51 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 67' ' ' GLN . 39.6 t -94.05 -13.78 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.058 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.104 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.26 -43.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -65.96 -60.83 2.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.378 0.608 . . . . 0.0 109.46 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 64' ' ' VAL . 18.3 mt-30 -48.12 -28.19 2.77 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.292 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.104 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -71.88 -38.44 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.2 178.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . -67.64 -56.78 10.29 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 5.5 ppt_? -44.95 -35.33 2.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -64.12 -50.19 69.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.08 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.617 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.2 mt -62.96 -52.62 62.29 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -53.51 -27.3 24.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.063 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -75.09 -32.89 61.57 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.833 ' HB2' HG21 ' A' ' 48' ' ' VAL . 33.0 mttm -76.79 -63.69 1.29 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.59 -43.19 11.97 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.792 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -56.2 -40.03 73.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.977 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.59 -24.33 13.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.952 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.42 -28.32 19.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.78 13.55 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.254 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.4 111.03 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 121.446 0.641 . . . . 0.0 110.126 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 23.6 ttpp -95.89 -57.48 2.35 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.787 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -110.75 148.67 31.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.65 164.93 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 0.0 112.182 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.02 87.87 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.944 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 12.0 t80 -81.17 112.37 18.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.93 111.02 4.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HD3' ' N ' ' A' ' 27' ' ' VAL . 3.1 tpt85 -99.82 -21.11 15.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.28 -97.83 1.04 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.81 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -89.42 33.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.903 2.402 . . . . 0.0 112.197 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 4.3 m-85 -99.93 135.7 40.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.95 154.78 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.7 t80 -46.86 97.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 110.35 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.453 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 1.9 t60 -105.35 -99.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.901 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 62' ' ' THR . . . -142.52 -30.94 0.12 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HG3' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mmt85 -85.87 -71.14 0.55 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.851 HG22 HG11 ' A' ' 27' ' ' VAL . 55.4 t -33.07 -35.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HZ1' ' HB ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -62.14 -76.42 0.06 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.667 0.746 . . . . 0.0 109.551 179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -45.32 -44.51 11.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.655 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -68.12 -49.24 62.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 110.221 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.709 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.61 -32.49 63.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.5 OUTLIER -68.79 -41.95 78.01 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.13 -57.48 8.88 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.971 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.45 -34.63 77.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.477 -1.362 . . . . 0.0 110.986 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.33 -26.61 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.411 . . . . 0.0 110.887 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.837 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -78.08 -36.57 48.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -69.19 -43.84 69.37 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.725 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 179.36 -31.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 119.999 -1.096 . . . . 0.0 114.904 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.891 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.7 mp -71.42 151.1 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.3 mp0 -128.76 96.01 4.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.713 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 p90 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.07 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.727 HD13 HG13 ' A' ' 81' ' ' ILE . 1.8 mp -117.28 131.96 56.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttt-85 -102.73 126.46 49.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.49 145.61 25.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.58 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.811 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -147.4 108.88 4.32 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.468 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 HD13 ' A' ' 100' ' ' LEU . 9.6 p -100.59 132.18 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.006 0.432 . . . . 0.0 111.761 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -113.35 143.99 43.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.278 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' CZ ' HG23 ' A' ' 97' ' ' VAL . 19.9 ptt-85 -151.53 118.76 5.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.093 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.78 16.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 110.788 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tt -177.36 -68.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.94 14.16 18.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.905 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.855 ' NE2' HD23 ' A' ' 53' ' ' LEU . 1.7 m-70 -127.33 150.18 49.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.655 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.72 HG21 ' HD2' ' A' ' 96' ' ' ARG . 22.5 pt -139.16 142.35 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -142.04 108.39 5.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.158 -177.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.003 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -93.73 121.01 34.73 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' NE2' HG21 ' A' ' 46' ' ' THR . 5.2 tt0 -114.75 118.64 34.15 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.847 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -101.99 103.82 15.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 46' ' ' THR . 3.5 mp -108.16 162.46 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.709 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.537 ' N ' HG22 ' A' ' 39' ' ' ILE . 3.0 t70 -92.87 113.58 25.9 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.039 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -92.97 24.82 3.48 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.253 0.971 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.8 -47.85 3.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.5 mtpt -132.19 118.12 19.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.77 90.36 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.453 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 43' ' ' LYS . 91.5 t -141.05 112.2 3.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 39' ' ' ILE . 1.6 m -78.83 117.48 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -95.65 -56.87 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.78 HG21 ' CB ' ' A' ' 75' ' ' LYS . 2.0 t -128.57 145.12 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 111.986 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 p -150.19 114.53 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.422 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.659 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -127.03 148.78 50.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.631 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.499 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . 15.2 p -150.22 136.14 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.726 ' CB ' HD21 ' A' ' 57' ' ' LEU . 19.1 m -44.62 -31.27 1.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.821 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.855 HD23 ' NE2' ' A' ' 33' ' ' HIS . 3.0 tm? -56.92 -61.95 2.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.602 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.42 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -58.4 -27.23 64.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.26 0.552 . . . . 0.0 110.043 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.4 mp -90.67 11.57 21.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.083 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 55' ' ' LEU . 7.5 mttm 2.07 63.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.617 0.767 . . . . 0.0 112.785 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.927 HD13 ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -57.6 156.51 8.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.542 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.23 88.61 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.68 -100.97 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -117.49 -169.77 1.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 0.0 110.824 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.79 -67.19 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.414 HG22 ' HD3' ' A' ' 96' ' ' ARG . 77.1 p -66.85 -17.64 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -49.74 70.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.927 ' HB ' HD13 ' A' ' 57' ' ' LEU . 99.5 t -94.0 -20.09 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.685 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.037 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.18 -39.55 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 111.551 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -67.77 -60.21 2.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' HB2' HG13 ' A' ' 64' ' ' VAL . 4.8 mt-30 -49.36 -24.59 1.97 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.572 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.037 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -76.98 -36.14 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.806 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -77.06 -35.8 37.53 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.941 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 4.3 ppt_? -65.03 -36.12 83.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.47 -55.13 26.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.003 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -62.69 -44.58 95.88 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.925 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.83 -27.8 60.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.742 177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.6 tt0 -72.94 -34.35 66.5 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.78 ' CB ' HG21 ' A' ' 48' ' ' VAL . 14.2 mttt -76.64 -63.19 1.4 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.072 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.688 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.29 -42.05 6.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.346 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.5 mt -58.0 -40.38 80.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.184 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -53.08 -23.63 8.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.41 -28.44 19.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.46 15.69 12.05 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.197 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.727 HG13 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -69.29 104.47 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.589 0.709 . . . . 0.0 110.152 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 110' ' ' GLU . 14.6 tttt -92.51 -56.38 3.05 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.388 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.43 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -110.0 145.03 37.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.384 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.757 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -132.1 164.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.469 0.652 . . . . 0.0 112.048 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -106.02 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.746 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.791 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.02 106.32 13.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.105 0.479 . . . . 0.0 111.373 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 45.0 2.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.176 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 7.7 ptt180 -41.51 -32.47 0.34 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.582 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.91 -121.46 6.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.433 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -88.99 36.33 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.6 m-30 -95.55 150.97 19.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.989 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -116.91 147.0 42.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -49.31 100.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.056 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -120.07 168.46 11.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.456 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.46 -38.16 3.86 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.912 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.72 ' HD2' HG21 ' A' ' 34' ' ' ILE . 45.1 mmt-85 -61.72 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.567 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 33.1 t -38.67 -40.97 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.57 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.4 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 0.0 111.001 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.28 -37.27 74.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.896 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD13 HG21 ' A' ' 27' ' ' VAL . 2.2 tt -67.48 -48.21 67.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 111.167 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -59.21 -33.4 70.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.953 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -67.17 -43.79 81.34 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.539 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.01 -62.06 5.27 Favored Glycine 0 CA--C 1.506 -0.517 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.925 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -54.98 -38.93 68.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 113.821 -1.19 . . . . 0.0 110.571 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.4 mmm-85 -79.79 -60.17 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -43.59 -43.15 5.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.158 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -62.01 -50.51 64.82 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.995 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.31 -26.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.125 -1.036 . . . . 0.0 114.808 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.847 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.4 mp -71.49 147.77 47.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.28 92.24 3.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.25 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.724 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.038 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp -120.42 133.56 55.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.36 125.26 50.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.694 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 26' ' ' SER . 5.1 tt -89.74 142.32 27.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.682 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.923 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.0 m -142.21 134.84 28.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.609 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.841 HG11 HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -119.79 134.58 62.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 0.0 110.831 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -122.92 132.31 54.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' CZ ' ' HD2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -137.32 118.83 14.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.214 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -89.24 -38.91 13.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.007 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tt -179.87 -58.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -119.03 3.87 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.4 ' NE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -111.31 154.82 23.98 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 100' ' ' LEU . 3.8 tp -141.34 123.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.83 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 51' ' ' SER . 16.9 m-85 -139.22 110.72 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.73 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -100.17 121.45 41.45 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.22 113.47 26.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.321 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.685 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.78 101.71 12.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.9 mp -104.84 164.03 4.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.573 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -94.44 113.98 25.93 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.809 178.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.3 t70 -91.38 25.54 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.335 1.022 . . . . 0.0 112.359 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -109.61 -48.15 3.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.71 ' O ' HG23 ' A' ' 45' ' ' VAL . 4.8 mttp -135.64 118.09 15.79 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.3 89.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.546 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 43' ' ' LYS . 66.3 t -137.86 112.49 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -75.5 114.54 14.18 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.622 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -93.11 -60.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.75 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -125.21 147.25 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 111.882 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 p -150.23 114.91 5.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -124.89 151.89 44.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 58.5 p -150.22 127.14 11.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.892 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.514 ' H ' HG23 ' A' ' 34' ' ' ILE . 14.2 m -53.05 -25.84 13.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.4 tm? -63.82 -52.21 61.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.014 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.25 -29.23 68.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.077 0.465 . . . . 0.0 110.47 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -91.4 10.58 26.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.9 mtmp? 1.77 63.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.468 0.707 . . . . 0.0 112.878 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.96 HD12 HG11 ' A' ' 64' ' ' VAL . 10.9 mt -80.99 176.16 10.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.852 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 68.29 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 64' ' ' VAL . . . -129.98 -159.01 9.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.84 -73.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -74.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 95' ' ' GLY . 60.6 p -91.69 14.72 14.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.255 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -87.81 -43.38 11.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 110.856 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.96 HG11 HD12 ' A' ' 57' ' ' LEU . 76.1 t -94.18 -26.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.049 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.83 -40.75 0.06 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 111.634 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.49 -60.02 3.12 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.768 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 28.3 mt-30 -48.24 -27.14 2.29 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.248 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.049 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.06 -36.24 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -73.98 -29.74 62.36 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.27 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 6.5 ppt_? -69.51 -36.17 76.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -73.94 -38.07 64.36 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 7.2 mt -65.4 -43.58 90.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.419 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -75.51 -30.97 60.0 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.085 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 21.2 mt-10 -75.65 -28.46 58.77 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.804 ' CE ' ' HB2' ' A' ' 50' ' ' ALA . 8.3 mtmm -76.12 -67.79 0.65 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.399 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.44 -40.89 8.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.795 HD11 ' HA3' ' A' ' 108' ' ' GLY . 11.0 mt -57.79 -39.02 76.53 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.718 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.5 -22.88 14.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.937 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.75 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.44 -27.38 20.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.21 19.69 9.26 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.077 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.736 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.92 103.79 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.588 0.708 . . . . 0.0 110.449 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLU . 19.1 tttp -91.54 -56.92 2.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.363 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.68 146.91 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -134.07 167.16 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.458 0.647 . . . . 0.0 112.169 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -102.21 103.74 14.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.255 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.731 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.5 t80 -80.75 110.58 16.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 112.723 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.0 106.36 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.066 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.695 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -92.34 -33.91 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.058 0.456 . . . . 0.0 110.304 -178.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.76 -110.22 2.76 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.722 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -90.31 32.7 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.849 2.366 . . . . 0.0 112.262 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 3.4 m-30 -102.27 152.79 20.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.131 0.491 . . . . 0.0 111.522 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.26 148.91 52.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.446 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.503 ' CD1' ' HE2' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -44.75 111.83 0.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.979 0.419 . . . . 0.0 110.334 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -124.01 -122.69 0.26 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.639 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 62' ' ' THR . . . -127.04 -12.4 3.21 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.964 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HD2' ' CZ ' ' A' ' 29' ' ' ARG . 1.7 mmt85 -87.95 -70.77 0.61 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.851 0.325 . . . . 0.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.841 HG22 HG11 ' A' ' 27' ' ' VAL . 55.8 t -36.14 -32.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 123.035 0.534 . . . . 0.0 111.672 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HE2' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -64.14 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.969 0.414 . . . . 0.0 110.96 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -44.25 -40.84 5.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.857 HD13 HD11 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -67.73 -45.77 74.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 110.214 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.84 -30.63 70.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.772 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -69.91 -49.0 56.41 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -45.74 -55.21 7.32 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 113.198 -1.501 . . . . 0.0 111.873 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.17 -45.04 13.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.772 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.9 pt-20 -56.63 -35.2 68.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.835 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -73.34 -49.08 16.55 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.119 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.795 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . -179.53 -29.99 0.05 OUTLIER Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.728 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 8.0 mp -71.15 146.86 48.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -128.04 91.71 3.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.104 178.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.669 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.026 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.853 0.358 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD13 HG13 ' A' ' 81' ' ' ILE . 1.4 mp -122.12 134.09 54.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.72 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -104.59 126.93 52.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.705 -178.467 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 26' ' ' SER . 3.0 tt -89.84 141.53 28.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.18 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.836 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -142.21 108.72 5.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.692 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 100' ' ' LEU . 4.7 p -95.78 125.45 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.16 144.15 40.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.83 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 26.2 tpt180 -150.12 118.63 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.765 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.9 p -89.93 -42.97 10.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.657 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -178.61 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 13.5 mtmt -119.27 -1.67 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.649 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 25.8 m170 -112.15 116.96 31.32 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.036 0.446 . . . . 0.0 111.492 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.788 HD11 HD13 ' A' ' 100' ' ' LEU . 5.8 tp -106.94 112.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.547 ' CD1' ' HB3' ' A' ' 51' ' ' SER . 8.9 m-85 -127.87 110.69 12.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.924 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -96.04 124.84 40.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.78 113.4 25.73 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.515 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.792 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -96.09 99.16 8.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.119 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.7 mp -99.84 163.42 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.127 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.1 t0 -93.95 114.08 26.22 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.754 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 22.0 t70 -91.5 25.47 2.62 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.438 1.086 . . . . 0.0 112.303 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -109.46 -47.92 3.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.89 118.25 15.7 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 90.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.613 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' LYS . 86.6 t -139.99 112.32 5.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -73.31 114.13 11.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.624 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -91.58 -64.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.624 HG23 HD21 ' A' ' 79' ' ' LEU . 2.1 t -121.7 145.87 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 111.792 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.9 p -150.36 114.82 5.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.041 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.73 156.25 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.547 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.1 145.56 26.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.237 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.603 ' N ' HG21 ' A' ' 68' ' ' VAL . 34.7 m -53.56 -82.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.689 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.656 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -59.14 -10.23 2.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.88 -64.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.689 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mp -55.79 -51.94 65.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.447 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.63 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 23.5 mt -56.8 115.35 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.278 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -109.38 85.51 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.19 175.39 28.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -101.58 -76.35 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 -155.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 95' ' ' GLY . 17.8 p -74.48 57.35 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.0 110.957 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -94.34 -59.18 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.814 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 67' ' ' GLN . 68.8 t -83.94 -19.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.075 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.83 -42.14 0.05 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.962 0.411 . . . . 0.0 111.965 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -65.76 -61.04 2.3 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.521 0.676 . . . . 0.0 109.301 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -48.67 -25.08 1.6 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.3 177.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.075 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.97 -33.23 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.671 178.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -79.77 -27.28 54.31 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.357 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -73.61 -38.37 65.12 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -71.38 -34.8 70.76 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.924 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -69.21 -49.6 54.98 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.322 178.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.986 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -67.46 -25.4 65.87 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.896 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -77.91 -31.28 51.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 48' ' ' VAL . 13.5 mttt -71.95 -69.34 0.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.515 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.28 -43.38 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.136 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.774 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -55.52 -39.23 70.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.052 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.28 -23.56 15.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.58 -27.16 20.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.29 16.69 10.83 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.156 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.737 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.7 103.02 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.725 0.774 . . . . 0.0 110.307 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -94.44 -51.93 4.55 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.75 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 135.16 54.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.02 165.1 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.4 0.619 . . . . 0.0 111.769 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -109.85 105.4 14.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.379 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.823 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.34 106.31 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.529 -178.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -129.73 44.08 3.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.008 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 16.3 ptt-85 -39.4 -47.84 1.84 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.827 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.93 -114.68 2.97 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.15 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.03 -13.53 21.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.426 2.084 . . . . 0.0 112.275 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.435 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 4.5 m-85 -60.63 138.11 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.02 0.438 . . . . 0.0 111.159 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 154.11 49.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.999 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' CE1' ' CE ' ' A' ' 98' ' ' LYS . 1.3 t80 -42.4 113.56 0.47 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -128.89 -77.95 0.56 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' O ' HG21 ' A' ' 62' ' ' THR . . . -155.37 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.167 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.716 ' HB3' HD13 ' A' ' 34' ' ' ILE . 37.0 mmt-85 -65.55 -60.85 2.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 42.1 t -35.97 -39.18 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.994 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' CE ' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.65 -80.16 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.391 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -53.77 -36.39 62.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.015 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.788 HD13 HD11 ' A' ' 34' ' ' ILE . 2.4 tt -68.98 -48.23 63.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.149 0.5 . . . . 0.0 110.972 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -62.79 -30.79 71.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.323 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.21 -45.04 70.85 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -49.77 -57.24 9.92 Favored Glycine 0 CA--C 1.508 -0.375 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.986 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.92 -33.12 74.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.357 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 6.1 mtm180 -88.46 -30.05 19.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.749 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.793 ' N ' ' O ' ' A' ' 102' ' ' GLU . 6.0 pt-20 -76.94 -34.36 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -71.17 -47.38 37.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.106 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.46 -29.47 0.07 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.878 -1.153 . . . . 0.0 114.942 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.792 ' CD2' HD12 ' A' ' 38' ' ' ILE . 7.9 mp -71.25 147.14 48.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.0 mt-10 -127.85 91.84 3.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.413 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.684 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.935 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 HG13 ' A' ' 81' ' ' ILE . 3.6 mp -110.63 134.89 52.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.761 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.1 ttp180 -103.85 125.34 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.442 -178.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.6 tt -89.81 143.81 26.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.755 179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 25' ' ' LEU . 50.9 m -145.43 108.69 4.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 0.0 111.343 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 97' ' ' VAL . 8.0 p -101.99 121.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 111.824 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -103.64 129.39 50.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.603 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' CD ' ' HB2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -136.69 118.55 15.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -89.75 -77.24 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.476 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mp -134.33 -61.24 0.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.828 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.29 18.32 12.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.557 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -117.71 164.05 15.56 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.997 0.427 . . . . 0.0 111.25 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.721 HD13 ' HB3' ' A' ' 96' ' ' ARG . 6.5 tp -155.8 126.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.958 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.6 ' OH ' HD11 ' A' ' 53' ' ' LEU . 18.8 m-85 -140.86 110.2 6.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.078 ' HB3' HD22 ' A' ' 72' ' ' LEU . . . -94.04 121.46 35.55 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.33 117.4 30.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.205 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.791 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -100.24 103.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.479 179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -105.95 161.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.449 -177.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 39' ' ' ILE . 16.2 t0 -92.7 114.32 26.84 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.962 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 25.4 t0 -92.05 23.58 3.69 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 124.277 0.985 . . . . 0.0 112.148 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.25 -47.82 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.6 mppt? -133.31 118.09 18.11 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.68 90.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.432 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.4 t -139.61 112.28 5.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.15 114.79 16.33 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -94.19 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.2 t -123.67 144.51 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.338 0.59 . . . . 0.0 112.093 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -150.24 114.78 5.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.826 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 72' ' ' LEU . . . -128.06 161.98 27.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.804 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.679 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -150.06 144.36 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.875 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 p -56.33 -48.43 76.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.5 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD11 ' OH ' ' A' ' 35' ' ' TYR . 3.7 pp -71.13 -7.91 49.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.76 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.41 -54.27 5.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.925 0.393 . . . . 0.0 111.696 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 51' ' ' SER . 5.7 mp -52.48 -46.85 66.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.173 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 55' ' ' LEU . 36.4 ttmt 179.2 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.527 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.89 HD23 ' N ' ' A' ' 58' ' ' LYS . 5.1 tt -41.62 137.73 1.54 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.656 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.89 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -132.12 -44.58 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.902 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.35 72.69 0.38 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.67 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 57' ' ' LEU . 14.0 m-20 -169.42 160.3 9.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.75 0.309 . . . . 0.0 110.73 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' CB ' ' NH2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -109.88 -88.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 9.3 p -93.19 11.89 26.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.65 0.262 . . . . 0.0 111.079 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -58.67 -53.24 60.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 67' ' ' GLN . 40.7 t -94.2 -16.3 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.56 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.059 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -30.5 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.26 -60.53 2.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.6 mt-30 -48.01 -26.11 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.419 178.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.059 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.66 -39.27 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.992 178.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.508 ' HA2' ' CG ' ' A' ' 72' ' ' LEU . . . -70.5 -37.42 69.01 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.815 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 16.1 ptt85 -64.27 -36.88 85.56 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.727 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -63.97 -54.95 26.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.097 178.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.078 HD22 ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -63.79 -42.15 97.8 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.46 -27.7 69.3 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.715 178.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 1.3 tt0 -78.04 -25.52 47.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.466 178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.838 ' HB2' HG21 ' A' ' 48' ' ' VAL . 2.4 mttp -82.4 -62.11 1.71 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -46.08 -43.28 14.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.407 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.738 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -55.97 -39.65 72.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.107 178.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -53.54 -23.95 12.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.878 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.612 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.38 -27.14 20.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.59 17.7 10.27 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.961 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.674 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.1 106.08 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.513 0.673 . . . . 0.0 110.346 -179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLU . 1.5 ttpt -92.45 -61.07 1.68 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.207 -178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.428 ' HG3' ' CB ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.39 146.32 34.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.356 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -131.72 165.78 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.205 0.526 . . . . 0.0 111.776 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.17 104.75 14.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.838 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.133 0.492 . . . . 0.0 111.741 -178.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -122.26 38.89 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.957 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.41 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 20.6 ptt180 -40.45 -33.38 0.26 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.516 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.77 -129.38 8.62 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.306 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.93 44.99 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.777 2.318 . . . . 0.0 112.298 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 29' ' ' ARG . 4.6 m-30 -97.38 153.71 17.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.007 0.432 . . . . 0.0 111.114 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -131.34 154.66 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.884 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.636 ' CE1' ' HG3' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -49.29 101.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.094 0.473 . . . . 0.0 110.201 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.418 ' N ' ' HE2' ' A' ' 98' ' ' LYS . 31.4 t-80 -111.92 -112.38 0.33 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.002 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -131.29 -37.12 0.31 Allowed Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.672 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.721 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.4 mpt_? -67.96 -71.06 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 27' ' ' VAL . 70.8 t -36.41 -32.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.968 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.636 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -63.74 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.037 0.446 . . . . 0.0 110.893 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -43.2 -40.79 3.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.334 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -69.81 -48.77 57.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.757 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.635 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -55.35 -30.69 60.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.52 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.849 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -71.68 -47.0 57.11 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 176.764 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.19 -57.27 7.23 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 176.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.009 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.78 -37.87 88.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.517 -1.342 . . . . 0.0 111.599 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -85.4 -33.16 22.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.068 0.461 . . . . 0.0 110.487 179.549 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.849 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.8 pt-20 -70.0 -37.53 75.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.702 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -68.24 -50.13 41.28 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.375 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 174.92 -26.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 119.945 -1.121 . . . . 0.0 114.978 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 38' ' ' ILE . 6.1 mp -71.34 144.68 49.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -127.95 96.75 4.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.47 178.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.715 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.093 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 7.8 tpp85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.895 0.379 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -104.71 134.05 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.229 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.33 129.13 53.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.546 -179.108 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.861 HD22 ' CE1' ' A' ' 86' ' ' PHE . 3.2 tt -89.47 141.27 28.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.392 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.837 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.7 108.37 4.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.777 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG21 ' NH2' ' A' ' 29' ' ' ARG . 14.9 p -97.06 126.98 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.765 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.76 141.56 42.22 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.679 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.874 ' HG2' HD12 ' A' ' 34' ' ' ILE . 35.7 mtt85 -150.11 118.69 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 p -89.91 -42.51 11.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.166 0.508 . . . . 0.0 110.416 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tt -179.98 -53.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.723 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' CG ' ' HA3' ' A' ' 59' ' ' GLY . 1.4 ttpt -119.29 -6.7 10.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.973 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -109.07 116.4 31.89 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.885 0.374 . . . . 0.0 111.617 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.892 HD11 HD13 ' A' ' 100' ' ' LEU . 2.0 tp -105.25 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.034 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 51' ' ' SER . 27.5 m-85 -146.93 109.24 4.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.842 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.45 125.47 38.08 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -113.85 113.45 24.91 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.837 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -97.87 102.98 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.905 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.6 mp -107.68 161.27 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.3 t0 -89.44 115.14 26.65 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.779 177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 4.0 t70 -92.3 24.08 3.57 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.376 1.048 . . . . 0.0 112.274 -178.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -109.49 -47.63 3.35 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 177.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' VAL . 2.5 mttp -133.54 118.12 17.92 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.95 89.83 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.301 -177.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' LYS . 98.6 t -137.88 112.52 9.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -76.38 119.19 19.91 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD22 HD13 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -100.84 -56.81 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.466 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.871 HG12 HD23 ' A' ' 72' ' ' LEU . 2.1 t -126.62 142.1 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.211 0.529 . . . . 0.0 112.208 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.2 p -150.4 115.21 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.997 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -122.98 163.76 19.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.059 0.457 . . . . 0.0 111.963 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.501 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . 18.2 p -146.06 126.9 14.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.046 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.588 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.1 p -56.35 -43.82 79.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.434 -179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -62.52 -10.28 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.089 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -84.16 -54.65 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.752 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.678 HD12 ' H ' ' A' ' 55' ' ' LEU . 4.8 mp -52.64 -44.81 66.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.191 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tttp 179.21 -34.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.513 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -43.79 154.32 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.683 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.65 25.03 4.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.724 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 32' ' ' LYS . . . 69.0 63.97 3.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.622 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -102.96 -48.15 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.97 -163.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.463 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 p -82.48 57.52 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.785 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -94.17 -58.19 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.074 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 67' ' ' GLN . 95.0 t -94.06 -17.19 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.621 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.07 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -33.94 -40.45 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.602 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -67.43 -60.13 2.82 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.47 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.507 ' HB2' HG13 ' A' ' 64' ' ' VAL . 1.9 mt-30 -49.34 -23.53 1.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.645 177.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.07 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -77.53 -35.5 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.524 178.573 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.48 -34.79 34.78 Favored Glycine 0 C--O 1.218 -0.901 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -64.77 -37.23 86.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.73 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.55 -46.41 76.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.6 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -61.55 -51.18 69.65 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.315 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.869 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -59.04 -25.87 64.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.745 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 18.2 tt0 -72.0 -35.59 69.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.467 0.651 . . . . 0.0 109.37 178.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 9.1 mttt -78.81 -63.76 1.34 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.994 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -42.96 -42.45 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.706 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.7 mt -58.45 -41.2 84.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.387 178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -50.28 -25.86 4.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.319 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.618 HD13 HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.189 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 113.94 15.12 8.77 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.855 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.83 102.66 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.13 0.491 . . . . 0.0 110.187 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -106.3 -23.37 12.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.841 -179.564 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -129.84 125.29 35.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.284 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.797 HG21 HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.09 165.41 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.435 0.636 . . . . 0.0 111.839 -179.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -112.14 111.63 22.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.754 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.861 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -80.95 111.41 17.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 111.789 -178.219 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.03 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 91' ' ' TYR . 9.4 ptt-85 -41.82 -37.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 116.01 -125.41 6.63 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.47 0.26 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.521 2.147 . . . . 0.0 112.877 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.471 ' CD2' ' CE1' ' A' ' 94' ' ' HIS . 4.4 m-85 -58.71 144.03 44.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.97 109.57 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.737 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.544 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER 0.11 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.123 0.569 . . . . 0.0 112.103 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -131.02 173.42 11.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.468 -179.009 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -36.58 -67.81 0.37 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.804 -0.635 . . . . 0.0 113.741 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -47.34 -66.36 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.593 0.235 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 94' ' ' HIS . 89.9 t -29.61 -45.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.022 0.529 . . . . 0.0 112.014 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.486 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -57.43 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.031 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -58.38 -37.6 75.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.075 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 34' ' ' ILE . 4.8 tt -64.68 -47.77 77.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.389 0.614 . . . . 0.0 111.238 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -65.08 -31.6 72.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.694 -178.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.767 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -66.58 -46.31 76.37 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.31 -59.4 5.83 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.958 177.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -57.74 -43.19 85.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 113.609 -1.295 . . . . 0.0 111.405 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.93 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -80.99 -48.14 12.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.302 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.767 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.3 pt-20 -52.89 -43.75 66.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.698 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -60.82 -48.39 86.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.19 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.648 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.46 -27.8 0.06 OUTLIER Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.609 178.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 7.1 mp -71.64 149.64 45.37 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.3 mp0 -129.14 91.82 3.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.091 178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.731 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.027 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 35.8 ttm180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.15 134.98 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.42 179.774 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 3.8 ttp180 -100.53 125.36 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.948 0.404 . . . . 0.0 111.067 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.8 tt -89.53 141.47 28.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.959 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.849 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -150.33 108.86 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.141 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.664 HG12 ' HZ ' ' A' ' 86' ' ' PHE . 5.0 p -102.48 120.45 52.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.215 0.531 . . . . 0.0 111.661 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.5 OUTLIER -97.38 144.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.683 -179.405 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.65 ' NH2' HG11 ' A' ' 27' ' ' VAL . 16.3 mtt85 -150.61 118.53 6.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.219 178.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.24 -35.85 12.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.671 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 179.93 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.459 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -119.3 6.59 11.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.485 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 33.5 m170 -115.89 103.14 10.33 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.467 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' CD1' ' A' ' 100' ' ' LEU . 9.5 tt -99.34 133.91 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.968 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.457 ' CG ' ' HB3' ' A' ' 51' ' ' SER . 33.3 m-85 -147.3 110.2 4.73 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -93.01 120.91 33.79 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 113.03 25.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.011 HD11 HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -95.83 98.76 8.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.221 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.6 mp -100.62 166.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.574 -177.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' N ' HG22 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -99.34 111.92 24.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.238 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.77 26.55 1.75 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.127 0.892 . . . . 0.0 112.304 -178.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -110.03 -47.45 3.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.692 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.0 mttp -135.11 118.13 16.38 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 174.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -43.19 90.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.439 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.2 t -137.92 112.62 9.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -78.38 119.64 22.0 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.547 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -102.92 -58.56 1.85 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.331 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.548 HG21 ' CB ' ' A' ' 75' ' ' LYS . 1.4 t -120.55 146.73 24.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.313 0.578 . . . . 0.0 111.916 -178.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -150.13 114.74 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.883 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 75' ' ' LYS . . . -121.89 156.41 33.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.14 126.75 10.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.635 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.4 p -56.76 -57.67 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 53' ' ' LEU . 3.0 tm? -58.82 -21.5 56.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -76.98 -55.08 5.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.074 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.16 -50.29 62.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.19 -33.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.18 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.734 HD11 ' HA ' ' A' ' 61' ' ' LYS . 6.5 tt -37.28 124.76 0.98 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.958 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.544 ' N ' HD23 ' A' ' 57' ' ' LEU . 3.3 tttm -131.96 -6.94 3.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.31 -107.2 1.53 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.521 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -56.45 106.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.734 ' HA ' HD11 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -82.9 -47.72 11.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.161 -179.718 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 95' ' ' GLY . 13.2 p -66.75 -38.0 85.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.981 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -54.18 -45.1 72.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.784 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' HB ' HD12 ' A' ' 57' ' ' LEU . 75.8 t -94.16 -20.83 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.65 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.039 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -43.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.109 0.48 . . . . 0.0 111.759 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -65.48 -59.08 4.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.532 0.682 . . . . 0.0 109.413 178.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 16.1 mt-30 -50.35 -23.66 2.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.473 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.039 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.61 -32.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.52 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -78.03 -29.88 52.86 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.227 -0.987 . . . . 0.0 110.9 178.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.16 -40.11 71.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -66.24 -40.31 90.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.011 HD21 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -63.76 -55.41 23.36 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.98 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -55.1 -24.93 28.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.04 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 2.0 tt0 -71.37 -37.51 71.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 18.2 mttt -71.82 -64.52 0.91 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.018 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.837 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.03 -41.02 7.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.536 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.729 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.6 mt -59.74 -40.18 87.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.243 178.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.26 -24.21 7.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.28 -28.06 20.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.236 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 110.08 13.27 16.02 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.532 HG22 ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -65.66 109.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 110.193 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' GLU . 11.6 tttm -93.58 -56.23 2.99 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.39 -178.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.471 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -112.93 151.1 30.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.272 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -135.33 161.53 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.509 0.671 . . . . 0.0 112.132 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 87.79 2.75 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 25' ' ' LEU . 19.9 t80 -80.7 108.33 14.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -176.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.37 98.58 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.685 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 7.3 tpt180 -90.42 11.66 20.89 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.467 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 90' ' ' PRO . . . 87.19 -113.94 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.147 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 2.3 Cg_endo -81.06 45.12 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.803 2.335 . . . . 0.0 112.122 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.469 ' CG ' ' HB3' ' A' ' 88' ' ' ARG . 3.2 m-85 -112.19 133.15 54.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 111.011 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -131.6 155.04 48.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 98' ' ' LYS . 1.3 t80 -33.06 94.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.864 0.364 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -103.82 -166.34 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -178.752 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.717 ' C ' ' HE2' ' A' ' 98' ' ' LYS . . . -76.18 -17.14 80.2 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.781 -0.645 . . . . 0.0 113.235 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' CB ' ' NE ' ' A' ' 29' ' ' ARG . 3.8 mmt85 -97.92 -64.55 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.484 ' O ' ' C ' ' A' ' 98' ' ' LYS . 13.6 t -28.84 -70.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -177.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.717 ' HE2' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -29.47 -60.18 0.15 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.223 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.666 ' N ' ' HG2' ' A' ' 98' ' ' LYS . . . -69.99 -46.89 64.19 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.398 -177.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' CD1' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -61.41 -47.69 84.64 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.814 0.816 . . . . 0.0 109.422 179.247 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.534 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -57.07 -40.36 76.72 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.64 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -62.58 -38.85 91.72 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -50.87 -59.34 8.15 Favored Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -60.89 -31.03 70.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.812 -1.194 . . . . 0.0 110.598 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.893 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 3.2 tpp85 -88.77 -25.52 22.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 4.7 pt-20 -82.7 -38.45 23.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.676 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -64.35 -46.35 90.86 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.638 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.729 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.81 -30.67 0.08 OUTLIER Glycine 0 C--N 1.341 0.835 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.556 178.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.57 146.56 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.471 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -128.32 99.7 5.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.127 178.328 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.721 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.064 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 tpp180 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.769 0.319 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.615 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -30.87 134.1 0.07 Allowed 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.356 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 13.6 ttp180 -93.36 124.5 37.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.908 -178.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.5 tt -89.66 145.99 24.85 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.255 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.802 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -150.38 119.06 6.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.212 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.775 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 54.8 t -101.29 139.99 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.863 0.363 . . . . 0.0 111.664 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HA ' ' OH ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -125.67 112.5 16.2 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.68 118.66 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.814 177.48 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -89.5 -78.88 0.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.55 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -131.58 -61.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.682 179.276 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -119.25 20.06 12.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.231 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.502 ' HA ' HD23 ' A' ' 53' ' ' LEU . 51.4 m170 -117.77 161.64 19.38 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.84 HD11 ' CD1' ' A' ' 100' ' ' LEU . 2.4 tp -151.37 128.05 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.939 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.61 ' OH ' HD11 ' A' ' 53' ' ' LEU . 29.4 m-85 -145.42 150.83 37.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.153 0.502 . . . . 0.0 111.8 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.847 ' HB3' HD13 ' A' ' 72' ' ' LEU . . . -132.67 121.11 22.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 113.13 24.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.187 0.518 . . . . 0.0 110.22 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -96.21 96.31 5.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' ASP . 1.5 mp -98.24 163.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.921 -177.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.574 ' HA ' HD22 ' A' ' 23' ' ' LEU . 5.5 t0 -96.9 109.31 22.06 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.574 177.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 18.2 p-10 -89.05 26.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.158 0.911 . . . . 0.0 112.273 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -110.67 -47.15 3.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mppp? -133.26 118.17 18.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 174.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.43 89.72 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.418 -177.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 43' ' ' LYS . 67.8 t -139.59 112.45 5.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -77.47 119.48 21.12 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -99.56 -59.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 1.9 t -121.91 146.17 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.344 0.592 . . . . 0.0 112.004 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 88.3 p -150.18 114.86 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.943 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.37 158.3 33.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.844 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -150.22 134.14 16.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.653 ' OG ' HD12 ' A' ' 57' ' ' LEU . 9.0 t -54.5 -45.3 73.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 111.053 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD11 ' OH ' ' A' ' 35' ' ' TYR . 4.5 pp -74.39 -7.86 54.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -69.09 -54.36 15.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.466 . . . . 0.0 111.401 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mp -52.52 -48.85 65.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.805 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.89 -33.1 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.639 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.653 HD12 ' OG ' ' A' ' 52' ' ' SER . 25.8 mt -49.39 176.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.5 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -123.47 -43.26 2.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.66 99.75 1.04 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.433 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -116.73 -41.19 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.983 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -176.3 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.483 HG21 ' C ' ' A' ' 95' ' ' GLY . 15.1 p -86.22 51.4 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 -49.1 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.614 HG21 ' CD1' ' A' ' 57' ' ' LEU . 93.8 t -93.87 -19.81 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.291 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -34.28 -38.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.794 -179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.628 0.728 . . . . 0.0 109.157 178.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 10.6 mt-30 -49.68 -24.11 2.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.299 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.03 -32.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -76.99 -31.77 51.91 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.242 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -71.42 -42.59 68.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -65.62 -38.02 88.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -65.48 -54.57 26.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.226 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -56.79 -24.22 48.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.938 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.27 -37.79 68.97 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 21.9 mttt -70.75 -67.12 0.53 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.095 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.825 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -43.6 -41.96 4.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.685 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.794 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -59.3 -40.52 86.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.052 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.53 -23.92 7.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.526 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.46 -27.97 20.01 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.129 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 109.38 14.31 14.88 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.273 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.526 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -70.77 106.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.556 0.693 . . . . 0.0 110.019 179.722 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' GLU . 5.0 tttp -93.17 -54.55 3.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.493 -178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -111.73 144.2 41.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.274 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -130.73 159.89 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.5 0.667 . . . . 0.0 112.028 -179.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.92 ' CE2' HD22 ' A' ' 25' ' ' LEU . 17.1 t80 -80.39 106.51 12.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.635 0.731 . . . . 0.0 112.548 -176.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.95 97.78 2.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.362 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.4 tpt85 -83.55 -7.07 59.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.52 -110.21 2.0 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.24 34.94 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.021 2.48 . . . . 0.0 112.092 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 88' ' ' ARG . 2.9 m-30 -77.1 138.28 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.823 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 93' ' ' TYR . 9.4 tptt -121.28 99.49 6.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.796 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.555 ' C ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER 0.61 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.676 0.61 . . . . 0.0 112.236 -179.313 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -116.77 163.55 15.98 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.338 -179.301 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' C ' HG21 ' A' ' 62' ' ' THR . . . -39.53 -60.64 1.69 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.55 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.421 ' HB2' ' CD ' ' A' ' 29' ' ' ARG . 33.6 mmt180 -47.72 -69.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.675 0.274 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.6 t -33.98 -38.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.809 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -62.64 -79.06 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.607 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -55.9 -34.45 65.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.542 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.84 ' CD1' HD11 ' A' ' 34' ' ' ILE . 3.8 tt -68.17 -51.83 41.37 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.297 0.57 . . . . 0.0 110.969 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -62.38 -29.63 70.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.671 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.798 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -69.02 -44.95 71.69 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.33 -57.66 7.96 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -62.25 -33.67 75.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.534 -1.333 . . . . 0.0 110.875 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 -22.84 23.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.884 0.373 . . . . 0.0 110.914 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.798 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -85.2 -34.87 21.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.41 -44.63 63.98 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.655 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.794 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.14 -31.03 0.08 OUTLIER Glycine 0 C--N 1.341 0.828 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.632 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.4 mp -71.42 147.01 48.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.4 mp0 -128.32 96.71 4.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.412 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 3.1 p90 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.842 0.353 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -43.32 125.06 3.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.843 -179.401 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -94.83 122.73 37.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.501 -178.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 26' ' ' SER . 2.7 tt -89.43 143.02 27.14 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.518 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.806 ' N ' HD23 ' A' ' 25' ' ' LEU . 1.3 m -146.23 108.55 4.44 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.008 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 6.7 p -97.03 119.23 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.321 0.582 . . . . 0.0 112.132 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.3 t80 -105.62 140.84 38.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.702 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 10.2 ptt85 -150.46 126.32 10.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.782 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 t -89.65 -85.78 0.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.924 -179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.87 -58.28 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.002 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.47 19.24 13.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.336 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -119.04 156.92 28.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.905 HD11 HD13 ' A' ' 100' ' ' LEU . 2.7 tp -142.76 132.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.115 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' HD21 ' A' ' 53' ' ' LEU . 39.1 m-85 -149.55 149.97 31.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 111.963 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . . . -133.74 128.4 34.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG2' HD11 ' A' ' 39' ' ' ILE . 2.1 tt0 -117.24 113.26 21.94 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.722 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -99.55 99.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.32 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.0 mp -104.32 160.05 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.794 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.699 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.0 t0 -91.36 114.19 26.65 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.51 22.74 2.85 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.077 0.861 . . . . 0.0 112.508 -178.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.67 -48.92 3.42 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -131.65 118.01 19.45 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 174.503 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.06 90.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.341 -177.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 43' ' ' LYS . 60.2 t -136.1 112.58 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -77.87 118.48 20.23 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 47' ' ' LEU . 1.1 mp -103.67 -50.85 3.32 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.859 HG21 ' HB2' ' A' ' 75' ' ' LYS . 2.0 t -126.86 142.59 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.442 0.639 . . . . 0.0 112.385 -178.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 80.8 p -150.08 115.01 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.498 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.607 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -126.0 161.78 26.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -150.32 127.06 10.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 179.527 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 68' ' ' VAL . 10.3 m -56.96 -26.93 60.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD21 ' CE1' ' A' ' 35' ' ' TYR . 2.9 pp -75.12 -39.51 60.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.02 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.55 69.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.3 mp -92.17 11.34 25.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.032 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' A' ' 55' ' ' LEU . 1.4 tptp 2.35 63.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.443 0.697 . . . . 0.0 112.618 -178.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.939 HD12 HG11 ' A' ' 64' ' ' VAL . 8.5 mt -79.08 176.08 9.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 61.84 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.4 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.42 -160.21 9.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.543 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.91 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.353 . . . . 0.0 110.96 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.05 -77.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.23 -23.98 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -38.56 71.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.939 HG11 HD12 ' A' ' 57' ' ' LEU . 79.2 t -93.99 -24.33 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.469 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.078 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.18 -40.93 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.961 0.41 . . . . 0.0 111.748 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -67.06 -60.36 2.69 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.385 0.612 . . . . 0.0 109.376 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.527 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.0 mt-30 -48.66 -27.04 2.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.194 178.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.078 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -74.63 -35.99 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.57 178.616 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -75.38 -36.93 43.01 Favored Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.068 178.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -62.14 -35.72 79.63 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -67.27 -45.93 75.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.067 178.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.659 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.5 mt -63.55 -53.95 43.8 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.666 0.746 . . . . 0.0 109.019 178.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.991 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -57.91 -25.75 61.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.905 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -76.66 -26.92 55.37 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.108 178.183 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.859 ' HB2' HG21 ' A' ' 48' ' ' VAL . 27.2 mttm -82.9 -63.01 1.45 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.536 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.841 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -45.57 -42.6 11.24 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.02 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 107' ' ' GLY . 10.6 mt -55.84 -40.15 72.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.127 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -52.63 -24.98 9.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.04 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.596 HD12 HG12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.52 -28.29 19.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.32 15.43 11.49 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.352 -179.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -66.52 106.21 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.519 0.676 . . . . 0.0 110.192 179.865 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.17 -56.78 3.03 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.165 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.435 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -113.73 144.72 42.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.261 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.16 161.7 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.651 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -104.85 103.28 12.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.999 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.762 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -81.56 108.42 15.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.124 0.487 . . . . 0.0 111.592 -179.078 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.41 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -129.24 45.81 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.115 179.486 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 1.3 ptt180 -41.53 -33.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.611 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.45 -117.96 5.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -88.74 20.07 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.771 2.314 . . . . 0.0 112.705 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 3.2 m-85 -80.92 138.74 36.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 0.0 111.214 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.02 151.34 25.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.348 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE1' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -47.6 106.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.649 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.32 164.57 18.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -44.85 -42.6 7.87 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.134 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HD2' HD13 ' A' ' 34' ' ' ILE . 1.1 mtt-85 -57.89 -70.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 0.0 110.668 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.0 t -37.45 -40.49 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.952 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.91 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.867 0.365 . . . . 0.0 110.906 -179.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' ' HA ' ' A' ' 66' ' ' ARG . . . -57.62 -35.36 70.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.699 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.905 HD13 HD11 ' A' ' 34' ' ' ILE . 3.4 tt -67.34 -49.6 63.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.084 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 97' ' ' VAL . . . -61.17 -29.57 69.87 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.172 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.854 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -69.88 -44.26 70.16 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.369 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.77 -56.96 9.05 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -64.87 -31.43 72.66 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 113.578 -1.311 . . . . 0.0 111.013 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -89.97 -25.7 20.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.022 0.439 . . . . 0.0 110.726 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.1 pt-20 -80.48 -37.66 31.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.68 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -66.8 -48.32 62.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.493 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 177.01 -29.16 0.07 OUTLIER Glycine 0 C--N 1.343 0.949 0 C-N-CA 119.905 -1.14 . . . . 0.0 115.023 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD11 ' HB3' ' A' ' 76' ' ' ALA . 6.5 mp -71.48 146.54 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 83' ' ' GLN . 1.2 mp0 -128.24 96.31 4.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.379 178.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.708 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.004 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.796 0.331 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.684 HD13 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -121.25 132.18 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.831 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 23.1 ttp85 -102.71 126.82 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.176 -179.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.941 HD23 ' N ' ' A' ' 26' ' ' SER . 5.3 tt -89.74 147.15 24.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.818 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.941 ' N ' HD23 ' A' ' 25' ' ' LEU . 2.1 m -139.16 158.58 43.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.581 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -146.09 127.45 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.967 0.413 . . . . 0.0 110.265 179.219 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -128.68 122.49 30.91 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.912 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 96' ' ' ARG . 3.4 ptt-85 -130.81 123.55 29.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.639 178.01 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.09 -91.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.833 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.39 -64.76 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.111 0.482 . . . . 0.0 109.829 179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 27.99 8.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.794 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -119.69 161.87 19.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.439 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 96' ' ' ARG . 3.5 tp -149.34 128.23 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.513 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.534 ' O ' HG22 ' A' ' 27' ' ' VAL . 27.4 m-85 -144.02 160.15 41.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.312 0.577 . . . . 0.0 111.839 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -145.77 126.97 14.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.006 177.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -115.33 113.18 23.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 110.679 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.2 92.34 3.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.575 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 40' ' ' ASP . 2.0 mp -96.58 161.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -94.53 115.44 27.6 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.826 177.953 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 6.7 t0 -92.42 28.67 1.89 Allowed 'General case' 0 N--CA 1.464 0.239 0 O-C-N 124.289 0.993 . . . . 0.0 112.22 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.45 -47.72 3.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.1 mptt -136.78 118.25 14.77 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 174.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.37 89.16 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.545 -177.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 43' ' ' LYS . 92.8 t -137.43 112.61 10.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.194 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -74.86 119.26 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 79' ' ' LEU . 1.8 mp -98.23 -63.63 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.48 HG13 ' HD3' ' A' ' 75' ' ' LYS . 2.2 t -120.23 147.51 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.402 0.62 . . . . 0.0 112.4 -178.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 53.4 p -150.27 129.44 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.82 179.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -141.75 157.61 44.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.494 . . . . 0.0 112.32 -179.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -150.39 129.19 12.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.515 179.594 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.45 ' N ' HG21 ' A' ' 68' ' ' VAL . 48.1 m -53.84 -25.13 18.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 53' ' ' LEU . 2.7 tm? -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.77 -28.4 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.115 0.483 . . . . 0.0 110.411 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' LEU . 3.6 mp -91.28 10.74 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.306 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 1.66 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.137 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.931 HD12 HG11 ' A' ' 64' ' ' VAL . 12.6 mt -79.26 176.04 10.04 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.723 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -93.04 69.8 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.811 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.4 -136.41 2.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.582 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.1 t-20 -140.33 -168.09 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.931 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.966 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 p -75.8 -25.14 56.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -40.42 72.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.138 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.931 HG11 HD12 ' A' ' 57' ' ' LEU . 73.2 t -94.06 -23.14 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.642 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.074 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -32.33 -41.66 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.735 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.01 -60.82 2.46 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.475 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.4 mt-30 -48.14 -26.19 1.78 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.241 177.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.074 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -77.49 -34.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.586 178.597 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' HA2' HD12 ' A' ' 72' ' ' LEU . . . -76.51 -31.33 54.68 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -67.94 -34.96 77.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.943 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' LYS . . . -72.52 -41.48 65.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.151 177.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.795 ' HG ' ' HB3' ' A' ' 50' ' ' ALA . 5.1 mt -63.68 -46.33 86.02 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.91 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -68.32 -27.18 66.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -67.43 -37.16 82.58 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 109.298 178.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 71' ' ' ALA . 3.2 mttt -81.34 -63.96 1.29 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.068 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -41.21 -42.34 2.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.135 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.7 mt -61.15 -40.33 93.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.963 179.4 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . -52.9 -22.57 5.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.23 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.599 HD13 HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -89.17 -27.09 20.92 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.028 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . 108.33 17.08 11.05 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.068 -179.017 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.684 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -70.84 103.91 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 121.694 0.759 . . . . 0.0 110.312 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLU . 10.2 ttpt -95.75 -46.71 6.48 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.07 -178.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 140.63 52.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.379 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -127.89 167.45 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.473 0.654 . . . . 0.0 111.975 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -103.74 105.17 15.31 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.752 ' HE1' HD22 ' A' ' 25' ' ' LEU . 1.6 t80 -80.67 106.24 12.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.823 0.82 . . . . 0.0 112.597 -177.291 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.41 105.46 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.257 -1.338 . . . . 0.0 107.834 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -90.39 -48.06 7.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.675 -178.029 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.3 -112.48 2.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.163 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -90.16 26.84 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.834 2.356 . . . . 0.0 112.59 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 m-30 -99.66 162.54 12.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.127 0.489 . . . . 0.0 111.368 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -132.01 148.07 52.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.886 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -44.61 103.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.609 -179.858 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.06 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.142 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.31 -42.51 25.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.129 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.451 ' HB3' HD13 ' A' ' 34' ' ' ILE . 12.8 mmt-85 -56.27 -71.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.537 0.208 . . . . 0.0 110.985 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -39.46 -43.12 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.742 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -58.04 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.041 0.448 . . . . 0.0 111.067 -179.643 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -57.36 -36.84 71.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.213 -179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 36' ' ' ALA . 1.2 tt -68.32 -49.11 62.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 110.82 -179.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.583 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -58.65 -32.99 69.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.333 -178.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.74 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -68.75 -47.83 65.28 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.599 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -47.04 -58.32 6.37 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 177.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.91 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -58.36 -42.55 87.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.363 -1.419 . . . . 0.0 111.354 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.871 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -79.55 -53.77 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.8 pt-20 -48.35 -41.25 28.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.258 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.665 ' O ' HD11 ' A' ' 77' ' ' LEU . . . -65.14 -49.58 61.35 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.842 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.748 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 178.66 -27.89 0.06 OUTLIER Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.16 -1.019 . . . . 0.0 114.522 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.871 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.1 mp -71.5 147.73 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LYS . 1.2 mp0 -128.35 91.91 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 178.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.9 p90 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.011 -179.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.875 0.369 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.755 HD13 HG13 ' A' ' 81' ' ' ILE . 1.1 mp -126.64 134.99 50.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' H ' ' A' ' 85' ' ' ALA . 5.6 ttp180 -105.28 124.64 49.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.771 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.813 HD22 ' CE1' ' A' ' 86' ' ' PHE . 2.1 tt -90.54 143.02 27.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.257 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.774 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -145.14 110.17 5.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.165 -179.816 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 2.2 p -100.83 123.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.072 0.463 . . . . 0.0 111.921 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.504 ' HB2' HH21 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -100.5 154.24 18.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 112.316 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HD3' ' HB2' ' A' ' 96' ' ' ARG . 18.1 mtm105 -150.29 118.81 6.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.32 179.133 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 -45.28 9.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.054 0.454 . . . . 0.0 110.994 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 tp 179.89 -63.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -115.29 22.2 13.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.285 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.435 ' CD2' ' HG ' ' A' ' 53' ' ' LEU . 29.6 m80 -122.2 173.15 7.77 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.958 -179.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 100' ' ' LEU . 5.2 tp -158.4 132.69 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 30.8 m-85 -148.21 148.69 30.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 100' ' ' LEU . . . -134.23 121.29 21.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.876 177.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -111.76 112.88 24.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD13 ' HG ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -98.31 105.3 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.106 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 40' ' ' ASP . 3.8 mp -108.26 160.08 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -88.83 116.33 27.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.831 178.109 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 23' ' ' LEU . 29.4 t0 -91.74 22.38 4.18 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.415 1.072 . . . . 0.0 112.256 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.04 -46.67 3.43 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.8 mmmt -133.16 118.31 18.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 174.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.56 86.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 43' ' ' LYS . 61.7 t -134.89 112.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 m -72.4 113.87 9.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.644 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -89.9 -57.29 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.713 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG23 HD21 ' A' ' 79' ' ' LEU . 2.3 t -131.62 152.76 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.234 0.54 . . . . 0.0 111.902 -178.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -150.31 119.61 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.934 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 72' ' ' LEU . . . -129.66 148.56 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 112.128 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.669 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -150.39 139.97 21.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.641 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.426 ' H ' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -50.96 -67.41 0.25 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 111.469 -179.737 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -58.22 -9.69 1.61 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . -69.05 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.032 0.444 . . . . 0.0 111.668 -179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mp -52.59 -51.95 57.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.639 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tttt 177.5 -37.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.137 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -83.36 117.62 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.704 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HA ' ' CB ' ' A' ' 53' ' ' LEU . 17.0 tttm -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.847 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.63 106.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.699 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.22 -30.03 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.621 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.04 -161.73 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.381 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -86.73 48.97 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -94.23 -55.01 3.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 67' ' ' GLN . 63.9 t -94.03 -18.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.924 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.007 ' O ' HG12 ' A' ' 68' ' ' VAL . . . -31.11 -42.53 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 111.95 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -66.03 -60.41 2.86 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.584 0.707 . . . . 0.0 109.205 178.648 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 25.2 mt-30 -49.18 -24.14 1.59 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.368 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.007 HG12 ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -81.17 -32.37 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.268 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -77.44 -26.82 60.57 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.276 178.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 7.5 ppt_? -77.31 -38.45 50.55 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.346 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.37 72.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.77 ' CD1' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.21 -52.12 17.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.981 178.428 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . . . -62.85 -23.67 67.41 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.532 178.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 42.7 mt-10 -77.79 -30.04 51.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB3' HG21 ' A' ' 48' ' ' VAL . 16.5 mttt -73.82 -68.29 0.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.416 177.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 109' ' ' LEU . . . -44.45 -42.44 7.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.104 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 108' ' ' GLY . 10.8 mt -57.12 -38.89 74.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.823 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . -54.55 -23.07 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.932 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.903 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.72 18.97 9.53 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.109 -178.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.41 104.93 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.559 0.695 . . . . 0.0 110.356 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 110' ' ' GLU . 4.1 tttt -90.99 -57.22 2.88 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.372 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.91 146.91 35.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.421 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -133.83 165.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.5 0.667 . . . . 0.0 112.023 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 24' ' ' ARG . . . -108.38 97.3 7.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.324 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.813 ' CE1' HD22 ' A' ' 25' ' ' LEU . 5.3 t80 -81.12 109.68 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.28 86.48 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.651 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 27' ' ' VAL . 6.0 tpt180 -77.66 -27.7 50.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.046 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.29 -109.31 1.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.226 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.19 34.2 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.823 2.348 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 28' ' ' PHE . 2.7 m-85 -96.34 138.11 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.124 0.488 . . . . 0.0 111.558 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 149.54 30.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.932 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.511 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -45.51 97.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.779 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 1.5 t-160 -110.5 159.11 17.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.459 -179.308 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -40.17 -51.44 3.55 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.492 -179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HB3' HD13 ' A' ' 34' ' ' ILE . 2.4 mtt-85 -55.0 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.636 0.255 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 21.9 t -40.28 -38.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.273 179.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -61.16 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.012 0.434 . . . . 0.0 110.592 -179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' ALA . . . -54.73 -36.08 64.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.99 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 34' ' ' ILE . 1.3 tt -70.35 -52.68 20.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.204 0.526 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.6 ' N ' HD23 ' A' ' 100' ' ' LEU . . . -56.41 -32.32 64.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.319 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.794 ' O ' ' N ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -69.6 -44.6 70.39 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.043 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 106' ' ' GLU . . . -48.79 -57.09 8.92 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . . . -61.78 -33.69 74.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.49 -1.355 . . . . 0.0 110.93 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.86 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 1.5 tpp85 -88.97 -24.11 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.951 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.794 ' N ' ' O ' ' A' ' 102' ' ' GLU . 5.6 pt-20 -83.6 -34.94 25.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 73' ' ' ALA . . . -69.3 -45.35 61.41 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.921 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 77' ' ' LEU . . . 176.03 -30.64 0.08 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.178 -1.011 . . . . 0.0 114.454 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.86 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 6.2 mp -71.36 142.81 50.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.193 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 2.0 mp0 -127.7 99.8 5.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.066 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.659 ' HZ ' ' HB3' ' A' ' 104' ' ' ALA . 2.1 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.091 -178.607 . . . . . . . . 1 1 . 1 stop_ save_